Nfe2l2 | Rat | (+)-albicanol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | albicanol inhibits the reaction [Galactose results in decreased expression of NFE2L2 mRNA] and albicanol inhibits the reaction [Galactose results in decreased expression of NFE2L2 protein] | CTD | PMID:33761044 |
Nfe2l2 | Rat | (+)-alpha-viniferin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 protein results in increased expression of HMOX1] affects the reaction [alpha-viniferin results in decreased susceptibility to Lipopolysaccharides] more ... | CTD | PMID:24859013 |
Nfe2l2 | Rat | (+)-alpha-viniferin | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to alpha-viniferin | CTD | PMID:24859013 |
Nfe2l2 | Rat | (+)-beta-thujone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFE2L2 mRNA | CTD | PMID:38000518 |
Nfe2l2 | Rat | (+)-catechin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Catechin results in increased expression of NFE2L2 protein | CTD | PMID:16799064 |
Nfe2l2 | Rat | (+)-epicatechin-3-O-gallate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein and BMAL1 protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein] | CTD | PMID:29061316 |
Nfe2l2 | Rat | (+)-isoborneol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | isoborneol inhibits the reaction [Ceruletide results in decreased expression of NFE2L2 protein] | CTD | PMID:33166053 |
Nfe2l2 | Rat | (+)-pilocarpine | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Pilocarpine results in increased expression of NFE2L2 protein | CTD | PMID:32234387 |
Nfe2l2 | Rat | (+)-schisandrin B | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | schizandrin B affects the localization of NFE2L2 protein | CTD | PMID:21250784 |
Nfe2l2 | Rat | (+)-schisandrin B | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Benzo(a)pyrene co-treated with schizandrin B] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:25946486 |
Nfe2l2 | Rat | (+)-taxifolin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | taxifolin results in increased expression of NFE2L2 protein | CTD | PMID:16799064 |
Nfe2l2 | Rat | (+)-taxifolin | multiple interactions | EXP | | 6480464 | alogliptin promotes the reaction [taxifolin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of NFE2L2 protein]] more ... | CTD | PMID:33840231 more ... |
Nfe2l2 | Rat | (+)-taxifolin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Chlorpyrifos inhibits the reaction [taxifolin results in decreased expression of NFE2L2 protein] | CTD | PMID:31152760 |
Nfe2l2 | Rat | (+)-taxifolin | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | taxifolin results in decreased expression of NFE2L2 protein | CTD | PMID:31152760 |
Nfe2l2 | Rat | (+)-trans-(S)-allethrin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | bioallethrin results in increased expression of NFE2L2 protein | CTD | PMID:35511042 |
Nfe2l2 | Rat | (+)-trans-(S)-allethrin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Vitamin E inhibits the reaction [bioallethrin results in increased expression of NFE2L2 protein] | CTD | PMID:35511042 |
Nfe2l2 | Rat | (-)-ephedrine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ephedrine inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein] | CTD | PMID:37778983 |
Nfe2l2 | Rat | (-)-epigallocatechin 3-gallate | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | epigallocatechin gallate results in increased expression of NFE2L2 mRNA and epigallocatechin gallate results in increased expression of NFE2L2 protein | CTD | PMID:16799064 and PMID:29572906 |
Nfe2l2 | Rat | (-)-epigallocatechin 3-gallate | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | epigallocatechin gallate results in decreased expression of NFE2L2 protein | CTD | PMID:35218280 |
Nfe2l2 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] which co-treated with epigallocatechin gallate] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:30395894 more ... |
Nfe2l2 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein more ... | CTD | PMID:29061316 and PMID:29572906 |
Nfe2l2 | Rat | (-)-epigallocatechin 3-gallate | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | epigallocatechin gallate affects the localization of NFE2L2 protein | CTD | PMID:25585349 |
Nfe2l2 | Rat | (-)-epigallocatechin 3-gallate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | epigallocatechin gallate results in increased expression of NFE2L2 mRNA | CTD | PMID:25585349 |
Nfe2l2 | Rat | (-)-selegiline | multiple interactions | EXP | | 6480464 | NFE2L2 mutant form inhibits the reaction [Selegiline inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased activity of NQO1 protein]] more ... | CTD | PMID:22019741 |
Nfe2l2 | Rat | (-)-selegiline | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Selegiline inhibits the reaction [Smoke analog affects the localization of NFE2L2 protein] | CTD | PMID:28108387 |
Nfe2l2 | Rat | (-)-selegiline | increases localization | EXP | | 6480464 | Selegiline results in increased localization of NFE2L2 protein | CTD | PMID:22019741 |
Nfe2l2 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NFE2L2 mRNA | CTD | PMID:36331819 |
Nfe2l2 | Rat | (E)-cinnamyl alcohol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA promotes the reaction [cinnamyl alcohol results in increased expression of HMOX1 mRNA] | CTD | PMID:26244607 |
Nfe2l2 | Rat | (R)-camphor | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFE2L2 mRNA | CTD | PMID:38000518 |
Nfe2l2 | Rat | (R)-carnitine | multiple interactions | EXP | | 6480464 | Carnitine inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 protein] | CTD | PMID:37312617 |
Nfe2l2 | Rat | (R)-linalyl acetate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFE2L2 mRNA | CTD | PMID:38000518 |
Nfe2l2 | Rat | (R)-lipoic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Paraquat co-treated with Thioctic Acid] results in increased expression of and affects the localization of NFE2L2 protein more ... | CTD | PMID:17197552 more ... |
Nfe2l2 | Rat | (R)-lipoic acid | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Thioctic Acid affects the localization of NFE2L2 protein | CTD | PMID:30758914 |
Nfe2l2 | Rat | (R)-lipoic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Thioctic Acid results in increased expression of NFE2L2 mRNA and Thioctic Acid results in increased expression of NFE2L2 protein | CTD | PMID:23649336 more ... |
Nfe2l2 | Rat | (R)-lipoic acid | increases expression | EXP | | 6480464 | Thioctic Acid results in increased expression of NFE2L2 protein | CTD | PMID:20237067 |
Nfe2l2 | Rat | (R)-lipoic acid | increases activity | EXP | | 6480464 | Thioctic Acid results in increased activity of NFE2L2 protein | CTD | PMID:20237067 |
Nfe2l2 | Rat | (R)-lipoic acid | multiple interactions | EXP | | 6480464 | [Thioctic Acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA more ... | CTD | PMID:20237067 more ... |
Nfe2l2 | Rat | (R)-lipoic acid | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Thioctic Acid results in decreased expression of NFE2L2 mRNA and Thioctic Acid results in decreased expression of NFE2L2 protein | CTD | PMID:22488045 |
Nfe2l2 | Rat | (R)-lipoic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Thioctic Acid co-treated with cyanoginosin LR] results in increased expression of NFE2L2 protein more ... | CTD | PMID:22488045 more ... |
Nfe2l2 | Rat | (R)-noradrenaline | increases expression | EXP | | 6480464 | Norepinephrine results in increased expression of NFE2L2 mRNA | CTD | PMID:14618266 |
Nfe2l2 | Rat | (R,R,R)-alpha-tocopherol | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] more ... | CTD | PMID:22389237 more ... |
Nfe2l2 | Rat | (R,R,R)-alpha-tocopherol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with alpha-Tocopherol co-treated with ferulic acid] promotes the reaction [[Ozone co-treated with Oxygen] results in increased localization of NFE2L2 protein] and alpha-Tocopherol promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein] | CTD | PMID:26270818 and PMID:36058301 |
Nfe2l2 | Rat | (S)-colchicine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [dihydroactinidiolide co-treated with Colchicine] results in increased expression of NFE2L2 mRNA | CTD | PMID:33617922 |
Nfe2l2 | Rat | (S)-colchicine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Colchicine inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFE2L2 mRNA] and Colchicine inhibits the reaction [Carbon Tetrachloride results in increased expression of NFE2L2 protein] | CTD | PMID:37573684 and PMID:38348705 |
Nfe2l2 | Rat | (S)-duloxetine hydrochloride | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Duloxetine Hydrochloride affects the localization of NFE2L2 protein | CTD | PMID:29134401 |
Nfe2l2 | Rat | (S)-naringenin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [naringenin co-treated with Paraquat] results in increased expression of NFE2L2 protein more ... | CTD | PMID:24561720 and PMID:31254498 |
Nfe2l2 | Rat | (S)-naringenin | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | naringenin results in increased activity of NFE2L2 protein | CTD | PMID:31254498 |
Nfe2l2 | Rat | (S)-naringenin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | naringenin results in increased expression of NFE2L2 mRNA | CTD | PMID:24561720 |
Nfe2l2 | Rat | (S)-ropivacaine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Ropivacaine results in increased susceptibility to Cisplatin] which results in decreased expression of NFE2L2 protein more ... | CTD | PMID:36858639 and PMID:39053794 |
Nfe2l2 | Rat | (Z)-ligustilide | decreases methylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | ligustilide results in decreased methylation of NFE2L2 promoter | CTD | PMID:23441843 |
Nfe2l2 | Rat | (Z)-ligustilide | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to ligustilide | CTD | PMID:30243965 |
Nfe2l2 | Rat | (Z)-ligustilide | increases methylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | ligustilide results in increased methylation of NFE2L2 promoter | CTD | PMID:30243965 |
Nfe2l2 | Rat | (Z)-ligustilide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | ligustilide results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:30243965 |
Nfe2l2 | Rat | 1,1'-azobis(N,N-dimethylformamide) | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Diamide | CTD | PMID:19303893 |
Nfe2l2 | Rat | 1,2,3-Trichloropropane | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | 1,2-dibromoethane | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ethylene Dibromide results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | 1,2-dichloroethane | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of NFE2L2 mRNA and ethylene dichloride results in increased expression of NFE2L2 protein | CTD | PMID:30664321 and PMID:37150348 |
Nfe2l2 | Rat | 1,2-dichloroethane | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [ethylene dichloride co-treated with Ethanol] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:30664321 and PMID:37150348 |
Nfe2l2 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:22206623 and PMID:26388957 |
Nfe2l2 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of NFE2L2 mRNA | CTD | PMID:22206623 |
Nfe2l2 | Rat | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of NFE2L2 protein | CTD | PMID:30720227 and PMID:32028820 |
Nfe2l2 | Rat | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 more ... | CTD | PMID:30720227 and PMID:32028820 |
Nfe2l2 | Rat | 1,2-dimethylhydrazine | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to 1 more ... | CTD | PMID:26388957 |
Nfe2l2 | Rat | 1,2-naphthoquinone | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to 1 more ... | CTD | PMID:19303893 and PMID:21384861 |
Nfe2l2 | Rat | 1,2-naphthoquinone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1 and 2-naphthoquinone results in increased expression of NFE2L2 mRNA | CTD | PMID:26862668 |
Nfe2l2 | Rat | 1,2-naphthoquinone | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 and 2-naphthoquinone results in increased activity of NFE2L2 protein | CTD | PMID:21384861 more ... |
Nfe2l2 | Rat | 1,2-naphthoquinone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to 1 and 2-naphthoquinone] | CTD | PMID:20932822 |
Nfe2l2 | Rat | 1,3-dichloropropan-2-ol | increases expression | EXP | | 6480464 | 1 and 3-dichloro-2-propanol results in increased expression of NFE2L2 protein | CTD | PMID:26143167 |
Nfe2l2 | Rat | 1,3-dichloropropan-2-ol | multiple interactions | EXP | | 6480464 | Dimethyl Fumarate inhibits the reaction [1 and 3-dichloro-2-propanol results in decreased expression of NFE2L2 protein] | CTD | PMID:36000575 |
Nfe2l2 | Rat | 1,3-dichloropropan-2-ol | decreases expression | EXP | | 6480464 | 1 and 3-dichloro-2-propanol results in decreased expression of NFE2L2 protein | CTD | PMID:36000575 |
Nfe2l2 | Rat | 1,3-dichloropropan-2-ol | affects binding | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1 and 3-dichloro-2-propanol binds to NFE2L2 protein | CTD | PMID:35870111 |
Nfe2l2 | Rat | 1,4,7-triazonane | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:32869927 |
Nfe2l2 | Rat | 1,4-benzoquinone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | quinone results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein | CTD | PMID:25437431 |
Nfe2l2 | Rat | 1,4-benzoquinone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | quinone results in increased expression of NFE2L2 mRNA | CTD | PMID:26862668 |
Nfe2l2 | Rat | 1,4-benzoquinone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA affects the reaction [quinone results in increased expression of GSS protein] more ... | CTD | PMID:21059386 and PMID:28645578 |
Nfe2l2 | Rat | 1,4-dichlorobenzene | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 4-dichlorobenzene results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | 1,4-dithiothreitol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Dithiothreitol inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein] | CTD | PMID:24489685 |
Nfe2l2 | Rat | 1,4-naphthoquinone | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to 1 and 4-naphthoquinone | CTD | PMID:31166132 |
Nfe2l2 | Rat | 1,4-naphthoquinone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1 and 4-naphthoquinone results in increased expression of NFE2L2 mRNA | CTD | PMID:26862668 |
Nfe2l2 | Rat | 1,4-phenylenediamine | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 4-phenylenediamine results in increased expression of NFE2L2 protein | CTD | PMID:19033392 |
Nfe2l2 | Rat | 1,4-phenylenediamine | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 4-phenylenediamine results in decreased expression of NFE2L2 mRNA | CTD | PMID:31967339 |
Nfe2l2 | Rat | 1,4-phenylenediamine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA promotes the reaction [4-phenylenediamine results in increased expression of HMOX1 mRNA] | CTD | PMID:26244607 |
Nfe2l2 | Rat | 1,8-cineole | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFE2L2 mRNA | CTD | PMID:38000518 |
Nfe2l2 | Rat | 1-Amino-2,4-dibromoanthraquinone | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1-amino-2 and 4-dibromoanthraquinone results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | 1-benzofuran | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | benzofuran results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | 1-bromopropane | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 promotes the reaction [1-bromopropane results in increased expression of GCLC mRNA] more ... | CTD | PMID:20211940 |
Nfe2l2 | Rat | 1-bromopropane | decreases expression | EXP | | 6480464 | 1-bromopropane results in decreased expression of NFE2L2 mRNA | CTD | PMID:27452781 |
Nfe2l2 | Rat | 1-bromopropane | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in decreased susceptibility to 1-bromopropane | CTD | PMID:20211940 |
Nfe2l2 | Rat | 1-chloro-2,4-dinitrobenzene | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Dinitrochlorobenzene results in increased expression of NFE2L2 protein] more ... | CTD | PMID:19033392 more ... |
Nfe2l2 | Rat | 1-chloro-2,4-dinitrobenzene | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in decreased expression of NFE2L2 mRNA | CTD | PMID:31967339 |
Nfe2l2 | Rat | 1-chloro-2,4-dinitrobenzene | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dinitrochlorobenzene results in decreased expression of NFE2L2 mRNA | CTD | PMID:34651546 |
Nfe2l2 | Rat | 1-chloro-2,4-dinitrobenzene | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dinitrochlorobenzene affects the expression of NFE2L2 protein | CTD | PMID:28219650 |
Nfe2l2 | Rat | 1-chloro-2,4-dinitrobenzene | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in increased expression of NFE2L2 protein | CTD | PMID:19033392 more ... |
Nfe2l2 | Rat | 1-chloro-2,4-dinitrobenzene | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Dinitrochlorobenzene and NFE2L2 affects the susceptibility to Dinitrochlorobenzene | CTD | PMID:19303893 and PMID:23564646 |
Nfe2l2 | Rat | 1-chloro-2,4-dinitrobenzene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dinitrochlorobenzene affects the localization of and results in increased activity of NFE2L2 protein more ... | CTD | PMID:18785192 more ... |
Nfe2l2 | Rat | 1-fluoro-2,4-dinitrobenzene | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Dinitrofluorobenzene results in increased expression of NFE2L2 protein | CTD | PMID:19427879 and PMID:26022718 |
Nfe2l2 | Rat | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to 1-Methyl-4-phenyl-1 more ... | CTD | PMID:22746536 |
Nfe2l2 | Rat | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:24991814 more ... |
Nfe2l2 | Rat | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1-Methyl-4-phenyl-1 more ... | CTD | PMID:24991814 more ... |
Nfe2l2 | Rat | 1-naphthyl isothiocyanate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of NFE2L2 protein more ... | CTD | PMID:19181614 more ... |
Nfe2l2 | Rat | 1-naphthyl isothiocyanate | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of NFE2L2 mRNA | CTD | PMID:37348807 |
Nfe2l2 | Rat | 1-naphthyl isothiocyanate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of NFE2L2 protein | CTD | PMID:36008890 |
Nfe2l2 | Rat | 1-naphthyl isothiocyanate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of NFE2L2 mRNA | CTD | PMID:27344345 |
Nfe2l2 | Rat | 1-nitropyrene | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1-nitropyrene results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein | CTD | PMID:28633978 |
Nfe2l2 | Rat | 1-octadec-9-enoylglycero-3-phosphate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | LPAR1 protein affects the reaction [lysophosphatidic acid results in increased stability of and affects the localization of NFE2L2 protein] and lysophosphatidic acid results in increased stability of and affects the localization of NFE2L2 protein | CTD | PMID:25398768 |
Nfe2l2 | Rat | 1-octadec-9-enoylglycero-3-phosphate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[ONO-8430506 results in decreased activity of ENPP2 protein] which results in decreased abundance of lysophosphatidic acid] which results in decreased expression of NFE2L2 | CTD | PMID:25398768 |
Nfe2l2 | Rat | 1-tert-Butoxy-2-propanol | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | propylene glycol mono-t-butyl ether results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | 13,14-dihydro-Delta(12)-prostaglandin J2 | multiple interactions | EXP | | 6480464 | NFE2L2 protein affects the reaction [9-deoxy-9 more ... | CTD | PMID:22982731 |
Nfe2l2 | Rat | 15-deoxy-Delta(12,14)-prostaglandin J2 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 15-deoxy-delta(12 more ... | CTD | PMID:19136476 and PMID:21728338 |
Nfe2l2 | Rat | 15-deoxy-Delta(12,14)-prostaglandin J2 | multiple interactions | EXP | | 6480464 | 15-deoxy-delta(12 more ... | CTD | PMID:22245093 |
Nfe2l2 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ethinyl Estradiol promotes the reaction [IL1B protein results in increased expression of NFE2L2 mRNA] | CTD | PMID:12072388 |
Nfe2l2 | Rat | 17alpha-ethynylestradiol | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | 17beta-estradiol | increases methylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | Estradiol results in increased methylation of NFE2L2 promoter | CTD | PMID:24894866 |
Nfe2l2 | Rat | 17beta-estradiol | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Estradiol results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | 17beta-estradiol | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of NFE2L2 mRNA and Estradiol results in decreased expression of NFE2L2 protein | CTD | PMID:23492819 more ... |
Nfe2l2 | Rat | 17beta-estradiol | affects localization | EXP | | 6480464 | Estradiol affects the localization of NFE2L2 protein | CTD | PMID:23027624 |
Nfe2l2 | Rat | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of NFE2L2 mRNA and Estradiol affects the expression of NFE2L2 protein | CTD | PMID:22389237 and PMID:24777823 |
Nfe2l2 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] more ... | CTD | PMID:22389237 more ... |
Nfe2l2 | Rat | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of NFE2L2 mRNA and Estradiol results in decreased expression of NFE2L2 protein | CTD | PMID:23027624 more ... |
Nfe2l2 | Rat | 17beta-estradiol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ascorbic Acid inhibits the reaction [Estradiol results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:23492819 more ... |
Nfe2l2 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | decreases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dihydrotestosterone results in decreased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | 1H-pyrazole | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | pyrazole affects the localization of NFE2L2 protein | CTD | PMID:25478736 |
Nfe2l2 | Rat | 2''-galloylhyperin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2''-galloylhyperin promotes the reaction [lipopolysaccharide and E coli O55-B5 results in increased expression of NFE2L2 protein] | CTD | PMID:30849337 |
Nfe2l2 | Rat | 2''-galloylhyperin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2''-galloylhyperin affects the localization of and results in increased activity of NFE2L2 protein and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2''-galloylhyperin affects the localization of and results in increased activity of NFE2L2 protein] | CTD | PMID:28213291 |
Nfe2l2 | Rat | 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2' more ... | CTD | PMID:31029725 |
Nfe2l2 | Rat | 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [2' more ... | CTD | PMID:31029725 |
Nfe2l2 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31173147 |
Nfe2l2 | Rat | 2,2-Bis(bromomethyl)propane-1,3-diol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:22019925 |
Nfe2l2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NFE2L2 mRNA | CTD | PMID:24058054 more ... |
Nfe2l2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NFE2L2 exon mutant form and Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA | CTD | PMID:15034205 more ... |
Nfe2l2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA | CTD | PMID:16054898 more ... |
Nfe2l2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin | CTD | PMID:21846477 |
Nfe2l2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NFE2L2 mRNA | CTD | PMID:22298810 and PMID:34747641 |
Nfe2l2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the localization of NFE2L2 mRNA | CTD | PMID:20599494 |
Nfe2l2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NFE2L2 mRNA | CTD | PMID:22298810 |
Nfe2l2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA | CTD | PMID:20106945 more ... |
Nfe2l2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | ammonium metavanadate affects the reaction [Tetrachlorodibenzodioxin affects the localization of NFE2L2 mRNA] more ... | CTD | PMID:20599494 more ... |
Nfe2l2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA] more ... | CTD | PMID:19497421 more ... |
Nfe2l2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [CYP2A5 promoter mutant form results in decreased activity of NFE2L2 protein] which results in decreased susceptibility to Tetrachlorodibenzodioxin more ... | CTD | PMID:16214954 more ... |
Nfe2l2 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:20951181 and PMID:32109520 |
Nfe2l2 | Rat | 2,3-dimethoxynaphthalene-1,4-dione | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to 2 more ... | CTD | PMID:20932822 |
Nfe2l2 | Rat | 2,4,6-trinitrobenzenesulfonic acid | affects expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid affects the expression of NFE2L2 protein | CTD | PMID:33412153 |
Nfe2l2 | Rat | 2,4,6-trinitrobenzenesulfonic acid | decreases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of NFE2L2 mRNA | CTD | PMID:31428839 and PMID:31669340 |
Nfe2l2 | Rat | 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | 4-methylesculetin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:31428839 more ... |
Nfe2l2 | Rat | 2,4-dinitrobromobenzene | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1-bromo-2 and 4-dinitrobenzene results in increased expression of NFE2L2 protein | CTD | PMID:26022718 |
Nfe2l2 | Rat | 2,4-dinitroiodobenzene | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1-iodo-2 and 4-dinitrobenzene results in increased expression of NFE2L2 protein | CTD | PMID:19427879 |
Nfe2l2 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of NFE2L2 mRNA | CTD | PMID:21346803 |
Nfe2l2 | Rat | 2,5-di-tert-butylbenzene-1,4-diol | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to 2 and 5-di-tert-butylhydroquinone | CTD | PMID:12842875 |
Nfe2l2 | Rat | 2,5-dihydroxybenzoic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2 and 5-dihydroxybenzoic acid promotes the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of NFE2L2 protein] | CTD | PMID:37120126 |
Nfe2l2 | Rat | 2,6-di-tert-butyl-4-methylphenol | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Butylated Hydroxytoluene | CTD | PMID:10535991 |
Nfe2l2 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of NFE2L2 mRNA | CTD | PMID:21346803 |
Nfe2l2 | Rat | 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Verapamil affects the localization of NFE2L2 protein | CTD | PMID:21525764 |
Nfe2l2 | Rat | 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile | multiple interactions | EXP | | 6480464 | Verapamil inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:30295103 and PMID:30526075 |
Nfe2l2 | Rat | 2-(chloromethyl)pyridine | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-chloromethylpyridine results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | 2-acetamidofluorene | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-Acetylaminofluorene results in increased expression of NFE2L2 mRNA | CTD | PMID:21607683 |
Nfe2l2 | Rat | 2-acetamidofluorene | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-Acetylaminofluorene results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | 2-amino-2-deoxy-D-galactopyranose | decreases expression | EXP | | 6480464 | Galactosamine results in decreased expression of NFE2L2 protein | CTD | PMID:22310181 |
Nfe2l2 | Rat | 2-amino-2-deoxy-D-galactopyranose | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Galactosamine results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Galactosamine co-treated with lipopolysaccharide more ... | CTD | PMID:28887131 and PMID:30236599 |
Nfe2l2 | Rat | 2-amino-2-deoxy-D-galactopyranose | affects localization | EXP | | 6480464 | Galactosamine affects the localization of NFE2L2 protein | CTD | PMID:22310181 |
Nfe2l2 | Rat | 2-amino-2-deoxy-D-galactopyranose | multiple interactions | EXP | | 6480464 | mangiferin affects the reaction [Galactosamine affects the localization of NFE2L2 protein] and mangiferin inhibits the reaction [Galactosamine results in decreased expression of NFE2L2 protein] | CTD | PMID:22310181 |
Nfe2l2 | Rat | 2-amino-3-hydroxypyridine | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-amino-3-hydroxypyridine results in decreased expression of NFE2L2 mRNA | CTD | PMID:31967339 |
Nfe2l2 | Rat | 2-aminoethoxydiphenylborane | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-aminoethoxydiphenylborane inhibits the reaction [bisphenol A results in increased expression of NFE2L2 protein] | CTD | PMID:33408296 |
Nfe2l2 | Rat | 2-chloroethanol | multiple interactions | EXP | | 6480464 | allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of NFE2L2 mRNA] more ... | CTD | PMID:31585129 |
Nfe2l2 | Rat | 2-chloroethanol | increases expression | EXP | | 6480464 | Ethylene Chlorohydrin results in increased expression of NFE2L2 mRNA and Ethylene Chlorohydrin results in increased expression of NFE2L2 protein | CTD | PMID:31585129 |
Nfe2l2 | Rat | 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid | increases expression | EXP | | 6480464 | anacardic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:29054681 |
Nfe2l2 | Rat | 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid | multiple interactions | EXP | | 6480464 | [anacardic acid results in increased susceptibility to manganese chloride] which results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:29054681 |
Nfe2l2 | Rat | 2-hydroxyethyl methacrylate | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | hydroxyethyl methacrylate results in increased expression of NFE2L2 protein | CTD | PMID:30497689 |
Nfe2l2 | Rat | 2-hydroxyethyl methacrylate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | hydroxyethyl methacrylate results in increased expression of NFE2L2 protein | CTD | PMID:37778984 |
Nfe2l2 | Rat | 2-methylcholine | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of NFE2L2 mRNA | CTD | PMID:21179406 |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:10874044 more ... |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | increases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein mutant form results in increased susceptibility to 2-tert-butylhydroquinone | CTD | PMID:23589329 |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone results in increased expression of NFE2L2 protein | CTD | PMID:12446695 more ... |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone affects the localization of NFE2L2 protein | CTD | PMID:25003661 more ... |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone results in increased activity of NFE2L2 protein | CTD | PMID:19715681 more ... |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to 2-tert-butylhydroquinone | CTD | PMID:20932822 |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | increases ubiquitination | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-tert-butylhydroquinone results in increased ubiquitination of NFE2L2 protein | CTD | PMID:18512965 |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | affects binding | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-tert-butylhydroquinone binds to NFE2L2 protein | CTD | PMID:19786557 |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | affects localization | EXP | | 6480464 | 2-tert-butylhydroquinone affects the localization of NFE2L2 protein | CTD | PMID:17676812 more ... |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | increases activity | EXP | | 6480464 | 2-tert-butylhydroquinone results in increased activity of NFE2L2 protein | CTD | PMID:18852027 |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | multiple interactions | EXP | | 6480464 | 2-tert-butylhydroquinone affects the localization of and results in increased activity of NFE2L2 protein more ... | CTD | PMID:15319326 more ... |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | increases stability | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-tert-butylhydroquinone results in increased stability of NFE2L2 protein | CTD | PMID:22275372 |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-tert-butylhydroquinone results in increased expression of NFE2L2 mRNA and 2-tert-butylhydroquinone results in increased expression of NFE2L2 protein | CTD | PMID:19183254 more ... |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-tert-butylhydroquinone inhibits the reaction [2 more ... | CTD | PMID:10473555 more ... |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-tert-butylhydroquinone results in increased activity of NFE2L2 protein and [2-tert-butylhydroquinone results in increased activity of NFE2L2 protein] which results in increased activity of GATA3 protein | CTD | PMID:22250088 and PMID:23945499 |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | increases expression | EXP | | 6480464 | 2-tert-butylhydroquinone results in increased expression of NFE2L2 mRNA and 2-tert-butylhydroquinone results in increased expression of NFE2L2 protein | CTD | PMID:17676812 more ... |
Nfe2l2 | Rat | 2-tert-butylhydroquinone | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to 2-tert-butylhydroquinone | CTD | PMID:22250088 |
Nfe2l2 | Rat | 20-hydroxyecdysone | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein]] and Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein] | CTD | PMID:26048653 |
Nfe2l2 | Rat | 20-hydroxyecdysone | increases response to substance | EXP | | 6480464 | NFE2L2 results in increased susceptibility to Ecdysterone | CTD | PMID:26048653 |
Nfe2l2 | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:24378064 more ... |
Nfe2l2 | Rat | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:37598416 |
Nfe2l2 | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 3 more ... | CTD | PMID:30768972 |
Nfe2l2 | Rat | 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Lipopolysaccharides co-treated with IFNG protein] promotes the reaction [3 more ... | CTD | PMID:30768972 |
Nfe2l2 | Rat | 3,3',4,4',5-pentachlorobiphenyl | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:31563530 |
Nfe2l2 | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 |
Nfe2l2 | Rat | 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:33096110 and PMID:37598416 |
Nfe2l2 | Rat | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [resveratrol co-treated with 3 more ... | CTD | PMID:24231106 |
Nfe2l2 | Rat | 3,3',5,5'-tetrabromobisphenol A | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [CYP2A5 promoter mutant form results in decreased activity of NFE2L2 protein] which results in decreased susceptibility to tetrabromobisphenol A | CTD | PMID:29788535 |
Nfe2l2 | Rat | 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA and [Rosmarinic Acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA | CTD | PMID:33476690 |
Nfe2l2 | Rat | 3,3',5-triiodo-L-thyronine | multiple interactions | EXP | | 6480464 | Triiodothyronine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NFE2L2 protein] | CTD | PMID:36868496 |
Nfe2l2 | Rat | 3,3'-diindolylmethane | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 3 more ... | CTD | PMID:23583297 |
Nfe2l2 | Rat | 3,3'-diindolylmethane | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | sulforaphane promotes the reaction [3 more ... | CTD | PMID:23583297 |
Nfe2l2 | Rat | 3,4-dihydroxybenzoic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | protocatechuic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 mRNA] | CTD | PMID:36807594 |
Nfe2l2 | Rat | 3,4-dihydroxybenzoic acid | increases expression | EXP | | 6480464 | protocatechuic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:36593721 |
Nfe2l2 | Rat | 3,4-dihydroxybenzoic acid | multiple interactions | EXP | | 6480464 | [protocatechuic acid co-treated with Cadmium Chloride] results in increased expression of NFE2L2 mRNA and protocatechuic acid inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 mRNA] | CTD | PMID:32392679 and PMID:36593721 |
Nfe2l2 | Rat | 3,5-diethoxycarbonyl-1,4-dihydrocollidine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 gene mutant form results in increased susceptibility to 3 more ... | CTD | PMID:30825315 |
Nfe2l2 | Rat | 3,5-diethoxycarbonyl-1,4-dihydrocollidine | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to 3 more ... | CTD | PMID:30825315 |
Nfe2l2 | Rat | 3,6-diaminoacridine | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Proflavine results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | 3-chloropropane-1,2-diol | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | alpha-Chlorohydrin results in increased expression of NFE2L2 mRNA | CTD | PMID:33913518 |
Nfe2l2 | Rat | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of NFE2L2 mRNA | CTD | PMID:35088268 |
Nfe2l2 | Rat | 3-hydroxybutyric acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 protein mutant form co-treated with Streptozocin] results in increased abundance of 3-Hydroxybutyric Acid | CTD | PMID:20086057 |
Nfe2l2 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA and [Rosmarinic Acid co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA | CTD | PMID:33476690 |
Nfe2l2 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased activity of NFE2L2 protein | CTD | PMID:33412187 |
Nfe2l2 | Rat | 3-methoxycatechol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 3-methoxycatechol results in increased expression of NFE2L2 mRNA | CTD | PMID:26862668 |
Nfe2l2 | Rat | 3-methylcatechol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 3-methylcatechol results in increased expression of NFE2L2 mRNA | CTD | PMID:26862668 |
Nfe2l2 | Rat | 3-methylcholanthrene | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of NFE2L2 mRNA and Methylcholanthrene results in increased expression of NFE2L2 protein | CTD | PMID:16723119 more ... |
Nfe2l2 | Rat | 3-methylcholanthrene | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Methylcholanthrene promotes the reaction [AHR protein binds to NFE2L2 promoter] | CTD | PMID:20348232 |
Nfe2l2 | Rat | 3-methylcholanthrene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Methylcholanthrene results in increased expression of PSMB5 mRNA] | CTD | PMID:16723119 |
Nfe2l2 | Rat | 3-Nitrobenzanthrone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [NFE2L2 protein affects the metabolism of 3-nitrobenzanthrone] which affects the abundance of 3-aminobenzanthrone | CTD | PMID:31746589 |
Nfe2l2 | Rat | 3-Nitrobenzanthrone | affects metabolic processing | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the metabolism of 3-nitrobenzanthrone | CTD | PMID:31746589 |
Nfe2l2 | Rat | 3-Nitrobenzanthrone | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to 3-nitrobenzanthrone | CTD | PMID:31746589 |
Nfe2l2 | Rat | 3-Nitrofluoranthene | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 3-nitrofluoranthene results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein | CTD | PMID:28633978 |
Nfe2l2 | Rat | 3-nitropropanoic acid | multiple interactions | EXP | | 6480464 | [naringin co-treated with 3-nitropropionic acid] affects the localization of NFE2L2 protein more ... | CTD | PMID:22871521 and PMID:38513929 |
Nfe2l2 | Rat | 3-nitropropanoic acid | decreases expression | EXP | | 6480464 | 3-nitropropionic acid results in decreased expression of NFE2L2 protein | CTD | PMID:38513929 |
Nfe2l2 | Rat | 3-O-Caffeoyl-1-O-methylquinic acid | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | 3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein | CTD | PMID:16631525 |
Nfe2l2 | Rat | 3-O-Caffeoyl-1-O-methylquinic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid affects the localization of NFE2L2 protein] more ... | CTD | PMID:16631525 |
Nfe2l2 | Rat | 3-phenylprop-2-enal | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | cinnamaldehyde results in increased activity of NFE2L2 protein | CTD | PMID:31187328 |
Nfe2l2 | Rat | 3-phenylprop-2-enal | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to cinnamaldehyde | CTD | PMID:37089166 |
Nfe2l2 | Rat | 3-phenylprop-2-enal | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | cinnamaldehyde inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:28219650 and PMID:31187328 |
Nfe2l2 | Rat | 3-phenylprop-2-enal | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | cinnamaldehyde analog results in increased expression of NFE2L2 protein and cinnamaldehyde results in increased expression of NFE2L2 protein | CTD | PMID:18482591 more ... |
Nfe2l2 | Rat | 3-phenylprop-2-enal | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | cinnamaldehyde affects the expression of NFE2L2 protein | CTD | PMID:28219650 |
Nfe2l2 | Rat | 3-phenylprop-2-enal | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 affects the susceptibility to cinnamaldehyde | CTD | PMID:23564646 |
Nfe2l2 | Rat | 3-phenylprop-2-enal | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [cinnamaldehyde results in increased activity of NFE2L2 protein] inhibits the reaction [TNF protein affects the localization of RELA protein] more ... | CTD | PMID:20351055 more ... |
Nfe2l2 | Rat | 3-phenylprop-2-enal | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | cinnamaldehyde affects the localization of NFE2L2 protein | CTD | PMID:18304597 and PMID:21469739 |
Nfe2l2 | Rat | 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of NFE2L2 mRNA | CTD | PMID:19162173 |
Nfe2l2 | Rat | 3H-1,2-dithiole-3-thione | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 and 2-dithiol-3-thione results in increased activity of NFE2L2 protein | CTD | PMID:22495766 |
Nfe2l2 | Rat | 3H-1,2-dithiole-3-thione | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:18367636 and PMID:22495766 |
Nfe2l2 | Rat | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of NFE2L2 mRNA | CTD | PMID:18648102 |
Nfe2l2 | Rat | 4,4'-diaminodiphenylmethane | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of NFE2L2 mRNA | CTD | PMID:39298647 |
Nfe2l2 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of NFE2L2 protein | CTD | PMID:36565802 |
Nfe2l2 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of NFE2L2 mRNA and bisphenol S results in decreased expression of NFE2L2 protein | CTD | PMID:36541330 |
Nfe2l2 | Rat | 4,6-dioxoheptanoic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form affects the reaction [succinylacetone results in increased expression of CYP2A5 mRNA] and NFE2L2 gene mutant form inhibits the reaction [succinylacetone results in increased expression of ALAS1 mRNA] | CTD | PMID:22859313 |
Nfe2l2 | Rat | 4-hydroxy-TEMPO | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [tempol inhibits the reaction [lipopolysaccharide more ... | CTD | PMID:38454815 |
Nfe2l2 | Rat | 4-hydroxy-TEMPO | decreases ubiquitination | ISO | NFE2L2 (Homo sapiens) | 6480464 | tempol results in decreased ubiquitination of NFE2L2 protein | CTD | PMID:38454815 |
Nfe2l2 | Rat | 4-hydroxy-TEMPO | multiple interactions | EXP | | 6480464 | tempol inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | CTD | PMID:25204689 |
Nfe2l2 | Rat | 4-hydroxy-TEMPO | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | tempol inhibits the reaction [lipopolysaccharide and E coli O55-B5 results in decreased expression of NFE2L2 protein] | CTD | PMID:38454815 |
Nfe2l2 | Rat | 4-Hydroxybenzyl isothiocyanate | increases expression | EXP | | 6480464 | 4-hydroxybenzyl isothiocyanate results in increased expression of NFE2L2 protein | CTD | PMID:22664424 |
Nfe2l2 | Rat | 4-hydroxyestrone | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to 4-hydroxyestrone | CTD | PMID:25231996 |
Nfe2l2 | Rat | 4-hydroxyestrone | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 4-hydroxyestrone results in decreased expression of NFE2L2 mRNA | CTD | PMID:25231996 |
Nfe2l2 | Rat | 4-hydroxynon-2-enal | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | 4-hydroxy-2-nonenal affects the localization of NFE2L2 protein | CTD | PMID:29108775 and PMID:30849339 |
Nfe2l2 | Rat | 4-hydroxynon-2-enal | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | AKR7A2 protein affects the reaction [NFE2L2 protein affects the susceptibility to 4-hydroxy-2-nonenal] | CTD | PMID:30849339 |
Nfe2l2 | Rat | 4-hydroxynon-2-enal | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to 4-hydroxy-2-nonenal | CTD | PMID:30849339 |
Nfe2l2 | Rat | 4-hydroxynon-2-enal | multiple interactions | EXP | | 6480464 | 4-hydroxy-2-nonenal promotes the reaction [NFE2L2 protein binds to GGT1 promoter] more ... | CTD | PMID:16195535 and PMID:24291486 |
Nfe2l2 | Rat | 4-hydroxynon-2-enal | increases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased expression of NFE2L2 protein | CTD | PMID:24291486 |
Nfe2l2 | Rat | 4-hydroxynon-2-enal | decreases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in decreased activity of NFE2L2 protein | CTD | PMID:16322078 |
Nfe2l2 | Rat | 4-hydroxynon-2-enal | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal affects the localization of and results in increased activity of NFE2L2 protein more ... | CTD | PMID:16322078 more ... |
Nfe2l2 | Rat | 4-hydroxynon-2-enal | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to 4-hydroxy-2-nonenal | CTD | PMID:24423726 |
Nfe2l2 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of NFE2L2 mRNA | CTD | PMID:28973697 |
Nfe2l2 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Fenretinide results in increased expression of NFE2L2 protein | CTD | PMID:25246272 |
Nfe2l2 | Rat | 4-methylcatechol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 4-methylcatechol results in increased expression of NFE2L2 mRNA | CTD | PMID:26862668 |
Nfe2l2 | Rat | 4-nitrobenzaldehyde | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to 4-nitrobenzaldehyde] | CTD | PMID:20932822 |
Nfe2l2 | Rat | 4-phenylbutyric acid | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA] and 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NFE2L2 protein] | CTD | PMID:20399799 |
Nfe2l2 | Rat | 4-phenylbutyric acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | ALPI protein inhibits the reaction [4-phenylbutyric acid results in increased phosphorylation of NFE2L2 protein] | CTD | PMID:32407927 |
Nfe2l2 | Rat | 5-aminolevulinic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form inhibits the reaction [Aminolevulinic Acid results in increased expression of CYP2A5 mRNA] and NFE2L2 gene mutant form promotes the reaction [Aminolevulinic Acid results in increased expression of HMOX1 mRNA] | CTD | PMID:22859313 |
Nfe2l2 | Rat | 5-aza-2'-deoxycytidine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Decitabine co-treated with trichostatin A] results in decreased methylation of NFE2L2 promoter and [trichostatin A co-treated with Decitabine] results in decreased methylation of NFE2L2 promoter | CTD | PMID:26991801 and PMID:31181187 |
Nfe2l2 | Rat | 5-aza-2'-deoxycytidine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Decitabine inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] | CTD | PMID:26409248 |
Nfe2l2 | Rat | 5-fluorouracil | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Fluorouracil | CTD | PMID:18692501 |
Nfe2l2 | Rat | 5-fluorouracil | affects localization | EXP | | 6480464 | Fluorouracil affects the localization of NFE2L2 protein | CTD | PMID:26921358 |
Nfe2l2 | Rat | 5-fluorouracil | multiple interactions | EXP | | 6480464 | Ascorbic Acid promotes the reaction [Fluorouracil affects the localization of NFE2L2 protein] | CTD | PMID:26921358 |
Nfe2l2 | Rat | 5-fluorouracil | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Fluorouracil affects the expression of NFE2L2 mRNA | CTD | PMID:34151400 |
Nfe2l2 | Rat | 5-fluorouracil | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Fluorouracil results in decreased expression of NFE2L2 protein | CTD | PMID:35101590 |
Nfe2l2 | Rat | 5-fluorouracil | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in decreased susceptibility to Fluorouracil | CTD | PMID:20722640 |
Nfe2l2 | Rat | 5-fluorouracil | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to Fluorouracil | CTD | PMID:21489257 |
Nfe2l2 | Rat | 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 mRNA] and NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 protein] | CTD | PMID:27725188 |
Nfe2l2 | Rat | 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 6-(4-chlorophenyl)imidazo(2 more ... | CTD | PMID:30114225 |
Nfe2l2 | Rat | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | multiple interactions | EXP | | 6480464 | 6-chloro-2 more ... | CTD | PMID:33661552 |
Nfe2l2 | Rat | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 6-chloro-2 more ... | CTD | PMID:36549428 and PMID:37436358 |
Nfe2l2 | Rat | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 6-chloro-2 more ... | CTD | PMID:36161741 and PMID:37436358 |
Nfe2l2 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of NFE2L2 mRNA | CTD | PMID:36038036 |
Nfe2l2 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of NFE2L2 mRNA | CTD | PMID:36843608 |
Nfe2l2 | Rat | 6alpha-methylprednisolone | multiple interactions | EXP | | 6480464 | Methylprednisolone inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 mRNA] | CTD | PMID:26093215 |
Nfe2l2 | Rat | 7,12-dimethyltetraphene | increases expression | EXP | | 6480464 | 9 more ... | CTD | PMID:22406437 |
Nfe2l2 | Rat | 7,12-dimethyltetraphene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [9 more ... | CTD | PMID:32553695 |
Nfe2l2 | Rat | 7,12-dimethyltetraphene | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 9 more ... | CTD | PMID:30114225 |
Nfe2l2 | Rat | 7,12-dimethyltetraphene | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 9 more ... | CTD | PMID:32553695 |
Nfe2l2 | Rat | 7,12-dimethyltetraphene | decreases expression | EXP | | 6480464 | 9 more ... | CTD | PMID:24995432 and PMID:33759307 |
Nfe2l2 | Rat | 7,12-dimethyltetraphene | multiple interactions | EXP | | 6480464 | betulin inhibits the reaction [9 more ... | CTD | PMID:24995432 and PMID:33759307 |
Nfe2l2 | Rat | 7,8-dihydroxycoumarin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [sodium arsenite co-treated with daphnetin] results in increased expression of NFE2L2 protein more ... | CTD | PMID:30738023 |
Nfe2l2 | Rat | 7,9-dihydro-1H-purine-2,6,8(3H)-trione | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | salinomycin inhibits the reaction [Uric Acid results in decreased expression of and results in decreased phosphorylation of NFE2L2 protein] and Uric Acid results in decreased expression of and results in decreased phosphorylation of NFE2L2 protein | CTD | PMID:39222901 |
Nfe2l2 | Rat | 8-(4-chlorophenylthio)-cAMP | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 8-((4-chlorophenyl)thio)cyclic-3' and 5'-AMP results in increased expression of NFE2L2 mRNA | CTD | PMID:27160211 |
Nfe2l2 | Rat | 9,10-phenanthroquinone | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | 9 and 10-phenanthrenequinone affects the localization of NFE2L2 protein | CTD | PMID:29108775 |
Nfe2l2 | Rat | 9-cis-retinoic acid | multiple interactions | EXP | | 6480464 | [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] results in increased activity of NFE2L2 protein | CTD | PMID:15150131 |
Nfe2l2 | Rat | 9-cis-retinoic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Alitretinoin inhibits the reaction [Dimethylformamide results in decreased activity of NFE2L2 protein] | CTD | PMID:31875996 |
Nfe2l2 | Rat | [6]-Shogaol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | KEAP1 protein affects the reaction [shogaol analog results in increased expression of NFE2L2 protein] more ... | CTD | PMID:23899529 and PMID:25148906 |
Nfe2l2 | Rat | [6]-Shogaol | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | shogaol analog results in increased expression of NFE2L2 protein | CTD | PMID:23899529 |
Nfe2l2 | Rat | [6]-Shogaol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | shogaol analog results in increased expression of NFE2L2 protein | CTD | PMID:23899529 |
Nfe2l2 | Rat | [6]-Shogaol | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | shogaol affects the localization of NFE2L2 protein more ... | CTD | PMID:25148906 |
Nfe2l2 | Rat | [6]-Shogaol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein] more ... | CTD | PMID:25148906 |
Nfe2l2 | Rat | [6]-Shogaol | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | shogaol affects the localization of NFE2L2 protein | CTD | PMID:25148906 |
Nfe2l2 | Rat | abamectin | multiple interactions | EXP | | 6480464 | Hesperidin inhibits the reaction [abamectin results in decreased expression of NFE2L2 mRNA] | CTD | PMID:34748272 |
Nfe2l2 | Rat | abamectin | decreases expression | EXP | | 6480464 | abamectin results in decreased expression of NFE2L2 mRNA | CTD | PMID:34748272 |
Nfe2l2 | Rat | acetic acid | decreases expression | EXP | | 6480464 | Acetic Acid results in decreased expression of NFE2L2 mRNA | CTD | PMID:29518435 and PMID:30594690 |
Nfe2l2 | Rat | acetic acid | multiple interactions | EXP | | 6480464 | Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in decreased expression of NFE2L2 mRNA] and Plant Extracts inhibits the reaction [Acetic Acid results in decreased expression of NFE2L2 mRNA] | CTD | PMID:29518435 and PMID:30594690 |
Nfe2l2 | Rat | acrolein | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Acrolein | CTD | PMID:19303893 |
Nfe2l2 | Rat | acrolein | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acrolein results in increased expression of NFE2L2 protein | CTD | PMID:28482051 and PMID:30608172 |
Nfe2l2 | Rat | acrolein | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acrolein results in increased expression of NFE2L2 mRNA and Acrolein results in increased expression of NFE2L2 protein | CTD | PMID:26862668 more ... |
Nfe2l2 | Rat | acrolein | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Acrolein | CTD | PMID:27633142 |
Nfe2l2 | Rat | acrolein | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in decreased susceptibility to Acrolein | CTD | PMID:18367636 |
Nfe2l2 | Rat | acrolein | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acrolein affects the localization of NFE2L2 protein | CTD | PMID:12763045 |
Nfe2l2 | Rat | acrolein | increases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Acrolein | CTD | PMID:19608619 |
Nfe2l2 | Rat | acrolein | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acrolein results in decreased expression of NFE2L2 protein | CTD | PMID:17197552 and PMID:18258206 |
Nfe2l2 | Rat | acrolein | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NFE2L2 mRNA more ... | CTD | PMID:17197552 more ... |
Nfe2l2 | Rat | acrolein | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acrolein results in increased activity of NFE2L2 protein | CTD | PMID:12084617 |
Nfe2l2 | Rat | acrolein | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acrolein affects the localization of NFE2L2 protein | CTD | PMID:12084617 and PMID:18048804 |
Nfe2l2 | Rat | acrolein | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:18028974 more ... |
Nfe2l2 | Rat | acrolein | affects localization | EXP | | 6480464 | Acrolein affects the localization of NFE2L2 protein | CTD | PMID:25145656 |
Nfe2l2 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of NFE2L2 mRNA and Acrylamide results in decreased expression of NFE2L2 protein | CTD | PMID:28959563 and PMID:36657526 |
Nfe2l2 | Rat | acrylamide | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of NFE2L2 mRNA | CTD | PMID:32763439 |
Nfe2l2 | Rat | acrylamide | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Acrylamide | CTD | PMID:33872730 |
Nfe2l2 | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of NFE2L2 mRNA | CTD | PMID:38604440 |
Nfe2l2 | Rat | acrylamide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Acrylamide co-treated with Streptozocin] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:32014472 more ... |
Nfe2l2 | Rat | acrylamide | multiple interactions | EXP | | 6480464 | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Acrylamide results in increased expression of NFE2L2 protein] more ... | CTD | PMID:29426002 more ... |
Nfe2l2 | Rat | acrylamide | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of NFE2L2 mRNA and Acrylamide results in decreased expression of NFE2L2 protein | CTD | PMID:28159594 |
Nfe2l2 | Rat | acrylamide | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acrylamide affects the localization of NFE2L2 protein | CTD | PMID:28526328 |
Nfe2l2 | Rat | acrylamide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | salvin inhibits the reaction [Acrylamide results in decreased expression of NFE2L2 mRNA] and salvin inhibits the reaction [Acrylamide results in decreased expression of NFE2L2 protein] | CTD | PMID:28159594 |
Nfe2l2 | Rat | acrylamide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acrylamide results in increased expression of NFE2L2 mRNA and Acrylamide results in increased expression of NFE2L2 protein | CTD | PMID:27836571 and PMID:34896238 |
Nfe2l2 | Rat | actinomycin D | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Dactinomycin inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein] and Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NFE2L2 mRNA] | CTD | PMID:22019695 and PMID:24632381 |
Nfe2l2 | Rat | Aescin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Escin results in increased expression of NFE2L2 protein | CTD | PMID:36905866 |
Nfe2l2 | Rat | Aescin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Escin results in increased expression of NFE2L2 protein | CTD | PMID:36905866 |
Nfe2l2 | Rat | Aescin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Escin inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:36905866 |
Nfe2l2 | Rat | Aescin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of NFE2L2 protein] and Escin results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:36905866 |
Nfe2l2 | Rat | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of NFE2L2 protein | CTD | PMID:25154877 |
Nfe2l2 | Rat | aflatoxin B1 | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of NFE2L2 protein | CTD | PMID:34089297 |
Nfe2l2 | Rat | aflatoxin B1 | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of NFE2L2 mRNA and Aflatoxin B1 results in decreased expression of NFE2L2 protein | CTD | PMID:35063475 |
Nfe2l2 | Rat | aflatoxin B1 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Curcumin inhibits the reaction [Aflatoxin B1 results in decreased expression of NFE2L2 mRNA] and Curcumin inhibits the reaction [Aflatoxin B1 results in decreased expression of NFE2L2 protein] | CTD | PMID:35063475 |
Nfe2l2 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of NFE2L2 mRNA | CTD | PMID:33354967 |
Nfe2l2 | Rat | aflatoxin B1 | increases methylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of NFE2L2 intron | CTD | PMID:30157460 |
Nfe2l2 | Rat | aflatoxin B1 | decreases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | aflatoxin B1 | decreases methylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of NFE2L2 gene | CTD | PMID:27153756 |
Nfe2l2 | Rat | aflatoxin B1 | increases response to substance | EXP | | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Aflatoxin B1 | CTD | PMID:27071940 |
Nfe2l2 | Rat | aflatoxin B1 | multiple interactions | EXP | | 6480464 | [Aflatoxin B1 co-treated with caryophyllene] results in increased expression of NFE2L2 protein and Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of NFE2L2 protein] | CTD | PMID:25154877 and PMID:34506763 |
Nfe2l2 | Rat | AL 8810 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | AL 8810 inhibits the reaction [Oxidopamine affects the localization of NFE2L2 protein] | CTD | PMID:33486071 |
Nfe2l2 | Rat | alachlor | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | alachlor results in increased activity of NFE2L2 protein | CTD | PMID:20143881 |
Nfe2l2 | Rat | aldehydo-D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NFE2L2 mRNA and Glucose results in decreased expression of NFE2L2 protein | CTD | PMID:21818840 more ... |
Nfe2l2 | Rat | aldehydo-D-glucose | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Glucose affects the localization of NFE2L2 protein | CTD | PMID:33270355 |
Nfe2l2 | Rat | aldehydo-D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of NFE2L2 mRNA and Glucose results in increased expression of NFE2L2 protein | CTD | PMID:29211853 |
Nfe2l2 | Rat | aldehydo-D-glucose | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Glucose | CTD | PMID:20086057 |
Nfe2l2 | Rat | aldehydo-D-glucose | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(1 more ... | CTD | PMID:17928392 more ... |
Nfe2l2 | Rat | aldehydo-D-glucose | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Glucose deficiency results in increased localization of NFE2L2 protein | CTD | PMID:17928392 |
Nfe2l2 | Rat | aldehydo-D-glucose | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Glucose deficiency results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:20103708 more ... |
Nfe2l2 | Rat | aldehydo-D-glucose | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Glucose results in decreased expression of NFE2L2 mRNA and Glucose results in decreased expression of NFE2L2 protein | CTD | PMID:21333731 more ... |
Nfe2l2 | Rat | aldehydo-D-glucose | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]] more ... | CTD | PMID:21333731 more ... |
Nfe2l2 | Rat | aldehydo-D-glucose | multiple interactions | EXP | | 6480464 | 4-benzyl-2-methyl-1 more ... | CTD | PMID:20028456 more ... |
Nfe2l2 | Rat | aldosterone | increases activity | EXP | | 6480464 | Aldosterone results in increased activity of NFE2L2 protein | CTD | PMID:25204689 |
Nfe2l2 | Rat | aldosterone | multiple interactions | EXP | | 6480464 | Spironolactone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] and tempol inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | CTD | PMID:25204689 |
Nfe2l2 | Rat | all-trans-retinal | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Retinaldehyde results in increased expression of NFE2L2 mRNA | CTD | PMID:25331497 and PMID:27751755 |
Nfe2l2 | Rat | all-trans-retinoic acid | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of NFE2L2 mRNA | CTD | PMID:15498508 |
Nfe2l2 | Rat | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of NFE2L2 protein | CTD | PMID:30267739 |
Nfe2l2 | Rat | all-trans-retinoic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Tretinoin inhibits the reaction [ginsenoside Rg1 inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFE2L2 protein]] more ... | CTD | PMID:22308036 and PMID:29964319 |
Nfe2l2 | Rat | all-trans-retinoic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of NFE2L2 mRNA and Tretinoin results in increased expression of NFE2L2 protein | CTD | PMID:23724009 and PMID:38040126 |
Nfe2l2 | Rat | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of NFE2L2 mRNA | CTD | PMID:20488242 |
Nfe2l2 | Rat | all-trans-retinoic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Tretinoin inhibits the reaction [Arsenic Trioxide affects the localization of NFE2L2 protein] and Tretinoin inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] | CTD | PMID:25003661 and PMID:30309986 |
Nfe2l2 | Rat | allethrin | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NFE2L2 mRNA and [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA | CTD | PMID:33396045 and PMID:34896426 |
Nfe2l2 | Rat | allicin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | allicin inhibits the reaction [arsenic trioxide results in decreased expression of NFE2L2 protein] | CTD | PMID:27561292 |
Nfe2l2 | Rat | alloxan | decreases expression | EXP | | 6480464 | Alloxan results in decreased expression of NFE2L2 mRNA | CTD | PMID:33359794 |
Nfe2l2 | Rat | alloxan | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan affects the localization of NFE2L2 protein]] more ... | CTD | PMID:33359794 |
Nfe2l2 | Rat | alloxan | affects localization | EXP | | 6480464 | Alloxan affects the localization of NFE2L2 protein | CTD | PMID:33359794 |
Nfe2l2 | Rat | allyl isothiocyanate | increases expression | EXP | | 6480464 | allyl isothiocyanate results in increased expression of NFE2L2 protein | CTD | PMID:22664424 |
Nfe2l2 | Rat | allyl isothiocyanate | multiple interactions | EXP | | 6480464 | allyl isothiocyanate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:30927557 and PMID:34635025 |
Nfe2l2 | Rat | allyl isothiocyanate | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | allyl isothiocyanate results in increased activity of NFE2L2 protein | CTD | PMID:24036144 |
Nfe2l2 | Rat | allyl isothiocyanate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [allyl isothiocyanate results in increased expression of GCLC mRNA] and NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to allyl isothiocyanate] | CTD | PMID:20932822 and PMID:24036144 |
Nfe2l2 | Rat | allyl methyl disulfide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of NFE2L2 protein] | CTD | PMID:37995826 |
Nfe2l2 | Rat | alogliptin | multiple interactions | EXP | | 6480464 | alogliptin inhibits the reaction [[Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:33840231 |
Nfe2l2 | Rat | alpha-D-galactose | affects localization | EXP | | 6480464 | Galactose affects the localization of NFE2L2 protein | CTD | PMID:25892055 |
Nfe2l2 | Rat | alpha-D-galactose | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | albicanol inhibits the reaction [Galactose results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:33761044 and PMID:36638877 |
Nfe2l2 | Rat | alpha-D-galactose | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Galactose results in decreased expression of NFE2L2 mRNA and Galactose results in decreased expression of NFE2L2 protein | CTD | PMID:33761044 and PMID:36638877 |
Nfe2l2 | Rat | alpha-D-galactose | multiple interactions | EXP | | 6480464 | Saponins inhibits the reaction [Galactose affects the localization of NFE2L2 protein] | CTD | PMID:25892055 |
Nfe2l2 | Rat | alpha-linolenic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein promotes the reaction [alpha-Linolenic Acid results in increased expression of CYP2A6 mRNA] more ... | CTD | PMID:28555106 |
Nfe2l2 | Rat | alpha-linolenic acid | multiple interactions | EXP | | 6480464 | alpha-Linolenic Acid inhibits the reaction [Cholesterol promotes the reaction [Particulate Matter results in increased expression of NFE2L2 mRNA]] more ... | CTD | PMID:30672636 |
Nfe2l2 | Rat | alpha-pinene | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NFE2L2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NFE2L2 mRNA | CTD | PMID:32699268 |
Nfe2l2 | Rat | alternariol | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | alternariol affects the localization of NFE2L2 protein | CTD | PMID:23154127 and PMID:35405071 |
Nfe2l2 | Rat | alternariol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[alternariol co-treated with altertoxin II] affects the localization of NFE2L2 protein] more ... | CTD | PMID:35405071 |
Nfe2l2 | Rat | Altertoxin II | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[alternariol co-treated with altertoxin II] affects the localization of NFE2L2 protein] more ... | CTD | PMID:27178040 and PMID:35405071 |
Nfe2l2 | Rat | Altertoxin II | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | altertoxin II affects the localization of NFE2L2 protein | CTD | PMID:35405071 |
Nfe2l2 | Rat | Altertoxin II | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | altertoxin II results in decreased expression of NFE2L2 mRNA | CTD | PMID:27178040 |
Nfe2l2 | Rat | aluminium atom | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:37415728 |
Nfe2l2 | Rat | aluminium hydroxide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Aluminum Hydroxide promotes the reaction [Thimerosal results in increased expression of NFE2L2 protein] | CTD | PMID:36411272 |
Nfe2l2 | Rat | aluminium hydroxide | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Aluminum Hydroxide results in increased expression of NFE2L2 protein | CTD | PMID:36411272 |
Nfe2l2 | Rat | aluminium(0) | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:37415728 |
Nfe2l2 | Rat | aminoguanidine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | pimagedine inhibits the reaction [Pyruvaldehyde affects the localization of NFE2L2 protein] | CTD | PMID:33930484 |
Nfe2l2 | Rat | amiodarone | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Amiodarone affects the expression of NFE2L2 mRNA | CTD | PMID:35641671 |
Nfe2l2 | Rat | amiodarone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Amiodarone results in increased expression of NFE2L2 mRNA | CTD | PMID:36586010 |
Nfe2l2 | Rat | amitraz | decreases expression | EXP | | 6480464 | amitraz results in decreased expression of NFE2L2 protein | CTD | PMID:31029719 |
Nfe2l2 | Rat | amitraz | multiple interactions | EXP | | 6480464 | KEAP1 protein affects the reaction [amitraz results in decreased expression of NFE2L2 protein] | CTD | PMID:31029719 |
Nfe2l2 | Rat | amlexanox | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | amlexanox results in increased expression of NFE2L2 protein | CTD | PMID:31697998 |
Nfe2l2 | Rat | amlexanox | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Acetaminophen co-treated with amlexanox] results in increased expression of NFE2L2 protein more ... | CTD | PMID:31697998 |
Nfe2l2 | Rat | ammonia | increases abundance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased abundance of Ammonia | CTD | PMID:29618784 |
Nfe2l2 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of NFE2L2 mRNA | CTD | PMID:16483693 |
Nfe2l2 | Rat | ammonium chloride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Ammonium Chloride results in increased activity of NFE2L2 protein] more ... | CTD | PMID:27867098 |
Nfe2l2 | Rat | ammonium chloride | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ammonium Chloride results in increased expression of NFE2L2 mRNA | CTD | PMID:27867098 |
Nfe2l2 | Rat | Ammothamnine | multiple interactions | EXP | | 6480464 | oxymatrine promotes the reaction [arsenic trioxide results in increased expression of NFE2L2 protein] | CTD | PMID:27713174 |
Nfe2l2 | Rat | Ammothamnine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [oxymatrine co-treated with IL1B protein] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:37196756 |
Nfe2l2 | Rat | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of NFE2L2 mRNA | CTD | PMID:30779732 |
Nfe2l2 | Rat | andrographolide | increases activity | EXP | | 6480464 | andrographolide results in increased activity of NFE2L2 protein | CTD | PMID:25110055 |
Nfe2l2 | Rat | andrographolide | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in decreased susceptibility to andrographolide | CTD | PMID:29355602 |
Nfe2l2 | Rat | andrographolide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form inhibits the reaction [andrographolide inhibits the reaction [Acetaminophen results in increased expression of ACTA2 protein]] | CTD | PMID:29355602 |
Nfe2l2 | Rat | andrographolide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | andrographolide results in increased expression of and affects the localization of NFE2L2 protein and NFE2L2 protein affects the reaction [andrographolide inhibits the reaction [cobaltous chloride results in increased expression of HIF1A mRNA]] | CTD | PMID:27297870 and PMID:35724838 |
Nfe2l2 | Rat | anethole | multiple interactions | EXP | | 6480464 | anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 mRNA] and anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 protein] | CTD | PMID:35430261 |
Nfe2l2 | Rat | angelica lactone | affects activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | angelica lactone affects the activity of NFE2L2 protein | CTD | PMID:11309284 |
Nfe2l2 | Rat | angiotensin II | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Angiotensin II results in increased expression of COL1A1 mRNA] and NFE2L2 protein affects the reaction [Angiotensin II results in increased expression of NOX4 protein] | CTD | PMID:33746155 |
Nfe2l2 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid results in increased activity of NFE2L2 protein] more ... | CTD | PMID:16631525 and PMID:23535287 |
Nfe2l2 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | pyrazolanthrone inhibits the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein] and pyrazolanthrone inhibits the reaction [Triclosan results in increased expression of NFE2L2 protein] | CTD | PMID:25449124 and PMID:34160118 |
Nfe2l2 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | EXP | | 6480464 | pyrazolanthrone inhibits the reaction [Acrylamide results in increased expression of NFE2L2 protein] more ... | CTD | PMID:17640564 more ... |
Nfe2l2 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | pyrazolanthrone results in decreased expression of NFE2L2 protein | CTD | PMID:25649257 |
Nfe2l2 | Rat | anthranilic acid | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | anthranilic acid results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | antimycin A | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Antimycin A results in increased expression of NFE2L2 mRNA | CTD | PMID:35430258 |
Nfe2l2 | Rat | antimycin A | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Antimycin A results in increased expression of NFE2L2 mRNA] | CTD | PMID:35430258 |
Nfe2l2 | Rat | apigenin | multiple interactions | EXP | | 6480464 | Apigenin affects the localization of and results in increased activity of NFE2L2 protein | CTD | PMID:22864849 |
Nfe2l2 | Rat | apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [Cisplatin results in increased expression of NFE2L2 mRNA] | CTD | PMID:24291008 |
Nfe2l2 | Rat | apocynin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [acetovanillone co-treated with AGT protein] results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:27983965 |
Nfe2l2 | Rat | aprepitant | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Aprepitant inhibits the reaction [Rotenone results in decreased expression of NFE2L2 protein]] and Aprepitant inhibits the reaction [Rotenone results in decreased expression of NFE2L2 protein] | CTD | PMID:37224993 |
Nfe2l2 | Rat | arachidonic acid | multiple interactions | EXP | | 6480464 | NFE2L2 gene mutant form inhibits the reaction [Arachidonic Acid metabolite results in increased expression of HMOX1 protein] | CTD | PMID:27012417 |
Nfe2l2 | Rat | arachidonic acid | increases expression | EXP | | 6480464 | Arachidonic Acid metabolite results in increased expression of NFE2L2 protein | CTD | PMID:27012417 |
Nfe2l2 | Rat | arachidonyl-2'-chloroethylamide | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | arachidonyl-2-chloroethylamide results in decreased expression of NFE2L2 mRNA | CTD | PMID:26847930 |
Nfe2l2 | Rat | arachidonyl-2'-chloroethylamide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | FOXO1 protein affects the reaction [arachidonyl-2-chloroethylamide results in decreased expression of NFE2L2 mRNA] | CTD | PMID:26847930 |
Nfe2l2 | Rat | aristolochic acid A | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | aristolochic acid I results in decreased expression of and affects the localization of NFE2L2 protein more ... | CTD | PMID:24530882 |
Nfe2l2 | Rat | aristolochic acid A | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [aristolochic acid I results in decreased expression of NFE2L2 mRNA] and Curcumin inhibits the reaction [aristolochic acid I results in decreased expression of NFE2L2 protein] | CTD | PMID:36037877 |
Nfe2l2 | Rat | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of NFE2L2 mRNA and aristolochic acid I results in decreased expression of NFE2L2 protein | CTD | PMID:36037877 |
Nfe2l2 | Rat | aristolochic acid A | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | aristolochic acid I results in decreased expression of NFE2L2 mRNA | CTD | PMID:24530882 |
Nfe2l2 | Rat | aristolochic acids | decreases expression | EXP | | 6480464 | Aristolochic Acids results in decreased expression of NFE2L2 protein | CTD | PMID:32660364 |
Nfe2l2 | Rat | aristolochic acids | multiple interactions | EXP | | 6480464 | NFE2L2 protein affects the reaction [Aristolochic Acids results in decreased expression of HMOX1 protein] more ... | CTD | PMID:32660364 |
Nfe2l2 | Rat | Aroclor 1254 | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of NFE2L2 mRNA | CTD | PMID:17851650 |
Nfe2l2 | Rat | Aroclor 1254 | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of NFE2L2 mRNA | CTD | PMID:25270620 |
Nfe2l2 | Rat | Aroclor 1254 | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of NFE2L2 mRNA | CTD | PMID:23650126 |
Nfe2l2 | Rat | arsane | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Arsenic co-treated with Arsenic] results in increased expression of NFE2L2 protein more ... | CTD | PMID:14567983 more ... |
Nfe2l2 | Rat | arsane | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Arsenic results in increased expression of NFE2L2 mRNA | CTD | PMID:35490796 |
Nfe2l2 | Rat | arsane | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Arsenic results in decreased expression of NFE2L2 protein | CTD | PMID:35821281 |
Nfe2l2 | Rat | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:35598369 more ... |
Nfe2l2 | Rat | arsane | increases methylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | Arsenic results in increased methylation of NFE2L2 promoter | CTD | PMID:29247444 |
Nfe2l2 | Rat | arsane | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in decreased susceptibility to Arsenic | CTD | PMID:19538980 |
Nfe2l2 | Rat | arsane | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] which co-treated with biochanin A] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:23000044 more ... |
Nfe2l2 | Rat | arsane | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 mRNA affects the susceptibility to Arsenic and NFE2L2 protein affects the susceptibility to Arsenic | CTD | PMID:19786557 and PMID:23000044 |
Nfe2l2 | Rat | arsane | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Arsenic results in increased expression of NFE2L2 mRNA and Arsenic results in increased expression of NFE2L2 protein | CTD | PMID:19786557 more ... |
Nfe2l2 | Rat | arsane | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Arsenic results in increased activity of NFE2L2 protein | CTD | PMID:19808700 |
Nfe2l2 | Rat | arsane | affects binding | ISO | Nfe2l2 (Mus musculus) | 6480464 | Arsenic binds to NFE2L2 protein | CTD | PMID:19786557 |
Nfe2l2 | Rat | arsenic acid | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | arsenic acid affects the localization of NFE2L2 protein | CTD | PMID:19429247 |
Nfe2l2 | Rat | arsenic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Sodium Selenite promotes the reaction [arsenic acid affects the localization of NFE2L2 protein] | CTD | PMID:19429247 |
Nfe2l2 | Rat | arsenic atom | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in decreased susceptibility to Arsenic | CTD | PMID:19538980 |
Nfe2l2 | Rat | arsenic atom | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Arsenic results in decreased expression of NFE2L2 protein | CTD | PMID:35821281 |
Nfe2l2 | Rat | arsenic atom | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Arsenic results in increased expression of NFE2L2 mRNA | CTD | PMID:35490796 |
Nfe2l2 | Rat | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:35598369 more ... |
Nfe2l2 | Rat | arsenic atom | increases methylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | Arsenic results in increased methylation of NFE2L2 promoter | CTD | PMID:29247444 |
Nfe2l2 | Rat | arsenic atom | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Arsenic results in increased expression of NFE2L2 mRNA and Arsenic results in increased expression of NFE2L2 protein | CTD | PMID:19786557 more ... |
Nfe2l2 | Rat | arsenic atom | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] which co-treated with biochanin A] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:23000044 more ... |
Nfe2l2 | Rat | arsenic atom | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 mRNA affects the susceptibility to Arsenic and NFE2L2 protein affects the susceptibility to Arsenic | CTD | PMID:19786557 and PMID:23000044 |
Nfe2l2 | Rat | arsenic atom | affects binding | ISO | Nfe2l2 (Mus musculus) | 6480464 | Arsenic binds to NFE2L2 protein | CTD | PMID:19786557 |
Nfe2l2 | Rat | arsenic atom | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Arsenic results in increased activity of NFE2L2 protein | CTD | PMID:19808700 |
Nfe2l2 | Rat | arsenic atom | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Arsenic co-treated with Arsenic] results in increased expression of NFE2L2 protein more ... | CTD | PMID:14567983 more ... |
Nfe2l2 | Rat | arsenic trichloride | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [arsenic trichloride results in increased expression of NQO1 mRNA] | CTD | PMID:19276070 |
Nfe2l2 | Rat | arsenic trichloride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to ATF6 promoter] more ... | CTD | PMID:35625704 |
Nfe2l2 | Rat | arsenite(3-) | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1-methylpropyl-2-imidazolyl disulfide promotes the reaction [arsenite results in increased expression of NFE2L2 protein] more ... | CTD | PMID:18550526 more ... |
Nfe2l2 | Rat | arsenite(3-) | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | arsenite results in increased activity of NFE2L2 protein | CTD | PMID:25701757 and PMID:33412187 |
Nfe2l2 | Rat | arsenite(3-) | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | arsenite results in decreased expression of NFE2L2 mRNA and arsenite results in decreased expression of NFE2L2 protein | CTD | PMID:28688901 |
Nfe2l2 | Rat | arsenite(3-) | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | arsenite results in increased expression of NFE2L2 mRNA and arsenite results in increased expression of NFE2L2 protein | CTD | PMID:32980394 |
Nfe2l2 | Rat | arsenite(3-) | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to arsenite | CTD | PMID:22476201 |
Nfe2l2 | Rat | arsenite(3-) | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | arsenite results in increased expression of NFE2L2 mRNA and arsenite results in increased expression of NFE2L2 protein | CTD | PMID:22476201 more ... |
Nfe2l2 | Rat | arsenite(3-) | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | arsenite affects the localization of NFE2L2 protein | CTD | PMID:19429247 |
Nfe2l2 | Rat | arsenite(3-) | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Dexamethasone co-treated with arsenite] results in increased activity of NFE2L2 protein more ... | CTD | PMID:10473555 more ... |
Nfe2l2 | Rat | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of NFE2L2 mRNA and Arsenic Trioxide results in decreased expression of NFE2L2 protein | CTD | PMID:24327821 more ... |
Nfe2l2 | Rat | arsenous acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of and affects the localization of NFE2L2 protein more ... | CTD | PMID:19350554 more ... |
Nfe2l2 | Rat | arsenous acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:22488045 more ... |
Nfe2l2 | Rat | arsenous acid | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Arsenic Trioxide affects the localization of NFE2L2 protein | CTD | PMID:19350554 more ... |
Nfe2l2 | Rat | arsenous acid | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA results in decreased susceptibility to Arsenic Trioxide and NFE2L2 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:22684020 and PMID:26708503 |
Nfe2l2 | Rat | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of NFE2L2 mRNA and Arsenic Trioxide results in increased expression of NFE2L2 protein | CTD | PMID:27592447 more ... |
Nfe2l2 | Rat | arsenous acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of NFE2L2 mRNA and Arsenic Trioxide results in increased expression of NFE2L2 protein | CTD | PMID:22155346 more ... |
Nfe2l2 | Rat | arsenous acid | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of NFE2L2 protein | CTD | PMID:24157283 more ... |
Nfe2l2 | Rat | arsenous acid | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein] more ... | CTD | PMID:24327821 more ... |
Nfe2l2 | Rat | arsenous acid | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Arsenic Trioxide | CTD | PMID:20707922 |
Nfe2l2 | Rat | arsenous acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of NFE2L2 mRNA and Arsenic Trioxide results in increased expression of NFE2L2 protein | CTD | PMID:22488045 and PMID:26187899 |
Nfe2l2 | Rat | arsenous acid | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of NFE2L2 protein | CTD | PMID:22155346 and PMID:27561292 |
Nfe2l2 | Rat | artesunate | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | artesunate affects the localization of NFE2L2 protein | CTD | PMID:26340163 |
Nfe2l2 | Rat | asperuloside | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [asperuloside co-treated with Dextran Sulfate] results in increased expression of NFE2L2 protein more ... | CTD | PMID:33974900 |
Nfe2l2 | Rat | asperuloside | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | asperuloside affects the localization of NFE2L2 protein | CTD | PMID:33974900 |
Nfe2l2 | Rat | astaxanthin | multiple interactions | EXP | | 6480464 | [astaxanthine co-treated with Cyclophosphamide] results in increased expression of NFE2L2 protein more ... | CTD | PMID:20038455 and PMID:23272707 |
Nfe2l2 | Rat | astaxanthin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | astaxanthine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which affects the localization of NFE2L2 protein] | CTD | PMID:33008094 |
Nfe2l2 | Rat | astaxanthin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [astaxanthine co-treated with Docosahexaenoic Acids] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:24157545 and PMID:33212048 |
Nfe2l2 | Rat | astaxanthin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | astaxanthine results in increased expression of NFE2L2 mRNA | CTD | PMID:24157545 and PMID:33212048 |
Nfe2l2 | Rat | astaxanthin | increases expression | EXP | | 6480464 | astaxanthine results in increased expression of NFE2L2 protein | CTD | PMID:20038455 |
Nfe2l2 | Rat | astilbin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | astilbin promotes the reaction [Cisplatin affects the localization of NFE2L2 protein] | CTD | PMID:29471006 |
Nfe2l2 | Rat | astilbin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | astilbin promotes the reaction [Cisplatin results in increased expression of NFE2L2 protein] | CTD | PMID:29471006 |
Nfe2l2 | Rat | astragaloside IV | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [astragaloside A co-treated with ginsenoside Rg1 co-treated with ginsenoside Rb1 co-treated with notoginsenoside R1] affects the localization of NFE2L2 protein | CTD | PMID:25422538 |
Nfe2l2 | Rat | astragaloside IV | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | astragaloside A affects the localization of NFE2L2 protein | CTD | PMID:25422538 |
Nfe2l2 | Rat | Atipamezole | multiple interactions | EXP | | 6480464 | atipamezole inhibits the reaction [Dexmedetomidine inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in decreased expression of NFE2L2 protein]] | CTD | PMID:30597158 |
Nfe2l2 | Rat | atorvastatin calcium | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Atorvastatin results in increased expression of NFE2L2 mRNA | CTD | PMID:30511338 |
Nfe2l2 | Rat | atorvastatin calcium | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Atorvastatin results in increased expression of NFE2L2 mRNA | CTD | PMID:38484826 |
Nfe2l2 | Rat | atorvastatin calcium | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Atorvastatin results in decreased expression of NFE2L2 protein | CTD | PMID:31423616 |
Nfe2l2 | Rat | atorvastatin calcium | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone inhibits the reaction [Atorvastatin results in decreased expression of NFE2L2 protein] and Atorvastatin results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein | CTD | PMID:31423616 and PMID:38484826 |
Nfe2l2 | Rat | atorvastatin calcium | multiple interactions | EXP | | 6480464 | [Atorvastatin co-treated with dapagliflozin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of NFE2L2 protein] and Atorvastatin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of NFE2L2 protein] | CTD | PMID:32259528 |
Nfe2l2 | Rat | atorvastatin calcium | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [PPARGC1B protein affects the susceptibility to Atorvastatin] which affects the expression of NFE2L2 mRNA and Atorvastatin inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of NFE2L2 protein] | CTD | PMID:30511338 and PMID:32976958 |
Nfe2l2 | Rat | ATP | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Lipopolysaccharides co-treated with Adenosine Triphosphate] affects the localization of NFE2L2 protein more ... | CTD | PMID:34217685 and PMID:38135199 |
Nfe2l2 | Rat | atrazine | multiple interactions | EXP | | 6480464 | lycopene promotes the reaction [Atrazine results in increased expression of NFE2L2 mRNA] | CTD | PMID:27102619 |
Nfe2l2 | Rat | atrazine | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Atrazine affects the expression of NFE2L2 mRNA and Atrazine affects the expression of NFE2L2 protein | CTD | PMID:34624533 |
Nfe2l2 | Rat | atrazine | affects expression | EXP | | 6480464 | Atrazine affects the expression of NFE2L2 mRNA and Atrazine affects the expression of NFE2L2 protein | CTD | PMID:34624533 |
Nfe2l2 | Rat | atrazine | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Atrazine affects the localization of NFE2L2 protein | CTD | PMID:36216167 |
Nfe2l2 | Rat | atrazine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Atrazine affects the localization of NFE2L2 protein] more ... | CTD | PMID:30360616 and PMID:36216167 |
Nfe2l2 | Rat | atrazine | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Atrazine results in increased expression of NFE2L2 mRNA and Atrazine results in increased expression of NFE2L2 protein | CTD | PMID:30360616 and PMID:36216167 |
Nfe2l2 | Rat | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of NFE2L2 mRNA | CTD | PMID:27102619 and PMID:33715114 |
Nfe2l2 | Rat | auranofin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Auranofin promotes the reaction [arsenite results in increased expression of NFE2L2 protein] | CTD | PMID:36343453 |
Nfe2l2 | Rat | auraptene | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to aurapten | CTD | PMID:19150646 |
Nfe2l2 | Rat | aureusidin | increases expression | EXP | | 6480464 | aureusidin results in increased expression of NFE2L2 mRNA | CTD | PMID:31790703 |
Nfe2l2 | Rat | aureusidin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | aureusidin results in increased expression of NFE2L2 mRNA | CTD | PMID:38056806 |
Nfe2l2 | Rat | aureusidin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | aureusidin affects the localization of NFE2L2 protein | CTD | PMID:38056806 |
Nfe2l2 | Rat | aureusidin | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [aureusidin affects the localization of NFE2L2 protein] more ... | CTD | PMID:31790703 |
Nfe2l2 | Rat | azathioprine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Azathioprine results in increased activity of NQO1 protein] | CTD | PMID:21803983 |
Nfe2l2 | Rat | Azoxymethane | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to [Azoxymethane co-treated with Dextran Sulfate] more ... | CTD | PMID:21355597 more ... |
Nfe2l2 | Rat | bafilomycin A1 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | bafilomycin A1 promotes the reaction [[Particulate Matter co-treated with Vitamin D] results in increased expression of NFE2L2 protein] more ... | CTD | PMID:30698894 |
Nfe2l2 | Rat | bafilomycin A1 | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | bafilomycin A1 results in increased expression of NFE2L2 protein | CTD | PMID:30698894 |
Nfe2l2 | Rat | baicalin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] affects the localization of NFE2L2 protein more ... | CTD | PMID:38016618 |
Nfe2l2 | Rat | BAPTA | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:21443188 |
Nfe2l2 | Rat | BAPTA | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:21443188 |
Nfe2l2 | Rat | Bardoxolone methyl | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | bardoxolone methyl inhibits the reaction [eriodictyol results in decreased phosphorylation of NFE2L2 protein] more ... | CTD | PMID:27358234 more ... |
Nfe2l2 | Rat | Bardoxolone methyl | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | bardoxolone methyl results in increased localization of NFE2L2 protein | CTD | PMID:21723306 |
Nfe2l2 | Rat | Bardoxolone methyl | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | bardoxolone methyl results in increased expression of NFE2L2 mRNA and bardoxolone methyl results in increased expression of NFE2L2 protein | CTD | PMID:21289052 and PMID:24530882 |
Nfe2l2 | Rat | Bardoxolone methyl | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in decreased susceptibility to bardoxolone methyl | CTD | PMID:27633142 |
Nfe2l2 | Rat | Bardoxolone methyl | increases activity | EXP | | 6480464 | bardoxolone methyl results in increased activity of NFE2L2 protein | CTD | PMID:24798383 |
Nfe2l2 | Rat | Bardoxolone methyl | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | bardoxolone methyl inhibits the reaction [aristolochic acid I results in decreased expression of and affects the localization of NFE2L2 protein] and bardoxolone methyl inhibits the reaction [aristolochic acid I results in decreased expression of NFE2L2 mRNA] | CTD | PMID:24530882 |
Nfe2l2 | Rat | Bardoxolone methyl | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | bardoxolone methyl results in increased expression of NFE2L2 protein | CTD | PMID:25246272 and PMID:27358234 |
Nfe2l2 | Rat | bathocuproine disulfonic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of NFE2L2 mRNA | CTD | PMID:15477007 |
Nfe2l2 | Rat | bendiocarb | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | bendiocarb results in increased activity of NFE2L2 protein | CTD | PMID:20143881 |
Nfe2l2 | Rat | benfotiamine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [benphothiamine metabolite results in increased expression of GCLM mRNA] more ... | CTD | PMID:29860433 |
Nfe2l2 | Rat | benzene | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Benzene results in increased expression of NFE2L2 mRNA | CTD | PMID:36306860 |
Nfe2l2 | Rat | benzene | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Benzene affects the localization of NFE2L2 protein | CTD | PMID:35661779 |
Nfe2l2 | Rat | benzene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Benzene results in increased expression of and affects the localization of NFE2L2 protein and shikonin inhibits the reaction [Benzene results in increased expression of and affects the localization of NFE2L2 protein] | CTD | PMID:36306860 |
Nfe2l2 | Rat | benzo[a]pyrene | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Benzo(a)pyrene affects the localization of NFE2L2 protein] more ... | CTD | PMID:21256954 more ... |
Nfe2l2 | Rat | benzo[a]pyrene | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the localization of NFE2L2 protein | CTD | PMID:35405071 |
Nfe2l2 | Rat | benzo[a]pyrene | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | benzo[a]pyrene | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of NFE2L2 protein | CTD | PMID:26546711 and PMID:35777681 |
Nfe2l2 | Rat | benzo[a]pyrene | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in decreased susceptibility to Benzo(a)pyrene | CTD | PMID:23056183 |
Nfe2l2 | Rat | benzo[a]pyrene | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Benzo(a)pyrene metabolite results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:15034205 more ... |
Nfe2l2 | Rat | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of NFE2L2 mRNA and Benzo(a)pyrene results in increased expression of NFE2L2 protein | CTD | PMID:19497421 and PMID:36736873 |
Nfe2l2 | Rat | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA] | CTD | PMID:19497421 |
Nfe2l2 | Rat | benzo[a]pyrene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Benzo(a)pyrene results in increased activity of AHR protein] which results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:11961136 more ... |
Nfe2l2 | Rat | benzo[a]pyrene | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of NFE2L2 mRNA and Benzo(a)pyrene results in increased expression of NFE2L2 protein | CTD | PMID:20106945 more ... |
Nfe2l2 | Rat | benzo[a]pyrene | affects activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the activity of NFE2L2 protein | CTD | PMID:20624995 |
Nfe2l2 | Rat | benzo[a]pyrene diol epoxide I | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Deferoxamine inhibits the reaction [7 more ... | CTD | PMID:36450496 |
Nfe2l2 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:36450496 |
Nfe2l2 | Rat | Benzo[k]fluoranthene | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | benzo(k)fluoranthene results in increased expression of NFE2L2 mRNA | CTD | PMID:26377693 |
Nfe2l2 | Rat | benzopyran | multiple interactions | EXP | | 6480464 | Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of NFE2L2 protein] | CTD | PMID:25154877 |
Nfe2l2 | Rat | benzoquinones | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Benzoquinones analog results in increased activity of and affects the localization of NFE2L2 protein | CTD | PMID:21651925 |
Nfe2l2 | Rat | benzoquinones | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Benzoquinones analog | CTD | PMID:21651925 |
Nfe2l2 | Rat | benzyl isothiocyanate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | benzyl isothiocyanate results in increased expression of and affects the localization of NFE2L2 protein more ... | CTD | PMID:20932822 and PMID:28821405 |
Nfe2l2 | Rat | benzyl isothiocyanate | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in increased susceptibility to benzyl isothiocyanate | CTD | PMID:28821405 |
Nfe2l2 | Rat | benzyl isothiocyanate | increases expression | EXP | | 6480464 | benzyl isothiocyanate results in increased expression of NFE2L2 protein | CTD | PMID:22664424 |
Nfe2l2 | Rat | benzyl isothiocyanate | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to benzyl isothiocyanate | CTD | PMID:19303893 |
Nfe2l2 | Rat | beraprost | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | beraprost inhibits the reaction [[Galactosamine co-treated with lipopolysaccharide and E coli O55-B5] results in increased expression of NFE2L2 mRNA] | CTD | PMID:28887131 |
Nfe2l2 | Rat | berberine | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Berberine results in increased expression of NFE2L2 protein | CTD | PMID:23954465 |
Nfe2l2 | Rat | berberine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Berberine inhibits the reaction [Particulate Matter results in decreased expression of NFE2L2 protein] | CTD | PMID:37839514 |
Nfe2l2 | Rat | berberine | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Berberine results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | berberine | multiple interactions | EXP | | 6480464 | Berberine inhibits the reaction [Bortezomib results in increased expression of NFE2L2 mRNA] and Berberine promotes the reaction [Bleomycin results in increased expression of NFE2L2 protein] | CTD | PMID:23523906 and PMID:35121005 |
Nfe2l2 | Rat | berberine | increases expression | EXP | | 6480464 | Berberine results in increased expression of NFE2L2 protein | CTD | PMID:23523906 |
Nfe2l2 | Rat | berberine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mutant form inhibits the reaction [Berberine inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]] more ... | CTD | PMID:23954465 |
Nfe2l2 | Rat | Bergenin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | bergenin affects the reaction [Pyruvaldehyde affects the expression of NFE2L2 protein] more ... | CTD | PMID:29148590 and PMID:38735593 |
Nfe2l2 | Rat | Bergenin | multiple interactions | EXP | | 6480464 | [Cadmium co-treated with bergenin] results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:37949422 |
Nfe2l2 | Rat | beta-carboline | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | norharman results in increased expression of NFE2L2 protein | CTD | PMID:35985368 |
Nfe2l2 | Rat | beta-naphthoflavone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in increased expression of NFE2L2 protein | CTD | PMID:12446695 |
Nfe2l2 | Rat | beta-propiolactone | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Propiolactone | CTD | PMID:20932822 |
Nfe2l2 | Rat | beta-tocopherol | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] | CTD | PMID:22389237 |
Nfe2l2 | Rat | Betanin | multiple interactions | EXP | | 6480464 | 6-chloro-2 more ... | CTD | PMID:33661552 |
Nfe2l2 | Rat | betulin | multiple interactions | EXP | | 6480464 | betulin inhibits the reaction [9 more ... | CTD | PMID:33759307 |
Nfe2l2 | Rat | bezafibrate | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Bezafibrate results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | bifenthrin | decreases expression | EXP | | 6480464 | bifenthrin results in decreased expression of NFE2L2 mRNA and bifenthrin results in decreased expression of NFE2L2 protein | CTD | PMID:29775722 |
Nfe2l2 | Rat | bifenthrin | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | bifenthrin results in decreased expression of NFE2L2 mRNA and bifenthrin results in decreased expression of NFE2L2 protein | CTD | PMID:32061760 |
Nfe2l2 | Rat | bifenthrin | increases expression | EXP | | 6480464 | bifenthrin results in increased expression of NFE2L2 mRNA and bifenthrin results in increased expression of NFE2L2 protein | CTD | PMID:29793499 and PMID:30102949 |
Nfe2l2 | Rat | bilirubin IXalpha | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Bilirubin affects the localization of NFE2L2 protein | CTD | PMID:23628428 |
Nfe2l2 | Rat | bilirubin IXalpha | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Bilirubin promotes the reaction [NFE2L2 protein results in increased expression of CYP2A5 mRNA] | CTD | PMID:23628428 |
Nfe2l2 | Rat | biochanin A | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] which co-treated with biochanin A] results in increased expression of NFE2L2 mRNA | CTD | PMID:33410021 |
Nfe2l2 | Rat | biphenyl-4-amine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 4-biphenylamine results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:25601990 |
Nfe2l2 | Rat | bis(2-chloroethyl) sulfide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Mustard Gas results in increased expression of NFE2L2 mRNA | CTD | PMID:15674844 and PMID:18955075 |
Nfe2l2 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of NFE2L2 mRNA and Diethylhexyl Phthalate results in decreased expression of NFE2L2 protein | CTD | PMID:31923814 more ... |
Nfe2l2 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of NFE2L2 mRNA | CTD | PMID:36438553 |
Nfe2l2 | Rat | bis(2-ethylhexyl) phthalate | increases methylation | EXP | | 6480464 | Diethylhexyl Phthalate results in increased methylation of NFE2L2 mRNA | CTD | PMID:31923814 |
Nfe2l2 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:35917956 more ... |
Nfe2l2 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of NFE2L2 mRNA and Diethylhexyl Phthalate results in increased expression of NFE2L2 protein | CTD | PMID:35917956 more ... |
Nfe2l2 | Rat | bis(2-ethylhexyl) phthalate | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate affects the expression of NFE2L2 protein | CTD | PMID:34822940 |
Nfe2l2 | Rat | bis(2-ethylhexyl) phthalate | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of NFE2L2 mRNA and Diethylhexyl Phthalate results in decreased expression of NFE2L2 protein | CTD | PMID:31112013 |
Nfe2l2 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 protein] more ... | CTD | PMID:26361869 more ... |
Nfe2l2 | Rat | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of NFE2L2 mRNA and Diethylhexyl Phthalate results in increased expression of NFE2L2 protein | CTD | PMID:22672789 more ... |
Nfe2l2 | Rat | bisdemethoxycurcumin | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | bisdemethoxycurcumin affects the localization of NFE2L2 protein | CTD | PMID:17535857 |
Nfe2l2 | Rat | bisdemethoxycurcumin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [demethoxycurcumin co-treated with bisdemethoxycurcumin] affects the localization of NFE2L2 protein and NFE2L2 protein affects the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 mRNA] | CTD | PMID:17535857 |
Nfe2l2 | Rat | bisphenol A | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of NFE2L2 mRNA and bisphenol A results in increased expression of NFE2L2 protein | CTD | PMID:23360430 more ... |
Nfe2l2 | Rat | bisphenol A | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of NFE2L2 protein | CTD | PMID:34664771 more ... |
Nfe2l2 | Rat | bisphenol A | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of NFE2L2 mRNA and bisphenol A results in decreased expression of NFE2L2 protein | CTD | PMID:33221593 more ... |
Nfe2l2 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | Fluvastatin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:31091348 more ... |
Nfe2l2 | Rat | bisphenol A | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | bisphenol A results in increased activity of NFE2L2 protein | CTD | PMID:36534918 |
Nfe2l2 | Rat | bisphenol A | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | bisphenol A affects the expression of NFE2L2 mRNA | CTD | PMID:30903817 |
Nfe2l2 | Rat | bisphenol A | decreases phosphorylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | bisphenol A results in decreased phosphorylation of NFE2L2 protein | CTD | PMID:29275510 |
Nfe2l2 | Rat | bisphenol A | affects methylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | bisphenol A affects the methylation of NFE2L2 promoter | CTD | PMID:27334623 |
Nfe2l2 | Rat | bisphenol A | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(1 more ... | CTD | PMID:28796629 more ... |
Nfe2l2 | Rat | bisphenol A | decreases methylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of NFE2L2 promoter | CTD | PMID:28796629 |
Nfe2l2 | Rat | bisphenol A | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of NFE2L2 mRNA and bisphenol A results in increased expression of NFE2L2 protein | CTD | PMID:28796629 and PMID:34281243 |
Nfe2l2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A analog results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:27208089 more ... |
Nfe2l2 | Rat | bisphenol A | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(7-(3 more ... | CTD | PMID:33408296 more ... |
Nfe2l2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NFE2L2 mRNA | CTD | PMID:25181051 |
Nfe2l2 | Rat | bisphenol A | increases stability | ISO | NFE2L2 (Homo sapiens) | 6480464 | bisphenol A results in increased stability of NFE2L2 protein modified form | CTD | PMID:23360430 |
Nfe2l2 | Rat | Bisphenol A diglycidyl ether | multiple interactions | EXP | | 6480464 | bisphenol A diglycidyl ether inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA]] | CTD | PMID:36249937 |
Nfe2l2 | Rat | bisphenol AF | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | bisphenol AF results in decreased expression of NFE2L2 protein | CTD | PMID:38043716 |
Nfe2l2 | Rat | bisphenol F | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | bisphenol F results in increased activity of NFE2L2 protein | CTD | PMID:36534918 |
Nfe2l2 | Rat | bisphenol F | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of NFE2L2 mRNA | CTD | PMID:38685157 |
Nfe2l2 | Rat | bixin | decreases ubiquitination | ISO | NFE2L2 (Homo sapiens) | 6480464 | bixin results in decreased ubiquitination of NFE2L2 protein | CTD | PMID:30698894 |
Nfe2l2 | Rat | bleomycin A2 | multiple interactions | EXP | | 6480464 | Berberine promotes the reaction [Bleomycin results in increased expression of NFE2L2 protein] more ... | CTD | PMID:23523906 more ... |
Nfe2l2 | Rat | bleomycin A2 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ephedrine inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein] | CTD | PMID:37778983 |
Nfe2l2 | Rat | bleomycin A2 | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Bleomycin results in decreased expression of NFE2L2 protein | CTD | PMID:37778983 |
Nfe2l2 | Rat | bleomycin A2 | decreases expression | EXP | | 6480464 | Bleomycin results in decreased expression of NFE2L2 mRNA and Bleomycin results in decreased expression of NFE2L2 protein | CTD | PMID:26093215 and PMID:26768587 |
Nfe2l2 | Rat | bleomycin A2 | increases expression | EXP | | 6480464 | Bleomycin results in increased expression of NFE2L2 protein | CTD | PMID:23523906 |
Nfe2l2 | Rat | bleomycin A2 | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Bleomycin affects the localization of NFE2L2 protein | CTD | PMID:23570914 |
Nfe2l2 | Rat | bleomycin A2 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | caffeic acid phenethyl ester inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:23570914 |
Nfe2l2 | Rat | bleomycin A2 | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Bleomycin results in decreased expression of NFE2L2 protein | CTD | PMID:23570914 |
Nfe2l2 | Rat | bleomycin A2 | increases phosphorylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | Bleomycin results in increased phosphorylation of NFE2L2 protein | CTD | PMID:23570914 |
Nfe2l2 | Rat | boric acid | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | boric acid affects the localization of NFE2L2 protein | CTD | PMID:30196486 |
Nfe2l2 | Rat | boric acid | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | boric acid affects the localization of NFE2L2 protein | CTD | PMID:30196486 |
Nfe2l2 | Rat | boric acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | EIF2AK3 protein affects the reaction [boric acid affects the localization of NFE2L2 protein] | CTD | PMID:30196486 |
Nfe2l2 | Rat | bortezomib | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Bortezomib results in increased expression of NFE2L2 protein] which results in increased expression of CBR3 mRNA and Bortezomib results in increased expression of NFE2L2 protein | CTD | PMID:20806931 |
Nfe2l2 | Rat | bortezomib | multiple interactions | EXP | | 6480464 | Berberine inhibits the reaction [Bortezomib results in increased expression of NFE2L2 mRNA] | CTD | PMID:35121005 |
Nfe2l2 | Rat | bortezomib | increases expression | EXP | | 6480464 | Bortezomib results in increased expression of NFE2L2 mRNA | CTD | PMID:35121005 |
Nfe2l2 | Rat | bortezomib | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Bortezomib results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | brefeldin A | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Brefeldin A inhibits the reaction [sodium arsenite results in increased activity of NFE2L2 protein] | CTD | PMID:20805060 |
Nfe2l2 | Rat | bromobenzene | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | bromobenzene results in increased localization of NFE2L2 protein | CTD | PMID:18078705 |
Nfe2l2 | Rat | bromobenzene | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | bromobenzene analog results in increased expression of NFE2L2 protein | CTD | PMID:19427879 |
Nfe2l2 | Rat | Bromochloroacetonitrile | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to bromochloroacetonitrile | CTD | PMID:35842135 |
Nfe2l2 | Rat | Bromochloroacetonitrile | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | bromochloroacetonitrile results in increased expression of NFE2L2 mRNA and bromochloroacetonitrile results in increased expression of NFE2L2 protein | CTD | PMID:35842135 |
Nfe2l2 | Rat | bromocriptine | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Bromocriptine results in increased localization of NFE2L2 protein | CTD | PMID:21867702 |
Nfe2l2 | Rat | bromosulfophthalein | affects abundance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the abundance of Sulfobromophthalein | CTD | PMID:19246623 |
Nfe2l2 | Rat | bromosulfophthalein | increases transport | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in increased transport of Sulfobromophthalein | CTD | PMID:19246623 |
Nfe2l2 | Rat | bromosulfophthalein | increases glutathionylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in increased glutathionylation of Sulfobromophthalein | CTD | PMID:19246623 |
Nfe2l2 | Rat | Brusatol | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | brusatol results in decreased expression of NFE2L2 protein | CTD | PMID:27639429 more ... |
Nfe2l2 | Rat | Brusatol | multiple interactions | EXP | | 6480464 | brusatol inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which affects the localization of NFE2L2 protein] | CTD | PMID:34695510 |
Nfe2l2 | Rat | Brusatol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [brusatol results in increased ubiquitination of and results in increased degradation of NFE2L2 protein] which results in increased susceptibility to Cisplatin more ... | CTD | PMID:21205897 more ... |
Nfe2l2 | Rat | bucladesine | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Bucladesine | CTD | PMID:22859313 |
Nfe2l2 | Rat | bucladesine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 gene mutant form results in increased susceptibility to Bucladesine] which results in increased expression of ALAS1 mRNA more ... | CTD | PMID:22859313 |
Nfe2l2 | Rat | buspirone | decreases expression | EXP | | 6480464 | Buspirone results in decreased expression of NFE2L2 mRNA | CTD | PMID:24136188 |
Nfe2l2 | Rat | buspirone | multiple interactions | EXP | | 6480464 | Buspirone inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA] | CTD | PMID:37341015 |
Nfe2l2 | Rat | buspirone | increases expression | EXP | | 6480464 | Buspirone results in increased expression of NFE2L2 mRNA | CTD | PMID:37341015 |
Nfe2l2 | Rat | busulfan | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Deferoxamine inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:32416107 |
Nfe2l2 | Rat | busulfan | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Busulfan results in increased expression of NFE2L2 mRNA | CTD | PMID:35641671 |
Nfe2l2 | Rat | busulfan | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Busulfan results in decreased expression of NFE2L2 protein | CTD | PMID:32416107 |
Nfe2l2 | Rat | but-2-en-4-olide | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | butenolide results in increased activity of NFE2L2 protein | CTD | PMID:30244016 |
Nfe2l2 | Rat | butane-2,3-dione | affects localization | EXP | | 6480464 | Diacetyl affects the localization of NFE2L2 protein | CTD | PMID:25145656 |
Nfe2l2 | Rat | butein | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | butein affects the localization of NFE2L2 protein | CTD | PMID:23318726 |
Nfe2l2 | Rat | butylated hydroxyanisole | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Butylated Hydroxyanisole results in increased stability of and results in increased expression of NFE2L2 protein | CTD | PMID:22530035 |
Nfe2l2 | Rat | butylated hydroxyanisole | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Butylated Hydroxyanisole | CTD | PMID:30844440 |
Nfe2l2 | Rat | butylated hydroxyanisole | multiple interactions | EXP | | 6480464 | Butylated Hydroxyanisole inhibits the reaction [Estradiol inhibits the reaction [NFE2L2 protein binds to SOD3 promoter]] | CTD | PMID:23027624 |
Nfe2l2 | Rat | butylated hydroxyanisole | increases expression | EXP | | 6480464 | Butylated Hydroxyanisole results in increased expression of NFE2L2 protein | CTD | PMID:23027624 |
Nfe2l2 | Rat | butylated hydroxyanisole | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Butylated Hydroxyanisole results in increased activity of NFE2L2 protein] which results in increased expression of ABCC2 mRNA more ... | CTD | PMID:11895860 more ... |
Nfe2l2 | Rat | butylated hydroxyanisole | affects activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Butylated Hydroxyanisole affects the activity of NFE2L2 protein | CTD | PMID:11309284 |
Nfe2l2 | Rat | Butylbenzyl phthalate | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | butylbenzyl phthalate results in decreased expression of NFE2L2 mRNA | CTD | PMID:27923775 |
Nfe2l2 | Rat | Butylbenzyl phthalate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:37021957 more ... |
Nfe2l2 | Rat | butyric acid | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Butyric Acid results in decreased expression of NFE2L2 mRNA | CTD | PMID:30439556 |
Nfe2l2 | Rat | butyric acid | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Butyric Acid results in decreased expression of NFE2L2 mRNA | CTD | PMID:37341073 |
Nfe2l2 | Rat | C.I. Natural Red 20 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | shikonin inhibits the reaction [Benzene results in increased expression of and affects the localization of NFE2L2 protein] | CTD | PMID:36306860 |
Nfe2l2 | Rat | cadmium acetate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [cadmium acetate results in increased expression of NFE2L2 protein] and cadmium acetate results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:21787718 |
Nfe2l2 | Rat | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of NFE2L2 mRNA more ... | CTD | PMID:17573173 more ... |
Nfe2l2 | Rat | cadmium atom | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cadmium results in decreased expression of NFE2L2 mRNA | CTD | PMID:37270049 |
Nfe2l2 | Rat | cadmium atom | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Cadmium | CTD | PMID:38896780 |
Nfe2l2 | Rat | cadmium atom | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cadmium results in increased localization of NFE2L2 protein | CTD | PMID:31756223 |
Nfe2l2 | Rat | cadmium atom | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cadmium results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | cadmium atom | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in decreased susceptibility to Cadmium | CTD | PMID:23056183 |
Nfe2l2 | Rat | cadmium atom | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to [Cadmium Chloride results in increased abundance of Cadmium]] which affects the activity of GPT protein more ... | CTD | PMID:10473555 more ... |
Nfe2l2 | Rat | cadmium atom | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cadmium affects the localization of NFE2L2 protein | CTD | PMID:16959797 |
Nfe2l2 | Rat | cadmium atom | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NFE2L2 protein more ... | CTD | PMID:16959797 more ... |
Nfe2l2 | Rat | cadmium atom | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cadmium results in increased activity of NFE2L2 promoter and Cadmium results in increased activity of NFE2L2 protein | CTD | PMID:21172416 and PMID:21643505 |
Nfe2l2 | Rat | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of NFE2L2 mRNA and Cadmium results in increased expression of NFE2L2 protein | CTD | PMID:21787725 more ... |
Nfe2l2 | Rat | cadmium dichloride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NFE2L2 protein more ... | CTD | PMID:10874044 more ... |
Nfe2l2 | Rat | cadmium dichloride | affects activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cadmium Chloride affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | cadmium dichloride | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of NFE2L2 mRNA | CTD | PMID:25596134 |
Nfe2l2 | Rat | cadmium dichloride | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cadmium Chloride affects the localization of NFE2L2 protein | CTD | PMID:16959797 more ... |
Nfe2l2 | Rat | cadmium dichloride | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of NFE2L2 protein | CTD | PMID:15878868 more ... |
Nfe2l2 | Rat | cadmium dichloride | decreases response to substance | EXP | | 6480464 | NFE2L2 protein results in decreased susceptibility to Cadmium Chloride | CTD | PMID:19682480 |
Nfe2l2 | Rat | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of NFE2L2 mRNA more ... | CTD | PMID:19682480 more ... |
Nfe2l2 | Rat | cadmium dichloride | increases activity | EXP | | 6480464 | Cadmium Chloride results in increased activity of NFE2L2 protein | CTD | PMID:19682480 and PMID:34405727 |
Nfe2l2 | Rat | cadmium dichloride | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Cadmium Chloride | CTD | PMID:19303893 |
Nfe2l2 | Rat | cadmium dichloride | increases stability | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cadmium Chloride results in increased stability of NFE2L2 protein | CTD | PMID:12441344 |
Nfe2l2 | Rat | cadmium dichloride | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Cadmium Chloride and NFE2L2 results in decreased susceptibility to Cadmium Chloride | CTD | PMID:18367636 more ... |
Nfe2l2 | Rat | cadmium dichloride | affects ubiquitination | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cadmium Chloride affects the ubiquitination of NFE2L2 protein | CTD | PMID:18512965 |
Nfe2l2 | Rat | cadmium dichloride | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cadmium Chloride results in increased localization of NFE2L2 protein | CTD | PMID:17303623 |
Nfe2l2 | Rat | cadmium dichloride | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:10874044 more ... |
Nfe2l2 | Rat | cadmium telluride | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | cadmium telluride analog results in increased activity of NFE2L2 protein | CTD | PMID:23485651 |
Nfe2l2 | Rat | cafestol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [cafestol co-treated with kahweol palmitate] affects the activity of NFE2L2 protein more ... | CTD | PMID:11309284 and PMID:18028974 |
Nfe2l2 | Rat | cafestol | multiple interactions | EXP | | 6480464 | [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased activity of NFE2L2 protein] | CTD | PMID:17110534 |
Nfe2l2 | Rat | caffeine | decreases expression | EXP | | 6480464 | Caffeine results in decreased expression of NFE2L2 mRNA and Caffeine results in decreased expression of NFE2L2 protein | CTD | PMID:34590332 |
Nfe2l2 | Rat | calciol | multiple interactions | EXP | | 6480464 | Cholecalciferol inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:29653100 more ... |
Nfe2l2 | Rat | calciol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Cholecalciferol co-treated with Dextran Sulfate] results in increased expression of NFE2L2 protein | CTD | PMID:33974900 |
Nfe2l2 | Rat | calcitriol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of NFE2L2 mRNA | CTD | PMID:12040012 |
Nfe2l2 | Rat | calcitriol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Calcitriol inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of NFE2L2 protein] | CTD | PMID:36321694 |
Nfe2l2 | Rat | calcium atom | increases abundance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased abundance of Calcium | CTD | PMID:29618784 |
Nfe2l2 | Rat | calcium(0) | increases abundance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased abundance of Calcium | CTD | PMID:29618784 |
Nfe2l2 | Rat | calycosin | multiple interactions | EXP | | 6480464 | 7 and 3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of NFE2L2 protein] | CTD | PMID:31726037 |
Nfe2l2 | Rat | calyculin a | decreases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | calyculin A results in decreased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | camphor | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFE2L2 mRNA | CTD | PMID:38000518 |
Nfe2l2 | Rat | camptothecin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Camptothecin results in increased expression of TERT mRNA] | CTD | PMID:30851366 |
Nfe2l2 | Rat | camptothecin | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Camptothecin results in increased activity of NFE2L2 protein | CTD | PMID:30851366 |
Nfe2l2 | Rat | cannabidiol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Cannabidiol results in increased expression of HMOX1 protein] | CTD | PMID:32708634 |
Nfe2l2 | Rat | cannabidiol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cannabidiol results in increased expression of NFE2L2 mRNA and Cannabidiol results in increased expression of NFE2L2 protein | CTD | PMID:27714895 more ... |
Nfe2l2 | Rat | capsaicin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Capsaicin results in increased localization of NFE2L2 protein] | CTD | PMID:17979524 |
Nfe2l2 | Rat | capsaicin | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Capsaicin results in increased localization of NFE2L2 protein | CTD | PMID:17979524 |
Nfe2l2 | Rat | carbamazepine | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of NFE2L2 mRNA | CTD | PMID:25979313 |
Nfe2l2 | Rat | carbamazepine | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Carbamazepine results in increased activity of NFE2L2 protein | CTD | PMID:24752500 |
Nfe2l2 | Rat | carbendazim | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | carbendazim results in increased expression of NFE2L2 protein | CTD | PMID:30851412 |
Nfe2l2 | Rat | carbendazim | multiple interactions | EXP | | 6480464 | Chitosan inhibits the reaction [carbendazim results in decreased expression of NFE2L2 mRNA] | CTD | PMID:35705592 |
Nfe2l2 | Rat | carbendazim | decreases expression | EXP | | 6480464 | carbendazim results in decreased expression of NFE2L2 mRNA | CTD | PMID:35705592 |
Nfe2l2 | Rat | carbimazole | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Carbimazole results in decreased expression of NFE2L2 mRNA] | CTD | PMID:38342389 |
Nfe2l2 | Rat | carbimazole | decreases expression | EXP | | 6480464 | Carbimazole results in decreased expression of NFE2L2 mRNA | CTD | PMID:38342389 |
Nfe2l2 | Rat | carbon disulfide | affects localization | EXP | | 6480464 | Carbon Disulfide affects the localization of NFE2L2 protein | CTD | PMID:27530093 |
Nfe2l2 | Rat | carbon monoxide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Carbon Monoxide inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] more ... | CTD | PMID:18845810 |
Nfe2l2 | Rat | carbon monoxide | increases expression | EXP | | 6480464 | Carbon Monoxide results in increased expression of NFE2L2 mRNA and Carbon Monoxide results in increased expression of NFE2L2 protein | CTD | PMID:25348283 and PMID:34032369 |
Nfe2l2 | Rat | carbon monoxide | multiple interactions | EXP | | 6480464 | [NFE2L2 protein co-treated with Carbon Monoxide] results in increased expression of GCLC mRNA more ... | CTD | PMID:25348283 and PMID:34032369 |
Nfe2l2 | Rat | carbon monoxide | increases localization | EXP | | 6480464 | Carbon Monoxide results in increased localization of NFE2L2 protein | CTD | PMID:18845810 |
Nfe2l2 | Rat | carbon monoxide | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Carbon Monoxide results in increased localization of NFE2L2 protein | CTD | PMID:18845810 |
Nfe2l2 | Rat | carbon monoxide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Carbon Monoxide results in increased expression of NFE2L2 mRNA | CTD | PMID:18845810 |
Nfe2l2 | Rat | carbon monoxide | decreases phosphorylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | Carbon Monoxide results in decreased phosphorylation of NFE2L2 protein | CTD | PMID:18845810 |
Nfe2l2 | Rat | carfilzomib | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | carfilzomib results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | carmustine | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Carmustine | CTD | PMID:19303893 |
Nfe2l2 | Rat | carnosic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin results in increased activity of NFE2L2 protein] more ... | CTD | PMID:26577515 more ... |
Nfe2l2 | Rat | carnosic acid | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | salvin results in increased activity of NFE2L2 protein | CTD | PMID:26577515 |
Nfe2l2 | Rat | Carnosol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [carnosol inhibits the reaction [IFNG protein results in increased abundance of Nitrites]] and NFE2L2 protein promotes the reaction [carnosol inhibits the reaction [Lipopolysaccharides results in increased abundance of Nitrites]] | CTD | PMID:23942037 |
Nfe2l2 | Rat | Carnosol | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | carnosol results in increased localization of NFE2L2 protein | CTD | PMID:20116392 |
Nfe2l2 | Rat | Carnosol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [NFE2L2 mutant form inhibits the reaction [carnosol results in increased expression of HMOX1 protein]] which results in increased expression of ICAM1 protein more ... | CTD | PMID:20116392 |
Nfe2l2 | Rat | carrageenan | affects localization | EXP | | 6480464 | Carrageenan affects the localization of NFE2L2 protein | CTD | PMID:28844677 |
Nfe2l2 | Rat | carrageenan | decreases expression | EXP | | 6480464 | Carrageenan results in decreased expression of NFE2L2 mRNA | CTD | PMID:34789018 |
Nfe2l2 | Rat | carrageenan | multiple interactions | EXP | | 6480464 | caffeic acid phenethyl ester inhibits the reaction [Carrageenan results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:28844677 and PMID:34789018 |
Nfe2l2 | Rat | carteolol | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Carteolol affects the expression of NFE2L2 mRNA | CTD | PMID:37120125 |
Nfe2l2 | Rat | carvacrol | multiple interactions | EXP | | 6480464 | carvacrol inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 protein] | CTD | PMID:34155936 |
Nfe2l2 | Rat | catalpol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 6-chloro-2 more ... | CTD | PMID:30682494 and PMID:37436358 |
Nfe2l2 | Rat | catalpol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 6-chloro-2 more ... | CTD | PMID:37436358 |
Nfe2l2 | Rat | CCCP | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [[Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [SQSTM1 protein binds to KEAP1 protein]] promotes the reaction [KEAP1 protein binds to NFE2L2 protein]] which results in decreased activity of NFE2L2 protein and [Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [SQSTM1 protein binds to KEAP1 protein]] promotes the reaction [KEAP1 protein binds to NFE2L2 protein] | CTD | PMID:30715550 |
Nfe2l2 | Rat | cefuroxime | decreases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cefuroxime results in decreased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | celastrol | multiple interactions | EXP | | 6480464 | celastrol inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:26768587 and PMID:30588110 |
Nfe2l2 | Rat | celastrol | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | celastrol results in increased activity of NFE2L2 protein | CTD | PMID:29643811 |
Nfe2l2 | Rat | celastrol | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | celastrol results in increased expression of NFE2L2 mRNA | CTD | PMID:29643811 |
Nfe2l2 | Rat | celastrol | increases expression | EXP | | 6480464 | celastrol results in increased expression of NFE2L2 protein | CTD | PMID:26768587 |
Nfe2l2 | Rat | ceric oxide | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | ceric oxide affects the localization of NFE2L2 protein | CTD | PMID:19429248 |
Nfe2l2 | Rat | cerium | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cerium results in decreased expression of NFE2L2 mRNA | CTD | PMID:35641671 |
Nfe2l2 | Rat | ceruletide | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ceruletide results in decreased expression of NFE2L2 protein | CTD | PMID:33166053 |
Nfe2l2 | Rat | ceruletide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | isoborneol inhibits the reaction [Ceruletide results in decreased expression of NFE2L2 protein] | CTD | PMID:33166053 |
Nfe2l2 | Rat | chalcone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Chalcone analog results in decreased ubiquitination of and results in decreased degradation of and affects the localization of NFE2L2 protein and NFE2L2 promotes the reaction [Chalcone analog results in increased abundance of Glutathione] | CTD | PMID:31299238 |
Nfe2l2 | Rat | chalcones | increases expression | EXP | | 6480464 | Chalcones analog results in increased expression of NFE2L2 protein | CTD | PMID:23963778 |
Nfe2l2 | Rat | chenodeoxycholic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Chenodeoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of FTL mRNA more ... | CTD | PMID:17724089 |
Nfe2l2 | Rat | chenodeoxycholic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Chenodeoxycholic Acid results in increased expression of NFE2L2 mRNA | CTD | PMID:25582706 |
Nfe2l2 | Rat | chenodeoxycholic acid | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to Chenodeoxycholic Acid | CTD | PMID:17724089 |
Nfe2l2 | Rat | chitosan | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Chitosan metabolite results in decreased susceptibility to Copper] which results in increased phosphorylation of NFE2L2 protein | CTD | PMID:25542178 |
Nfe2l2 | Rat | chitosan | multiple interactions | EXP | | 6480464 | [Rutin co-treated with Chitosan] inhibits the reaction [Cyclophosphamide results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:30928397 more ... |
Nfe2l2 | Rat | chitosan | affects localization | EXP | | 6480464 | Chitosan analog affects the localization of NFE2L2 protein | CTD | PMID:30928397 |
Nfe2l2 | Rat | chlorambucil | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Chlorambucil and Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Chlorambucil] | CTD | PMID:19608619 |
Nfe2l2 | Rat | chlorambucil | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Chlorambucil | CTD | PMID:19303893 |
Nfe2l2 | Rat | chlorambucil | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Buthionine Sulfoximine affects the reaction [[NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Chlorambucil] more ... | CTD | PMID:19303893 and PMID:20932822 |
Nfe2l2 | Rat | chlorambucil | increases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Chlorambucil | CTD | PMID:19608619 |
Nfe2l2 | Rat | chlormidazole | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | chlormidazole results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | chloroacetaldehyde | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | chloroacetaldehyde results in decreased expression of NFE2L2 mRNA | CTD | PMID:25596134 |
Nfe2l2 | Rat | chloroacetaldehyde | affects activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | chloroacetaldehyde affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | Chloroacetonitrile | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to chloroacetonitrile | CTD | PMID:35842135 |
Nfe2l2 | Rat | Chloroacetonitrile | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | chloroacetonitrile results in increased expression of NFE2L2 mRNA and chloroacetonitrile results in increased expression of NFE2L2 protein | CTD | PMID:35842135 |
Nfe2l2 | Rat | chlorogenic acid | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in decreased susceptibility to Chlorogenic Acid | CTD | PMID:29136249 |
Nfe2l2 | Rat | chlorogenic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein] more ... | CTD | PMID:29136249 |
Nfe2l2 | Rat | chlorogenic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Chlorogenic Acid co-treated with Acetaminophen] affects the localization of and results in increased activity of NFE2L2 protein and Chlorogenic Acid inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] | CTD | PMID:29136249 and PMID:33242462 |
Nfe2l2 | Rat | chlorogenic acid | increases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 results in increased susceptibility to Chlorogenic Acid | CTD | PMID:29136249 |
Nfe2l2 | Rat | chlorogenic acid | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Chlorogenic Acid affects the localization of NFE2L2 protein | CTD | PMID:29136249 |
Nfe2l2 | Rat | chlorogenic acid | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Chlorogenic Acid results in increased localization of NFE2L2 protein | CTD | PMID:15944151 |
Nfe2l2 | Rat | chloropicrin | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | chloropicrin results in decreased expression of NFE2L2 mRNA | CTD | PMID:26352163 |
Nfe2l2 | Rat | chlorpromazine | decreases expression | EXP | | 6480464 | Chlorpromazine results in decreased expression of NFE2L2 mRNA | CTD | PMID:25596134 |
Nfe2l2 | Rat | chlorpromazine | affects activity | EXP | | 6480464 | Chlorpromazine affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | chlorpyrifos | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Chlorpyrifos results in increased expression of NFE2L2 mRNA | CTD | PMID:23850137 |
Nfe2l2 | Rat | chlorpyrifos | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of NFE2L2 mRNA | CTD | PMID:36152060 |
Nfe2l2 | Rat | chlorpyrifos | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of NFE2L2 mRNA | CTD | PMID:37019170 |
Nfe2l2 | Rat | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of NFE2L2 mRNA | CTD | PMID:30497708 more ... |
Nfe2l2 | Rat | chlorpyrifos | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Chlorpyrifos affects the expression of NFE2L2 protein | CTD | PMID:28887667 and PMID:33930485 |
Nfe2l2 | Rat | chlorpyrifos | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Chlorpyrifos results in decreased expression of NFE2L2 mRNA and Chlorpyrifos results in decreased expression of NFE2L2 protein | CTD | PMID:30835941 |
Nfe2l2 | Rat | chlorpyrifos | multiple interactions | EXP | | 6480464 | [Edaravone co-treated with Chlorpyrifos] results in increased expression of NFE2L2 protein more ... | CTD | PMID:30497708 more ... |
Nfe2l2 | Rat | chlorpyrifos | affects response to substance | EXP | | 6480464 | NFE2L2 protein affects the susceptibility to Chlorpyrifos | CTD | PMID:30758894 |
Nfe2l2 | Rat | chlorpyrifos | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Chlorpyrifos inhibits the reaction [taxifolin results in decreased expression of NFE2L2 protein] and Ginsenosides inhibits the reaction [Chlorpyrifos results in decreased expression of NFE2L2 mRNA] | CTD | PMID:31152760 and PMID:36152060 |
Nfe2l2 | Rat | chlorpyrifos | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine affects the reaction [Chlorpyrifos affects the expression of NFE2L2 protein] more ... | CTD | PMID:23850137 more ... |
Nfe2l2 | Rat | cholesterol | increases expression | EXP | | 6480464 | Cholesterol results in increased expression of NFE2L2 mRNA | CTD | PMID:30672636 |
Nfe2l2 | Rat | cholesterol | multiple interactions | EXP | | 6480464 | alpha-Linolenic Acid inhibits the reaction [Cholesterol promotes the reaction [Particulate Matter results in increased expression of NFE2L2 mRNA]] more ... | CTD | PMID:30672636 |
Nfe2l2 | Rat | cholic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cholic Acid results in increased expression of NFE2L2 mRNA | CTD | PMID:25582706 |
Nfe2l2 | Rat | choline | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency] affects the localization of NFE2L2 protein more ... | CTD | PMID:20350562 |
Nfe2l2 | Rat | chromium atom | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [chromous chloride results in increased abundance of Chromium] which results in decreased expression of NFE2L2 protein | CTD | PMID:30359721 |
Nfe2l2 | Rat | chromium(6+) | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of NFE2L2 mRNA and [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of NFE2L2 protein | CTD | PMID:25820237 |
Nfe2l2 | Rat | chromium(6+) | increases acetylation | EXP | | 6480464 | chromium hexavalent ion results in increased acetylation of NFE2L2 protein | CTD | PMID:35024197 |
Nfe2l2 | Rat | chromium(6+) | multiple interactions | EXP | | 6480464 | [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:35024197 and PMID:36849043 |
Nfe2l2 | Rat | chromium(6+) | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | chromium hexavalent ion results in increased activity of NFE2L2 protein | CTD | PMID:30715550 |
Nfe2l2 | Rat | chromium(6+) | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | chromium hexavalent ion promotes the reaction [NFE2L2 protein binds to SIRT3 promoter] | CTD | PMID:30715550 |
Nfe2l2 | Rat | chrysin | multiple interactions | EXP | | 6480464 | chrysin affects the localization of and results in increased activity of NFE2L2 protein more ... | CTD | PMID:22864849 and PMID:33121995 |
Nfe2l2 | Rat | chrysin | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | chrysin results in decreased expression of NFE2L2 mRNA and chrysin results in decreased expression of NFE2L2 protein | CTD | PMID:23994249 |
Nfe2l2 | Rat | chrysin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | chrysin inhibits the reaction [NFE2L2 protein results in decreased susceptibility to Doxorubicin] | CTD | PMID:23994249 |
Nfe2l2 | Rat | cidofovir anhydrous | affects activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cidofovir affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | cidofovir anhydrous | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cidofovir affects the expression of NFE2L2 mRNA | CTD | PMID:25596134 |
Nfe2l2 | Rat | cilostazol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | cilostazol results in increased expression of NFE2L2 protein | CTD | PMID:20131233 |
Nfe2l2 | Rat | cilostazol | multiple interactions | EXP | | 6480464 | Cilostazol inhibits the reaction [Cyclophosphamide results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:30295103 and PMID:32456565 |
Nfe2l2 | Rat | cilostazol | increases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 results in increased susceptibility to cilostazol | CTD | PMID:20131233 |
Nfe2l2 | Rat | cilostazol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mutant form inhibits the reaction [cilostazol results in increased expression of HMOX1 protein] | CTD | PMID:20131233 |
Nfe2l2 | Rat | cinnamyl alcohol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA promotes the reaction [cinnamyl alcohol results in increased expression of HMOX1 mRNA] | CTD | PMID:26244607 |
Nfe2l2 | Rat | ciprofibrate | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | ciprofibrate results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | cisplatin | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to Cisplatin and NFE2L2 results in decreased susceptibility to Cisplatin | CTD | PMID:20530669 more ... |
Nfe2l2 | Rat | cisplatin | affects localization | EXP | | 6480464 | Cisplatin affects the localization of NFE2L2 protein modified form | CTD | PMID:35842499 |
Nfe2l2 | Rat | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of NFE2L2 mRNA and Cisplatin results in decreased expression of NFE2L2 protein | CTD | PMID:32259551 more ... |
Nfe2l2 | Rat | cisplatin | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of NFE2L2 protein | CTD | PMID:39053794 |
Nfe2l2 | Rat | cisplatin | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cisplatin results in decreased expression of NFE2L2 mRNA and Cisplatin results in decreased expression of NFE2L2 protein | CTD | PMID:33952797 more ... |
Nfe2l2 | Rat | cisplatin | affects expression | EXP | | 6480464 | Cisplatin affects the expression of NFE2L2 protein | CTD | PMID:30125553 |
Nfe2l2 | Rat | cisplatin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cisplatin affects the localization of NFE2L2 protein | CTD | PMID:29471006 |
Nfe2l2 | Rat | cisplatin | affects activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cisplatin affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | cisplatin | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Cisplatin | CTD | PMID:23933386 |
Nfe2l2 | Rat | cisplatin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cisplatin results in increased expression of NFE2L2 mRNA and Cisplatin results in increased expression of NFE2L2 protein | CTD | PMID:23384965 more ... |
Nfe2l2 | Rat | cisplatin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of NFE2L2 mRNA | CTD | PMID:27594783 more ... |
Nfe2l2 | Rat | cisplatin | multiple interactions | EXP | | 6480464 | 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:24291008 more ... |
Nfe2l2 | Rat | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of NFE2L2 mRNA and Cisplatin results in increased expression of NFE2L2 protein | CTD | PMID:24291008 more ... |
Nfe2l2 | Rat | cisplatin | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Cisplatin | CTD | PMID:20605904 and PMID:20932822 |
Nfe2l2 | Rat | cisplatin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:20605904 more ... |
Nfe2l2 | Rat | cisplatin | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Cisplatin | CTD | PMID:19303893 |
Nfe2l2 | Rat | cisplatin | increases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mutant form results in increased susceptibility to Cisplatin | CTD | PMID:24817946 |
Nfe2l2 | Rat | cisplatin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [brusatol results in increased ubiquitination of and results in increased degradation of NFE2L2 protein] which results in increased susceptibility to Cisplatin more ... | CTD | PMID:20530669 more ... |
Nfe2l2 | Rat | citraconic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [citraconic acid results in increased expression of CYTB mRNA] more ... | CTD | PMID:27277809 |
Nfe2l2 | Rat | citraconic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | citraconic acid promotes the reaction [NFE2L2 protein results in increased expression of FTL protein] and NFE2L2 protein affects the reaction [citraconic acid results in increased expression of FTL protein] | CTD | PMID:28289076 |
Nfe2l2 | Rat | citraconic acid | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | citraconic acid affects the localization of NFE2L2 protein | CTD | PMID:27277809 |
Nfe2l2 | Rat | clodronic acid | affects activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Clodronic Acid affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of NFE2L2 protein | CTD | PMID:20180811 |
Nfe2l2 | Rat | clofibrate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Clofibrate results in increased expression of NFE2L2 mRNA | CTD | PMID:25270620 |
Nfe2l2 | Rat | clorgyline | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Clorgyline results in increased expression of NFE2L2 mRNA | CTD | PMID:19691856 |
Nfe2l2 | Rat | clozapine | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Clozapine | CTD | PMID:21540358 |
Nfe2l2 | Rat | cobalt atom | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[tungsten carbide co-treated with Cobalt] results in increased localization of NFE2L2 protein] which results in increased expression of NQO1 mRNA more ... | CTD | PMID:20528745 |
Nfe2l2 | Rat | cobalt atom | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cobalt results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | cobalt dichloride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [cobaltous chloride results in increased expression of NFE2L2 protein] more ... | CTD | PMID:27297870 and PMID:29966676 |
Nfe2l2 | Rat | cobalt dichloride | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to cobaltous chloride | CTD | PMID:29966676 |
Nfe2l2 | Rat | cocaine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cocaine results in increased activity of and affects the localization of NFE2L2 protein more ... | CTD | PMID:30393195 |
Nfe2l2 | Rat | coenzyme Q10 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of NFE2L2 mRNA] | CTD | PMID:33271250 |
Nfe2l2 | Rat | coenzyme Q10 | increases expression | EXP | | 6480464 | coenzyme Q10 results in increased expression of NFE2L2 mRNA | CTD | PMID:32116774 |
Nfe2l2 | Rat | coenzyme Q10 | multiple interactions | EXP | | 6480464 | coenzyme Q10 inhibits the reaction [lead acetate affects the localization of NFE2L2 protein] more ... | CTD | PMID:27174133 more ... |
Nfe2l2 | Rat | colistin | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Colistin results in decreased expression of NFE2L2 protein | CTD | PMID:34560125 |
Nfe2l2 | Rat | colistin | multiple interactions | EXP | | 6480464 | dapagliflozin inhibits the reaction [Colistin results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:33882723 |
Nfe2l2 | Rat | colistin | decreases expression | EXP | | 6480464 | Colistin results in decreased expression of NFE2L2 protein | CTD | PMID:33882723 |
Nfe2l2 | Rat | coniferyl aldehyde | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein more ... | CTD | PMID:26275128 |
Nfe2l2 | Rat | coniferyl aldehyde | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | coniferaldehyde results in increased expression of NFE2L2 protein | CTD | PMID:26275128 |
Nfe2l2 | Rat | copper atom | multiple interactions | EXP | | 6480464 | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in increased expression of NFE2L2 mRNA | CTD | PMID:20302851 |
Nfe2l2 | Rat | copper atom | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Copper results in increased localization of NFE2L2 protein | CTD | PMID:34676557 |
Nfe2l2 | Rat | copper atom | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which affects the expression of NFE2L2 mRNA more ... | CTD | PMID:25542178 and PMID:30911355 |
Nfe2l2 | Rat | copper atom | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene results in decreased susceptibility to Copper | CTD | PMID:24462598 |
Nfe2l2 | Rat | copper atom | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene promotes the reaction [Copper results in increased expression of MT1 mRNA] | CTD | PMID:24462598 |
Nfe2l2 | Rat | copper atom | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Copper results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | copper(0) | multiple interactions | EXP | | 6480464 | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in increased expression of NFE2L2 mRNA | CTD | PMID:20302851 |
Nfe2l2 | Rat | copper(0) | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Copper results in increased localization of NFE2L2 protein | CTD | PMID:34676557 |
Nfe2l2 | Rat | copper(0) | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which affects the expression of NFE2L2 mRNA more ... | CTD | PMID:25542178 and PMID:30911355 |
Nfe2l2 | Rat | copper(0) | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene results in decreased susceptibility to Copper | CTD | PMID:24462598 |
Nfe2l2 | Rat | copper(0) | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene promotes the reaction [Copper results in increased expression of MT1 mRNA] | CTD | PMID:24462598 |
Nfe2l2 | Rat | copper(0) | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Copper results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | copper(II) sulfate | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of NFE2L2 mRNA | CTD | PMID:19549813 |
Nfe2l2 | Rat | copper(II) sulfate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Copper Sulfate results in increased expression of NFE2L2 mRNA and Copper Sulfate results in increased expression of NFE2L2 protein | CTD | PMID:37353053 |
Nfe2l2 | Rat | copper(II) sulfate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [Copper Sulfate results in increased expression of NFE2L2 mRNA] more ... | CTD | PMID:22003191 and PMID:37353053 |
Nfe2l2 | Rat | cordycepin | multiple interactions | EXP | | 6480464 | cordycepin affects the reaction [Lipopolysaccharides affects the localization of NFE2L2 protein] | CTD | PMID:29702279 |
Nfe2l2 | Rat | cordycepin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | cordycepin inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 protein] | CTD | PMID:38014886 |
Nfe2l2 | Rat | cordycepin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | cordycepin inhibits the reaction [erastin results in decreased expression of NFE2L2 protein] | CTD | PMID:38014886 |
Nfe2l2 | Rat | corilagin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | corilagin inhibits the reaction [TNFSF11 protein results in decreased expression of NFE2L2 mRNA] | CTD | PMID:35307913 |
Nfe2l2 | Rat | corn oil | decreases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Corn Oil results in decreased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | cortisol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Hydrocortisone results in increased activity of NR3C1 protein] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein] more ... | CTD | PMID:22606287 and PMID:33476690 |
Nfe2l2 | Rat | cortisol | multiple interactions | EXP | | 6480464 | [HSD11B1 protein affects the susceptibility to Hydrocortisone] which results in decreased activity of NFE2L2 protein more ... | CTD | PMID:22606287 |
Nfe2l2 | Rat | cortisone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein] and [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]] | CTD | PMID:22606287 |
Nfe2l2 | Rat | cortisone | multiple interactions | EXP | | 6480464 | [HSD11B1 protein affects the susceptibility to Cortisone] which results in decreased activity of NFE2L2 protein | CTD | PMID:22606287 |
Nfe2l2 | Rat | corynoline | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 6-chloro-2 more ... | CTD | PMID:34477289 and PMID:36161741 |
Nfe2l2 | Rat | coumarin | affects activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | coumarin affects the activity of NFE2L2 protein | CTD | PMID:11309284 |
Nfe2l2 | Rat | coumarin | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | coumarin results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | creatinine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in increased abundance of Creatinine | CTD | PMID:28710020 |
Nfe2l2 | Rat | crocin-1 | multiple interactions | EXP | | 6480464 | crocin inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 protein] and crocin inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 protein] | CTD | PMID:32259551 and PMID:32920515 |
Nfe2l2 | Rat | crotonaldehyde | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-butenal affects the localization of NFE2L2 protein | CTD | PMID:21238556 |
Nfe2l2 | Rat | crotonaldehyde | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to 2-butenal | CTD | PMID:21238556 |
Nfe2l2 | Rat | crotonaldehyde | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein promotes the reaction [2-butenal results in increased expression of HMOX1 protein] | CTD | PMID:21238556 |
Nfe2l2 | Rat | cumene hydroperoxide | increases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to cumene hydroperoxide | CTD | PMID:19608619 |
Nfe2l2 | Rat | cumene hydroperoxide | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to cumene hydroperoxide | CTD | PMID:19303893 |
Nfe2l2 | Rat | cumene hydroperoxide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide and Buthionine Sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to cumene hydroperoxide] | CTD | PMID:19608619 |
Nfe2l2 | Rat | cumene hydroperoxide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to cumene hydroperoxide]] and NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to cumene hydroperoxide] | CTD | PMID:20932822 |
Nfe2l2 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of NFE2L2 mRNA | CTD | PMID:26577399 |
Nfe2l2 | Rat | curcumin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Curcumin co-treated with Acetaminophen] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:17449203 more ... |
Nfe2l2 | Rat | curcumin | increases expression | EXP | | 6480464 | Curcumin analog results in increased expression of NFE2L2 protein more ... | CTD | PMID:30946834 and PMID:36305173 |
Nfe2l2 | Rat | curcumin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Curcumin results in increased expression of NFE2L2 mRNA and Curcumin results in increased expression of NFE2L2 protein | CTD | PMID:31521693 and PMID:34758851 |
Nfe2l2 | Rat | curcumin | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Curcumin results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:31187328 |
Nfe2l2 | Rat | curcumin | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in decreased susceptibility to Curcumin | CTD | PMID:29571711 |
Nfe2l2 | Rat | curcumin | decreases methylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | Curcumin analog results in decreased methylation of NFE2L2 promoter | CTD | PMID:26991801 |
Nfe2l2 | Rat | curcumin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Curcumin affects the localization of NFE2L2 protein and Curcumin analog affects the localization of NFE2L2 protein | CTD | PMID:23954767 |
Nfe2l2 | Rat | curcumin | increases localization | EXP | | 6480464 | Curcumin results in increased localization of NFE2L2 protein | CTD | PMID:18006204 |
Nfe2l2 | Rat | curcumin | affects localization | EXP | | 6480464 | Curcumin affects the localization of NFE2L2 protein | CTD | PMID:17640564 |
Nfe2l2 | Rat | curcumin | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Curcumin affects the localization of NFE2L2 protein] more ... | CTD | PMID:17640564 more ... |
Nfe2l2 | Rat | curcumin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Curcumin analog results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:18321868 more ... |
Nfe2l2 | Rat | curcumin | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Curcumin affects the localization of NFE2L2 protein | CTD | PMID:17535857 more ... |
Nfe2l2 | Rat | curcumin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Curcumin co-treated with Acetaminophen] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:17535857 more ... |
Nfe2l2 | Rat | cyanidin cation | increases activity | EXP | | 6480464 | cyanidin results in increased activity of NFE2L2 protein | CTD | PMID:27166148 |
Nfe2l2 | Rat | cyanidin cation | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | cyanidin affects the expression of NFE2L2 protein | CTD | PMID:26505893 |
Nfe2l2 | Rat | cyanocob(III)alamin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of NFE2L2 protein] | CTD | PMID:37263574 |
Nfe2l2 | Rat | cyanocob(III)alamin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of NFE2L2 protein] | CTD | PMID:37263574 |
Nfe2l2 | Rat | cycloheximide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [SB 203580 co-treated with Cycloheximide] inhibits the reaction [Quercetin results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:22019695 more ... |
Nfe2l2 | Rat | cycloheximide | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cycloheximide results in decreased expression of NFE2L2 protein | CTD | PMID:12441344 more ... |
Nfe2l2 | Rat | cycloheximide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Cycloheximide] results in increased expression of NFE2L2 protein more ... | CTD | PMID:12441344 more ... |
Nfe2l2 | Rat | cycloheximide | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cycloheximide results in decreased expression of NFE2L2 protein | CTD | PMID:25896339 |
Nfe2l2 | Rat | cyclophosphamide | multiple interactions | EXP | | 6480464 | [astaxanthine co-treated with Cyclophosphamide] results in increased expression of NFE2L2 protein more ... | CTD | PMID:20038455 more ... |
Nfe2l2 | Rat | cyclophosphamide | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cyclophosphamide results in decreased expression of NFE2L2 mRNA | CTD | PMID:32129080 |
Nfe2l2 | Rat | cyclophosphamide | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Cyclophosphamide | CTD | PMID:27633142 |
Nfe2l2 | Rat | cyclophosphamide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cyclophosphamide promotes the reaction [NFE2L2 gene mutant form results in decreased expression of CAT protein] more ... | CTD | PMID:27633142 |
Nfe2l2 | Rat | cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of NFE2L2 mRNA and Cyclophosphamide results in increased expression of NFE2L2 protein | CTD | PMID:20038455 and PMID:37419146 |
Nfe2l2 | Rat | cyclophosphamide | decreases expression | EXP | | 6480464 | Cyclophosphamide results in decreased expression of NFE2L2 mRNA and Cyclophosphamide results in decreased expression of NFE2L2 protein | CTD | PMID:20038455 more ... |
Nfe2l2 | Rat | cyclosporin A | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of NFE2L2 protein | CTD | PMID:23958496 |
Nfe2l2 | Rat | cyclosporin A | affects activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cyclosporine affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | cyclosporin A | affects activity | EXP | | 6480464 | Cyclosporine affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of NFE2L2 mRNA and Cyclosporine results in decreased expression of NFE2L2 protein | CTD | PMID:25596134 and PMID:33710703 |
Nfe2l2 | Rat | cyclosporin A | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of NFE2L2 mRNA | CTD | PMID:20106945 more ... |
Nfe2l2 | Rat | cyclosporin A | multiple interactions | EXP | | 6480464 | nilotinib inhibits the reaction [Cyclosporine results in decreased expression of NFE2L2 protein] | CTD | PMID:33710703 |
Nfe2l2 | Rat | cyfluthrin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | cyfluthrin results in increased expression of NFE2L2 mRNA | CTD | PMID:31330490 |
Nfe2l2 | Rat | cyfluthrin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Melatonin inhibits the reaction [cyfluthrin results in increased expression of NFE2L2 mRNA] | CTD | PMID:31330490 |
Nfe2l2 | Rat | cyhalothrin | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NFE2L2 mRNA and [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA | CTD | PMID:33396045 and PMID:34896426 |
Nfe2l2 | Rat | cylindrospermopsin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | cylindrospermopsin results in increased expression of NFE2L2 mRNA | CTD | PMID:20936652 |
Nfe2l2 | Rat | Cynaropicrin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | cynaropicrin affects the localization of NFE2L2 protein | CTD | PMID:25680693 |
Nfe2l2 | Rat | Cynaropicrin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | cynaropicrin results in increased expression of NFE2L2 mRNA | CTD | PMID:25680693 |
Nfe2l2 | Rat | Cynaropicrin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | AHR mutant form inhibits the reaction [cynaropicrin affects the localization of NFE2L2 protein] more ... | CTD | PMID:25680693 |
Nfe2l2 | Rat | cypermethrin | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NFE2L2 mRNA more ... | CTD | PMID:33396045 more ... |
Nfe2l2 | Rat | cypermethrin | decreases expression | EXP | | 6480464 | cypermethrin results in decreased expression of NFE2L2 mRNA | CTD | PMID:35876585 |
Nfe2l2 | Rat | cypermethrin | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | cypermethrin results in decreased expression of NFE2L2 mRNA and cypermethrin results in decreased expression of NFE2L2 protein | CTD | PMID:31907151 |
Nfe2l2 | Rat | cypermethrin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | cypermethrin results in increased expression of NFE2L2 mRNA | CTD | PMID:32028016 |
Nfe2l2 | Rat | cyproconazole | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | cyproconazole results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | cyproterone acetate | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Cyproterone Acetate results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NFE2L2 mRNA and Glucose results in decreased expression of NFE2L2 protein | CTD | PMID:21818840 more ... |
Nfe2l2 | Rat | D-glucose | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Glucose affects the localization of NFE2L2 protein | CTD | PMID:33270355 |
Nfe2l2 | Rat | D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of NFE2L2 mRNA and Glucose results in increased expression of NFE2L2 protein | CTD | PMID:29211853 |
Nfe2l2 | Rat | D-glucose | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Glucose | CTD | PMID:20086057 |
Nfe2l2 | Rat | D-glucose | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Glucose results in decreased expression of NFE2L2 mRNA and Glucose results in decreased expression of NFE2L2 protein | CTD | PMID:21333731 more ... |
Nfe2l2 | Rat | D-glucose | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]] more ... | CTD | PMID:21333731 more ... |
Nfe2l2 | Rat | D-glucose | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(1 more ... | CTD | PMID:17928392 more ... |
Nfe2l2 | Rat | D-glucose | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Glucose deficiency results in increased localization of NFE2L2 protein | CTD | PMID:17928392 |
Nfe2l2 | Rat | D-glucose | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Glucose deficiency results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:20103708 more ... |
Nfe2l2 | Rat | D-glucose | multiple interactions | EXP | | 6480464 | 4-benzyl-2-methyl-1 more ... | CTD | PMID:20028456 more ... |
Nfe2l2 | Rat | D-penicillamine | increases expression | EXP | | 6480464 | Penicillamine results in increased expression of NFE2L2 mRNA | CTD | PMID:19575532 |
Nfe2l2 | Rat | dapagliflozin | multiple interactions | EXP | | 6480464 | [Atorvastatin co-treated with dapagliflozin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of NFE2L2 protein] more ... | CTD | PMID:32259528 more ... |
Nfe2l2 | Rat | dazomet | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | dazomet results in increased activity of NFE2L2 protein | CTD | PMID:20143881 |
Nfe2l2 | Rat | DDE | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA and Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 protein | CTD | PMID:25263748 |
Nfe2l2 | Rat | DDE | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:25263748 |
Nfe2l2 | Rat | DDT | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | DDT results in increased expression of NFE2L2 mRNA | CTD | PMID:31521043 |
Nfe2l2 | Rat | decabromodiphenyl ether | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | decabromobiphenyl ether results in decreased expression of NFE2L2 protein | CTD | PMID:31039416 |
Nfe2l2 | Rat | decabromodiphenyl ether | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of NFE2L2 protein] | CTD | PMID:33675858 |
Nfe2l2 | Rat | decabromodiphenyl ether | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | decabromobiphenyl ether results in increased expression of NFE2L2 mRNA and decabromobiphenyl ether results in increased expression of NFE2L2 protein | CTD | PMID:34571075 |
Nfe2l2 | Rat | decabromodiphenyl ether | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of NFE2L2 mRNA and decabromobiphenyl ether results in decreased expression of NFE2L2 protein | CTD | PMID:33675858 and PMID:35266255 |
Nfe2l2 | Rat | delta-tocopherol | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] | CTD | PMID:22389237 |
Nfe2l2 | Rat | demethoxycurcumin | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | demethoxycurcumin affects the localization of NFE2L2 protein | CTD | PMID:17535857 |
Nfe2l2 | Rat | demethoxycurcumin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [demethoxycurcumin co-treated with bisdemethoxycurcumin] affects the localization of NFE2L2 protein and NFE2L2 protein affects the reaction [demethoxycurcumin results in increased expression of HMOX1 mRNA] | CTD | PMID:17535857 |
Nfe2l2 | Rat | Dendrobine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | dendrobine promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein] more ... | CTD | PMID:36058301 |
Nfe2l2 | Rat | deoxycholic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Deoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA and [Deoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLM mRNA | CTD | PMID:17724089 |
Nfe2l2 | Rat | deoxycholic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Deoxycholic Acid results in increased expression of NFE2L2 mRNA | CTD | PMID:25582706 |
Nfe2l2 | Rat | deoxynivalenol | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | deoxynivalenol analog results in increased activity of NFE2L2 protein and deoxynivalenol results in increased activity of NFE2L2 protein | CTD | PMID:30244016 |
Nfe2l2 | Rat | deoxynivalenol | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | deoxynivalenol results in decreased expression of NFE2L2 mRNA | CTD | PMID:37419272 |
Nfe2l2 | Rat | deoxynivalenol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Selenomethionine inhibits the reaction [deoxynivalenol results in increased expression of NFE2L2 protein] | CTD | PMID:38040082 |
Nfe2l2 | Rat | deoxynivalenol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of NFE2L2 mRNA] and Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of NFE2L2 protein] | CTD | PMID:34677630 and PMID:37419272 |
Nfe2l2 | Rat | deoxynivalenol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | deoxynivalenol results in increased expression of NFE2L2 mRNA | CTD | PMID:34677630 |
Nfe2l2 | Rat | deoxynivalenol | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | deoxynivalenol results in increased expression of NFE2L2 mRNA and deoxynivalenol results in increased expression of NFE2L2 protein | CTD | PMID:34400200 and PMID:38040082 |
Nfe2l2 | Rat | desferrioxamine B | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Deferoxamine inhibits the reaction [7 more ... | CTD | PMID:26945724 more ... |
Nfe2l2 | Rat | desferrioxamine B | multiple interactions | EXP | | 6480464 | Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 mRNA] and Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 protein] | CTD | PMID:39276841 |
Nfe2l2 | Rat | desferrioxamine B | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Deferoxamine inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein] and Deferoxamine inhibits the reaction [Valproic Acid results in decreased expression of NFE2L2 protein] | CTD | PMID:32416107 and PMID:39147356 |
Nfe2l2 | Rat | desipramine | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Desipramine | CTD | PMID:21540358 |
Nfe2l2 | Rat | dexamethasone | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dexamethasone results in decreased expression of NFE2L2 mRNA | CTD | PMID:17627975 |
Nfe2l2 | Rat | dexamethasone | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dexamethasone affects the expression of NFE2L2 protein | CTD | PMID:28940008 |
Nfe2l2 | Rat | dexamethasone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide co-treated with Dexamethasone] affects the localization of NFE2L2 protein more ... | CTD | PMID:33476690 and PMID:35405071 |
Nfe2l2 | Rat | dexamethasone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Dexamethasone co-treated with Arsenic] results in increased activity of NFE2L2 protein more ... | CTD | PMID:26363199 more ... |
Nfe2l2 | Rat | dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [NFE2L2 protein results in increased expression of GSTA2 mRNA] | CTD | PMID:15870285 |
Nfe2l2 | Rat | dexmedetomidine | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dexmedetomidine inhibits the reaction [Isoflurane results in decreased expression of NFE2L2 mRNA]] more ... | CTD | PMID:30597158 and PMID:36027947 |
Nfe2l2 | Rat | dexmedetomidine | increases expression | EXP | | 6480464 | Dexmedetomidine results in increased expression of NFE2L2 mRNA and Dexmedetomidine results in increased expression of NFE2L2 protein | CTD | PMID:36027947 |
Nfe2l2 | Rat | dexmedetomidine | increases phosphorylation | EXP | | 6480464 | Dexmedetomidine results in increased phosphorylation of NFE2L2 protein | CTD | PMID:36027947 |
Nfe2l2 | Rat | dexmedetomidine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Dexmedetomidine promotes the reaction [Ropivacaine results in increased expression of and results in increased localization of NFE2L2 protein] more ... | CTD | PMID:36858639 |
Nfe2l2 | Rat | dextran sulfate | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 affects the susceptibility to Dextran Sulfate | CTD | PMID:20404090 |
Nfe2l2 | Rat | dextran sulfate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [asperuloside co-treated with Dextran Sulfate] results in increased expression of NFE2L2 protein more ... | CTD | PMID:23056183 more ... |
Nfe2l2 | Rat | dextran sulfate | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dextran Sulfate results in decreased expression of NFE2L2 mRNA and Dextran Sulfate results in decreased expression of NFE2L2 protein | CTD | PMID:23261717 more ... |
Nfe2l2 | Rat | dextromethorphan | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [PRKCD protein affects the susceptibility to Dextromethorphan] which affects the activity of and affects the localization of NFE2L2 protein more ... | CTD | PMID:34740715 |
Nfe2l2 | Rat | Di-n-octyl phthalate | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | di-n-octyl phthalate results in decreased expression of NFE2L2 protein | CTD | PMID:34822940 |
Nfe2l2 | Rat | Di-n-octyl phthalate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of NFE2L2 mRNA | CTD | PMID:37364641 |
Nfe2l2 | Rat | diallyl disulfide | multiple interactions | EXP | | 6480464 | diallyl disulfide inhibits the reaction [Carbon Tetrachloride results in decreased expression of and affects the localization of NFE2L2 protein] | CTD | PMID:24293383 |
Nfe2l2 | Rat | diallyl disulfide | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | diallyl disulfide results in decreased expression of NFE2L2 mRNA | CTD | PMID:34896185 |
Nfe2l2 | Rat | diallyl disulfide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | diallyl disulfide affects the reaction [lipopolysaccharide more ... | CTD | PMID:34896185 and PMID:35526736 |
Nfe2l2 | Rat | diallyl disulfide | decreases degradation | ISO | Nfe2l2 (Mus musculus) | 6480464 | diallyl disulfide results in decreased degradation of NFE2L2 protein | CTD | PMID:34896185 |
Nfe2l2 | Rat | Diallyl sulfide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | allyl sulfide inhibits the reaction [[ethylene dichloride co-treated with Ethanol] results in increased expression of NFE2L2 protein] and NFE2L2 protein promotes the reaction [allyl sulfide results in increased expression of NQO1 mRNA] | CTD | PMID:17353348 and PMID:37150348 |
Nfe2l2 | Rat | Diallyl sulfide | multiple interactions | EXP | | 6480464 | allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of NFE2L2 mRNA] and allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of NFE2L2 protein] | CTD | PMID:31585129 |
Nfe2l2 | Rat | diallyl trisulfide | increases activity | EXP | | 6480464 | diallyl trisulfide results in increased activity of NFE2L2 protein | CTD | PMID:20237067 |
Nfe2l2 | Rat | diallyl trisulfide | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | diallyl trisulfide results in increased localization of NFE2L2 protein | CTD | PMID:30317421 |
Nfe2l2 | Rat | diallyl trisulfide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein] more ... | CTD | PMID:24489685 |
Nfe2l2 | Rat | diallyl trisulfide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | diallyl trisulfide results in increased expression of and affects the localization of NFE2L2 protein and NFE2L2 gene mutant form inhibits the reaction [diallyl trisulfide results in increased expression of HMOX1 protein] | CTD | PMID:24489685 |
Nfe2l2 | Rat | diallyl trisulfide | increases expression | EXP | | 6480464 | diallyl trisulfide results in increased expression of NFE2L2 mRNA and diallyl trisulfide results in increased expression of NFE2L2 protein | CTD | PMID:18768114 more ... |
Nfe2l2 | Rat | diallyl trisulfide | multiple interactions | EXP | | 6480464 | [diallyl trisulfide promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA more ... | CTD | PMID:20237067 more ... |
Nfe2l2 | Rat | diarsenic trioxide | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Arsenic Trioxide affects the localization of NFE2L2 protein | CTD | PMID:19350554 more ... |
Nfe2l2 | Rat | diarsenic trioxide | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of NFE2L2 protein | CTD | PMID:22155346 and PMID:27561292 |
Nfe2l2 | Rat | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of NFE2L2 mRNA and Arsenic Trioxide results in increased expression of NFE2L2 protein | CTD | PMID:27592447 more ... |
Nfe2l2 | Rat | diarsenic trioxide | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein] more ... | CTD | PMID:24327821 more ... |
Nfe2l2 | Rat | diarsenic trioxide | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA results in decreased susceptibility to Arsenic Trioxide and NFE2L2 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:22684020 and PMID:26708503 |
Nfe2l2 | Rat | diarsenic trioxide | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of NFE2L2 protein | CTD | PMID:24157283 more ... |
Nfe2l2 | Rat | diarsenic trioxide | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of NFE2L2 mRNA and Arsenic Trioxide results in increased expression of NFE2L2 protein | CTD | PMID:22155346 more ... |
Nfe2l2 | Rat | diarsenic trioxide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of and affects the localization of NFE2L2 protein more ... | CTD | PMID:19350554 more ... |
Nfe2l2 | Rat | diarsenic trioxide | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Arsenic Trioxide | CTD | PMID:20707922 |
Nfe2l2 | Rat | diarsenic trioxide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:22488045 more ... |
Nfe2l2 | Rat | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of NFE2L2 mRNA and Arsenic Trioxide results in decreased expression of NFE2L2 protein | CTD | PMID:24327821 more ... |
Nfe2l2 | Rat | diarsenic trioxide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of NFE2L2 mRNA and Arsenic Trioxide results in increased expression of NFE2L2 protein | CTD | PMID:22488045 and PMID:26187899 |
Nfe2l2 | Rat | dibenziodolium | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | diphenyleneiodonium inhibits the reaction [phenethyl isothiocyanate affects the localization of NFE2L2 protein] | CTD | PMID:26945724 |
Nfe2l2 | Rat | dibenzofurans | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dibenzofurans results in increased expression of NFE2L2 mRNA | CTD | PMID:34254344 |
Nfe2l2 | Rat | Dibromoacetonitrile | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to dibromoacetonitrile | CTD | PMID:35842135 |
Nfe2l2 | Rat | Dibromoacetonitrile | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | dibromoacetonitrile results in increased expression of NFE2L2 mRNA and dibromoacetonitrile results in increased expression of NFE2L2 protein | CTD | PMID:35842135 |
Nfe2l2 | Rat | Dibutyl phosphate | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of NFE2L2 mRNA | CTD | PMID:37042841 |
Nfe2l2 | Rat | dibutyl phthalate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of NFE2L2 mRNA and Dibutyl Phthalate results in increased expression of NFE2L2 protein | CTD | PMID:21266533 more ... |
Nfe2l2 | Rat | dibutyl phthalate | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of NFE2L2 protein | CTD | PMID:33254669 |
Nfe2l2 | Rat | dibutyl phthalate | affects localization | EXP | | 6480464 | Dibutyl Phthalate affects the localization of NFE2L2 protein | CTD | PMID:33254669 |
Nfe2l2 | Rat | dibutyl phthalate | multiple interactions | EXP | | 6480464 | 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2 more ... | CTD | PMID:30910607 and PMID:33254669 |
Nfe2l2 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of NFE2L2 protein | CTD | PMID:30910607 and PMID:35690178 |
Nfe2l2 | Rat | dibutyl phthalate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2 more ... | CTD | PMID:28295950 more ... |
Nfe2l2 | Rat | dichloroacetic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of NFE2L2 mRNA | CTD | PMID:28962523 |
Nfe2l2 | Rat | Dichloroacetonitrile | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to dichloroacetonitrile | CTD | PMID:35842135 |
Nfe2l2 | Rat | Dichloroacetonitrile | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | dichloroacetonitrile results in increased expression of NFE2L2 mRNA and dichloroacetonitrile results in increased expression of NFE2L2 protein | CTD | PMID:35842135 |
Nfe2l2 | Rat | dichloroacetyl chloride | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:32073640 |
Nfe2l2 | Rat | dichloroacetyl chloride | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-tert-butylhydroquinone inhibits the reaction [2 more ... | CTD | PMID:32073640 |
Nfe2l2 | Rat | dichloromethane | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[Particulate Matter co-treated with Methylene Chloride] results in increased abundance of Polycyclic Aromatic Hydrocarbons] which affects the expression of NFE2L2 mRNA | CTD | PMID:29335169 |
Nfe2l2 | Rat | dichloromethane | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Methylene Chloride results in increased expression of NFE2L2 mRNA | CTD | PMID:34280354 |
Nfe2l2 | Rat | dichloromethane | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Methylene Chloride results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | dichlorvos | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Dichlorvos results in increased activity of NFE2L2 protein | CTD | PMID:20143881 |
Nfe2l2 | Rat | dichlorvos | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 mRNA] and PON1 protein inhibits the reaction [Dichlorvos results in decreased expression of NFE2L2 protein] | CTD | PMID:25891459 and PMID:26814074 |
Nfe2l2 | Rat | dichlorvos | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dichlorvos results in decreased expression of NFE2L2 mRNA and Dichlorvos results in decreased expression of NFE2L2 protein | CTD | PMID:25891459 and PMID:26814074 |
Nfe2l2 | Rat | diclofenac | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Diclofenac results in increased expression of SRXN1 mRNA] | CTD | PMID:24752500 |
Nfe2l2 | Rat | diclofenac | multiple interactions | EXP | | 6480464 | diacerein inhibits the reaction [Diclofenac results in decreased expression of NFE2L2 protein] | CTD | PMID:38582345 |
Nfe2l2 | Rat | diclofenac | decreases expression | EXP | | 6480464 | Diclofenac results in decreased expression of NFE2L2 protein | CTD | PMID:38582345 |
Nfe2l2 | Rat | diclofenac | increases stability | ISO | NFE2L2 (Homo sapiens) | 6480464 | Diclofenac results in increased stability of NFE2L2 protein | CTD | PMID:24752500 |
Nfe2l2 | Rat | dicyclanil | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA and Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with dicyclanil] results in increased expression of NFE2L2 mRNA] | CTD | PMID:19182440 |
Nfe2l2 | Rat | diethyl maleate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form inhibits the reaction [diethyl maleate results in increased expression of SLC7A11 mRNA] more ... | CTD | PMID:12235164 and PMID:22003191 |
Nfe2l2 | Rat | diethyl maleate | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | diethyl maleate results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | diethyl maleate | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | diethyl maleate results in increased expression of NFE2L2 protein | CTD | PMID:27358234 |
Nfe2l2 | Rat | diethyl maleate | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | diethyl maleate affects the localization of NFE2L2 protein | CTD | PMID:27982581 |
Nfe2l2 | Rat | diethyl maleate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [diethyl maleate co-treated with TNF protein] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:20806931 more ... |
Nfe2l2 | Rat | diethyl maleate | increases expression | EXP | | 6480464 | diethyl maleate results in increased expression of NFE2L2 protein | CTD | PMID:21465251 |
Nfe2l2 | Rat | diethyl maleate | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in decreased susceptibility to diethyl maleate | CTD | PMID:12235164 |
Nfe2l2 | Rat | diethyl maleate | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | diethyl maleate affects the localization of NFE2L2 protein | CTD | PMID:12235164 |
Nfe2l2 | Rat | diethyl phthalate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:37021957 more ... |
Nfe2l2 | Rat | diethyl phthalate | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | diethyl phthalate results in decreased expression of NFE2L2 protein | CTD | PMID:37942807 |
Nfe2l2 | Rat | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of NFE2L2 mRNA | CTD | PMID:37077353 |
Nfe2l2 | Rat | dihydroactinidiolide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [dihydroactinidiolide co-treated with amyloid beta-protein (25-35)] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:33617922 |
Nfe2l2 | Rat | dihydroartemisinin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | artenimol analog affects the localization of NFE2L2 protein | CTD | PMID:26340163 |
Nfe2l2 | Rat | dihydrolipoic acid | multiple interactions | EXP | | 6480464 | [dihydrolipoic acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA and dihydrolipoic acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer] | CTD | PMID:20237067 |
Nfe2l2 | Rat | dihydrolipoic acid | increases expression | EXP | | 6480464 | dihydrolipoic acid results in increased expression of NFE2L2 protein | CTD | PMID:20237067 |
Nfe2l2 | Rat | dihydrolipoic acid | increases activity | EXP | | 6480464 | dihydrolipoic acid results in increased activity of NFE2L2 protein | CTD | PMID:20237067 |
Nfe2l2 | Rat | dihydroxyacetone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Dihydroxyacetone results in increased expression of NFE2L2 protein | CTD | PMID:32506039 |
Nfe2l2 | Rat | diisobutyl phthalate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of NFE2L2 mRNA and [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NFE2L2 mRNA | CTD | PMID:37021957 and PMID:39150890 |
Nfe2l2 | Rat | Diisodecyl phthalate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of NFE2L2 mRNA and [Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of NFE2L2 protein | CTD | PMID:27871981 and PMID:37364641 |
Nfe2l2 | Rat | diisononyl phthalate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:37021957 more ... |
Nfe2l2 | Rat | Dimerumic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [dimerumic acid results in decreased expression of ACTA2 mRNA] more ... | CTD | PMID:24036144 |
Nfe2l2 | Rat | Dimerumic acid | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | dimerumic acid results in increased activity of NFE2L2 protein | CTD | PMID:24036144 |
Nfe2l2 | Rat | dimethomorph | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Sulfur co-treated with quinoxyfen co-treated with dimethomorph] results in decreased expression of NFE2L2 mRNA | CTD | PMID:35564597 |
Nfe2l2 | Rat | dimethyl fumarate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of FTH1 mRNA] more ... | CTD | PMID:28289076 and PMID:28790194 |
Nfe2l2 | Rat | dimethyl fumarate | multiple interactions | EXP | | 6480464 | [Glyburide co-treated with Dimethyl Fumarate] inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:36000575 and PMID:36999408 |
Nfe2l2 | Rat | dimethyl fumarate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dimethyl Fumarate results in increased expression of NFE2L2 protein | CTD | PMID:29950142 |
Nfe2l2 | Rat | dimethyl fumarate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dimethyl Fumarate inhibits the reaction [sodium aescinate results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:23942037 more ... |
Nfe2l2 | Rat | dimethyl fumarate | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Dimethyl Fumarate affects the localization of NFE2L2 protein | CTD | PMID:27277809 |
Nfe2l2 | Rat | dimethyl sulfoxide | multiple interactions | EXP | | 6480464 | [Dimethyl Sulfoxide co-treated with resveratrol] inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | CTD | PMID:26497626 |
Nfe2l2 | Rat | dimethyl sulfoxide | multiple interactions | EXP | | 155882543 | dimethyl sulfoxide promotes the reaction [ischemia-reperfusion injury increases expression of Nfe2l2 protein in nucleus] | RGD | |
Nfe2l2 | Rat | dimethyl sulfoxide | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Dimethyl Sulfoxide | CTD | PMID:32023790 |
Nfe2l2 | Rat | dimethyl sulfoxide | increases expression | EXP | | 6480464 | Dimethyl Sulfoxide results in increased expression of NFE2L2 protein modified form | CTD | PMID:36305173 |
Nfe2l2 | Rat | dimethyl sulfoxide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dimethyl Sulfoxide promotes the reaction [NFE2L2 protein binds to AHR promoter] and JDP2 protein affects the reaction [Dimethyl Sulfoxide promotes the reaction [NFE2L2 protein binds to AHR promoter]] | CTD | PMID:33723743 |
Nfe2l2 | Rat | dimethyl sulfoxide | decreases expression | EXP | | 6480464 | Dimethyl Sulfoxide results in decreased expression of NFE2L2 protein | CTD | PMID:26497626 |
Nfe2l2 | Rat | dimethylarsinic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of and affects the localization of NFE2L2 protein more ... | CTD | PMID:24161444 and PMID:33434570 |
Nfe2l2 | Rat | dioscin | multiple interactions | EXP | | 6480464 | dioscin inhibits the reaction [Doxorubicin results in decreased expression of and affects the localization of NFE2L2 protein] and NR1H4 protein affects the reaction [dioscin inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]] | CTD | PMID:28082111 |
Nfe2l2 | Rat | dioscin | multiple interactions | EXP | | 15090820 | dioscin inhibited the reaction [thioacetamide decreased expression of Nfe2L2 protein in liver] | RGD | |
Nfe2l2 | Rat | diosmetin | multiple interactions | EXP | | 6480464 | diosmetin promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NFE2L2 protein] more ... | CTD | PMID:35191607 |
Nfe2l2 | Rat | dioxygen | multiple interactions | EXP | | 6480464 | [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Hemin] affects the localization of NFE2L2 protein more ... | CTD | PMID:20028456 more ... |
Nfe2l2 | Rat | dioxygen | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of NFE2L2 mRNA and Oxygen deficiency results in increased expression of NFE2L2 protein | CTD | PMID:34023435 |
Nfe2l2 | Rat | dioxygen | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Oxygen deficiency results in decreased expression of NFE2L2 protein and Oxygen results in decreased expression of NFE2L2 protein | CTD | PMID:30096613 and PMID:39110510 |
Nfe2l2 | Rat | dioxygen | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of NFE2L2 mRNA and Oxygen deficiency results in increased expression of NFE2L2 protein | CTD | PMID:31610156 |
Nfe2l2 | Rat | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of NFE2L2 mRNA and Oxygen deficiency results in increased expression of NFE2L2 protein | CTD | PMID:31629700 |
Nfe2l2 | Rat | dioxygen | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Oxygen affects the localization of NFE2L2 protein | CTD | PMID:30529165 |
Nfe2l2 | Rat | dioxygen | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the susceptibility to Oxygen deficiency and NFE2L2 protein affects the susceptibility to Oxygen | CTD | PMID:30096613 and PMID:30529165 |
Nfe2l2 | Rat | dioxygen | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Oxygen deficiency | CTD | PMID:29966676 |
Nfe2l2 | Rat | dioxygen | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Oxygen deficiency | CTD | PMID:29255069 |
Nfe2l2 | Rat | dioxygen | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone promotes the reaction [Oxygen deficiency results in increased expression of NFE2L2 protein] more ... | CTD | PMID:26270818 more ... |
Nfe2l2 | Rat | dioxygen | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Oxygen deficiency affects the expression of NFE2L2 mRNA and Oxygen deficiency affects the expression of NFE2L2 protein | CTD | PMID:25448280 |
Nfe2l2 | Rat | dioxygen | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(1 more ... | CTD | PMID:25922074 more ... |
Nfe2l2 | Rat | dioxygen | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of NFE2L2 mRNA and Oxygen deficiency results in decreased expression of NFE2L2 protein | CTD | PMID:25596134 and PMID:31885778 |
Nfe2l2 | Rat | dioxygen | affects activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Oxygen deficiency affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | diphenyl diselenide | multiple interactions | EXP | | 6480464 | diphenyldiselenide inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:33639173 and PMID:36174737 |
Nfe2l2 | Rat | diprotium oxide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of NFE2L2 mRNA | CTD | PMID:29335169 |
Nfe2l2 | Rat | diquat | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Diquat results in increased expression of NFE2L2 protein | CTD | PMID:20826540 |
Nfe2l2 | Rat | diquat | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Diquat results in decreased expression of NFE2L2 mRNA and Diquat results in decreased expression of NFE2L2 protein | CTD | PMID:33475796 more ... |
Nfe2l2 | Rat | diquat | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Diquat | CTD | PMID:16962985 and PMID:22762311 |
Nfe2l2 | Rat | diquat | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in decreased susceptibility to Diquat | CTD | PMID:23056183 |
Nfe2l2 | Rat | diquat | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Diquat results in increased activity of NFE2L2 protein | CTD | PMID:20143881 and PMID:21172416 |
Nfe2l2 | Rat | diquat | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Ellagic Acid co-treated with Diquat] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:20826540 more ... |
Nfe2l2 | Rat | diquat | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Diquat results in increased activity of NFE2L2 protein | CTD | PMID:16962985 |
Nfe2l2 | Rat | disodium selenite | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Sodium Selenite promotes the reaction [arsenic acid affects the localization of NFE2L2 protein] and Sodium Selenite promotes the reaction [arsenite affects the localization of NFE2L2 protein] | CTD | PMID:19429247 |
Nfe2l2 | Rat | disodium selenite | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Sodium Selenite affects the reaction [Mercuric Chloride affects the localization of NFE2L2 protein] and Sodium Selenite affects the reaction [methylmercuric chloride affects the localization of NFE2L2 protein] | CTD | PMID:24816296 |
Nfe2l2 | Rat | disodium selenite | multiple interactions | EXP | | 6480464 | [Sodium Selenite co-treated with Plant Extracts] inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:26085057 more ... |
Nfe2l2 | Rat | dithionite(2-) | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [dihydroactinidiolide co-treated with Dithionite] results in increased expression of NFE2L2 mRNA | CTD | PMID:33617922 |
Nfe2l2 | Rat | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of NFE2L2 mRNA | CTD | PMID:21551480 |
Nfe2l2 | Rat | dorsomorphin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | dorsomorphin inhibits the reaction [amlexanox inhibits the reaction [Acetaminophen results in decreased expression of NFE2L2 protein]] | CTD | PMID:31697998 |
Nfe2l2 | Rat | dorsomorphin | multiple interactions | EXP | | 6480464 | dorsomorphin inhibits the reaction [FNDC5 protein modified form inhibits the reaction [Doxorubicin results in decreased phosphorylation of NFE2L2 protein]] | CTD | PMID:37499777 |
Nfe2l2 | Rat | dorsomorphin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:24211276 more ... |
Nfe2l2 | Rat | doxorubicin | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Doxorubicin | CTD | PMID:19303893 |
Nfe2l2 | Rat | doxorubicin | decreases phosphorylation | EXP | | 6480464 | Doxorubicin results in decreased phosphorylation of NFE2L2 protein | CTD | PMID:37499777 |
Nfe2l2 | Rat | doxorubicin | affects uptake | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the uptake of Doxorubicin | CTD | PMID:39427782 |
Nfe2l2 | Rat | doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of NFE2L2 protein | CTD | PMID:39043266 |
Nfe2l2 | Rat | doxorubicin | increases ubiquitination | ISO | Nfe2l2 (Mus musculus) | 6480464 | Doxorubicin results in increased ubiquitination of NFE2L2 protein | CTD | PMID:39089415 |
Nfe2l2 | Rat | doxorubicin | increases ubiquitination | EXP | | 6480464 | Doxorubicin results in increased ubiquitination of NFE2L2 protein | CTD | PMID:39089415 |
Nfe2l2 | Rat | doxorubicin | affects localization | EXP | | 6480464 | Doxorubicin affects the localization of NFE2L2 protein | CTD | PMID:30928397 and PMID:37030624 |
Nfe2l2 | Rat | doxorubicin | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of NFE2L2 mRNA and Doxorubicin results in decreased expression of NFE2L2 protein | CTD | PMID:29061315 more ... |
Nfe2l2 | Rat | doxorubicin | multiple interactions | EXP | | 6480464 | [FNDC5 protein modified form co-treated with Doxorubicin] affects the localization of NFE2L2 protein more ... | CTD | PMID:25268985 more ... |
Nfe2l2 | Rat | doxorubicin | decreases activity | EXP | | 6480464 | Doxorubicin results in decreased activity of NFE2L2 protein | CTD | PMID:25268985 |
Nfe2l2 | Rat | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of NFE2L2 mRNA and Doxorubicin results in decreased expression of NFE2L2 protein | CTD | PMID:25169008 more ... |
Nfe2l2 | Rat | doxorubicin | increases expression | EXP | | 6480464 | [Doxorubicin results in increased expression of NFE2L2 protein] which results in increased expression of GSTP1 mRNA more ... | CTD | PMID:24211725 more ... |
Nfe2l2 | Rat | doxorubicin | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of NFE2L2 mRNA and Doxorubicin results in decreased expression of NFE2L2 protein | CTD | PMID:26969377 and PMID:29803840 |
Nfe2l2 | Rat | doxorubicin | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA results in decreased susceptibility to Doxorubicin and NFE2L2 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:23994249 and PMID:26708503 |
Nfe2l2 | Rat | doxorubicin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Doxorubicin co-treated with resveratrol] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:23994249 more ... |
Nfe2l2 | Rat | doxorubicin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Doxorubicin results in increased expression of NFE2L2 mRNA | CTD | PMID:21040762 more ... |
Nfe2l2 | Rat | doxorubicin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of NFE2L2 mRNA more ... | CTD | PMID:21040762 more ... |
Nfe2l2 | Rat | echinacoside | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | echinacoside results in increased activity of and affects the localization of NFE2L2 protein | CTD | PMID:22735309 |
Nfe2l2 | Rat | echinacoside | multiple interactions | EXP | | 6480464 | [echinacoside co-treated with Hydrogen Peroxide] affects the localization of NFE2L2 protein | CTD | PMID:31412289 |
Nfe2l2 | Rat | edaravone | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Edaravone affects the localization of NFE2L2 protein | CTD | PMID:25422538 |
Nfe2l2 | Rat | edaravone | multiple interactions | EXP | | 6480464 | [Edaravone co-treated with Chlorpyrifos] results in increased expression of NFE2L2 protein and Edaravone promotes the reaction [Carbon Monoxide results in increased expression of NFE2L2 protein] | CTD | PMID:25348283 and PMID:30758894 |
Nfe2l2 | Rat | elemental selenium | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Selenium results in decreased expression of NFE2L2 mRNA | CTD | PMID:19244175 |
Nfe2l2 | Rat | elemental selenium | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased expression of NFE2L2 protein and [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | CTD | PMID:32233808 and PMID:37415728 |
Nfe2l2 | Rat | elemental selenium | affects activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Selenium affects the activity of NFE2L2 protein | CTD | PMID:18279678 |
Nfe2l2 | Rat | elemental selenium | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Selenium affects the activity of HMOX1 protein] | CTD | PMID:18279678 |
Nfe2l2 | Rat | elemental selenium | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of NFE2L2 mRNA | CTD | PMID:19244175 |
Nfe2l2 | Rat | ellagic acid | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ellagic Acid affects the localization of NFE2L2 protein | CTD | PMID:22386815 |
Nfe2l2 | Rat | ellagic acid | multiple interactions | EXP | | 6480464 | Ellagic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFE2L2 protein] | CTD | PMID:35236242 |
Nfe2l2 | Rat | ellagic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ellagic Acid results in increased expression of NFE2L2 mRNA | CTD | PMID:30503583 |
Nfe2l2 | Rat | ellagic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Ellagic Acid co-treated with Diquat] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:30503583 and PMID:35268077 |
Nfe2l2 | Rat | ellagic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ellagic Acid results in increased expression of NFE2L2 mRNA and Ellagic Acid results in increased expression of NFE2L2 protein | CTD | PMID:22386815 and PMID:23546295 |
Nfe2l2 | Rat | ellagic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Paraquat co-treated with Ellagic Acid] results in increased expression of and affects the localization of NFE2L2 protein more ... | CTD | PMID:23546295 |
Nfe2l2 | Rat | ellagic acid | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Ellagic Acid | CTD | PMID:22386815 |
Nfe2l2 | Rat | emodin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Emodin promotes the reaction [Tobacco Smoke Pollution results in increased expression of and results in increased activity of NFE2L2 protein] more ... | CTD | PMID:26139382 and PMID:37393915 |
Nfe2l2 | Rat | emodin | affects localization | EXP | | 6480464 | Emodin affects the localization of NFE2L2 protein | CTD | PMID:34971761 |
Nfe2l2 | Rat | emodin | multiple interactions | EXP | | 6480464 | 2-tert-butylhydroquinone inhibits the reaction [Emodin results in decreased expression of and results in decreased localization of NFE2L2 protein] more ... | CTD | PMID:34971761 and PMID:37393915 |
Nfe2l2 | Rat | emodin | decreases expression | EXP | | 6480464 | Emodin results in decreased expression of NFE2L2 mRNA | CTD | PMID:37393915 |
Nfe2l2 | Rat | emodin | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Emodin results in decreased expression of NFE2L2 mRNA | CTD | PMID:37393915 |
Nfe2l2 | Rat | enalapril | decreases expression | EXP | | 6480464 | Enalapril results in decreased expression of NFE2L2 mRNA | CTD | PMID:18765277 |
Nfe2l2 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of NFE2L2 mRNA | CTD | PMID:31464424 |
Nfe2l2 | Rat | epalrestat | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | epalrestat affects the localization of and results in increased activity of NFE2L2 protein | CTD | PMID:28204799 |
Nfe2l2 | Rat | epalrestat | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | epalrestat affects the localization of and results in increased activity of NFE2L2 protein | CTD | PMID:28204799 |
Nfe2l2 | Rat | epoxiconazole | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | epoxiconazole results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | epoxomicin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | epoxomicin results in increased expression of NFE2L2 protein | CTD | PMID:22558124 |
Nfe2l2 | Rat | epoxomicin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein alternative form inhibits the reaction [epoxomicin results in increased expression of CDH1 protein] | CTD | PMID:35124418 |
Nfe2l2 | Rat | epoxomicin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | epoxomicin results in increased expression of NFE2L2 protein | CTD | PMID:22558124 |
Nfe2l2 | Rat | erastin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [erastin results in increased expression of SESN2 protein] | CTD | PMID:31323261 |
Nfe2l2 | Rat | erastin | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to erastin | CTD | PMID:38636790 |
Nfe2l2 | Rat | erastin | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | erastin results in decreased expression of NFE2L2 protein | CTD | PMID:38014886 |
Nfe2l2 | Rat | erastin | increases expression | EXP | | 6480464 | erastin results in increased expression of NFE2L2 protein | CTD | PMID:32937103 |
Nfe2l2 | Rat | erastin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | cordycepin inhibits the reaction [erastin results in decreased expression of NFE2L2 protein] and NFE2L2 protein affects the reaction [erastin results in increased expression of SESN2 protein] | CTD | PMID:31323261 and PMID:38014886 |
Nfe2l2 | Rat | erastin | multiple interactions | EXP | | 6480464 | NFE2L2 protein promotes the reaction [erastin results in increased expression of FTH1 protein] more ... | CTD | PMID:32937103 |
Nfe2l2 | Rat | erdosteine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | erdosteine promotes the reaction [Cisplatin results in increased expression of NFE2L2 protein] | CTD | PMID:26193055 |
Nfe2l2 | Rat | erdosteine | multiple interactions | EXP | | 6480464 | [erdosteine co-treated with Isoproterenol] results in increased expression of NFE2L2 protein | CTD | PMID:33210414 |
Nfe2l2 | Rat | ergosta-4,6,8(14),22-tetraen-3-one | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | ergosta-4 more ... | CTD | PMID:28578904 |
Nfe2l2 | Rat | eriodictyol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | eriodictyol results in increased expression of NFE2L2 protein | CTD | PMID:16799064 |
Nfe2l2 | Rat | eriodictyol | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | eriodictyol results in decreased expression of NFE2L2 protein | CTD | PMID:37020356 |
Nfe2l2 | Rat | eriodictyol | decreases phosphorylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | eriodictyol results in decreased phosphorylation of NFE2L2 protein | CTD | PMID:37020356 |
Nfe2l2 | Rat | eriodictyol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | bardoxolone methyl inhibits the reaction [eriodictyol results in decreased phosphorylation of NFE2L2 protein] | CTD | PMID:37020356 |
Nfe2l2 | Rat | eriodictyol | increases expression | EXP | | 6480464 | eriodictyol results in increased expression of NFE2L2 mRNA and eriodictyol results in increased expression of NFE2L2 protein | CTD | PMID:28978146 |
Nfe2l2 | Rat | eriodictyol | multiple interactions | EXP | | 6480464 | eriodictyol promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 mRNA] and eriodictyol promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein] | CTD | PMID:28978146 |
Nfe2l2 | Rat | erythromycin A | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Erythromycin inhibits the reaction [Particulate Matter results in increased activity of NFE2L2 protein] and Erythromycin inhibits the reaction [Vehicle Emissions results in increased activity of NFE2L2 protein] | CTD | PMID:23291319 |
Nfe2l2 | Rat | esculetin | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | esculetin results in increased localization of NFE2L2 protein | CTD | PMID:20933534 |
Nfe2l2 | Rat | esculetin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | esculetin affects the localization of NFE2L2 protein | CTD | PMID:30171828 |
Nfe2l2 | Rat | etacrynic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Ethacrynic Acid] | CTD | PMID:20932822 |
Nfe2l2 | Rat | etacrynic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ethacrynic Acid results in increased expression of and affects the localization of NFE2L2 protein and ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [Ethacrynic Acid affects the localization of NFE2L2 protein]] | CTD | PMID:26945724 and PMID:35724838 |
Nfe2l2 | Rat | etacrynic acid | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ethacrynic Acid affects the localization of NFE2L2 protein | CTD | PMID:20934533 more ... |
Nfe2l2 | Rat | etacrynic acid | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Ethacrynic Acid | CTD | PMID:19303893 |
Nfe2l2 | Rat | etacrynic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ethacrynic Acid results in increased expression of NFE2L2 protein | CTD | PMID:20934533 |
Nfe2l2 | Rat | ethanol | multiple interactions | EXP | | 6480464 | [Dietary Fats co-treated with Ethanol] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:17347304 more ... |
Nfe2l2 | Rat | ethanol | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ethanol affects the expression of NFE2L2 protein | CTD | PMID:35526736 |
Nfe2l2 | Rat | ethanol | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Ethanol | CTD | PMID:34116071 |
Nfe2l2 | Rat | ethanol | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ethanol results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | ethanol | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ethanol results in decreased expression of NFE2L2 mRNA and Ethanol results in decreased expression of NFE2L2 protein | CTD | PMID:30853489 more ... |
Nfe2l2 | Rat | ethanol | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ethanol results in increased expression of NFE2L2 protein | CTD | PMID:22996800 more ... |
Nfe2l2 | Rat | ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of NFE2L2 mRNA and Ethanol results in decreased expression of NFE2L2 protein | CTD | PMID:26460608 more ... |
Nfe2l2 | Rat | ethanol | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to Ethanol | CTD | PMID:23994065 |
Nfe2l2 | Rat | ethanol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ethanol results in increased expression of NFE2L2 protein | CTD | PMID:23994065 |
Nfe2l2 | Rat | ethanol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Plant Extracts co-treated with Ethanol] results in increased expression of and affects the localization of NFE2L2 protein] more ... | CTD | PMID:22552773 more ... |
Nfe2l2 | Rat | ethanol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Ethanol co-treated with Benzo(a)pyrene]] which results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:22484158 more ... |
Nfe2l2 | Rat | ethanol | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Ethanol | CTD | PMID:22627062 and PMID:30248482 |
Nfe2l2 | Rat | ethanol | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ethanol results in decreased expression of NFE2L2 mRNA | CTD | PMID:15513904 and PMID:34995708 |
Nfe2l2 | Rat | ethanol | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ethanol affects the localization of NFE2L2 protein | CTD | PMID:17433488 and PMID:22530035 |
Nfe2l2 | Rat | ethionamide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA promotes the reaction [Ethionamide results in increased susceptibility to arsenic trioxide] | CTD | PMID:26708503 |
Nfe2l2 | Rat | ethoxyquin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein promotes the reaction [Ethoxyquin results in increased expression of AKR1B10 mRNA] | CTD | PMID:21277289 |
Nfe2l2 | Rat | ethoxyquin | affects activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ethoxyquin affects the activity of NFE2L2 protein | CTD | PMID:11309284 |
Nfe2l2 | Rat | ethoxyquin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Ethoxyquin results in increased activity of NFE2L2 protein] which results in increased expression of ABCC2 mRNA more ... | CTD | PMID:15833929 and PMID:15919853 |
Nfe2l2 | Rat | Ethyl phenylglycidate | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to ethyl 3-phenylglycidate | CTD | PMID:20932822 |
Nfe2l2 | Rat | ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Egtazic Acid inhibits the reaction [2-tert-butylhydroquinone promotes the reaction [CREBBP protein binds to NFE2L2 protein]] more ... | CTD | PMID:21443188 |
Nfe2l2 | Rat | ethylene glycol dimethacrylate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA promotes the reaction [ethylene dimethacrylate results in increased expression of HMOX1 mRNA] | CTD | PMID:26244607 |
Nfe2l2 | Rat | etoposide | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA results in decreased susceptibility to Etoposide and NFE2L2 protein results in decreased susceptibility to Etoposide | CTD | PMID:26708503 and PMID:33148531 |
Nfe2l2 | Rat | etoposide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Etoposide results in increased expression of SRXN1 protein] more ... | CTD | PMID:27982581 and PMID:33148531 |
Nfe2l2 | Rat | eugenol | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Eugenol affects the expression of NFE2L2 protein | CTD | PMID:17275817 |
Nfe2l2 | Rat | eugenol | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Eugenol results in decreased expression of NFE2L2 mRNA | CTD | PMID:31967339 |
Nfe2l2 | Rat | eugenol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Eugenol promotes the reaction [NFE2L2 protein results in increased expression of NQO1 mRNA] | CTD | PMID:17275817 |
Nfe2l2 | Rat | falcarindiol | multiple interactions | EXP | | 6480464 | falcarindiol inhibits the reaction [KEAP1 protein results in decreased activity of NFE2L2 protein] | CTD | PMID:20026152 |
Nfe2l2 | Rat | farnesol | multiple interactions | EXP | | 6480464 | Farnesol inhibits the reaction [Chlorpyrifos results in decreased expression of NFE2L2 mRNA] | CTD | PMID:38849050 |
Nfe2l2 | Rat | farrerol | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | farrerol affects the localization of NFE2L2 protein | CTD | PMID:26111761 |
Nfe2l2 | Rat | farrerol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [farrerol affects the localization of NFE2L2 protein] more ... | CTD | PMID:26111761 |
Nfe2l2 | Rat | fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 protein | CTD | PMID:18775883 |
Nfe2l2 | Rat | fenofibrate | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Fenofibrate results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | fenofibrate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Fenofibrate inhibits the reaction [triptolide results in increased expression of NFE2L2 mRNA] and Fenofibrate inhibits the reaction [triptolide results in increased expression of NFE2L2 protein] | CTD | PMID:31241159 |
Nfe2l2 | Rat | fenofibrate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of NFE2L2 protein] | CTD | PMID:32730863 |
Nfe2l2 | Rat | fenofibrate | affects activity | EXP | | 6480464 | Fenofibrate affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | fenofibrate | decreases expression | EXP | | 6480464 | Fenofibrate results in decreased expression of NFE2L2 mRNA | CTD | PMID:25596134 |
Nfe2l2 | Rat | fenofibrate | affects activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Fenofibrate affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | fenpyroximate | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | fenpyroximate results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | fenvalerate | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NFE2L2 mRNA and [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA | CTD | PMID:33396045 and PMID:34896426 |
Nfe2l2 | Rat | ferroheme b | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mutant form inhibits the reaction [Heme results in increased expression of HMOX1 mRNA] | CTD | PMID:10874044 |
Nfe2l2 | Rat | ferrostatin-1 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein] and ferrostatin-1 inhibits the reaction [Valproic Acid results in decreased expression of NFE2L2 protein] | CTD | PMID:32416107 and PMID:39147356 |
Nfe2l2 | Rat | ferrostatin-1 | multiple interactions | EXP | | 6480464 | ferrostatin-1 inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 protein] and ferrostatin-1 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 mRNA] | CTD | PMID:39276841 |
Nfe2l2 | Rat | ferrostatin-1 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | ferrostatin-1 inhibits the reaction [7 more ... | CTD | PMID:36450496 |
Nfe2l2 | Rat | ferulic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | ferulic acid inhibits the reaction [sodium arsenate results in decreased expression of NFE2L2 mRNA] | CTD | PMID:30503583 |
Nfe2l2 | Rat | ferulic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with alpha-Tocopherol co-treated with ferulic acid] promotes the reaction [[Ozone co-treated with Oxygen] results in increased localization of NFE2L2 protein] | CTD | PMID:26270818 |
Nfe2l2 | Rat | ferulic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | ferulic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:30503583 |
Nfe2l2 | Rat | fisetin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | fisetin results in increased expression of NFE2L2 protein | CTD | PMID:16799064 |
Nfe2l2 | Rat | fisetin | increases expression | EXP | | 6480464 | fisetin results in increased expression of NFE2L2 protein | CTD | PMID:38278314 |
Nfe2l2 | Rat | fisetin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [fisetin results in decreased expression of MMP2 protein] more ... | CTD | PMID:30076913 |
Nfe2l2 | Rat | flufenacet | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | FOE 5043 results in increased activity of NFE2L2 protein | CTD | PMID:20143881 |
Nfe2l2 | Rat | fluoranthene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of NFE2L2 mRNA and [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFE2L2 mRNA | CTD | PMID:28329830 and PMID:37888695 |
Nfe2l2 | Rat | fluorescein 5-isothiocyanate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of NFE2L2 protein | CTD | PMID:27871981 |
Nfe2l2 | Rat | fluoxastrobin | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | fluoxastrobin results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | fluoxetine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Fluoxetine inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | CTD | PMID:36169195 |
Nfe2l2 | Rat | fluoxetine | increases expression | EXP | | 6480464 | Fluoxetine results in increased expression of NFE2L2 protein | CTD | PMID:34669537 |
Nfe2l2 | Rat | fluoxetine | multiple interactions | EXP | | 6480464 | vinpocetine inhibits the reaction [Fluoxetine results in increased expression of NFE2L2 protein] | CTD | PMID:34669537 |
Nfe2l2 | Rat | flutamide | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Flutamide | CTD | PMID:21540358 |
Nfe2l2 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of NFE2L2 mRNA | CTD | PMID:24136188 |
Nfe2l2 | Rat | flutriafol | decreases expression | EXP | | 6480464 | flutriafol results in decreased expression of NFE2L2 protein | CTD | PMID:34200939 |
Nfe2l2 | Rat | flutriafol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [flutriafol results in increased localization of NFE2L2 protein] | CTD | PMID:34200939 |
Nfe2l2 | Rat | flutriafol | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | flutriafol results in increased localization of NFE2L2 protein | CTD | PMID:34200939 |
Nfe2l2 | Rat | fluvastatin | multiple interactions | EXP | | 6480464 | Fluvastatin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:35465754 |
Nfe2l2 | Rat | folic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:22206623 and PMID:37263574 |
Nfe2l2 | Rat | folic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Folic Acid co-treated with Arsenic] results in increased expression of NFE2L2 mRNA and [Vitamin B 6 co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of NFE2L2 protein] | CTD | PMID:35490796 and PMID:37263574 |
Nfe2l2 | Rat | formaldehyde | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Formaldehyde co-treated with epigallocatechin gallate] results in increased expression of NFE2L2 protein | CTD | PMID:30395894 |
Nfe2l2 | Rat | formetanate | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | formetanate results in increased activity of NFE2L2 protein | CTD | PMID:20143881 |
Nfe2l2 | Rat | formononetin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [formononetin co-treated with Hydrogen Peroxide] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:34077701 |
Nfe2l2 | Rat | formononetin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | formononetin inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 mRNA] and formononetin inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | CTD | PMID:37269934 |
Nfe2l2 | Rat | Forsythiaside | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | forsythiaside inhibits the reaction [lipopolysaccharide more ... | CTD | PMID:38729284 |
Nfe2l2 | Rat | fructose | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Fructose promotes the reaction [PPARD gene mutant form results in increased phosphorylation of NFE2L2 protein] and Plant Preparations inhibits the reaction [Fructose results in increased expression of NFE2L2 protein] | CTD | PMID:27531227 and PMID:29289645 |
Nfe2l2 | Rat | fructose | multiple interactions | EXP | | 6480464 | [Atorvastatin co-treated with dapagliflozin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of NFE2L2 protein] more ... | CTD | PMID:32259528 |
Nfe2l2 | Rat | fructose | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Fructose co-treated with Palmitic Acid] results in decreased expression of NFE2L2 protein and Fenofibrate inhibits the reaction [[Fructose co-treated with Palmitic Acid] results in decreased expression of NFE2L2 protein] | CTD | PMID:32730863 |
Nfe2l2 | Rat | fructose | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Fructose results in increased expression of NFE2L2 protein | CTD | PMID:27531227 |
Nfe2l2 | Rat | fulvestrant | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | fulvestrant inhibits the reaction [ginsenoside Rb1 results in increased localization of NFE2L2 protein] | CTD | PMID:19781563 |
Nfe2l2 | Rat | fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [gypenoside analog affects the localization of NFE2L2 protein] and fulvestrant inhibits the reaction [Phytoestrogens affects the localization of NFE2L2 protein] | CTD | PMID:24726523 |
Nfe2l2 | Rat | fumonisin B1 | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | fumonisin B1 results in increased expression of NFE2L2 mRNA | CTD | PMID:16221962 |
Nfe2l2 | Rat | fumonisin B1 | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | fumonisin B1 affects the expression of NFE2L2 mRNA | CTD | PMID:35697133 |
Nfe2l2 | Rat | fumonisin B1 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [fumonisin B1 results in decreased expression of MIR27B mRNA] which results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:33496827 |
Nfe2l2 | Rat | fumonisin B1 | decreases methylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | fumonisin B1 results in decreased methylation of NFE2L2 promoter | CTD | PMID:33496827 |
Nfe2l2 | Rat | fumonisin B1 | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | fumonisin B1 results in increased expression of NFE2L2 mRNA and fumonisin B1 results in increased expression of NFE2L2 protein | CTD | PMID:33496827 |
Nfe2l2 | Rat | fumonisin B1 | increases methylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | fumonisin B1 results in increased methylation of NFE2L2 mRNA | CTD | PMID:33496827 |
Nfe2l2 | Rat | furan | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | furan results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | furazolidone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Furazolidone results in increased expression of NFE2L2 protein | CTD | PMID:26687534 and PMID:27996348 |
Nfe2l2 | Rat | furazolidone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | CDKN1A mutant form inhibits the reaction [Furazolidone results in increased expression of NFE2L2 protein] more ... | CTD | PMID:26687534 and PMID:27996348 |
Nfe2l2 | Rat | furosemide | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Furosemide | CTD | PMID:24813929 |
Nfe2l2 | Rat | furosemide | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Furosemide results in increased localization of NFE2L2 protein | CTD | PMID:18078705 |
Nfe2l2 | Rat | Fusaric acid | increases phosphorylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | Fusaric Acid results in increased phosphorylation of NFE2L2 protein | CTD | PMID:30582969 |
Nfe2l2 | Rat | gadolinium atom | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of NFE2L2 mRNA | CTD | PMID:34878122 |
Nfe2l2 | Rat | gadolinium trichloride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [gadolinium chloride results in increased abundance of Gadolinium] which results in increased expression of NFE2L2 mRNA | CTD | PMID:34878122 |
Nfe2l2 | Rat | galactose | multiple interactions | EXP | | 6480464 | Saponins inhibits the reaction [Galactose affects the localization of NFE2L2 protein] | CTD | PMID:25892055 |
Nfe2l2 | Rat | galactose | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | albicanol inhibits the reaction [Galactose results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:33761044 and PMID:36638877 |
Nfe2l2 | Rat | galactose | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Galactose results in decreased expression of NFE2L2 mRNA and Galactose results in decreased expression of NFE2L2 protein | CTD | PMID:33761044 and PMID:36638877 |
Nfe2l2 | Rat | galactose | affects localization | EXP | | 6480464 | Galactose affects the localization of NFE2L2 protein | CTD | PMID:25892055 |
Nfe2l2 | Rat | galangin | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | galangin results in decreased expression of NFE2L2 protein | CTD | PMID:29113808 |
Nfe2l2 | Rat | galangin | multiple interactions | EXP | | 6480464 | [Cadmium co-treated with galangin] results in increased expression of NFE2L2 protein and galangin inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein] | CTD | PMID:35384154 and PMID:35843304 |
Nfe2l2 | Rat | galanthamine | multiple interactions | EXP | | 6480464 | Galantamine inhibits the reaction [Scopolamine results in decreased expression of NFE2L2 protein] | CTD | PMID:27346436 |
Nfe2l2 | Rat | galanthamine Trifluoroacetic acid | multiple interactions | EXP | | 6480464 | Galantamine inhibits the reaction [Scopolamine results in decreased expression of NFE2L2 protein] | CTD | PMID:27346436 |
Nfe2l2 | Rat | gallic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein more ... | CTD | PMID:29061316 and PMID:30853489 |
Nfe2l2 | Rat | gallic acid | multiple interactions | EXP | | 6480464 | [Gallic Acid co-treated with Dust] results in increased expression of NFE2L2 mRNA and Gallic Acid affects the reaction [[Dietary Fats co-treated with Dust] affects the expression of NFE2L2 mRNA] | CTD | PMID:33953864 and PMID:34745924 |
Nfe2l2 | Rat | gallium nitrate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | SB 203580 inhibits the reaction [gallium nitrate results in increased activity of NFE2L2 protein] | CTD | PMID:18586083 |
Nfe2l2 | Rat | gallium nitrate | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | gallium nitrate results in increased activity of NFE2L2 protein | CTD | PMID:18586083 |
Nfe2l2 | Rat | gallocatechin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein and BMAL1 protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the localization of NFE2L2 protein] | CTD | PMID:29061316 |
Nfe2l2 | Rat | gamma-hexachlorocyclohexane | decreases expression | EXP | | 6480464 | Hexachlorocyclohexane results in decreased expression of NFE2L2 mRNA | CTD | PMID:17785943 |
Nfe2l2 | Rat | gamma-tocopherol | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | gamma-Tocopherol results in increased expression of NFE2L2 mRNA and gamma-Tocopherol results in increased expression of NFE2L2 protein | CTD | PMID:19115203 |
Nfe2l2 | Rat | gamma-tocopherol | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] | CTD | PMID:22389237 |
Nfe2l2 | Rat | Gastrodin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 4-benzyl-2-methyl-1 more ... | CTD | PMID:26634892 more ... |
Nfe2l2 | Rat | Gastrodin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | gastrodin results in increased expression of NFE2L2 protein | CTD | PMID:31698019 |
Nfe2l2 | Rat | Gastrodin | multiple interactions | EXP | | 6480464 | 4-benzyl-2-methyl-1 more ... | CTD | PMID:31468582 and PMID:33764184 |
Nfe2l2 | Rat | Gastrodin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [gastrodin co-treated with Oleic Acid] results in increased phosphorylation of and affects the localization of NFE2L2 protein more ... | CTD | PMID:26634892 |
Nfe2l2 | Rat | gemcitabine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | CASC9 protein affects the reaction [Gemcitabine results in increased expression of NFE2L2 mRNA] more ... | CTD | PMID:35913601 |
Nfe2l2 | Rat | gemcitabine | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to Gemcitabine | CTD | PMID:21489257 |
Nfe2l2 | Rat | gemcitabine | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Gemcitabine results in increased expression of NFE2L2 mRNA and Gemcitabine results in increased expression of NFE2L2 protein | CTD | PMID:35913601 |
Nfe2l2 | Rat | Genipin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Lipopolysaccharides co-treated with genipin] results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | genistein | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Genistein results in decreased expression of NFE2L2 mRNA | CTD | PMID:24967385 |
Nfe2l2 | Rat | genistein | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Genistein inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein] | CTD | PMID:30734460 |
Nfe2l2 | Rat | genistein | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Genistein results in increased expression of NFE2L2 protein | CTD | PMID:21573189 |
Nfe2l2 | Rat | genistein | multiple interactions | EXP | | 6480464 | Genistein inhibits the reaction [lead acetate results in decreased expression of NFE2L2 protein] | CTD | PMID:26797587 |
Nfe2l2 | Rat | genistein | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Genistein results in increased expression of NFE2L2 mRNA | CTD | PMID:23295412 and PMID:32186404 |
Nfe2l2 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of NFE2L2 mRNA | CTD | PMID:30458643 and PMID:38056816 |
Nfe2l2 | Rat | gentamycin | multiple interactions | EXP | | 6480464 | Cholecalciferol inhibits the reaction [Gentamicins results in decreased expression of NFE2L2 mRNA] and Curcumin inhibits the reaction [Gentamicins results in decreased expression of NFE2L2 mRNA] | CTD | PMID:30458643 and PMID:38056816 |
Nfe2l2 | Rat | Geraniin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Geraniin promotes the reaction [lipopolysaccharide and E coli O55-B5 affects the localization of NFE2L2 protein] | CTD | PMID:27181634 |
Nfe2l2 | Rat | geraniol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | geraniol results in increased expression of NFE2L2 mRNA | CTD | PMID:27683099 |
Nfe2l2 | Rat | geraniol | multiple interactions | EXP | | 6480464 | geraniol promotes the reaction [Doxorubicin results in increased expression of NFE2L2 mRNA] and geraniol promotes the reaction [Doxorubicin results in increased expression of NFE2L2 protein] | CTD | PMID:34343525 |
Nfe2l2 | Rat | geraniol | increases expression | EXP | | 6480464 | geraniol results in increased expression of NFE2L2 protein | CTD | PMID:28334550 |
Nfe2l2 | Rat | Gingerenone A | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | gingerenone A inhibits the reaction [Dextran Sulfate results in decreased expression of NFE2L2 protein] | CTD | PMID:36135333 |
Nfe2l2 | Rat | Gingerenone A | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | gingerenone A inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | CTD | PMID:36135333 |
Nfe2l2 | Rat | ginkgolide B | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | ginkgolide B inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of NFE2L2 protein] | CTD | PMID:32976958 |
Nfe2l2 | Rat | ginkgolide B | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | ginkgolide B inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of and affects the localization of NFE2L2 protein] | CTD | PMID:32976958 |
Nfe2l2 | Rat | Ginkgolide C | increases localization | EXP | | 6480464 | ginkgolide C results in increased localization of NFE2L2 protein | CTD | PMID:35707280 |
Nfe2l2 | Rat | Ginkgolide C | multiple interactions | EXP | | 6480464 | ginkgolide C inhibits the reaction [Paraquat affects the localization of NFE2L2 protein] | CTD | PMID:35707280 |
Nfe2l2 | Rat | ginsenoside Rb1 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rb1 results in increased localization of NFE2L2 protein] more ... | CTD | PMID:19781563 and PMID:22780686 |
Nfe2l2 | Rat | ginsenoside Rb1 | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | ginsenoside Rb1 affects the localization of NFE2L2 protein | CTD | PMID:25422538 |
Nfe2l2 | Rat | ginsenoside Rb1 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [astragaloside A co-treated with ginsenoside Rg1 co-treated with ginsenoside Rb1 co-treated with notoginsenoside R1] affects the localization of NFE2L2 protein | CTD | PMID:25422538 |
Nfe2l2 | Rat | ginsenoside Rb1 | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | ginsenoside Rb1 results in increased expression of NFE2L2 mRNA | CTD | PMID:22780686 |
Nfe2l2 | Rat | ginsenoside Rg1 | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | ginsenoside Rg1 results in increased expression of NFE2L2 mRNA | CTD | PMID:22780686 |
Nfe2l2 | Rat | ginsenoside Rg1 | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | ginsenoside Rg1 affects the localization of NFE2L2 protein | CTD | PMID:25422538 |
Nfe2l2 | Rat | ginsenoside Rg1 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [astragaloside A co-treated with ginsenoside Rg1 co-treated with ginsenoside Rb1 co-treated with notoginsenoside R1] affects the localization of NFE2L2 protein more ... | CTD | PMID:25422538 and PMID:29964319 |
Nfe2l2 | Rat | ginsenoside Rg1 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [ginsenoside Rg1 co-treated with ginsenoside 20S-protopanaxatriol] results in increased expression of NFE2L2 protein | CTD | PMID:22780686 |
Nfe2l2 | Rat | Ginsenoside Rh4 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | ginsenoside Rh4 inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of NFE2L2 mRNA] and ginsenoside Rh4 inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of NFE2L2 protein] | CTD | PMID:33359794 |
Nfe2l2 | Rat | Ginsenoside Rh4 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ginsenoside Rh4 inhibits the reaction [Alloxan affects the localization of NFE2L2 protein]] more ... | CTD | PMID:33359794 |
Nfe2l2 | Rat | gliclazide | multiple interactions | EXP | | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 mRNA] and Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 protein] | CTD | PMID:21439372 |
Nfe2l2 | Rat | glucoraphanin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | glucoraphanin analog affects the localization of NFE2L2 protein | CTD | PMID:20868228 |
Nfe2l2 | Rat | glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NFE2L2 mRNA and Glucose results in decreased expression of NFE2L2 protein | CTD | PMID:21818840 more ... |
Nfe2l2 | Rat | glucose | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Glucose affects the localization of NFE2L2 protein | CTD | PMID:33270355 |
Nfe2l2 | Rat | glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of NFE2L2 mRNA and Glucose results in increased expression of NFE2L2 protein | CTD | PMID:29211853 |
Nfe2l2 | Rat | glucose | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Glucose | CTD | PMID:20086057 |
Nfe2l2 | Rat | glucose | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Glucose results in decreased expression of NFE2L2 mRNA and Glucose results in decreased expression of NFE2L2 protein | CTD | PMID:21333731 more ... |
Nfe2l2 | Rat | glucose | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]] more ... | CTD | PMID:21333731 more ... |
Nfe2l2 | Rat | glucose | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(1 more ... | CTD | PMID:17928392 more ... |
Nfe2l2 | Rat | glucose | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Glucose deficiency results in increased localization of NFE2L2 protein | CTD | PMID:17928392 |
Nfe2l2 | Rat | glucose | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Glucose deficiency results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:20103708 more ... |
Nfe2l2 | Rat | glucose | multiple interactions | EXP | | 6480464 | 4-benzyl-2-methyl-1 more ... | CTD | PMID:20028456 more ... |
Nfe2l2 | Rat | glutathione | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Buthionine Sulfoximine results in decreased abundance of Glutathione] which affects the localization of NFE2L2 protein] more ... | CTD | PMID:16631525 more ... |
Nfe2l2 | Rat | glutathione | increases abundance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in increased abundance of Glutathione | CTD | PMID:28219650 |
Nfe2l2 | Rat | glutathione | decreases abundance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in decreased abundance of Glutathione | CTD | PMID:27633142 and PMID:29618784 |
Nfe2l2 | Rat | glutathione | affects abundance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the abundance of Glutathione | CTD | PMID:20124447 |
Nfe2l2 | Rat | glutathione | multiple interactions | EXP | | 6480464 | NFE2L2 protein inhibits the reaction [triptolide results in decreased abundance of Glutathione] | CTD | PMID:22820427 |
Nfe2l2 | Rat | glutathione | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [ATG5 gene mutant form results in increased activity of NFE2L2 protein] affects the reaction [Acetaminophen affects the abundance of Glutathione] more ... | CTD | PMID:19303893 more ... |
Nfe2l2 | Rat | glutathione | increases abundance | EXP | | 6480464 | NFE2L2 protein results in increased abundance of Glutathione | CTD | PMID:16524372 |
Nfe2l2 | Rat | glutathione | affects abundance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 affects the abundance of Glutathione and NFE2L2 protein affects the abundance of Glutathione | CTD | PMID:11287661 and PMID:19303893 |
Nfe2l2 | Rat | glutathione | decreases abundance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 gene mutant form results in decreased abundance of Glutathione | CTD | PMID:19608619 |
Nfe2l2 | Rat | glutathione disulfide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which affects the abundance of Glutathione Disulfide | CTD | PMID:35204234 |
Nfe2l2 | Rat | Glutathione ethyl ester | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | S-ethyl glutathione inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] | CTD | PMID:17980396 |
Nfe2l2 | Rat | glyburide | multiple interactions | EXP | | 6480464 | [Glyburide co-treated with Dimethyl Fumarate] inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:30817903 more ... |
Nfe2l2 | Rat | glycine betaine | multiple interactions | EXP | | 6480464 | Betaine inhibits the reaction [Doxorubicin results in increased expression of NFE2L2 mRNA] and Betaine inhibits the reaction [Doxorubicin results in increased expression of NFE2L2 protein] | CTD | PMID:37840533 and PMID:38651543 |
Nfe2l2 | Rat | glycine betaine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Betaine inhibits the reaction [Acetaminophen results in increased expression of NFE2L2 mRNA] and Betaine inhibits the reaction [Acetaminophen results in increased expression of NFE2L2 protein] | CTD | PMID:32081044 |
Nfe2l2 | Rat | glycogen | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Streptozocin results in decreased abundance of Glycogen] | CTD | PMID:20086057 |
Nfe2l2 | Rat | glycyrrhetinate | multiple interactions | EXP | | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA] and 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 protein] | CTD | PMID:28414158 |
Nfe2l2 | Rat | glycyrrhetinate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Glycyrrhetinic Acid results in increased expression of NFE2L2 | CTD | PMID:23341968 |
Nfe2l2 | Rat | glycyrrhetinate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Glycyrrhetinic Acid results in increased expression of NFE2L2] which results in decreased susceptibility to Carbon Tetrachloride and Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride affects the localization of NFE2L2 protein] | CTD | PMID:23341968 |
Nfe2l2 | Rat | glycyrrhetinic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Glycyrrhetinic Acid results in increased expression of NFE2L2 | CTD | PMID:23341968 |
Nfe2l2 | Rat | glycyrrhetinic acid | multiple interactions | EXP | | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA] and 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 protein] | CTD | PMID:28414158 |
Nfe2l2 | Rat | glycyrrhetinic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Glycyrrhetinic Acid results in increased expression of NFE2L2] which results in decreased susceptibility to Carbon Tetrachloride and Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride affects the localization of NFE2L2 protein] | CTD | PMID:23341968 |
Nfe2l2 | Rat | glyphosate | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Glyphosate results in decreased expression of NFE2L2 mRNA | CTD | PMID:34748853 |
Nfe2l2 | Rat | glyphosate | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of NFE2L2 mRNA] | CTD | PMID:33797725 |
Nfe2l2 | Rat | glyphosate | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Glyphosate results in increased expression of NFE2L2 mRNA | CTD | PMID:36625791 |
Nfe2l2 | Rat | glyphosate | decreases expression | EXP | | 6480464 | Glyphosate results in decreased expression of NFE2L2 mRNA | CTD | PMID:33797725 |
Nfe2l2 | Rat | gold atom | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Gold results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | gold atom | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Gold analog results in increased expression of NFE2L2 mRNA and Gold analog results in increased expression of NFE2L2 protein | CTD | PMID:36057382 |
Nfe2l2 | Rat | gold(0) | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Gold results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | gold(0) | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Gold analog results in increased expression of NFE2L2 mRNA and Gold analog results in increased expression of NFE2L2 protein | CTD | PMID:36057382 |
Nfe2l2 | Rat | gossypin | multiple interactions | EXP | | 6480464 | gossypin inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | CTD | PMID:37148149 |
Nfe2l2 | Rat | guggulsterone | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to pregna-4 more ... | CTD | PMID:22851183 |
Nfe2l2 | Rat | guggulsterone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | pregna-4 more ... | CTD | PMID:37573684 |
Nfe2l2 | Rat | GW 501516 | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | GW 501516 results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | harman | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | harman results in increased expression of NFE2L2 protein | CTD | PMID:35985368 |
Nfe2l2 | Rat | heme b | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mutant form inhibits the reaction [Heme results in increased expression of HMOX1 mRNA] | CTD | PMID:10874044 |
Nfe2l2 | Rat | hemin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Antineoplastic Agents binds to and results in decreased activity of NFE2L2 protein] inhibits the reaction [Hemin results in increased expression of SESN2 protein] more ... | CTD | PMID:16959797 more ... |
Nfe2l2 | Rat | hemin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Hemin results in increased expression of NFE2L2 protein | CTD | PMID:31054940 |
Nfe2l2 | Rat | hemin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Hemin results in increased expression of NFE2L2 protein | CTD | PMID:27777014 |
Nfe2l2 | Rat | hemin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Hemin affects the localization of NFE2L2 protein | CTD | PMID:16959797 and PMID:21525764 |
Nfe2l2 | Rat | hemin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form inhibits the reaction [Hemin results in increased expression of CYP2A5 mRNA] and NFE2L2 protein affects the reaction [Hemin results in increased expression of HMOX1 mRNA] | CTD | PMID:10473555 and PMID:22859313 |
Nfe2l2 | Rat | hemin | multiple interactions | EXP | | 6480464 | [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Hemin] affects the localization of NFE2L2 protein more ... | CTD | PMID:23272707 more ... |
Nfe2l2 | Rat | hemin | decreases expression | EXP | | 6480464 | Hemin results in decreased expression of NFE2L2 protein | CTD | PMID:25824035 |
Nfe2l2 | Rat | hemin | increases expression | EXP | | 6480464 | Hemin results in increased expression of NFE2L2 protein | CTD | PMID:25824035 |
Nfe2l2 | Rat | heparin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Heparin analog results in increased expression of NFE2L2 mRNA | CTD | PMID:26476401 |
Nfe2l2 | Rat | hesperetin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | hesperetin inhibits the reaction [Benzo(a)pyrene results in decreased expression of NFE2L2 protein] and hesperetin promotes the reaction [Cisplatin results in increased expression of NFE2L2 protein] | CTD | PMID:26546711 and PMID:31153982 |
Nfe2l2 | Rat | hesperetin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | hesperetin results in increased expression of NFE2L2 protein | CTD | PMID:31153982 |
Nfe2l2 | Rat | hesperetin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with hesperetin] results in increased expression of NFE2L2 protein | CTD | PMID:31153982 |
Nfe2l2 | Rat | hesperidin | multiple interactions | EXP | | 6480464 | Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:28935427 more ... |
Nfe2l2 | Rat | hesperidin | increases expression | EXP | | 6480464 | Hesperidin results in increased expression of NFE2L2 mRNA | CTD | PMID:36966900 |
Nfe2l2 | Rat | hexachlorobenzene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Hexachlorobenzene co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 protein | CTD | PMID:28634113 |
Nfe2l2 | Rat | hexadecanoic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of NFE2L2 protein]] more ... | CTD | PMID:26847930 and PMID:38174997 |
Nfe2l2 | Rat | hexadecanoic acid | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Palmitic Acid results in decreased expression of NFE2L2 protein | CTD | PMID:38174997 |
Nfe2l2 | Rat | hexadecanoic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Fructose co-treated with Palmitic Acid] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:32730863 more ... |
Nfe2l2 | Rat | homocysteine | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Homocysteine affects the localization of NFE2L2 protein modified form | CTD | PMID:22964297 |
Nfe2l2 | Rat | homocysteine | decreases expression | EXP | | 6480464 | Homocysteine results in decreased expression of NFE2L2 protein | CTD | PMID:38729282 |
Nfe2l2 | Rat | homocysteine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Homocysteine results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:22964297 |
Nfe2l2 | Rat | homocysteine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein] and Homocysteine results in decreased phosphorylation of and results in decreased expression of NFE2L2 protein | CTD | PMID:22964297 |
Nfe2l2 | Rat | homocysteine | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Homocysteine results in increased expression of NFE2L2 mRNA | CTD | PMID:22964297 |
Nfe2l2 | Rat | homoeriodictyol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | homoeriodictyol results in increased expression of and results in increased localization of NFE2L2 protein more ... | CTD | PMID:29902531 |
Nfe2l2 | Rat | hydrogen chloride | increases localization | EXP | | 6480464 | Hydrochloric Acid results in increased localization of NFE2L2 protein | CTD | PMID:18617559 |
Nfe2l2 | Rat | hydrogen chloride | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 gene mutant form results in increased susceptibility to Hydrochloric Acid] which results in increased expression of CAR3 mRNA more ... | CTD | PMID:29618784 |
Nfe2l2 | Rat | hydrogen chloride | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Hydrochloric Acid | CTD | PMID:29618784 |
Nfe2l2 | Rat | hydrogen peroxide | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased localization of NFE2L2 protein | CTD | PMID:22021338 |
Nfe2l2 | Rat | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of NFE2L2 protein | CTD | PMID:34047419 |
Nfe2l2 | Rat | hydrogen peroxide | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Hydrogen Peroxide affects the expression of NFE2L2 protein | CTD | PMID:36356655 |
Nfe2l2 | Rat | hydrogen peroxide | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the localization of NFE2L2 protein | CTD | PMID:32980322 more ... |
Nfe2l2 | Rat | hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:26286524 more ... |
Nfe2l2 | Rat | hydrogen peroxide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Hydrogen Peroxide results in increased expression of NFE2L2 protein | CTD | PMID:29950142 and PMID:31194955 |
Nfe2l2 | Rat | hydrogen peroxide | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in decreased expression of NFE2L2 mRNA and Hydrogen Peroxide results in decreased expression of NFE2L2 protein | CTD | PMID:21573189 more ... |
Nfe2l2 | Rat | hydrogen peroxide | affects localization | EXP | | 6480464 | Hydrogen Peroxide affects the localization of NFE2L2 protein | CTD | PMID:24437944 and PMID:31412289 |
Nfe2l2 | Rat | hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of NFE2L2 protein | CTD | PMID:22606287 |
Nfe2l2 | Rat | hydrogen peroxide | increases activity | EXP | | 6480464 | Hydrogen Peroxide results in increased activity of NFE2L2 protein | CTD | PMID:22606287 |
Nfe2l2 | Rat | hydrogen peroxide | multiple interactions | EXP | | 6480464 | [alpha-Tocopherol co-treated with Hydrogen Peroxide] affects the localization of NFE2L2 protein more ... | CTD | PMID:22606287 more ... |
Nfe2l2 | Rat | hydrogen peroxide | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of NFE2L2 mRNA and Hydrogen Peroxide results in increased expression of NFE2L2 protein | CTD | PMID:23410634 more ... |
Nfe2l2 | Rat | hydrogen peroxide | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Hydrogen Peroxide | CTD | PMID:19303893 |
Nfe2l2 | Rat | hydrogen peroxide | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:18367636 |
Nfe2l2 | Rat | hydrogen peroxide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:18367636 more ... |
Nfe2l2 | Rat | hydrogen peroxide | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of NFE2L2 mRNA and Hydrogen Peroxide affects the expression of NFE2L2 protein | CTD | PMID:20044591 and PMID:30703377 |
Nfe2l2 | Rat | hydrogen peroxide | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:17360324 |
Nfe2l2 | Rat | hydrogen peroxide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | (+)-JQ1 compound promotes the reaction [Hydrogen Peroxide results in increased activity of and affects the localization of NFE2L2 protein] more ... | CTD | PMID:14567983 more ... |
Nfe2l2 | Rat | hydrogen sulfide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Hydrogen Sulfide results in increased expression of NFE2L2 protein | CTD | PMID:29932956 |
Nfe2l2 | Rat | hydrogen sulfide | multiple interactions | EXP | | 6480464 | [sodium bisulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Paraquat promotes the reaction [KEAP1 protein binds to NFE2L2 protein]] more ... | CTD | PMID:32064027 |
Nfe2l2 | Rat | hydroquinone | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | hydroquinone results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | hydroquinone | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | hydroquinone results in decreased expression of NFE2L2 mRNA | CTD | PMID:31967339 |
Nfe2l2 | Rat | hydroquinone | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | hydroquinone results in increased expression of NFE2L2 mRNA and hydroquinone results in increased expression of NFE2L2 protein | CTD | PMID:23290930 |
Nfe2l2 | Rat | hydroquinone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 mRNA affects the reaction [hydroquinone results in increased expression of HMOX1 protein] | CTD | PMID:23290930 |
Nfe2l2 | Rat | hydroquinone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | hydroquinone results in increased expression of NFE2L2 protein | CTD | PMID:28645578 more ... |
Nfe2l2 | Rat | hydroquinone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of and affects the localization of NFE2L2 protein] more ... | CTD | PMID:21059386 more ... |
Nfe2l2 | Rat | hydroquinone O-beta-D-glucopyranoside | multiple interactions | EXP | | 6480464 | Arbutin inhibits the reaction [Ethanol results in decreased expression of NFE2L2 mRNA] | CTD | PMID:34346143 |
Nfe2l2 | Rat | hydroquinones | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to Hydroquinones | CTD | PMID:20932822 |
Nfe2l2 | Rat | hydroxysafflor yellow A | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | hydroxysafflor yellow A inhibits the reaction [Ovalbumin results in decreased expression of NFE2L2 protein] | CTD | PMID:37195255 |
Nfe2l2 | Rat | hydroxyurea | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Hydroxyurea results in decreased expression of NFE2L2 mRNA | CTD | PMID:34748853 |
Nfe2l2 | Rat | hypochlorous acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] | CTD | PMID:18156441 |
Nfe2l2 | Rat | hypochlorous acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Hypochlorous Acid results in increased expression of NFE2L2 protein | CTD | PMID:17980396 |
Nfe2l2 | Rat | hypochlorous acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of NFE2L2 mRNA] more ... | CTD | PMID:17980396 |
Nfe2l2 | Rat | hypochlorous acid | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Hypochlorous Acid | CTD | PMID:18156441 |
Nfe2l2 | Rat | hypochlorous acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Hypochlorous Acid results in increased expression of NFE2L2 mRNA | CTD | PMID:18156441 |
Nfe2l2 | Rat | hypoxanthine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Hypoxanthine co-treated with potassium oxonate] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:39222901 |
Nfe2l2 | Rat | iberin | increases expression | EXP | | 6480464 | iberin results in increased expression of NFE2L2 protein | CTD | PMID:22664424 |
Nfe2l2 | Rat | ibuprofen | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ibuprofen results in increased expression of NFE2L2 mRNA | CTD | PMID:25596134 |
Nfe2l2 | Rat | ibuprofen | affects activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ibuprofen affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | ifosfamide | affects activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ifosfamide affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | ifosfamide | multiple interactions | EXP | | 6480464 | morin inhibits the reaction [Ifosfamide results in decreased expression of NFE2L2 protein] | CTD | PMID:31722249 |
Nfe2l2 | Rat | ifosfamide | decreases expression | EXP | | 6480464 | Ifosfamide results in decreased expression of NFE2L2 protein | CTD | PMID:31722249 |
Nfe2l2 | Rat | Ile(5)-angiotensin II | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Angiotensin II results in increased expression of COL1A1 mRNA] and NFE2L2 protein affects the reaction [Angiotensin II results in increased expression of NOX4 protein] | CTD | PMID:33746155 |
Nfe2l2 | Rat | imidacloprid | affects expression | EXP | | 6480464 | imidacloprid affects the expression of NFE2L2 mRNA | CTD | PMID:39002876 |
Nfe2l2 | Rat | imperatorin | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to imperatorin | CTD | PMID:19150646 |
Nfe2l2 | Rat | indirubin | increases expression | EXP | | 6480464 | indirubin results in increased expression of NFE2L2 mRNA | CTD | PMID:20951181 |
Nfe2l2 | Rat | indole-3-methanol | decreases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | indole-3-carbinol results in decreased activity of NFE2L2 protein | CTD | PMID:16082211 |
Nfe2l2 | Rat | indole-3-methanol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [indole-3-carbinol co-treated with phenethyl isothiocyanate] results in increased expression of NFE2L2 mRNA | CTD | PMID:32070777 |
Nfe2l2 | Rat | indole-3-methanol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | indole-3-carbinol inhibits the reaction [Doxorubicin affects the expression of and affects the localization of NFE2L2 protein] | CTD | PMID:29775573 |
Nfe2l2 | Rat | indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:22129741 and PMID:28619389 |
Nfe2l2 | Rat | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of NFE2L2 mRNA | CTD | PMID:21396975 |
Nfe2l2 | Rat | indole-3-methanol | affects activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | indole-3-carbinol affects the activity of NFE2L2 protein | CTD | PMID:11309284 |
Nfe2l2 | Rat | indolin-2-one | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-oxindole results in decreased ubiquitination of and results in decreased degradation of NFE2L2 protein and 2-oxindole results in increased activity of and results in increased expression of and results in increased stability of NFE2L2 protein | CTD | PMID:22245129 |
Nfe2l2 | Rat | indoline | multiple interactions | EXP | | 6480464 | [Thiazoles analog binds to indoline analog] inhibits the reaction [SESN2 protein promotes the reaction [Hydrogen Peroxide results in increased activity of NFE2L2 protein]] more ... | CTD | PMID:32275923 and PMID:34351043 |
Nfe2l2 | Rat | indometacin | affects localization | EXP | | 6480464 | Indomethacin affects the localization of NFE2L2 protein | CTD | PMID:25110317 |
Nfe2l2 | Rat | indometacin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased activity of NFE2L2 protein | CTD | PMID:33412187 |
Nfe2l2 | Rat | indometacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [Carrageenan results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:28648817 and PMID:34789018 |
Nfe2l2 | Rat | indometacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of NFE2L2 mRNA | CTD | PMID:28648817 |
Nfe2l2 | Rat | indometacin | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Indomethacin results in increased localization of NFE2L2 protein | CTD | PMID:11909699 |
Nfe2l2 | Rat | indometacin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Indomethacin inhibits the reaction [KEAP1 protein binds to NFE2L2 protein]] more ... | CTD | PMID:11909699 |
Nfe2l2 | Rat | inositol | multiple interactions | EXP | | 6480464 | Inositol inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein] | CTD | PMID:35243728 |
Nfe2l2 | Rat | iodoform | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | iodoform results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | ionomycin | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Ionomycin | CTD | PMID:12842875 |
Nfe2l2 | Rat | ionomycin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NFE2L2 protein | CTD | PMID:24632381 |
Nfe2l2 | Rat | ionomycin | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Ionomycin | CTD | PMID:12842875 |
Nfe2l2 | Rat | irinotecan | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Irinotecan results in increased expression of NFE2L2 mRNA | CTD | PMID:34699766 |
Nfe2l2 | Rat | irinotecan | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Luteolin inhibits the reaction [Irinotecan results in increased expression of NFE2L2 mRNA] more ... | CTD | PMID:34699766 |
Nfe2l2 | Rat | iron atom | multiple interactions | EXP | | 6480464 | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in increased expression of NFE2L2 mRNA and leonurine promotes the reaction [Iron affects the localization of NFE2L2 protein] | CTD | PMID:20302851 and PMID:35247364 |
Nfe2l2 | Rat | iron atom | affects localization | EXP | | 6480464 | Iron affects the localization of NFE2L2 protein | CTD | PMID:35247364 |
Nfe2l2 | Rat | iron atom | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Particulate Matter results in increased abundance of Iron] which affects the localization of NFE2L2 protein and [Particulate Matter results in increased abundance of Iron] which results in increased expression of NFE2L2 mRNA | CTD | PMID:26419736 |
Nfe2l2 | Rat | iron atom | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Iron results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | iron atom | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [SLC40A1 protein results in increased export of Iron] | CTD | PMID:21303654 |
Nfe2l2 | Rat | iron dextran | increases expression | EXP | | 6480464 | Iron-Dextran Complex results in increased expression of NFE2L2 protein | CTD | PMID:38432408 |
Nfe2l2 | Rat | iron dichloride | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | ferrous chloride results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:27037625 |
Nfe2l2 | Rat | iron dichloride | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | ferrous chloride results in increased expression of NFE2L2 mRNA | CTD | PMID:27037625 |
Nfe2l2 | Rat | iron trichloride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | ferric chloride promotes the reaction [2-tert-butylhydroquinone results in increased expression of NFE2L2 protein] and ferric chloride promotes the reaction [hydroquinone results in increased expression of NFE2L2 protein] | CTD | PMID:28645578 |
Nfe2l2 | Rat | iron(0) | multiple interactions | EXP | | 6480464 | [Iron co-treated with Diethylnitrosamine co-treated with Copper] results in increased expression of NFE2L2 mRNA and leonurine promotes the reaction [Iron affects the localization of NFE2L2 protein] | CTD | PMID:20302851 and PMID:35247364 |
Nfe2l2 | Rat | iron(0) | affects localization | EXP | | 6480464 | Iron affects the localization of NFE2L2 protein | CTD | PMID:35247364 |
Nfe2l2 | Rat | iron(0) | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Particulate Matter results in increased abundance of Iron] which affects the localization of NFE2L2 protein and [Particulate Matter results in increased abundance of Iron] which results in increased expression of NFE2L2 mRNA | CTD | PMID:26419736 |
Nfe2l2 | Rat | iron(0) | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [SLC40A1 protein results in increased export of Iron] | CTD | PMID:21303654 |
Nfe2l2 | Rat | iron(0) | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Iron results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | iron(2+) sulfate (anhydrous) | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [Ethacrynic Acid affects the localization of NFE2L2 protein]] and ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [phenethyl isothiocyanate results in increased expression of and affects the localization of NFE2L2 protein]] | CTD | PMID:26945724 |
Nfe2l2 | Rat | iron(2+) sulfate (anhydrous) | increases expression | EXP | | 6480464 | ferrous sulfate results in increased expression of NFE2L2 mRNA | CTD | PMID:28583816 |
Nfe2l2 | Rat | iron(2+) sulfate (anhydrous) | multiple interactions | EXP | | 6480464 | 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of NFE2L2 mRNA] more ... | CTD | PMID:28583816 |
Nfe2l2 | Rat | iron(III) citrate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | trigonelline inhibits the reaction [ferric citrate affects the localization of NFE2L2 protein] | CTD | PMID:29959986 |
Nfe2l2 | Rat | iron(III) citrate | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | ferric citrate affects the localization of NFE2L2 protein | CTD | PMID:29959986 |
Nfe2l2 | Rat | iron(III) nitrilotriacetate | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | ferric nitrilotriacetate affects the localization of NFE2L2 protein | CTD | PMID:18617210 |
Nfe2l2 | Rat | isoflurane | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(1 more ... | CTD | PMID:32663520 and PMID:33508982 |
Nfe2l2 | Rat | isoflurane | decreases expression | EXP | | 6480464 | Isoflurane results in decreased expression of NFE2L2 mRNA and Isoflurane results in decreased expression of NFE2L2 protein | CTD | PMID:36027947 |
Nfe2l2 | Rat | isoflurane | decreases phosphorylation | EXP | | 6480464 | Isoflurane results in decreased phosphorylation of NFE2L2 protein | CTD | PMID:36027947 |
Nfe2l2 | Rat | isoflurane | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dexmedetomidine inhibits the reaction [Isoflurane results in decreased expression of NFE2L2 mRNA]] more ... | CTD | PMID:36027947 |
Nfe2l2 | Rat | isoflurane | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Isoflurane results in increased expression of NFE2L2 mRNA and Isoflurane results in increased expression of NFE2L2 protein | CTD | PMID:32663520 and PMID:33508982 |
Nfe2l2 | Rat | isoimperatorin | affects localization | EXP | | 6480464 | isoimperatorin affects the localization of NFE2L2 protein | CTD | PMID:16829687 |
Nfe2l2 | Rat | isoliquiritigenin | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | isoliquiritigenin results in decreased expression of NFE2L2 mRNA | CTD | PMID:38311047 |
Nfe2l2 | Rat | isoniazide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Isoniazid results in increased expression of NFE2L2 mRNA | CTD | PMID:33771660 |
Nfe2l2 | Rat | isoniazide | multiple interactions | EXP | | 6480464 | chrysin inhibits the reaction [Isoniazid results in increased expression of NFE2L2 mRNA] | CTD | PMID:33121995 |
Nfe2l2 | Rat | isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of NFE2L2 mRNA | CTD | PMID:33121995 |
Nfe2l2 | Rat | isoniazide | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Isoniazid results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | isophorone diisocyanate | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 affects the susceptibility to isophorone diisocyanate | CTD | PMID:23564646 |
Nfe2l2 | Rat | isoprenaline | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of NFE2L2 mRNA and Isoproterenol results in decreased expression of NFE2L2 protein | CTD | PMID:28266775 more ... |
Nfe2l2 | Rat | isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of NFE2L2 mRNA and Isoproterenol results in increased expression of NFE2L2 protein | CTD | PMID:35430261 |
Nfe2l2 | Rat | isoprenaline | multiple interactions | EXP | | 6480464 | [erdosteine co-treated with Isoproterenol] results in increased expression of NFE2L2 protein more ... | CTD | PMID:30303030 more ... |
Nfe2l2 | Rat | isorhamnetin | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to 3-methylquercetin | CTD | PMID:24211276 |
Nfe2l2 | Rat | isorhamnetin | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 3-methylquercetin results in increased activity of NFE2L2 protein | CTD | PMID:24211276 |
Nfe2l2 | Rat | isorhamnetin | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to 3-methylquercetin | CTD | PMID:24211276 |
Nfe2l2 | Rat | isorhamnetin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] more ... | CTD | PMID:24211276 and PMID:27151496 |
Nfe2l2 | Rat | isorhamnetin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | 3-methylquercetin affects the localization of NFE2L2 protein | CTD | PMID:27151496 |
Nfe2l2 | Rat | isorhamnetin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein more ... | CTD | PMID:24211276 |
Nfe2l2 | Rat | Isosorbide | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Isosorbide | CTD | PMID:32023790 |
Nfe2l2 | Rat | isothiocyanate | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Isothiocyanates results in increased activity of NFE2L2 protein | CTD | PMID:15570060 |
Nfe2l2 | Rat | kaempferol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [kaempferol co-treated with Quercetin] results in increased expression of NFE2L2 mRNA and kaempferol inhibits the reaction [Benzo(a)pyrene results in increased expression of NFE2L2 mRNA] | CTD | PMID:21256954 and PMID:25111660 |
Nfe2l2 | Rat | kaempferol | multiple interactions | EXP | | 6480464 | kaempferol inhibits the reaction [Chlorpyrifos results in decreased expression of NFE2L2 mRNA] | CTD | PMID:30497708 |
Nfe2l2 | Rat | kaempferol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | kaempferol affects the reaction [propacetamol affects the expression of NFE2L2 protein] | CTD | PMID:29574133 |
Nfe2l2 | Rat | kaempferol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | kaempferol results in increased expression of NFE2L2 mRNA | CTD | PMID:21256954 and PMID:25111660 |
Nfe2l2 | Rat | kahweol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [[cafestol co-treated with kahweol] results in decreased susceptibility to Acrolein] and NFE2L2 protein promotes the reaction [[cafestol co-treated with kahweol] results in increased expression of NQO1 mRNA] | CTD | PMID:18028974 |
Nfe2l2 | Rat | kahweol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [kahweol results in increased expression of HMOX1 protein] | CTD | PMID:31306736 |
Nfe2l2 | Rat | kahweol | multiple interactions | EXP | | 6480464 | [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased activity of NFE2L2 protein] | CTD | PMID:17110534 |
Nfe2l2 | Rat | kainic acid | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Kainic Acid affects the localization of NFE2L2 protein | CTD | PMID:18619545 |
Nfe2l2 | Rat | ketamine | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Ketamine results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:36305173 |
Nfe2l2 | Rat | ketamine | decreases expression | EXP | | 6480464 | Ketamine results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:36305173 |
Nfe2l2 | Rat | ketanserin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ketanserin inhibits the reaction [Tobacco Smoke Pollution affects the localization of NFE2L2 protein] | CTD | PMID:22048642 |
Nfe2l2 | Rat | ketoconazole | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Ketoconazole results in increased activity of AHR protein] which results in increased activity of and results in increased localization of NFE2L2 protein more ... | CTD | PMID:21753779 |
Nfe2l2 | Rat | ketoconazole | increases expression | EXP | | 6480464 | Ketoconazole results in increased expression of NFE2L2 mRNA and Ketoconazole results in increased expression of NFE2L2 protein | CTD | PMID:31168027 and PMID:37077353 |
Nfe2l2 | Rat | ketoconazole | multiple interactions | EXP | | 6480464 | [Ketoconazole co-treated with Carbon Tetrachloride] results in increased expression of NFE2L2 protein | CTD | PMID:31168027 |
Nfe2l2 | Rat | ketoconazole | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ketoconazole results in increased expression of NFE2L2 mRNA and Ketoconazole results in increased expression of NFE2L2 protein | CTD | PMID:21753779 |
Nfe2l2 | Rat | kresoxim-methyl | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | kresoxim-methyl results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | KT 5823 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | KT 5823 inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 mRNA] and KT 5823 inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] | CTD | PMID:27774770 |
Nfe2l2 | Rat | L-1,4-dithiothreitol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Dithiothreitol inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein] | CTD | PMID:24489685 |
Nfe2l2 | Rat | L-ascorbic acid | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 protein] more ... | CTD | PMID:22008531 more ... |
Nfe2l2 | Rat | L-ascorbic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ascorbic Acid inhibits the reaction [Diquat results in decreased expression of NFE2L2 protein] | CTD | PMID:33475796 |
Nfe2l2 | Rat | L-ascorbic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ascorbic Acid results in increased expression of NFE2L2 mRNA and Ascorbic Acid results in increased expression of NFE2L2 protein | CTD | PMID:31610155 |
Nfe2l2 | Rat | L-ascorbic acid | affects localization | EXP | | 6480464 | Ascorbic Acid affects the localization of NFE2L2 protein | CTD | PMID:23027624 and PMID:26921358 |
Nfe2l2 | Rat | L-ascorbic acid | increases expression | EXP | | 6480464 | Ascorbic Acid results in increased expression of NFE2L2 protein | CTD | PMID:22008531 and PMID:23027624 |
Nfe2l2 | Rat | L-ascorbic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with alpha-Tocopherol co-treated with ferulic acid] promotes the reaction [[Ozone co-treated with Oxygen] results in increased localization of NFE2L2 protein] more ... | CTD | PMID:21199573 more ... |
Nfe2l2 | Rat | L-cystine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to [Air Pollutants results in increased abundance of Particulate Matter]] which affects the abundance of Cystine | CTD | PMID:35204234 |
Nfe2l2 | Rat | L-glutamic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [dihydroactinidiolide co-treated with Glutamic Acid] results in increased expression of NFE2L2 mRNA | CTD | PMID:33617922 |
Nfe2l2 | Rat | L-glutamic acid | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Glutamic Acid affects the localization of NFE2L2 protein | CTD | PMID:31698019 |
Nfe2l2 | Rat | L-glutamic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | gastrodin affects the reaction [Glutamic Acid affects the localization of NFE2L2 protein] | CTD | PMID:31698019 |
Nfe2l2 | Rat | L-methionine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency] affects the localization of NFE2L2 protein more ... | CTD | PMID:20350562 |
Nfe2l2 | Rat | lactacystin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | lactacystin results in increased expression of NFE2L2 protein | CTD | PMID:12446695 |
Nfe2l2 | Rat | lactacystin | decreases degradation | EXP | | 6480464 | lactacystin results in decreased degradation of NFE2L2 protein | CTD | PMID:26598004 |
Nfe2l2 | Rat | lactacystin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | lactacystin results in increased expression of NFE2L2 protein | CTD | PMID:12441344 and PMID:15322212 |
Nfe2l2 | Rat | lactacystin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | lactacystin promotes the reaction [Cadmium Chloride results in increased expression of NFE2L2 protein] | CTD | PMID:12441344 |
Nfe2l2 | Rat | lactacystin | multiple interactions | EXP | | 6480464 | lactacystin promotes the reaction [manganese chloride affects the localization of and results in increased activity of NFE2L2 protein] and lactacystin promotes the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] | CTD | PMID:21384399 |
Nfe2l2 | Rat | lactulose | multiple interactions | EXP | | 6480464 | Lactulose promotes the reaction [Methamphetamine results in increased expression of NFE2L2 mRNA] | CTD | PMID:30450033 |
Nfe2l2 | Rat | lansoprazole | increases expression | EXP | | 6480464 | Lansoprazole results in increased expression of NFE2L2 mRNA | CTD | PMID:28412091 |
Nfe2l2 | Rat | lansoprazole | multiple interactions | EXP | | 6480464 | Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in increased expression of NFE2L2 mRNA] more ... | CTD | PMID:19628634 and PMID:28412091 |
Nfe2l2 | Rat | lansoprazole | increases phosphorylation | EXP | | 6480464 | Lansoprazole results in increased phosphorylation of NFE2L2 protein | CTD | PMID:19628634 |
Nfe2l2 | Rat | lanthanum trichloride | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | lanthanum chloride results in increased expression of NFE2L2 mRNA and lanthanum chloride results in increased expression of NFE2L2 protein | CTD | PMID:24142884 and PMID:33098623 |
Nfe2l2 | Rat | lapatinib | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | lapatinib metabolite results in increased activity of NFE2L2 protein | CTD | PMID:26958860 |
Nfe2l2 | Rat | lapatinib | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [CYP3A4 protein results in increased metabolism of lapatinib] which results in increased activity of NFE2L2 protein and [CYP3A5 protein results in increased metabolism of lapatinib] which results in increased activity of NFE2L2 protein | CTD | PMID:26958860 |
Nfe2l2 | Rat | lawsone | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | lawsone results in decreased expression of NFE2L2 mRNA | CTD | PMID:31967339 |
Nfe2l2 | Rat | lead diacetate | multiple interactions | EXP | | 6480464 | 2-tert-butylhydroquinone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 protein] more ... | CTD | PMID:23274417 more ... |
Nfe2l2 | Rat | lead diacetate | affects localization | EXP | | 6480464 | lead acetate affects the localization of NFE2L2 protein | CTD | PMID:32116774 |
Nfe2l2 | Rat | lead diacetate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:35527006 and PMID:38180308 |
Nfe2l2 | Rat | lead diacetate | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | lead acetate results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | lead diacetate | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | lead acetate results in increased expression of NFE2L2 mRNA | CTD | PMID:26498409 |
Nfe2l2 | Rat | lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of NFE2L2 mRNA | CTD | PMID:23274417 and PMID:34051273 |
Nfe2l2 | Rat | lead diacetate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [lead acetate results in increased abundance of Lead] inhibits the reaction [Ascorbic Acid results in increased expression of NFE2L2 protein] more ... | CTD | PMID:26498409 more ... |
Nfe2l2 | Rat | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of NFE2L2 mRNA and lead acetate results in decreased expression of NFE2L2 protein | CTD | PMID:26797587 more ... |
Nfe2l2 | Rat | lead(0) | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Lead results in increased expression of NFE2L2 mRNA | CTD | PMID:16243960 |
Nfe2l2 | Rat | lead(0) | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Lead results in increased localization of NFE2L2 protein | CTD | PMID:31756223 |
Nfe2l2 | Rat | lead(0) | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [lead acetate results in increased abundance of Lead] inhibits the reaction [Ascorbic Acid results in increased expression of NFE2L2 protein] more ... | CTD | PMID:31610155 |
Nfe2l2 | Rat | lead(0) | decreases expression | EXP | | 6480464 | Lead results in decreased expression of NFE2L2 protein | CTD | PMID:29630945 |
Nfe2l2 | Rat | lead(0) | multiple interactions | EXP | | 6480464 | 2-tert-butylhydroquinone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 protein] more ... | CTD | PMID:29630945 more ... |
Nfe2l2 | Rat | lead(0) | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Lead results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | lead(0) | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:16243960 and PMID:38180308 |
Nfe2l2 | Rat | lead(II) chloride | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [lead chloride affects the localization of NFE2L2 protein] promotes the reaction [NFE2L2 protein binds to CYP2A5 promoter] and NFE2L2 protein affects the reaction [lead chloride results in increased expression of CYP2A5 mRNA] | CTD | PMID:20402460 |
Nfe2l2 | Rat | lead(II) chloride | multiple interactions | EXP | | 6480464 | [lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of NFE2L2 protein and [Sodium Selenite co-treated with zinc chloride] inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of NFE2L2 protein] | CTD | PMID:36646412 |
Nfe2l2 | Rat | lead(II) chloride | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | lead chloride results in decreased expression of NFE2L2 protein | CTD | PMID:30359721 |
Nfe2l2 | Rat | lead(II) chloride | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | lead chloride affects the localization of NFE2L2 protein | CTD | PMID:20402460 |
Nfe2l2 | Rat | leflunomide | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | leflunomide results in increased expression of NFE2L2 mRNA | CTD | PMID:28988120 |
Nfe2l2 | Rat | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of NFE2L2 mRNA | CTD | PMID:24136188 |
Nfe2l2 | Rat | lenvatinib | decreases expression | EXP | | 6480464 | lenvatinib results in decreased expression of NFE2L2 mRNA | CTD | PMID:34019861 |
Nfe2l2 | Rat | Leonurine | multiple interactions | EXP | | 6480464 | leonurine promotes the reaction [Iron affects the localization of NFE2L2 protein] | CTD | PMID:35247364 |
Nfe2l2 | Rat | letrozole | multiple interactions | EXP | | 6480464 | indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:28619389 |
Nfe2l2 | Rat | letrozole | decreases expression | EXP | | 6480464 | letrozole results in decreased expression of NFE2L2 protein | CTD | PMID:28619389 |
Nfe2l2 | Rat | levetiracetam | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Levetiracetam results in decreased expression of NFE2L2 protein] | CTD | PMID:37098359 |
Nfe2l2 | Rat | levetiracetam | decreases expression | EXP | | 6480464 | Levetiracetam results in decreased expression of NFE2L2 protein | CTD | PMID:37098359 |
Nfe2l2 | Rat | levofloxacin | decreases expression | EXP | | 6480464 | Levofloxacin results in decreased expression of NFE2L2 mRNA | CTD | PMID:24136188 |
Nfe2l2 | Rat | Liensinine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | liensinine inhibits the reaction [Lipopolysaccharides affects the localization of NFE2L2 protein] | CTD | PMID:38692452 |
Nfe2l2 | Rat | Liensinine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | liensinine inhibits the reaction [Lipopolysaccharides affects the localization of NFE2L2 protein] | CTD | PMID:38692452 |
Nfe2l2 | Rat | linagliptin | multiple interactions | EXP | | 6480464 | indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole results in decreased expression of NFE2L2 protein]] more ... | CTD | PMID:28619389 |
Nfe2l2 | Rat | linalool | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFE2L2 mRNA and linalool metabolite results in increased expression of and results in increased activity of NFE2L2 protein | CTD | PMID:29029310 and PMID:38000518 |
Nfe2l2 | Rat | linalyl acetate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFE2L2 mRNA | CTD | PMID:38000518 |
Nfe2l2 | Rat | linoleic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Linoleic Acid metabolite results in increased expression of NFE2L2 protein more ... | CTD | PMID:26879219 and PMID:28555106 |
Nfe2l2 | Rat | linoleic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Linoleic Acid metabolite results in increased expression of NFE2L2 protein | CTD | PMID:26879219 |
Nfe2l2 | Rat | linoleic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA promotes the reaction [Linoleic Acid metabolite results in increased expression of HMOX1 mRNA] more ... | CTD | PMID:26879219 and PMID:28555106 |
Nfe2l2 | Rat | linsidomine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 and 2-dithiol-3-thione promotes the reaction [NFE2L2 results in decreased susceptibility to linsidomine] | CTD | PMID:18367636 |
Nfe2l2 | Rat | linsidomine | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to linsidomine | CTD | PMID:16092930 |
Nfe2l2 | Rat | linsidomine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [linsidomine results in increased expression of NFE2L2 protein] which results in decreased susceptibility to Oxidopamine | CTD | PMID:16092930 |
Nfe2l2 | Rat | linsidomine | multiple interactions | EXP | | 6480464 | linsidomine results in increased localization of and results in increased activity of NFE2L2 protein | CTD | PMID:12446173 |
Nfe2l2 | Rat | linsidomine | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in decreased susceptibility to linsidomine | CTD | PMID:18367636 |
Nfe2l2 | Rat | lipoamide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | lipoamide inhibits the reaction [Acrolein results in decreased expression of NFE2L2 protein] | CTD | PMID:18258206 |
Nfe2l2 | Rat | lipoic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Paraquat co-treated with Thioctic Acid] results in increased expression of and affects the localization of NFE2L2 protein more ... | CTD | PMID:17197552 more ... |
Nfe2l2 | Rat | lipoic acid | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Thioctic Acid affects the localization of NFE2L2 protein | CTD | PMID:30758914 |
Nfe2l2 | Rat | lipoic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Thioctic Acid results in increased expression of NFE2L2 mRNA and Thioctic Acid results in increased expression of NFE2L2 protein | CTD | PMID:23649336 more ... |
Nfe2l2 | Rat | lipoic acid | increases activity | EXP | | 6480464 | Thioctic Acid results in increased activity of NFE2L2 protein | CTD | PMID:20237067 |
Nfe2l2 | Rat | lipoic acid | increases expression | EXP | | 6480464 | Thioctic Acid results in increased expression of NFE2L2 protein | CTD | PMID:20237067 |
Nfe2l2 | Rat | lipoic acid | multiple interactions | EXP | | 6480464 | [Thioctic Acid promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA more ... | CTD | PMID:20237067 more ... |
Nfe2l2 | Rat | lipoic acid | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Thioctic Acid results in decreased expression of NFE2L2 mRNA and Thioctic Acid results in decreased expression of NFE2L2 protein | CTD | PMID:22488045 |
Nfe2l2 | Rat | lipoic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Thioctic Acid co-treated with cyanoginosin LR] results in increased expression of NFE2L2 protein more ... | CTD | PMID:22488045 more ... |
Nfe2l2 | Rat | lipopolysaccharide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of NFE2L2 protein | CTD | PMID:26505893 more ... |
Nfe2l2 | Rat | lipopolysaccharide | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Lipopolysaccharides affects the localization of NFE2L2 protein | CTD | PMID:38692452 |
Nfe2l2 | Rat | lipopolysaccharide | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Lipopolysaccharides affects the localization of NFE2L2 protein | CTD | PMID:38692452 |
Nfe2l2 | Rat | lipopolysaccharide | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | lipopolysaccharide | affects localization | EXP | | 6480464 | Lipopolysaccharides affects the localization of NFE2L2 protein | CTD | PMID:29702279 |
Nfe2l2 | Rat | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of NFE2L2 protein | CTD | PMID:22610192 and PMID:28881715 |
Nfe2l2 | Rat | lipopolysaccharide | decreases expression | EXP | | 6480464 | Lipopolysaccharides results in decreased expression of NFE2L2 protein | CTD | PMID:26497626 and PMID:37148149 |
Nfe2l2 | Rat | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [Dimethyl Sulfoxide co-treated with Resveratrol] inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:22610192 more ... |
Nfe2l2 | Rat | lipopolysaccharide | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased expression of NFE2L2 mRNA and Lipopolysaccharides results in decreased expression of NFE2L2 protein | CTD | PMID:26363199 more ... |
Nfe2l2 | Rat | lipopolysaccharide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 6-chloro-2 more ... | CTD | PMID:21382476 more ... |
Nfe2l2 | Rat | lipopolysaccharide | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of NFE2L2 protein | CTD | PMID:17959236 |
Nfe2l2 | Rat | lipopolysaccharide | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of NFE2L2 protein | CTD | PMID:26497626 more ... |
Nfe2l2 | Rat | lipopolysaccharide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 6-chloro-2 more ... | CTD | PMID:16890772 more ... |
Nfe2l2 | Rat | lipoxin A4 | affects localization | EXP | | 6480464 | lipoxin A4 affects the localization of NFE2L2 protein | CTD | PMID:23826208 |
Nfe2l2 | Rat | lipoxin A4 | multiple interactions | EXP | | 6480464 | lipoxin A4 promotes the reaction [NFE2L2 protein binds to HMOX1 enhancer] | CTD | PMID:23826208 |
Nfe2l2 | Rat | liquiritigenin | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in decreased susceptibility to liquiritigenin | CTD | PMID:29908794 |
Nfe2l2 | Rat | liquiritigenin | multiple interactions | EXP | | 6480464 | liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of NFE2L2 mRNA] | CTD | PMID:29908794 |
Nfe2l2 | Rat | liquiritin | multiple interactions | EXP | | 6480464 | liquiritin inhibits the reaction [Monocrotaline results in decreased expression of NFE2L2 mRNA] | CTD | PMID:29908794 |
Nfe2l2 | Rat | liquiritin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | liquiritin promotes the reaction [1-Naphthylisothiocyanate results in increased expression of NFE2L2 protein] | CTD | PMID:36008890 |
Nfe2l2 | Rat | liquiritin | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in decreased susceptibility to liquiritin | CTD | PMID:29908794 |
Nfe2l2 | Rat | liraglutide | multiple interactions | EXP | | 6480464 | Liraglutide inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 protein] | CTD | PMID:31362085 |
Nfe2l2 | Rat | lithium atom | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Lithium results in decreased activity of GSK3B protein] which results in increased activity of NFE2L2 protein | CTD | PMID:18619545 |
Nfe2l2 | Rat | lithium atom | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Lithium Chloride results in increased abundance of Lithium] which affects the localization of NFE2L2 protein and [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of NFE2L2 mRNA | CTD | PMID:26074776 |
Nfe2l2 | Rat | lithium atom | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Lithium results in increased activity of NFE2L2 protein | CTD | PMID:18619545 |
Nfe2l2 | Rat | lithium chloride | multiple interactions | EXP | | 6480464 | Lithium Chloride affects the reaction [triptolide affects the expression of NFE2L2 protein] more ... | CTD | PMID:30926361 more ... |
Nfe2l2 | Rat | lithium chloride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Lithium Chloride results in increased abundance of Lithium] which affects the localization of NFE2L2 protein and [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of NFE2L2 mRNA | CTD | PMID:26074776 |
Nfe2l2 | Rat | lithium hydride | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Lithium results in increased activity of NFE2L2 protein | CTD | PMID:18619545 |
Nfe2l2 | Rat | lithium hydride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Lithium Chloride results in increased abundance of Lithium] which affects the localization of NFE2L2 protein and [Lithium Chloride results in increased abundance of Lithium] which results in increased expression of NFE2L2 mRNA | CTD | PMID:26074776 |
Nfe2l2 | Rat | lithium hydride | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Lithium results in decreased activity of GSK3B protein] which results in increased activity of NFE2L2 protein | CTD | PMID:18619545 |
Nfe2l2 | Rat | lithocholic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA more ... | CTD | PMID:17724089 more ... |
Nfe2l2 | Rat | lithocholic acid | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Lithocholic Acid results in decreased expression of NFE2L2 mRNA and Lithocholic Acid results in decreased expression of NFE2L2 protein | CTD | PMID:29794447 |
Nfe2l2 | Rat | lithocholic acid | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to Lithocholic Acid | CTD | PMID:17724089 |
Nfe2l2 | Rat | lithocholic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of FTL mRNA more ... | CTD | PMID:17724089 more ... |
Nfe2l2 | Rat | lixisenatide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [lixisenatide inhibits the reaction [Lipopolysaccharides results in increased expression of MUC5AC mRNA]] and NFE2L2 protein affects the reaction [lixisenatide inhibits the reaction [Lipopolysaccharides results in increased expression of MUC5AC protein]] | CTD | PMID:38229325 |
Nfe2l2 | Rat | loganin | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | loganin affects the expression of NFE2L2 protein | CTD | PMID:21864639 |
Nfe2l2 | Rat | loliolide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Hydrogen Peroxide co-treated with loliolide] results in increased expression of NFE2L2 protein | CTD | PMID:30231594 |
Nfe2l2 | Rat | losartan | decreases expression | EXP | | 6480464 | Losartan results in decreased expression of NFE2L2 mRNA | CTD | PMID:18765277 |
Nfe2l2 | Rat | losartan | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Losartan inhibits the reaction [AGT protein results in decreased expression of NFE2L2 protein] | CTD | PMID:28578904 |
Nfe2l2 | Rat | losartan | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Losartan inhibits the reaction [AGT protein results in decreased expression of NFE2L2 protein] | CTD | PMID:28578904 |
Nfe2l2 | Rat | lovastatin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Doxorubicin inhibits the reaction [Lovastatin results in increased expression of NFE2L2 mRNA] and Lovastatin inhibits the reaction [Doxorubicin results in increased expression of NFE2L2 mRNA] | CTD | PMID:22712078 and PMID:28710503 |
Nfe2l2 | Rat | Lucidone | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to lucidone | CTD | PMID:23712098 |
Nfe2l2 | Rat | Lucidone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [lucidone co-treated with 2 more ... | CTD | PMID:22484158 and PMID:23712098 |
Nfe2l2 | Rat | lutein | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | arsenic trioxide promotes the reaction [Lutein results in increased expression of NFE2L2 mRNA] more ... | CTD | PMID:25815309 and PMID:26187899 |
Nfe2l2 | Rat | lutein | multiple interactions | EXP | | 6480464 | Lutein inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 protein] | CTD | PMID:34435724 |
Nfe2l2 | Rat | lutein | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Lutein results in increased expression of NFE2L2 mRNA and Lutein results in increased expression of NFE2L2 protein | CTD | PMID:25815309 and PMID:26187899 |
Nfe2l2 | Rat | luteolin | multiple interactions | EXP | | 6480464 | [Luteolin results in increased activity of NFE2L2 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium more ... | CTD | PMID:17982879 more ... |
Nfe2l2 | Rat | luteolin | multiple interactions | EXP | | 155882543 | luteolin inhibits the reaction [ischemia-reperfusion injury increases expression of Nfe2l2 protein in nucleus] | RGD | |
Nfe2l2 | Rat | luteolin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Luteolin promotes the reaction [Rotenone results in increased expression of NFE2L2 mRNA] | CTD | PMID:30207190 |
Nfe2l2 | Rat | luteolin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Luteolin results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of SESN2 mRNA more ... | CTD | PMID:32407927 more ... |
Nfe2l2 | Rat | luteolin | increases activity | EXP | | 6480464 | Luteolin results in increased activity of NFE2L2 protein | CTD | PMID:17982879 |
Nfe2l2 | Rat | Luteolin 7-methyl ether | affects localization | EXP | | 6480464 | hydroxygenkwanin affects the localization of NFE2L2 protein | CTD | PMID:38942164 |
Nfe2l2 | Rat | LY294002 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2''-galloylhyperin affects the localization of and results in increased activity of NFE2L2 protein] more ... | CTD | PMID:19073151 more ... |
Nfe2l2 | Rat | LY294002 | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of NFE2L2 protein | CTD | PMID:29353218 |
Nfe2l2 | Rat | LY294002 | decreases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of NFE2L2 protein | CTD | PMID:29353218 |
Nfe2l2 | Rat | LY294002 | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of NFE2L2 protein | CTD | PMID:23994249 more ... |
Nfe2l2 | Rat | LY294002 | decreases activity | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of NFE2L2 protein | CTD | PMID:18815141 |
Nfe2l2 | Rat | LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one analog inhibits the reaction [gypenoside analog affects the localization of NFE2L2 protein] more ... | CTD | PMID:17640564 more ... |
Nfe2l2 | Rat | LY294002 | increases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of NFE2L2 protein | CTD | PMID:22406437 |
Nfe2l2 | Rat | LY294002 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of NFE2L2 protein]] more ... | CTD | PMID:19647727 more ... |
Nfe2l2 | Rat | lycopene | increases expression | EXP | | 6480464 | lycopene results in increased expression of NFE2L2 mRNA and lycopene results in increased expression of NFE2L2 protein | CTD | PMID:19551842 and PMID:27102619 |
Nfe2l2 | Rat | lycopene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Atrazine affects the localization of NFE2L2 protein] more ... | CTD | PMID:30360616 more ... |
Nfe2l2 | Rat | lycopene | multiple interactions | EXP | | 6480464 | lycopene promotes the reaction [Atrazine results in increased expression of NFE2L2 mRNA] | CTD | PMID:27102619 |
Nfe2l2 | Rat | Macrosphelide B | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | macrosphelide B affects the localization of NFE2L2 protein | CTD | PMID:37777167 |
Nfe2l2 | Rat | Macrosphelide B | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [macrosphelide B results in increased expression of HMOX1 protein] | CTD | PMID:37777167 |
Nfe2l2 | Rat | magnesium dichloride | multiple interactions | EXP | | 6480464 | [2-tert-butylhydroquinone promotes the reaction [[NFE2L2 protein binds to HMOX1 promoter] which results in increased expression of HMOX1 mRNA]] which results in decreased susceptibility to Magnesium Chloride | CTD | PMID:21107535 |
Nfe2l2 | Rat | malathion | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Malathion results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | maleic acid | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [maleic acid affects the expression of NFE2L2 protein] | CTD | PMID:25119790 |
Nfe2l2 | Rat | maleic acid | affects expression | EXP | | 6480464 | maleic acid affects the expression of NFE2L2 protein | CTD | PMID:25119790 |
Nfe2l2 | Rat | malonaldehyde | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution results in increased abundance of Malondialdehyde] | CTD | PMID:24633890 |
Nfe2l2 | Rat | malonaldehyde | multiple interactions | EXP | | 6480464 | NFE2L2 protein promotes the reaction [FNDC5 protein results in decreased abundance of Malondialdehyde] | CTD | PMID:32165127 |
Nfe2l2 | Rat | malvidin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | malvidin inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] inhibits the reaction [PPARGC1A protein binds to NFE2L2 protein]] more ... | CTD | PMID:38135199 |
Nfe2l2 | Rat | malvidin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | malvidin affects the expression of and affects the localization of NFE2L2 protein | CTD | PMID:38135199 |
Nfe2l2 | Rat | maneb | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Maneb results in increased expression of NFE2L2 protein] which results in increased expression of GCLC mRNA more ... | CTD | PMID:21402726 |
Nfe2l2 | Rat | maneb | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Maneb | CTD | PMID:23764462 |
Nfe2l2 | Rat | maneb | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in decreased abundance of Glutathione more ... | CTD | PMID:23764462 |
Nfe2l2 | Rat | manganese atom | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:17573173 and PMID:37415728 |
Nfe2l2 | Rat | manganese atom | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in decreased expression of NFE2L2 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of NFE2L2 mRNA | CTD | PMID:38503349 and PMID:39836092 |
Nfe2l2 | Rat | manganese atom | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in increased abundance of Manganese | CTD | PMID:23764462 |
Nfe2l2 | Rat | manganese(0) | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:17573173 and PMID:37415728 |
Nfe2l2 | Rat | manganese(0) | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in decreased expression of NFE2L2 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of NFE2L2 mRNA | CTD | PMID:38503349 and PMID:39836092 |
Nfe2l2 | Rat | manganese(0) | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 gene mutant form results in increased susceptibility to Maneb] which results in increased abundance of Manganese | CTD | PMID:23764462 |
Nfe2l2 | Rat | manganese(II) chloride | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [manganese chloride co-treated with lipopolysaccharide more ... | CTD | PMID:21963524 and PMID:25288107 |
Nfe2l2 | Rat | manganese(II) chloride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in decreased expression of NFE2L2 mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of NFE2L2 mRNA | CTD | PMID:38503349 and PMID:39836092 |
Nfe2l2 | Rat | manganese(II) chloride | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | manganese chloride results in increased expression of NFE2L2 protein | CTD | PMID:21963524 and PMID:25288107 |
Nfe2l2 | Rat | manganese(II) chloride | affects expression | EXP | | 6480464 | manganese chloride affects the expression of NFE2L2 protein | CTD | PMID:22154916 |
Nfe2l2 | Rat | manganese(II) chloride | decreases response to substance | EXP | | 6480464 | NFE2L2 protein results in decreased susceptibility to manganese chloride | CTD | PMID:21107535 |
Nfe2l2 | Rat | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of NFE2L2 protein | CTD | PMID:21107535 and PMID:21384399 |
Nfe2l2 | Rat | manganese(II) chloride | multiple interactions | EXP | | 6480464 | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] more ... | CTD | PMID:21107535 more ... |
Nfe2l2 | Rat | mangiferin | multiple interactions | EXP | | 6480464 | bisphenol A diglycidyl ether inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA]] more ... | CTD | PMID:22310181 and PMID:36249937 |
Nfe2l2 | Rat | masoprocol | multiple interactions | EXP | | 6480464 | Masoprocol affects the localization of and results in increased activity of NFE2L2 protein | CTD | PMID:18852027 |
Nfe2l2 | Rat | mechlorethamine | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form affects the susceptibility to Mechlorethamine | CTD | PMID:26454883 |
Nfe2l2 | Rat | mechlorethamine | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Mechlorethamine | CTD | PMID:20932822 |
Nfe2l2 | Rat | medroxyprogesterone acetate | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Medroxyprogesterone Acetate results in increased expression of NFE2L2 mRNA | CTD | PMID:18497975 |
Nfe2l2 | Rat | meglumine amidotrizoate | multiple interactions | EXP | | 6480464 | Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in increased expression of NFE2L2 mRNA] more ... | CTD | PMID:28412091 and PMID:31173751 |
Nfe2l2 | Rat | meglumine amidotrizoate | decreases expression | EXP | | 6480464 | Diatrizoate Meglumine results in decreased expression of NFE2L2 protein | CTD | PMID:31173751 |
Nfe2l2 | Rat | meglumine amidotrizoate | increases expression | EXP | | 6480464 | Diatrizoate Meglumine results in increased expression of NFE2L2 mRNA | CTD | PMID:28412091 |
Nfe2l2 | Rat | MeIQx | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-amino-3 more ... | CTD | PMID:20307560 |
Nfe2l2 | Rat | MeIQx | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [2-amino-3 more ... | CTD | PMID:20307560 |
Nfe2l2 | Rat | melatonin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 4-phenyl-2-propionamidotetraline inhibits the reaction [Melatonin inhibits the reaction [KL mutant form affects the localization of and results in decreased activity of NFE2L2 protein]] more ... | CTD | PMID:25288107 more ... |
Nfe2l2 | Rat | melatonin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Melatonin results in increased expression of NFE2L2 mRNA | CTD | PMID:33962019 |
Nfe2l2 | Rat | melatonin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 6-chloro-2 more ... | CTD | PMID:31330490 more ... |
Nfe2l2 | Rat | melatonin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Melatonin results in increased expression of NFE2L2 protein | CTD | PMID:25288107 |
Nfe2l2 | Rat | melatonin | increases expression | EXP | | 6480464 | Melatonin results in increased expression of NFE2L2 protein | CTD | PMID:20433640 |
Nfe2l2 | Rat | melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [[Dietary Fats co-treated with Ethanol] results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:20433640 more ... |
Nfe2l2 | Rat | meloxicam | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | meloxicam inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein] | CTD | PMID:20851755 |
Nfe2l2 | Rat | menadione | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Vitamin K 3 | CTD | PMID:19608619 |
Nfe2l2 | Rat | menadione | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Vitamin K 3 results in increased expression of NFE2L2 mRNA | CTD | PMID:23410634 and PMID:26862668 |
Nfe2l2 | Rat | menadione | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Vitamin K 3 | CTD | PMID:19303893 |
Nfe2l2 | Rat | menadione | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of NFE2L2 mRNA | CTD | PMID:20044591 |
Nfe2l2 | Rat | menadione | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Vitamin K 3] | CTD | PMID:20932822 |
Nfe2l2 | Rat | mercury atom | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Mercuric Chloride results in increased abundance of Mercury] which results in decreased expression of NFE2L2 protein | CTD | PMID:30359721 |
Nfe2l2 | Rat | mercury atom | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:27837179 and PMID:37415728 |
Nfe2l2 | Rat | mercury atom | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Mercury results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | mercury atom | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Mercury results in increased expression of NFE2L2 mRNA | CTD | PMID:16243960 |
Nfe2l2 | Rat | mercury atom | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Mercury results in increased expression of GSTA1 mRNA] and NFE2L2 protein affects the reaction [Mercury results in increased expression of NQO1 mRNA] | CTD | PMID:16243960 |
Nfe2l2 | Rat | mercury dibromide | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of NFE2L2 mRNA | CTD | PMID:26272509 |
Nfe2l2 | Rat | mercury dibromide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA | CTD | PMID:27188386 |
Nfe2l2 | Rat | mercury dichloride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Mercuric Chloride results in increased abundance of Mercury] which results in decreased expression of NFE2L2 protein more ... | CTD | PMID:17959236 more ... |
Nfe2l2 | Rat | mercury dichloride | multiple interactions | EXP | | 6480464 | [lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of NFE2L2 protein more ... | CTD | PMID:27837179 more ... |
Nfe2l2 | Rat | mercury dichloride | decreases expression | EXP | | 6480464 | Mercuric Chloride results in decreased expression of NFE2L2 protein | CTD | PMID:32134168 |
Nfe2l2 | Rat | mercury dichloride | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Mercuric Chloride affects the localization of NFE2L2 protein | CTD | PMID:24816296 |
Nfe2l2 | Rat | mercury dichloride | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Mercuric Chloride results in decreased expression of NFE2L2 mRNA | CTD | PMID:23202902 |
Nfe2l2 | Rat | mercury dichloride | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Mercuric Chloride results in increased expression of NFE2L2 protein | CTD | PMID:17959236 and PMID:21843634 |
Nfe2l2 | Rat | mercury dichloride | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Mercuric Chloride | CTD | PMID:19303893 |
Nfe2l2 | Rat | mercury(0) | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Mercury results in increased expression of GSTA1 mRNA] and NFE2L2 protein affects the reaction [Mercury results in increased expression of NQO1 mRNA] | CTD | PMID:16243960 |
Nfe2l2 | Rat | mercury(0) | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:27837179 and PMID:37415728 |
Nfe2l2 | Rat | mercury(0) | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Mercuric Chloride results in increased abundance of Mercury] which results in decreased expression of NFE2L2 protein | CTD | PMID:30359721 |
Nfe2l2 | Rat | mercury(0) | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Mercury results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | mercury(0) | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Mercury results in increased expression of NFE2L2 mRNA | CTD | PMID:16243960 |
Nfe2l2 | Rat | mesalamine | multiple interactions | EXP | | 6480464 | Mesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid affects the expression of NFE2L2 protein] | CTD | PMID:33412153 |
Nfe2l2 | Rat | mesalamine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Mesalamine] results in increased activity of NFE2L2 protein | CTD | PMID:27818126 |
Nfe2l2 | Rat | metformin | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein] and Metformin inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | CTD | PMID:33639173 and PMID:36999408 |
Nfe2l2 | Rat | metformin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Metformin promotes the reaction [[Streptozocin co-treated with Niacinamide] results in increased expression of NFE2L2 protein] | CTD | PMID:37120126 |
Nfe2l2 | Rat | metformin | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Metformin results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | metformin | affects activity | EXP | | 6480464 | Metformin affects the activity of NFE2L2 protein | CTD | PMID:25596134 |
Nfe2l2 | Rat | metformin | decreases expression | EXP | | 6480464 | Metformin results in decreased expression of NFE2L2 mRNA and Metformin results in decreased expression of NFE2L2 protein | CTD | PMID:22627169 and PMID:25596134 |
Nfe2l2 | Rat | metformin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Metformin inhibits the reaction [2-tert-butylhydroquinone results in increased stability of and affects the localization of NFE2L2 protein] and Metformin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L2 protein] | CTD | PMID:23707609 and PMID:33838154 |
Nfe2l2 | Rat | metformin | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Metformin results in decreased expression of NFE2L2 mRNA and Metformin results in decreased expression of NFE2L2 protein | CTD | PMID:23707609 and PMID:33838154 |
Nfe2l2 | Rat | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of NFE2L2 mRNA | CTD | PMID:19564919 and PMID:30450033 |
Nfe2l2 | Rat | methamphetamine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 6-formyl-5-isopropyl-3-hydroxymethyl-7-methyl-1H-indene affects the reaction [Methamphetamine affects the expression of NFE2L2 protein] more ... | CTD | PMID:31928234 and PMID:37567421 |
Nfe2l2 | Rat | methamphetamine | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of NFE2L2 protein | CTD | PMID:37567421 |
Nfe2l2 | Rat | methamphetamine | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Methamphetamine | CTD | PMID:37567421 |
Nfe2l2 | Rat | methamphetamine | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Methamphetamine affects the expression of NFE2L2 protein | CTD | PMID:31928234 |
Nfe2l2 | Rat | methamphetamine | multiple interactions | EXP | | 6480464 | Lactulose promotes the reaction [Methamphetamine results in increased expression of NFE2L2 mRNA] more ... | CTD | PMID:19564919 and PMID:30450033 |
Nfe2l2 | Rat | methamphetamine | affects localization | EXP | | 6480464 | Methamphetamine affects the localization of NFE2L2 protein | CTD | PMID:19564919 |
Nfe2l2 | Rat | methotrexate | multiple interactions | EXP | | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:28414158 more ... |
Nfe2l2 | Rat | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of NFE2L2 protein | CTD | PMID:35842499 |
Nfe2l2 | Rat | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of NFE2L2 mRNA and Methotrexate results in decreased expression of NFE2L2 protein | CTD | PMID:28414158 more ... |
Nfe2l2 | Rat | methoxyacetic acid | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | methoxyacetic acid results in decreased expression of NFE2L2 protein | CTD | PMID:21573189 |
Nfe2l2 | Rat | methoxyacetic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | withanone inhibits the reaction [methoxyacetic acid results in decreased expression of NFE2L2 protein] | CTD | PMID:21573189 |
Nfe2l2 | Rat | methyl 3,4,5-trihydroxybenzoate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | methyl gallate results in increased expression of NFE2L2 protein | CTD | PMID:27777014 |
Nfe2l2 | Rat | methyl methanesulfonate | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Methyl Methanesulfonate | CTD | PMID:20932822 |
Nfe2l2 | Rat | methyl methanesulfonate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Methyl Methanesulfonate results in increased expression of BTG2 mRNA] and NFE2L2 protein affects the reaction [Methyl Methanesulfonate results in increased expression of SRXN1 mRNA] | CTD | PMID:22003191 |
Nfe2l2 | Rat | methylarsonic acid | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | monomethylarsonic acid results in decreased expression of NFE2L2 mRNA | CTD | PMID:24091636 |
Nfe2l2 | Rat | methylarsonic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | monomethylarsonic acid results in increased expression of and affects the localization of NFE2L2 protein and NFE2L2 mutant form inhibits the reaction [monomethylarsonic acid results in increased expression of NQO1 protein] | CTD | PMID:24161444 |
Nfe2l2 | Rat | methylene blue | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Methylene Blue co-treated with MAPT protein mutant form] affects the localization of NFE2L2 protein more ... | CTD | PMID:24556215 |
Nfe2l2 | Rat | methylene blue | multiple interactions | EXP | | 6480464 | Methylene Blue inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of NFE2L2 mRNA] | CTD | PMID:31428839 |
Nfe2l2 | Rat | methylglyoxal | affects localization | EXP | | 6480464 | Pyruvaldehyde affects the localization of NFE2L2 protein | CTD | PMID:23331247 |
Nfe2l2 | Rat | methylglyoxal | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Pyruvaldehyde results in decreased expression of NFE2L2 mRNA | CTD | PMID:30447388 |
Nfe2l2 | Rat | methylglyoxal | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | bergenin affects the reaction [Pyruvaldehyde affects the expression of NFE2L2 protein] | CTD | PMID:29148590 |
Nfe2l2 | Rat | methylglyoxal | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Pyruvaldehyde affects the expression of NFE2L2 protein | CTD | PMID:29148590 |
Nfe2l2 | Rat | methylglyoxal | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Pyruvaldehyde | CTD | PMID:28263721 |
Nfe2l2 | Rat | methylglyoxal | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Pyruvaldehyde affects the localization of NFE2L2 protein | CTD | PMID:25451587 and PMID:33930484 |
Nfe2l2 | Rat | methylglyoxal | decreases phosphorylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | Pyruvaldehyde results in decreased phosphorylation of NFE2L2 protein | CTD | PMID:22917016 |
Nfe2l2 | Rat | methylglyoxal | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Resveratrol results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Pyruvaldehyde more ... | CTD | PMID:22917016 more ... |
Nfe2l2 | Rat | methylisothiazolinone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of and results in increased activity of NFE2L2 protein | CTD | PMID:30806763 |
Nfe2l2 | Rat | methyllycaconitine | multiple interactions | EXP | | 6480464 | methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [3-nitropropionic acid results in decreased expression of NFE2L2 protein]] | CTD | PMID:38513929 |
Nfe2l2 | Rat | methylmercury chloride | affects localization | EXP | | 6480464 | methylmercuric chloride affects the localization of NFE2L2 protein | CTD | PMID:20421342 and PMID:28736149 |
Nfe2l2 | Rat | methylmercury chloride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of NFE2L2 protein] and Sodium Selenite affects the reaction [methylmercuric chloride affects the localization of NFE2L2 protein] | CTD | PMID:24816296 and PMID:27917510 |
Nfe2l2 | Rat | methylmercury chloride | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | methylmercuric chloride affects the localization of NFE2L2 protein | CTD | PMID:24816296 |
Nfe2l2 | Rat | methylmercury chloride | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | methylmercuric chloride results in decreased expression of NFE2L2 mRNA | CTD | PMID:23202902 and PMID:29850906 |
Nfe2l2 | Rat | methylmercury chloride | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of NFE2L2 mRNA and methylmercuric chloride results in increased expression of NFE2L2 protein | CTD | PMID:23179753 more ... |
Nfe2l2 | Rat | methylmercury chloride | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | methylmercuric chloride affects the localization of NFE2L2 protein | CTD | PMID:20402460 |
Nfe2l2 | Rat | methylmercury chloride | decreases response to substance | EXP | | 6480464 | NFE2L2 protein results in decreased susceptibility to methylmercuric chloride | CTD | PMID:20421342 |
Nfe2l2 | Rat | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of NFE2L2 mRNA and methylmercuric chloride results in increased expression of NFE2L2 protein | CTD | PMID:20421342 more ... |
Nfe2l2 | Rat | methylmercury chloride | multiple interactions | EXP | | 6480464 | [methylmercuric chloride affects the localization of NFE2L2 protein] which results in increased expression of HMOX1 mRNA more ... | CTD | PMID:20421342 more ... |
Nfe2l2 | Rat | methylparaben | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | methylparaben results in increased expression of NFE2L2 mRNA | CTD | PMID:31745603 |
Nfe2l2 | Rat | Methysticin | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | methysticin affects the localization of NFE2L2 protein | CTD | PMID:28448946 |
Nfe2l2 | Rat | metolachlor | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | metolachlor results in increased activity of NFE2L2 protein | CTD | PMID:20143881 |
Nfe2l2 | Rat | metrafenone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Sulfur co-treated with metrafenone] results in decreased expression of NFE2L2 mRNA and [Sulfur co-treated with zoxamide co-treated with metrafenone] results in decreased expression of NFE2L2 mRNA | CTD | PMID:35564597 |
Nfe2l2 | Rat | mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid affects the reaction [Simvastatin results in increased localization of NFE2L2 protein] | CTD | PMID:18787804 |
Nfe2l2 | Rat | micafungin | multiple interactions | EXP | | 6480464 | MALT1 protein inhibits the reaction [Micafungin inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]] more ... | CTD | PMID:39089415 |
Nfe2l2 | Rat | micafungin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Micafungin inhibits the reaction [Doxorubicin promotes the reaction [MALT1 protein binds to NFE2L2 protein]] more ... | CTD | PMID:39089415 |
Nfe2l2 | Rat | microcystin-LR | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [cyanoginosin LR affects the localization of and results in increased activity of NFE2L2 protein] which results in increased expression of HMOX1 mRNA more ... | CTD | PMID:20600217 and PMID:20722399 |
Nfe2l2 | Rat | microcystin-LR | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Thioctic Acid co-treated with cyanoginosin LR] results in increased expression of NFE2L2 protein | CTD | PMID:32061150 |
Nfe2l2 | Rat | microcystin-LR | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | cyanoginosin LR affects the expression of NFE2L2 protein | CTD | PMID:20600217 |
Nfe2l2 | Rat | microcystin-LR | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to cyanoginosin LR | CTD | PMID:20722399 |
Nfe2l2 | Rat | microcystin-LR | decreases degradation | ISO | NFE2L2 (Homo sapiens) | 6480464 | cyanoginosin LR results in decreased degradation of NFE2L2 protein | CTD | PMID:20722399 |
Nfe2l2 | Rat | mifepristone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]] more ... | CTD | PMID:22606287 and PMID:22736252 |
Nfe2l2 | Rat | mifepristone | multiple interactions | EXP | | 6480464 | [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [HSD11B1 protein results in decreased activity of NFE2L2 protein] more ... | CTD | PMID:22606287 and PMID:24812154 |
Nfe2l2 | Rat | mirtazapine | increases expression | EXP | | 6480464 | Mirtazapine results in increased expression of NFE2L2 protein | CTD | PMID:37403423 |
Nfe2l2 | Rat | MK-2206 | multiple interactions | EXP | | 6480464 | MK 2206 inhibits the reaction [PHLDA3 protein inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of and affects the localization of and results in increased activity of NFE2L2 protein]] | CTD | PMID:34351043 |
Nfe2l2 | Rat | monascin | increases phosphorylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | monascin results in increased phosphorylation of NFE2L2 protein | CTD | PMID:23954466 |
Nfe2l2 | Rat | monascin | increases expression | EXP | | 6480464 | monascin results in increased expression of NFE2L2 mRNA | CTD | PMID:23954466 |
Nfe2l2 | Rat | monascin | multiple interactions | EXP | | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [monascin results in increased expression of NFE2L2 mRNA] and PPARG mutant form inhibits the reaction [monascin results in increased expression of NFE2L2 mRNA] | CTD | PMID:23954466 |
Nfe2l2 | Rat | monascin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | monascin inhibits the reaction [S100B protein results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:23331247 |
Nfe2l2 | Rat | monascin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | monascin affects the localization of NFE2L2 protein | CTD | PMID:23331247 |
Nfe2l2 | Rat | monascin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | monascin results in increased expression of NFE2L2 mRNA | CTD | PMID:23331247 |
Nfe2l2 | Rat | mono(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of NFE2L2 mRNA | CTD | PMID:32566080 |
Nfe2l2 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | RSL3 compound promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of NFE2L2 protein] | CTD | PMID:36438553 |
Nfe2l2 | Rat | mono(2-ethylhexyl) phthalate | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of NFE2L2 protein | CTD | PMID:36438553 |
Nfe2l2 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NFE2L2 protein] more ... | CTD | PMID:37286014 more ... |
Nfe2l2 | Rat | mono(2-ethylhexyl) phthalate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of NFE2L2 mRNA and mono-(2-ethylhexyl)phthalate results in increased expression of NFE2L2 protein | CTD | PMID:33360214 more ... |
Nfe2l2 | Rat | Monobutylphthalate | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | monobutyl phthalate results in decreased expression of NFE2L2 protein | CTD | PMID:30965081 |
Nfe2l2 | Rat | monocrotaline | multiple interactions | EXP | | 6480464 | liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of NFE2L2 mRNA] and liquiritin inhibits the reaction [Monocrotaline results in decreased expression of NFE2L2 mRNA] | CTD | PMID:29908794 |
Nfe2l2 | Rat | monocrotaline | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form affects the susceptibility to Monocrotaline | CTD | PMID:31504964 |
Nfe2l2 | Rat | monocrotaline | decreases expression | EXP | | 6480464 | Monocrotaline results in decreased expression of NFE2L2 mRNA | CTD | PMID:29908794 |
Nfe2l2 | Rat | monocrotophos | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Monocrotophos promotes the reaction [AIFM1 protein binds to NFE2L2 protein] | CTD | PMID:33078895 |
Nfe2l2 | Rat | monocrotophos | decreases expression | EXP | | 6480464 | Monocrotophos results in decreased expression of NFE2L2 mRNA | CTD | PMID:35403558 |
Nfe2l2 | Rat | monocrotophos | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Monocrotophos results in increased expression of NFE2L2 protein | CTD | PMID:28887667 |
Nfe2l2 | Rat | monosodium L-glutamate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Tea inhibits the reaction [Sodium Glutamate results in decreased expression of NFE2L2 mRNA] and Tea inhibits the reaction [Sodium Glutamate results in decreased expression of NFE2L2 protein] | CTD | PMID:29679905 |
Nfe2l2 | Rat | monosodium L-glutamate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Sodium Glutamate results in increased expression of NFE2L2 mRNA | CTD | PMID:25473020 |
Nfe2l2 | Rat | monosodium L-glutamate | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Sodium Glutamate results in decreased expression of NFE2L2 mRNA and Sodium Glutamate results in decreased expression of NFE2L2 protein | CTD | PMID:29679905 |
Nfe2l2 | Rat | morin | multiple interactions | EXP | | 6480464 | [1 more ... | CTD | PMID:26767949 more ... |
Nfe2l2 | Rat | Morroniside | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | morroniside affects the expression of NFE2L2 protein | CTD | PMID:21963495 |
Nfe2l2 | Rat | Morroniside | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | morroniside promotes the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and affects the localization of NFE2L2 protein] and morroniside results in increased expression of and results in increased phosphorylation of NFE2L2 protein | CTD | PMID:34029560 |
Nfe2l2 | Rat | myo-inositol hexakisphosphate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Phytic Acid inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein] | CTD | PMID:38000455 |
Nfe2l2 | Rat | myricetin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | myricetin results in increased expression of NFE2L2 protein | CTD | PMID:16799064 |
Nfe2l2 | Rat | N'-(2,4-dimethylphenyl)-N-methylformamidine | multiple interactions | EXP | | 6480464 | KEAP1 protein affects the reaction [U 40481 results in decreased expression of NFE2L2 protein] | CTD | PMID:31029719 |
Nfe2l2 | Rat | N'-(2,4-dimethylphenyl)-N-methylformamidine | decreases expression | EXP | | 6480464 | U 40481 results in decreased expression of NFE2L2 protein | CTD | PMID:31029719 |
Nfe2l2 | Rat | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:28659758 |
Nfe2l2 | Rat | N,N-dimethylformamide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of NFE2L2 protein] | CTD | PMID:37995826 |
Nfe2l2 | Rat | N,N-dimethylformamide | decreases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Dimethylformamide results in decreased activity of NFE2L2 protein | CTD | PMID:31875996 |
Nfe2l2 | Rat | N,N-dimethylformamide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Alitretinoin inhibits the reaction [Dimethylformamide results in decreased activity of NFE2L2 protein] more ... | CTD | PMID:31875996 |
Nfe2l2 | Rat | N,N-dimethylformamide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dimethylformamide results in increased expression of NFE2L2 protein | CTD | PMID:37995826 |
Nfe2l2 | Rat | N-(1-naphthyl)ethylenediamine | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | N-(1-naphthyl)ethylenediamine results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | multiple interactions | EXP | | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [T-2 Toxin results in increased expression of NFE2L2 protein] | CTD | PMID:29870751 |
Nfe2l2 | Rat | N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | decreases expression | EXP | | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased expression of NFE2L2 protein | CTD | PMID:29870751 |
Nfe2l2 | Rat | N-acetyl-1,4-benzoquinone imine | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | N-acetyl-4-benzoquinoneimine affects the localization of NFE2L2 protein | CTD | PMID:18785192 |
Nfe2l2 | Rat | N-acetyl-1,4-benzoquinone imine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of NQO1 mRNA] and NFE2L2 protein promotes the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] | CTD | PMID:18785192 and PMID:19246624 |
Nfe2l2 | Rat | N-acetyl-1,4-benzoquinone imine | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | N-acetyl-4-benzoquinoneimine results in increased activity of NFE2L2 protein | CTD | PMID:18785192 |
Nfe2l2 | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine affects the reaction [Chlorpyrifos affects the expression of NFE2L2 protein] more ... | CTD | PMID:11909699 more ... |
Nfe2l2 | Rat | N-acetyl-L-cysteine | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine results in increased expression of NFE2L2 mRNA and Acetylcysteine results in increased expression of NFE2L2 protein | CTD | PMID:35123993 and PMID:35430258 |
Nfe2l2 | Rat | N-acetyl-L-cysteine | increases expression | EXP | | 6480464 | Acetylcysteine results in increased expression of NFE2L2 mRNA | CTD | PMID:30633982 |
Nfe2l2 | Rat | N-acetyl-L-cysteine | affects localization | EXP | | 6480464 | Acetylcysteine affects the localization of NFE2L2 protein | CTD | PMID:30633982 |
Nfe2l2 | Rat | N-acetyl-L-cysteine | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acetylcysteine results in decreased expression of NFE2L2 mRNA | CTD | PMID:36786954 |
Nfe2l2 | Rat | N-acetyl-L-cysteine | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine affects the localization of NFE2L2 protein | CTD | PMID:22564156 |
Nfe2l2 | Rat | N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] more ... | CTD | PMID:17540521 more ... |
Nfe2l2 | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [6-formylindolo(3 more ... | CTD | PMID:15322212 more ... |
Nfe2l2 | Rat | N-acetylsphingosine | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [N-acetylsphingosine results in decreased localization of NFE2L2 protein] and N-acetylsphingosine inhibits the reaction [2-tert-butylhydroquinone results in increased localization of NFE2L2 protein] | CTD | PMID:15319326 |
Nfe2l2 | Rat | N-acetylsphingosine | decreases localization | EXP | | 6480464 | N-acetylsphingosine results in decreased localization of NFE2L2 protein | CTD | PMID:15319326 |
Nfe2l2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-tert-butyl-4-quinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein] more ... | CTD | PMID:18550526 more ... |
Nfe2l2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of NFE2L2 protein modified form | CTD | PMID:30703377 |
Nfe2l2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases ubiquitination | ISO | NFE2L2 (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein | CTD | PMID:28645578 |
Nfe2l2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | decreases degradation | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of NFE2L2 protein | CTD | PMID:26598004 |
Nfe2l2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases ubiquitination | ISO | Nfe2l2 (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein | CTD | PMID:27939242 |
Nfe2l2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L2 protein | CTD | PMID:12441344 more ... |
Nfe2l2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L2 protein | CTD | PMID:22606287 |
Nfe2l2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde affects the reaction [triptolide affects the expression of NFE2L2 protein] more ... | CTD | PMID:15319326 more ... |
Nfe2l2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of NFE2L2 protein | CTD | PMID:12441344 |
Nfe2l2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | decreases degradation | ISO | Nfe2l2 (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of NFE2L2 protein | CTD | PMID:14510636 and PMID:29618784 |
Nfe2l2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [2-tert-butylhydroquinone co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] promotes the reaction [NFE2L2 protein binds to KEAP1 protein] more ... | CTD | PMID:14510636 more ... |
Nfe2l2 | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L2 protein] which results in increased expression of CBR3 mRNA more ... | CTD | PMID:12446695 more ... |
Nfe2l2 | Rat | N-methyl-4-phenylpyridinium | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to 1-Methyl-4-phenylpyridinium | CTD | PMID:12842875 |
Nfe2l2 | Rat | N-methyl-4-phenylpyridinium | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of NFE2L2 mRNA and 1-Methyl-4-phenylpyridinium results in decreased expression of NFE2L2 protein | CTD | PMID:31187328 and PMID:34967706 |
Nfe2l2 | Rat | N-methyl-4-phenylpyridinium | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [1-Methyl-4-phenylpyridinium co-treated with puerarin] affects the localization of NFE2L2 protein more ... | CTD | PMID:31187328 more ... |
Nfe2l2 | Rat | N-methyl-4-phenylpyridinium | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein promotes the reaction [Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NQO1 mRNA]] more ... | CTD | PMID:30965670 |
Nfe2l2 | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of NFE2L2 mRNA | CTD | PMID:30965670 |
Nfe2l2 | Rat | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of NFE2L2 protein | CTD | PMID:23272707 |
Nfe2l2 | Rat | N-methyl-4-phenylpyridinium | affects localization | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein | CTD | PMID:26048653 |
Nfe2l2 | Rat | N-methyl-4-phenylpyridinium | decreases localization | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased localization of NFE2L2 protein | CTD | PMID:22019741 |
Nfe2l2 | Rat | N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein]] more ... | CTD | PMID:17982879 more ... |
Nfe2l2 | Rat | N-methylnicotinate | decreases phosphorylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | trigonelline results in decreased phosphorylation of NFE2L2 protein | CTD | PMID:33148531 |
Nfe2l2 | Rat | N-methylnicotinate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | oltipraz affects the reaction [trigonelline affects the reaction [INS2 protein affects the expression of NFE2L2 protein]] more ... | CTD | PMID:29211853 |
Nfe2l2 | Rat | N-methylnicotinate | multiple interactions | EXP | | 6480464 | oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of NFE2L2 protein]] and trigonelline inhibits the reaction [Glucose results in increased expression of NFE2L2 protein] | CTD | PMID:29211853 |
Nfe2l2 | Rat | N-methylnicotinate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | trigonelline inhibits the reaction [EGF protein results in increased phosphorylation of NFE2L2 protein] more ... | CTD | PMID:24015256 more ... |
Nfe2l2 | Rat | N-Methylolacrylamide | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | N-methylolacrylamide results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | N-nitrosodiethylamine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:19182440 more ... |
Nfe2l2 | Rat | N-nitrosodiethylamine | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of NFE2L2 mRNA | CTD | PMID:21607683 and PMID:35523338 |
Nfe2l2 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:18775883 more ... |
Nfe2l2 | Rat | N-nitrosodimethylamine | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Dimethylnitrosamine results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of NFE2L2 protein | CTD | PMID:30172374 |
Nfe2l2 | Rat | N-nitrosodimethylamine | multiple interactions | EXP | | 6480464 | Ramalin inhibits the reaction [Dimethylnitrosamine results in decreased expression of NFE2L2 protein] | CTD | PMID:30172374 |
Nfe2l2 | Rat | N-phosphocreatine | multiple interactions | EXP | | 6480464 | Phosphocreatine affects the reaction [Doxorubicin affects the expression of NFE2L2 protein] and Phosphocreatine inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein] | CTD | PMID:34358621 more ... |
Nfe2l2 | Rat | N-tosyl-L-phenylalanyl chloromethyl ketone | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Tosylphenylalanyl Chloromethyl Ketone | CTD | PMID:22851183 |
Nfe2l2 | Rat | N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine | multiple interactions | EXP | | 6480464 | Ranitidine inhibits the reaction [Indomethacin results in decreased expression of NFE2L2 mRNA] | CTD | PMID:28648817 |
Nfe2l2 | Rat | NADP zwitterion | affects abundance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the abundance of NADP | CTD | PMID:21775727 |
Nfe2l2 | Rat | NADP zwitterion | affects oxidation | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the oxidation of NADP | CTD | PMID:29950142 |
Nfe2l2 | Rat | NADP(+) | affects abundance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the abundance of NADP | CTD | PMID:21775727 |
Nfe2l2 | Rat | NADP(+) | affects oxidation | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the oxidation of NADP | CTD | PMID:29950142 |
Nfe2l2 | Rat | naphthalene | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | naphthalene results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | naphthalene-1,2-diol | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1 and 2-dihydroxynaphthalene analog results in increased activity of NFE2L2 protein | CTD | PMID:25807370 |
Nfe2l2 | Rat | naphthalene-1,2-diol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Buthionine Sulfoximine promotes the reaction [1 more ... | CTD | PMID:25807370 |
Nfe2l2 | Rat | naphthalene-1,5-diamine | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 and 5-naphthalenediamine results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | naringin | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin affects the localization of NFE2L2 protein] more ... | CTD | PMID:22871521 more ... |
Nfe2l2 | Rat | naringin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | CHAC2 protein promotes the reaction [naringin promotes the reaction [Acetaminophen results in increased expression of NFE2L2 protein]] more ... | CTD | PMID:35166444 more ... |
Nfe2l2 | Rat | naringin | affects localization | EXP | | 6480464 | naringin affects the localization of NFE2L2 protein | CTD | PMID:22871521 and PMID:25773745 |
Nfe2l2 | Rat | nebivolol | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Nebivolol results in increased expression of NFE2L2 | CTD | PMID:23886954 |
Nfe2l2 | Rat | nefazodone | decreases expression | EXP | | 6480464 | nefazodone results in decreased expression of NFE2L2 mRNA | CTD | PMID:24136188 |
Nfe2l2 | Rat | neoastilbin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | astilbin promotes the reaction [Cisplatin affects the localization of NFE2L2 protein] | CTD | PMID:29471006 |
Nfe2l2 | Rat | neoastilbin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | astilbin promotes the reaction [Cisplatin results in increased expression of NFE2L2 protein] | CTD | PMID:29471006 |
Nfe2l2 | Rat | nickel dichloride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [nickel chloride results in increased expression of NFE2L2 protein] more ... | CTD | PMID:16806455 and PMID:18437699 |
Nfe2l2 | Rat | nickel dichloride | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | nickel chloride results in increased expression of NFE2L2 protein | CTD | PMID:16806455 and PMID:18437699 |
Nfe2l2 | Rat | nickel dichloride | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | nickel chloride affects the localization of NFE2L2 protein | CTD | PMID:16806455 |
Nfe2l2 | Rat | nickel sulfate | increases methylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | nickel sulfate results in increased methylation of NFE2L2 promoter | CTD | PMID:25957741 |
Nfe2l2 | Rat | nickel sulfate | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of NFE2L2 protein | CTD | PMID:19033392 |
Nfe2l2 | Rat | nickel sulfate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Quercetin inhibits the reaction [nickel sulfate results in increased methylation of NFE2L2 promoter] | CTD | PMID:25957741 |
Nfe2l2 | Rat | nicorandil | multiple interactions | EXP | | 6480464 | Nicorandil inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein] | CTD | PMID:31376360 |
Nfe2l2 | Rat | nicotinamide | multiple interactions | EXP | | 6480464 | [Streptozocin co-treated with Niacinamide] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:21439372 |
Nfe2l2 | Rat | nicotinamide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:33949241 and PMID:37120126 |
Nfe2l2 | Rat | nifedipine | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Nifedipine affects the localization of NFE2L2 protein | CTD | PMID:21525764 |
Nfe2l2 | Rat | nilotinib | multiple interactions | EXP | | 6480464 | nilotinib inhibits the reaction [Cyclosporine results in decreased expression of NFE2L2 protein] | CTD | PMID:33710703 |
Nfe2l2 | Rat | nimesulide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Sulfaphenazole affects the reaction [nimesulide affects the localization of NFE2L2 protein] | CTD | PMID:20405857 |
Nfe2l2 | Rat | nimesulide | decreases expression | EXP | | 6480464 | nimesulide results in decreased expression of NFE2L2 mRNA | CTD | PMID:24136188 |
Nfe2l2 | Rat | nimesulide | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | nimesulide affects the localization of NFE2L2 protein | CTD | PMID:20405857 |
Nfe2l2 | Rat | nimesulide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 mutant form inhibits the reaction [nimesulide results in increased expression of NQO1] | CTD | PMID:20405857 |
Nfe2l2 | Rat | nimesulide | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | nimesulide affects the localization of NFE2L2 protein | CTD | PMID:20405857 |
Nfe2l2 | Rat | nitrites | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein inhibits the reaction [IFNG protein results in increased abundance of Nitrites] more ... | CTD | PMID:23942037 |
Nfe2l2 | Rat | nitrites | multiple interactions | EXP | | 6480464 | [Nitrites co-treated with Oxygen deficiency] results in increased expression of NFE2L2 mRNA | CTD | PMID:22892143 |
Nfe2l2 | Rat | nitrofurantoin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Nitrofurantoin results in increased expression of GCLC protein] more ... | CTD | PMID:34021431 |
Nfe2l2 | Rat | nitrogen mustard | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | caffeic acid phenethyl ester promotes the reaction [Nitrogen Mustard Compounds results in increased expression of NFE2L2 protein] | CTD | PMID:17204746 |
Nfe2l2 | Rat | nitrogen mustard | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Nitrogen Mustard Compounds results in increased expression of NFE2L2 protein | CTD | PMID:17204746 |
Nfe2l2 | Rat | nitroprusside | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Nitroprusside inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein] | CTD | PMID:29353218 |
Nfe2l2 | Rat | nitroprusside | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Nitroprusside results in decreased expression of NFE2L2 protein | CTD | PMID:31066958 |
Nfe2l2 | Rat | nitroprusside | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Deferoxamine inhibits the reaction [Nitroprusside results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:31066958 |
Nfe2l2 | Rat | nitroprusside | multiple interactions | EXP | | 6480464 | Nitroprusside inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein] | CTD | PMID:29353218 |
Nfe2l2 | Rat | nitroprusside | decreases expression | EXP | | 6480464 | Nitroprusside results in decreased expression of NFE2L2 protein | CTD | PMID:29353218 |
Nfe2l2 | Rat | nitroprusside | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Nitroprusside results in decreased expression of NFE2L2 protein | CTD | PMID:29353218 |
Nfe2l2 | Rat | nobiletin | multiple interactions | EXP | | 6480464 | nobiletin inhibits the reaction [Acetaminophen results in decreased expression of NFE2L2 protein] | CTD | PMID:31777137 |
Nfe2l2 | Rat | Nonylphenol | increases expression | EXP | | 6480464 | nonylphenol results in increased expression of NFE2L2 protein | CTD | PMID:30481583 |
Nfe2l2 | Rat | notoginsenoside R1 | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | notoginsenoside R1 affects the localization of NFE2L2 protein | CTD | PMID:25422538 |
Nfe2l2 | Rat | notoginsenoside R1 | affects localization | EXP | | 6480464 | notoginsenoside R1 affects the localization of NFE2L2 protein | CTD | PMID:24437944 and PMID:24720662 |
Nfe2l2 | Rat | notoginsenoside R1 | multiple interactions | EXP | | 6480464 | NFE2L2 promotes the reaction [notoginsenoside R1 results in increased expression of GCLC protein] more ... | CTD | PMID:24437944 |
Nfe2l2 | Rat | notoginsenoside R1 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [notoginsenoside R1 inhibits the reaction [triethylene glycol dimethacrylate results in decreased expression of and affects the localization of NFE2L2 protein]] more ... | CTD | PMID:25422538 and PMID:33689844 |
Nfe2l2 | Rat | NSC 23766 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NSC 23766 inhibits the reaction [Doxorubicin results in increased expression of NFE2L2 mRNA] | CTD | PMID:28710503 |
Nfe2l2 | Rat | obeticholic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | obeticholic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:27939613 |
Nfe2l2 | Rat | obeticholic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Dietary Fats co-treated with obeticholic acid] results in decreased expression of NFE2L2 protein | CTD | PMID:35267068 |
Nfe2l2 | Rat | ochratoxin A | multiple interactions | EXP | | 6480464 | [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased activity of NFE2L2 protein] and ochratoxin A inhibits the reaction [NFE2L2 protein binds to GSTP1 protein] | CTD | PMID:17110534 |
Nfe2l2 | Rat | ochratoxin A | increases methylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | ochratoxin A results in increased methylation of NFE2L2 promoter | CTD | PMID:30559759 |
Nfe2l2 | Rat | ochratoxin A | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | AHR protein affects the reaction [ochratoxin A results in increased expression of NFE2L2 mRNA] more ... | CTD | PMID:30291945 |
Nfe2l2 | Rat | ochratoxin A | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | ochratoxin A results in increased expression of NFE2L2 mRNA | CTD | PMID:30291945 |
Nfe2l2 | Rat | ochratoxin A | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | ochratoxin A affects the localization of NFE2L2 protein | CTD | PMID:30291945 |
Nfe2l2 | Rat | ochratoxin A | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to ochratoxin A] which results in decreased expression of CAT mRNA more ... | CTD | PMID:28710020 |
Nfe2l2 | Rat | ochratoxin A | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to ochratoxin A | CTD | PMID:28710020 |
Nfe2l2 | Rat | ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of NFE2L2 mRNA | CTD | PMID:24120684 |
Nfe2l2 | Rat | ochratoxin A | decreases activity | EXP | | 6480464 | ochratoxin A results in decreased activity of NFE2L2 protein | CTD | PMID:17110534 |
Nfe2l2 | Rat | octadecanoic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | stearic acid results in increased expression of NFE2L2 mRNA and stearic acid results in increased expression of NFE2L2 protein | CTD | PMID:28555106 |
Nfe2l2 | Rat | okadaic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of NFE2L2 protein | CTD | PMID:12446695 |
Nfe2l2 | Rat | olanzapine | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Olanzapine results in decreased expression of NFE2L2 protein | CTD | PMID:37019375 |
Nfe2l2 | Rat | oleanolic acid | multiple interactions | EXP | | 6480464 | Oleanolic Acid inhibits the reaction [Ethanol results in decreased expression of NFE2L2 protein] and Oleanolic Acid promotes the reaction [Ethanol affects the localization of NFE2L2 protein] | CTD | PMID:25111957 |
Nfe2l2 | Rat | oleanolic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Oleanolic Acid results in increased expression of NFE2L2 mRNA and Oleanolic Acid results in increased expression of NFE2L2 protein | CTD | PMID:18706400 more ... |
Nfe2l2 | Rat | oleanolic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein] and Oleanolic Acid promotes the reaction [NFE2L2 protein results in increased expression of SREBF1 mRNA] | CTD | PMID:20100471 and PMID:28796629 |
Nfe2l2 | Rat | oleanolic acid | increases expression | EXP | | 6480464 | Oleanolic Acid results in increased expression of NFE2L2 mRNA | CTD | PMID:18706400 |
Nfe2l2 | Rat | oleanolic acid | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Oleanolic Acid results in increased activity of NFE2L2 protein | CTD | PMID:19283895 |
Nfe2l2 | Rat | oleanolic acid | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Oleanolic Acid affects the localization of NFE2L2 protein | CTD | PMID:19283895 |
Nfe2l2 | Rat | oleanolic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Oleanolic Acid results in increased activity of NQO1 protein] more ... | CTD | PMID:19283895 and PMID:25280775 |
Nfe2l2 | Rat | oleic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Oleic Acid results in increased expression of NFE2L2 mRNA and Oleic Acid results in increased expression of NFE2L2 protein | CTD | PMID:28555106 |
Nfe2l2 | Rat | oleic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NFE2L2 mRNA and FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NFE2L2 mRNA] | CTD | PMID:26847930 |
Nfe2l2 | Rat | oleic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [gastrodin co-treated with Oleic Acid] results in increased phosphorylation of and affects the localization of NFE2L2 protein more ... | CTD | PMID:26634892 more ... |
Nfe2l2 | Rat | Olmesartan medoxomil | multiple interactions | EXP | | 6480464 | Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in decreased expression of NFE2L2 mRNA] | CTD | PMID:30594690 |
Nfe2l2 | Rat | oltipraz | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | oltipraz results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | oltipraz | multiple interactions | EXP | | 6480464 | oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of NFE2L2 protein]] | CTD | PMID:29211853 |
Nfe2l2 | Rat | oltipraz | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | oltipraz results in increased activity of NFE2L2 protein | CTD | PMID:25752797 |
Nfe2l2 | Rat | oltipraz | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [oltipraz co-treated with NFE2L2 protein mutant form] affects the expression of ABCG5 mRNA more ... | CTD | PMID:15833929 more ... |
Nfe2l2 | Rat | oltipraz | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to oltipraz | CTD | PMID:19150646 and PMID:20086057 |
Nfe2l2 | Rat | oltipraz | affects activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | oltipraz affects the activity of NFE2L2 protein | CTD | PMID:11309284 |
Nfe2l2 | Rat | omeprazole | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 mRNA] and NFE2L2 protein affects the reaction [Omeprazole results in increased expression of HMOX1 protein] | CTD | PMID:27725188 |
Nfe2l2 | Rat | Ophiopogonin D | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | ophiopogonin D results in decreased expression of NFE2L2 protein | CTD | PMID:35905946 |
Nfe2l2 | Rat | Ophiopogonin D | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 3-(2 and 4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [ophiopogonin D results in decreased expression of NFE2L2 protein] | CTD | PMID:35905946 |
Nfe2l2 | Rat | orlistat | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Orlistat co-treated with Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in decreased expression of NFE2L2 mRNA | CTD | PMID:33476690 |
Nfe2l2 | Rat | orlistat | multiple interactions | EXP | | 6480464 | Orlistat inhibits the reaction [Dietary Fats results in decreased expression of NFE2L2 mRNA] | CTD | PMID:32450208 |
Nfe2l2 | Rat | oxaliplatin | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to oxaliplatin | CTD | PMID:23933386 |
Nfe2l2 | Rat | oxaliplatin | decreases expression | EXP | | 6480464 | Oxaliplatin results in decreased expression of NFE2L2 mRNA | CTD | PMID:38037725 |
Nfe2l2 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | naringin inhibits the reaction [Oxaliplatin results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:30254294 and PMID:38037725 |
Nfe2l2 | Rat | oxaliplatin | increases expression | EXP | | 6480464 | Oxaliplatin results in increased expression of NFE2L2 mRNA and Oxaliplatin results in increased expression of NFE2L2 protein | CTD | PMID:30254294 |
Nfe2l2 | Rat | oxazepam | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Oxazepam results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | oxidopamine | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Oxidopamine affects the localization of NFE2L2 protein | CTD | PMID:33486071 |
Nfe2l2 | Rat | oxidopamine | affects localization | EXP | | 6480464 | Oxidopamine affects the localization of NFE2L2 protein | CTD | PMID:34302886 |
Nfe2l2 | Rat | oxidopamine | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Oxidopamine results in decreased expression of NFE2L2 protein | CTD | PMID:29057453 |
Nfe2l2 | Rat | oxidopamine | increases expression | EXP | | 6480464 | Oxidopamine results in increased expression of NFE2L2 mRNA and Oxidopamine results in increased expression of NFE2L2 protein | CTD | PMID:21397656 |
Nfe2l2 | Rat | oxidopamine | increases activity | EXP | | 6480464 | Oxidopamine results in increased activity of NFE2L2 protein | CTD | PMID:17676812 |
Nfe2l2 | Rat | oxidopamine | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxidopamine results in increased expression of NFE2L2 protein] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxidopamine results in increased localization of NFE2L2 protein] | CTD | PMID:21397656 |
Nfe2l2 | Rat | oxidopamine | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to Oxidopamine | CTD | PMID:16092930 |
Nfe2l2 | Rat | oxidopamine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxidopamine affects the localization of NFE2L2 protein] more ... | CTD | PMID:16092930 and PMID:33486071 |
Nfe2l2 | Rat | oxidopamine | increases localization | EXP | | 6480464 | Oxidopamine results in increased localization of NFE2L2 protein | CTD | PMID:21397656 |
Nfe2l2 | Rat | Oxyfluorfen | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | oxyfluorofen results in increased activity of NFE2L2 protein | CTD | PMID:20143881 |
Nfe2l2 | Rat | ozone | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ozone results in increased expression of NFE2L2 mRNA and Ozone results in increased expression of NFE2L2 protein | CTD | PMID:23766849 and PMID:27240593 |
Nfe2l2 | Rat | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Ozone]] which results in increased expression of NFE2L2 mRNA | CTD | PMID:36423397 |
Nfe2l2 | Rat | ozone | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ozone results in decreased expression of NFE2L2 protein | CTD | PMID:30090343 and PMID:36376488 |
Nfe2l2 | Rat | ozone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ozone results in increased expression of NFE2L2 protein | CTD | PMID:25218903 |
Nfe2l2 | Rat | ozone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of NFE2L2 protein more ... | CTD | PMID:23019345 more ... |
Nfe2l2 | Rat | ozone | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Ozone | CTD | PMID:23766849 |
Nfe2l2 | Rat | ozone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NFE2L2 mRNA more ... | CTD | PMID:26270818 more ... |
Nfe2l2 | Rat | p-chloromercuribenzoic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of NFE2L2 mRNA | CTD | PMID:26272509 |
Nfe2l2 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA | CTD | PMID:27188386 |
Nfe2l2 | Rat | p-cresol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 4-cresol results in increased expression of NFE2L2 mRNA | CTD | PMID:29214717 |
Nfe2l2 | Rat | paclitaxel | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 results in decreased susceptibility to Paclitaxel | CTD | PMID:20530669 |
Nfe2l2 | Rat | paclitaxel | multiple interactions | EXP | | 6480464 | Hesperidin inhibits the reaction [Paclitaxel results in decreased expression of NFE2L2 mRNA] | CTD | PMID:35921949 and PMID:36966900 |
Nfe2l2 | Rat | paclitaxel | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [KEAP1 protein results in decreased stability of NFE2L2 protein] which results in increased susceptibility to Paclitaxel | CTD | PMID:20530669 |
Nfe2l2 | Rat | paclitaxel | decreases expression | EXP | | 6480464 | Paclitaxel results in decreased expression of NFE2L2 mRNA | CTD | PMID:15585946 more ... |
Nfe2l2 | Rat | paeoniflorin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | peoniflorin affects the localization of NFE2L2 protein | CTD | PMID:23403272 |
Nfe2l2 | Rat | paeoniflorin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | peoniflorin promotes the reaction [Particulate Matter results in increased expression of NFE2L2 protein] | CTD | PMID:38705442 |
Nfe2l2 | Rat | paeoniflorin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(1 more ... | CTD | PMID:23403272 and PMID:38705442 |
Nfe2l2 | Rat | Palbinone | multiple interactions | EXP | | 6480464 | palbinone inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA] | CTD | PMID:32202043 |
Nfe2l2 | Rat | pallidol | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | pallidol results in increased activity of NFE2L2 protein | CTD | PMID:25466015 |
Nfe2l2 | Rat | palmatine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | palmatine inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | CTD | PMID:36169195 |
Nfe2l2 | Rat | panobinostat | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA | CTD | PMID:27188386 |
Nfe2l2 | Rat | panobinostat | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | panobinostat results in increased expression of NFE2L2 mRNA | CTD | PMID:26272509 |
Nfe2l2 | Rat | paracetamol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Acetaminophen co-treated with amlexanox] results in increased expression of NFE2L2 protein more ... | CTD | PMID:11134556 more ... |
Nfe2l2 | Rat | paracetamol | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of NFE2L2 mRNA and Acetaminophen results in decreased expression of NFE2L2 protein | CTD | PMID:30273691 more ... |
Nfe2l2 | Rat | paracetamol | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Acetaminophen | CTD | PMID:17935745 more ... |
Nfe2l2 | Rat | paracetamol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Chlorogenic Acid co-treated with Acetaminophen] results in increased phosphorylation of and affects the localization of and results in increased activity of NFE2L2 protein] more ... | CTD | PMID:29136249 more ... |
Nfe2l2 | Rat | paracetamol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of NFE2L2 more ... | CTD | PMID:24631341 more ... |
Nfe2l2 | Rat | paracetamol | multiple interactions | EXP | | 6480464 | Acetaminophen results in decreased expression of and affects the localization of NFE2L2 protein more ... | CTD | PMID:26767949 more ... |
Nfe2l2 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of NFE2L2 mRNA and Acetaminophen results in decreased expression of NFE2L2 protein | CTD | PMID:17202758 more ... |
Nfe2l2 | Rat | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of NFE2L2 mRNA | CTD | PMID:16701773 |
Nfe2l2 | Rat | paracetamol | affects sulfation | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the sulfation of Acetaminophen | CTD | PMID:19246624 |
Nfe2l2 | Rat | paracetamol | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Acetaminophen | CTD | PMID:19371629 |
Nfe2l2 | Rat | paracetamol | affects glucuronidation | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the glucuronidation of Acetaminophen | CTD | PMID:19246624 |
Nfe2l2 | Rat | paracetamol | affects glutathionylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the glutathionylation of Acetaminophen | CTD | PMID:19246624 |
Nfe2l2 | Rat | paracetamol | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acetaminophen results in increased expression of NFE2L2 mRNA and Acetaminophen results in increased expression of NFE2L2 protein | CTD | PMID:11287661 more ... |
Nfe2l2 | Rat | paracetamol | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acetaminophen results in increased activity of NFE2L2 protein | CTD | PMID:17002867 more ... |
Nfe2l2 | Rat | paracetamol | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acetaminophen results in increased localization of NFE2L2 protein | CTD | PMID:18078705 |
Nfe2l2 | Rat | paracetamol | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of NFE2L2 mRNA | CTD | PMID:17562736 |
Nfe2l2 | Rat | paracetamol | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Acetaminophen affects the localization of NFE2L2 protein | CTD | PMID:17935745 more ... |
Nfe2l2 | Rat | paracetamol | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Acetaminophen | CTD | PMID:21540358 |
Nfe2l2 | Rat | paracetamol | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Acetaminophen and NFE2L2 results in decreased susceptibility to Acetaminophen | CTD | PMID:11134556 more ... |
Nfe2l2 | Rat | paraquat | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Paraquat results in decreased expression of NFE2L2 mRNA and Paraquat results in decreased expression of NFE2L2 protein | CTD | PMID:17215068 more ... |
Nfe2l2 | Rat | paraquat | increases phosphorylation | EXP | | 6480464 | Paraquat results in increased phosphorylation of NFE2L2 protein | CTD | PMID:30112919 |
Nfe2l2 | Rat | paraquat | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Paraquat | CTD | PMID:29950142 |
Nfe2l2 | Rat | paraquat | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Paraquat affects the localization of NFE2L2 protein | CTD | PMID:30562684 and PMID:30571954 |
Nfe2l2 | Rat | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of NFE2L2 mRNA and Paraquat results in decreased expression of NFE2L2 protein | CTD | PMID:28624451 and PMID:35236239 |
Nfe2l2 | Rat | paraquat | affects expression | EXP | | 6480464 | Paraquat affects the expression of NFE2L2 protein | CTD | PMID:31715309 |
Nfe2l2 | Rat | paraquat | increases phosphorylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | Paraquat results in increased phosphorylation of NFE2L2 protein | CTD | PMID:27788593 |
Nfe2l2 | Rat | paraquat | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Paraquat affects the expression of NFE2L2 protein | CTD | PMID:28428137 |
Nfe2l2 | Rat | paraquat | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Paraquat affects the expression of NFE2L2 protein | CTD | PMID:28428137 and PMID:29071302 |
Nfe2l2 | Rat | paraquat | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Paraquat results in decreased expression of NFE2L2 mRNA and Paraquat results in decreased expression of NFE2L2 protein | CTD | PMID:20851755 more ... |
Nfe2l2 | Rat | paraquat | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Paraquat results in increased expression of NFE2L2 mRNA and Paraquat results in increased expression of NFE2L2 protein | CTD | PMID:22709784 more ... |
Nfe2l2 | Rat | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of NFE2L2 mRNA and Paraquat results in increased expression of NFE2L2 protein | CTD | PMID:20095329 more ... |
Nfe2l2 | Rat | paraquat | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Paraquat results in increased expression of NFE2L2 mRNA and Paraquat results in increased expression of NFE2L2 protein | CTD | PMID:22983789 more ... |
Nfe2l2 | Rat | paraquat | affects localization | EXP | | 6480464 | Paraquat affects the localization of NFE2L2 protein | CTD | PMID:22678742 more ... |
Nfe2l2 | Rat | paraquat | increases response to substance | EXP | | 6480464 | NFE2L2 protein results in increased susceptibility to Paraquat | CTD | PMID:22678742 |
Nfe2l2 | Rat | paraquat | multiple interactions | EXP | | 6480464 | [Mifepristone co-treated with Paraquat] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:20095329 more ... |
Nfe2l2 | Rat | paraquat | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to Paraquat | CTD | PMID:22493042 |
Nfe2l2 | Rat | paraquat | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Mifepristone co-treated with NFE2L2 protein] inhibits the reaction [Paraquat results in decreased activity of CAT protein] more ... | CTD | PMID:20851755 more ... |
Nfe2l2 | Rat | paraquat | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-tert-butylhydroquinone inhibits the reaction [Paraquat results in increased expression of NFE2L2 protein] more ... | CTD | PMID:17823202 more ... |
Nfe2l2 | Rat | parathion-methyl | increases methylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | Methyl Parathion results in increased methylation of NFE2L2 promoter | CTD | PMID:29540303 |
Nfe2l2 | Rat | pazopanib | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [pazopanib results in decreased activity of TERT protein] more ... | CTD | PMID:38613465 |
Nfe2l2 | Rat | pazopanib | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | pazopanib results in increased expression of NFE2L2 protein | CTD | PMID:38613465 |
Nfe2l2 | Rat | pelargonidin | decreases methylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | pelargonidin results in decreased methylation of NFE2L2 promoter | CTD | PMID:31181187 |
Nfe2l2 | Rat | pelargonidin | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to pelargonidin | CTD | PMID:31181187 |
Nfe2l2 | Rat | pentachloronitrobenzene | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | quintozene results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | perfluorobutanesulfonic acid | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | perfluorobutanesulfonic acid results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | perfluorobutanesulfonic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | perfluorobutanesulfonic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:35337807 |
Nfe2l2 | Rat | perfluorodecanoic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [perfluorodecanoic acid results in increased expression of ABCC3 mRNA] and NFE2L2 protein affects the reaction [perfluorodecanoic acid results in increased expression of ABCC4 mRNA] | CTD | PMID:18757529 |
Nfe2l2 | Rat | perfluorodecanoic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | perfluorodecanoic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:35337807 |
Nfe2l2 | Rat | perfluorohexanesulfonic acid | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | perfluorohexanesulfonic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:35337807 |
Nfe2l2 | Rat | perfluorohexanesulfonic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [perfluorohexanesulfonic acid co-treated with Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of NFE2L2 mRNA | CTD | PMID:32991729 |
Nfe2l2 | Rat | perfluorohexanoic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | perfluorohexanoic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:35337807 |
Nfe2l2 | Rat | perfluorononanoic acid | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | perfluoro-n-nonanoic acid results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | perfluorononanoic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:35337807 |
Nfe2l2 | Rat | perfluorononanoic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [perfluoro-n-nonanoic acid results in increased expression of HOXB7 mRNA] more ... | CTD | PMID:32534105 |
Nfe2l2 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of and affects the localization of and results in decreased activity of NFE2L2 protein | CTD | PMID:26844784 |
Nfe2l2 | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:35337807 |
Nfe2l2 | Rat | perfluorooctane-1-sulfonic acid | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to perfluorooctane sulfonic acid | CTD | PMID:33812015 |
Nfe2l2 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of NFE2L2 mRNA | CTD | PMID:32790152 |
Nfe2l2 | Rat | perfluorooctane-1-sulfonic acid | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in increased activity of NFE2L2 protein | CTD | PMID:26548598 more ... |
Nfe2l2 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:26548598 more ... |
Nfe2l2 | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in increased expression of NFE2L2 mRNA and perfluorooctane sulfonic acid results in increased expression of NFE2L2 protein | CTD | PMID:26548598 more ... |
Nfe2l2 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of and affects the localization of and results in decreased activity of NFE2L2 protein | CTD | PMID:26844784 |
Nfe2l2 | Rat | perfluorooctanesulfonamide | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | perfluorooctanesulfonamide analog results in increased expression of NFE2L2 mRNA | CTD | PMID:35337807 |
Nfe2l2 | Rat | perfluorooctanoic acid | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | perfluorooctanoic acid affects the expression of NFE2L2 mRNA | CTD | PMID:18281256 |
Nfe2l2 | Rat | perfluorooctanoic acid | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to perfluorooctanoic acid | CTD | PMID:33812015 |
Nfe2l2 | Rat | perfluorooctanoic acid | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | perfluorooctanoic acid | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of NFE2L2 mRNA | CTD | PMID:23567314 and PMID:32790152 |
Nfe2l2 | Rat | perfluorooctanoic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:18281256 and PMID:30685356 |
Nfe2l2 | Rat | perfluorooctanoic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [CYP2A5 promoter mutant form results in decreased activity of NFE2L2 protein] which results in decreased susceptibility to perfluorooctanoic acid more ... | CTD | PMID:18281256 more ... |
Nfe2l2 | Rat | perfluoroundecanoic acid | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | perfluoroundecanoic acid results in decreased expression of NFE2L2 mRNA | CTD | PMID:23567314 |
Nfe2l2 | Rat | perillyl aldehyde | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | perillaldehyde promotes the reaction [NFE2L2 protein binds to TXN enhancer] | CTD | PMID:19123792 |
Nfe2l2 | Rat | permethrin | increases expression | EXP | | 6480464 | Permethrin results in increased expression of NFE2L2 mRNA | CTD | PMID:23566817 and PMID:23806482 |
Nfe2l2 | Rat | permethrin | decreases expression | EXP | | 6480464 | Permethrin results in decreased expression of NFE2L2 mRNA | CTD | PMID:29477483 and PMID:31175960 |
Nfe2l2 | Rat | permethrin | multiple interactions | EXP | | 6480464 | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:28659758 |
Nfe2l2 | Rat | peroxides | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Peroxides | CTD | PMID:20932822 |
Nfe2l2 | Rat | pevonedistat | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | pevonedistat inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 mRNA] | CTD | PMID:34476871 |
Nfe2l2 | Rat | phalloidin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 gene mutant form results in increased susceptibility to Phalloidine] which results in decreased expression of MT1 mRNA more ... | CTD | PMID:25280775 |
Nfe2l2 | Rat | phalloidin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Phalloidine results in increased expression of NFE2L2 mRNA | CTD | PMID:25280775 |
Nfe2l2 | Rat | phalloidin | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Phalloidine | CTD | PMID:25280775 |
Nfe2l2 | Rat | phenacetin | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Phenacetin results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | phenanthrene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFE2L2 mRNA | CTD | PMID:37888695 |
Nfe2l2 | Rat | phenethyl caffeate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | caffeic acid phenethyl ester inhibits the reaction [Bleomycin results in decreased expression of NFE2L2 protein] | CTD | PMID:23570914 |
Nfe2l2 | Rat | phenethyl caffeate | multiple interactions | EXP | | 6480464 | caffeic acid phenethyl ester inhibits the reaction [Carrageenan results in decreased expression of NFE2L2 mRNA] | CTD | PMID:34789018 |
Nfe2l2 | Rat | phenethyl caffeate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | caffeic acid phenethyl ester promotes the reaction [Nitrogen Mustard Compounds results in increased expression of NFE2L2 protein] | CTD | PMID:17204746 |
Nfe2l2 | Rat | phenethyl isothiocyanate | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | phenethyl isothiocyanate affects the localization of NFE2L2 protein | CTD | PMID:20402460 |
Nfe2l2 | Rat | phenethyl isothiocyanate | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | phenethyl isothiocyanate results in increased activity of NFE2L2 protein | CTD | PMID:32070777 |
Nfe2l2 | Rat | phenethyl isothiocyanate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [indole-3-carbinol co-treated with phenethyl isothiocyanate] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:26945724 and PMID:32070777 |
Nfe2l2 | Rat | phenethyl isothiocyanate | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | phenethyl isothiocyanate results in increased expression of NFE2L2 mRNA and phenethyl isothiocyanate results in increased expression of NFE2L2 protein | CTD | PMID:25246272 and PMID:32070777 |
Nfe2l2 | Rat | phenethyl isothiocyanate | increases expression | EXP | | 6480464 | phenethyl isothiocyanate results in increased expression of NFE2L2 protein | CTD | PMID:22664424 |
Nfe2l2 | Rat | phenethyl isothiocyanate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form affects the reaction [phenethyl isothiocyanate promotes the reaction [lipopolysaccharide more ... | CTD | PMID:20402460 and PMID:25387343 |
Nfe2l2 | Rat | phenformin | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Phenformin results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | phenobarbital | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form affects the reaction [Phenobarbital results in increased expression of CYP2A5 mRNA] more ... | CTD | PMID:19482888 more ... |
Nfe2l2 | Rat | phenobarbital | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Phenobarbital results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of NFE2L2 mRNA | CTD | PMID:19162173 |
Nfe2l2 | Rat | phenobarbital | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:20935162 and PMID:28414157 |
Nfe2l2 | Rat | phenobarbital | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of NFE2L2 mRNA | CTD | PMID:19482888 and PMID:27160211 |
Nfe2l2 | Rat | Phenyl glycidyl ether | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | phenylglycidyl ether analog results in increased activity of NFE2L2 protein | CTD | PMID:21751775 |
Nfe2l2 | Rat | Phenyl glycidyl ether | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | phenylglycidyl ether analog promotes the reaction [NFE2L2 protein results in increased expression of AKR1C2 mRNA] | CTD | PMID:21751775 |
Nfe2l2 | Rat | phenylarsine oxide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | oxophenylarsine binds to and results in increased activity of NFE2L2 protein | CTD | PMID:19786557 |
Nfe2l2 | Rat | phenylarsine oxide | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | oxophenylarsine results in increased activity of NFE2L2 protein | CTD | PMID:19808700 |
Nfe2l2 | Rat | phenylhydrazine | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | phenylhydrazine results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | phenylmercury acetate | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of NFE2L2 mRNA | CTD | PMID:26272509 |
Nfe2l2 | Rat | phenylmercury acetate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA | CTD | PMID:27188386 |
Nfe2l2 | Rat | PhIP | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of NFE2L2 mRNA | CTD | PMID:20307560 |
Nfe2l2 | Rat | PhIP | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [2-amino-3 more ... | CTD | PMID:20307560 |
Nfe2l2 | Rat | phloretin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Phloretin] results in increased expression of NFE2L2 mRNA | CTD | PMID:33410021 |
Nfe2l2 | Rat | phlorizin | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Phlorhizin results in decreased expression of NFE2L2 mRNA | CTD | PMID:22538082 |
Nfe2l2 | Rat | phlorizin chalcone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | MAPK1 protein affects the reaction [isosalipurposide affects the localization of NFE2L2 protein] and MAPK3 protein affects the reaction [isosalipurposide affects the localization of NFE2L2 protein] | CTD | PMID:26028482 |
Nfe2l2 | Rat | phlorizin chalcone | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | isosalipurposide affects the localization of NFE2L2 protein | CTD | PMID:26028482 |
Nfe2l2 | Rat | phorbol 13-acetate 12-myristate | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of NFE2L2 mRNA | CTD | PMID:24632381 |
Nfe2l2 | Rat | phorbol 13-acetate 12-myristate | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of NFE2L2 protein | CTD | PMID:20438634 |
Nfe2l2 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NFE2L2 protein more ... | CTD | PMID:24632381 |
Nfe2l2 | Rat | phorone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form inhibits the reaction [phorone results in increased expression of CYP2A5 mRNA] and NFE2L2 gene mutant form inhibits the reaction [phorone results in increased expression of CYP2B10 mRNA] | CTD | PMID:24494203 |
Nfe2l2 | Rat | phoxim | increases expression | EXP | | 6480464 | phoxim results in increased expression of NFE2L2 mRNA | CTD | PMID:30003487 |
Nfe2l2 | Rat | phytoestrogen | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Phytoestrogens affects the localization of NFE2L2 protein] more ... | CTD | PMID:24726523 |
Nfe2l2 | Rat | picolinic acid | multiple interactions | EXP | | 6480464 | picolinic acid inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | CTD | PMID:22790776 |
Nfe2l2 | Rat | picoxystrobin | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | picoxystrobin results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | picoxystrobin | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | picoxystrobin results in decreased expression of NFE2L2 mRNA | CTD | PMID:33512557 |
Nfe2l2 | Rat | pioglitazone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein promotes the reaction [Pioglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NQO1 mRNA]] more ... | CTD | PMID:30965670 |
Nfe2l2 | Rat | piperonyl butoxide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Piperonyl Butoxide results in increased expression of NFE2L2 mRNA | CTD | PMID:19690152 |
Nfe2l2 | Rat | piperonyl butoxide | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Piperonyl Butoxide results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | piperonyl butoxide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] results in increased expression of NFE2L2 mRNA | CTD | PMID:19690152 |
Nfe2l2 | Rat | pipoxolan | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | pipoxolan inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 affects the localization of NFE2L2 protein] | CTD | PMID:32677756 |
Nfe2l2 | Rat | pirinixic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:16985257 |
Nfe2l2 | Rat | pirinixic acid | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | pirinixic acid results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | pirinixic acid | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of NFE2L2 mRNA | CTD | PMID:18445702 and PMID:20936131 |
Nfe2l2 | Rat | platycodin D | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | platycodin D results in increased localization of NFE2L2 protein | CTD | PMID:24854572 |
Nfe2l2 | Rat | plumbagin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA affects the reaction [plumbagin results in decreased susceptibility to tert-Butylhydroperoxide] and NFE2L2 mRNA affects the reaction [plumbagin results in increased expression of HMOX1 mRNA] | CTD | PMID:20028456 |
Nfe2l2 | Rat | plumbagin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | plumbagin affects the localization of NFE2L2 protein | CTD | PMID:20028456 |
Nfe2l2 | Rat | plumbagin | multiple interactions | EXP | | 6480464 | NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]] | CTD | PMID:20028456 |
Nfe2l2 | Rat | plumbagin | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mRNA affects the susceptibility to plumbagin | CTD | PMID:20028456 |
Nfe2l2 | Rat | poly(ethylene) | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:38180308 |
Nfe2l2 | Rat | poly(vinyl chloride) | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:38180308 |
Nfe2l2 | Rat | polysulfur | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Sulfur co-treated with metrafenone] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:35564597 |
Nfe2l2 | Rat | porphyrins | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Porphyrins results in increased expression of NFE2L2 mRNA | CTD | PMID:31385236 |
Nfe2l2 | Rat | Potassium 2,6-dihydroxytriazinecarboxylate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Hypoxanthine co-treated with potassium oxonate] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:39222901 |
Nfe2l2 | Rat | potassium dichromate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Potassium Dichromate inhibits the reaction [sodium arsenite promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] and Potassium Dichromate inhibits the reaction [sodium arsenite results in increased localization of NFE2L2 protein] | CTD | PMID:16775837 |
Nfe2l2 | Rat | potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of NFE2L2 protein | CTD | PMID:18548744 |
Nfe2l2 | Rat | potassium dichromate | multiple interactions | EXP | | 6480464 | [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:18548744 and PMID:36849043 |
Nfe2l2 | Rat | potassium dichromate | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Potassium Dichromate results in increased activity of NFE2L2 protein | CTD | PMID:17420218 |
Nfe2l2 | Rat | potassium dichromate | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Potassium Dichromate | CTD | PMID:17420218 |
Nfe2l2 | Rat | potassium dichromate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Potassium Dichromate affects the localization of and results in decreased ubiquitination of NFE2L2 protein] which results in increased expression of HMOX1 mRNA more ... | CTD | PMID:17420218 |
Nfe2l2 | Rat | potassium iodide | decreases expression | EXP | | 6480464 | Potassium Iodide results in decreased expression of NFE2L2 protein | CTD | PMID:32593569 |
Nfe2l2 | Rat | prazosin | decreases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Prazosin results in decreased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | prednisolone | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Prednisolone results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | pregnenolone | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Pregnenolone results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | pregnenolone 16alpha-carbonitrile | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | probucol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein inhibits the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]] | CTD | PMID:23942037 |
Nfe2l2 | Rat | probucol | multiple interactions | EXP | | 6480464 | NFE2L2 protein affects the reaction [Probucol inhibits the reaction [Lipopolysaccharides results in increased expression of GFAP protein]] more ... | CTD | PMID:28881715 |
Nfe2l2 | Rat | procyanidin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(1 more ... | CTD | PMID:39117098 |
Nfe2l2 | Rat | procyanidin B1 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | procyanidin B1 affects the localization of and results in increased activity of and results in increased stability of NFE2L2 protein | CTD | PMID:30544155 |
Nfe2l2 | Rat | procyanidin B1 | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | procyanidin B1 results in increased expression of NFE2L2 protein | CTD | PMID:30544155 |
Nfe2l2 | Rat | procyanidin B1 | decreases ubiquitination | ISO | NFE2L2 (Homo sapiens) | 6480464 | procyanidin B1 results in decreased ubiquitination of NFE2L2 protein | CTD | PMID:30544155 |
Nfe2l2 | Rat | procyanidin B2 | multiple interactions | EXP | | 6480464 | procyanidin B2 inhibits the reaction [Carrageenan affects the localization of NFE2L2 protein] | CTD | PMID:28844677 |
Nfe2l2 | Rat | prodigiosin | multiple interactions | EXP | | 6480464 | Prodigiosin inhibits the reaction [Aluminum Chloride results in decreased expression of NFE2L2 mRNA] | CTD | PMID:36447373 |
Nfe2l2 | Rat | progesterone | affects expression | EXP | | 6480464 | Progesterone affects the expression of NFE2L2 mRNA | CTD | PMID:24777823 |
Nfe2l2 | Rat | propacetamol | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | propacetamol affects the expression of NFE2L2 protein | CTD | PMID:29574133 |
Nfe2l2 | Rat | propacetamol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | kaempferol affects the reaction [propacetamol affects the expression of NFE2L2 protein] | CTD | PMID:29574133 |
Nfe2l2 | Rat | propiconazole | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | propiconazole results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | prostaglandin E2 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein inhibits the reaction [Dimethyl Fumarate inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]] more ... | CTD | PMID:23942037 |
Nfe2l2 | Rat | prostaglandin J2 | multiple interactions | EXP | | 6480464 | [9-deoxy-delta-9-prostaglandin D2 co-treated with alitretinoin] results in increased activity of NFE2L2 protein | CTD | PMID:15150131 |
Nfe2l2 | Rat | psoralen | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ficusin results in decreased expression of NFE2L2 protein | CTD | PMID:35597499 |
Nfe2l2 | Rat | psoralen | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 5-(3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2 more ... | CTD | PMID:35597499 |
Nfe2l2 | Rat | pterostilbene | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | pterostilbene results in increased expression of NFE2L2 protein | CTD | PMID:26700463 |
Nfe2l2 | Rat | pterostilbene | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | pterostilbene affects the localization of NFE2L2 protein | CTD | PMID:31139082 |
Nfe2l2 | Rat | pterostilbene | increases phosphorylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | pterostilbene results in increased phosphorylation of NFE2L2 protein | CTD | PMID:25341683 |
Nfe2l2 | Rat | pterostilbene | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone promotes the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein] more ... | CTD | PMID:25341683 more ... |
Nfe2l2 | Rat | pterostilbene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]] more ... | CTD | PMID:21355597 and PMID:26700463 |
Nfe2l2 | Rat | puerarin | affects localization | EXP | | 6480464 | puerarin affects the localization of NFE2L2 protein | CTD | PMID:24975872 |
Nfe2l2 | Rat | puerarin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [1-Methyl-4-phenylpyridinium co-treated with puerarin] affects the localization of NFE2L2 protein more ... | CTD | PMID:32763437 |
Nfe2l2 | Rat | puerarin | multiple interactions | EXP | | 6480464 | [1-Methyl-4-phenylpyridinium co-treated with puerarin] results in increased activity of and affects the localization of NFE2L2 protein more ... | CTD | PMID:24975872 and PMID:32763437 |
Nfe2l2 | Rat | Punicalagin | multiple interactions | EXP | | 6480464 | punicalagin inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 protein] | CTD | PMID:37806379 |
Nfe2l2 | Rat | pyocyanine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:24015256 |
Nfe2l2 | Rat | pyocyanine | increases activity | EXP | | 6480464 | Pyocyanine results in increased activity of NFE2L2 protein | CTD | PMID:27613716 |
Nfe2l2 | Rat | pyocyanine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Pyocyanine results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:24015256 |
Nfe2l2 | Rat | pyrene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [phenanthrene co-treated with fluoranthene co-treated with pyrene] results in increased expression of NFE2L2 mRNA | CTD | PMID:37888695 |
Nfe2l2 | Rat | pyrethrins | affects expression | EXP | | 6480464 | Pyrethrins affects the expression of NFE2L2 mRNA | CTD | PMID:34896426 |
Nfe2l2 | Rat | pyridaben | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | pyridaben results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | Pyridostigmine bromide | multiple interactions | EXP | | 6480464 | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:28659758 |
Nfe2l2 | Rat | pyrogallol | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Pyrogallol results in decreased expression of NFE2L2 mRNA | CTD | PMID:31967339 |
Nfe2l2 | Rat | pyrrolidine dithiocarbamate | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | pyrrolidine dithiocarbamic acid results in increased expression of NFE2L2 mRNA | CTD | PMID:15477007 |
Nfe2l2 | Rat | pyrrolidine dithiocarbamate | multiple interactions | EXP | | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 protein] | CTD | PMID:34340576 |
Nfe2l2 | Rat | pyrrolidine dithiocarbamate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of NFE2L2 mRNA | CTD | PMID:15477007 |
Nfe2l2 | Rat | quercetin | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin affects the localization of NFE2L2 protein] more ... | CTD | PMID:22056766 more ... |
Nfe2l2 | Rat | quercetin | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Quercetin affects the localization of NFE2L2 protein | CTD | PMID:17433488 more ... |
Nfe2l2 | Rat | quercetin | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Quercetin results in increased localization of NFE2L2 protein | CTD | PMID:20933534 and PMID:22996356 |
Nfe2l2 | Rat | quercetin | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Quercetin affects the localization of NFE2L2 protein | CTD | PMID:22138401 and PMID:36584933 |
Nfe2l2 | Rat | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of NFE2L2 protein | CTD | PMID:25339115 |
Nfe2l2 | Rat | quercetin | decreases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Quercetin results in decreased activity of NFE2L2 protein | CTD | PMID:22197970 |
Nfe2l2 | Rat | quercetin | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Quercetin results in increased activity of NFE2L2 protein | CTD | PMID:17462537 and PMID:22197970 |
Nfe2l2 | Rat | quercetin | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of NFE2L2 mRNA and Quercetin results in decreased expression of NFE2L2 protein | CTD | PMID:21632981 and PMID:22197970 |
Nfe2l2 | Rat | quercetin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Quercetin analog results in increased expression of NFE2L2 protein more ... | CTD | PMID:16799064 more ... |
Nfe2l2 | Rat | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of NFE2L2 protein | CTD | PMID:16303981 |
Nfe2l2 | Rat | quercetin | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Quercetin | CTD | PMID:19576171 |
Nfe2l2 | Rat | quercetin | affects localization | EXP | | 6480464 | Quercetin affects the localization of NFE2L2 protein | CTD | PMID:20554019 more ... |
Nfe2l2 | Rat | quercetin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Quercetin results in increased expression of NFE2L2 mRNA and Quercetin results in increased expression of NFE2L2 protein | CTD | PMID:23295412 more ... |
Nfe2l2 | Rat | quercetin | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Quercetin results in increased activity of NFE2L2 protein | CTD | PMID:20579867 more ... |
Nfe2l2 | Rat | quercetin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Quercetin results in increased expression of GCLC protein] more ... | CTD | PMID:21216973 more ... |
Nfe2l2 | Rat | quercetin | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in increased susceptibility to Quercetin | CTD | PMID:26445592 |
Nfe2l2 | Rat | quercetin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin affects the localization of NFE2L2 protein] more ... | CTD | PMID:17433488 more ... |
Nfe2l2 | Rat | quercetin | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to Quercetin | CTD | PMID:25896339 |
Nfe2l2 | Rat | quercetin 3-O-beta-D-galactopyranoside | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | hyperoside affects the localization of NFE2L2 protein | CTD | PMID:26772156 |
Nfe2l2 | Rat | quercetin 3-O-beta-D-glucofuranoside | multiple interactions | EXP | | 6480464 | isoquercitrin inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA] | CTD | PMID:30817903 |
Nfe2l2 | Rat | quercetin 3-O-beta-D-glucopyranoside | multiple interactions | EXP | | 6480464 | isoquercitrin inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA] | CTD | PMID:30817903 |
Nfe2l2 | Rat | quercetin 4'-O-beta-D-glucopyranoside | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein]] and spiraeoside inhibits the reaction [Glucose results in decreased expression of NFE2L2 protein] | CTD | PMID:32602595 |
Nfe2l2 | Rat | quinolin-8-ol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Oxyquinoline results in increased expression of NFE2L2 mRNA | CTD | PMID:26862668 |
Nfe2l2 | Rat | quinolinic acid | multiple interactions | EXP | | 6480464 | Quinolinic Acid results in increased activity of and affects the localization of NFE2L2 protein | CTD | PMID:30876764 |
Nfe2l2 | Rat | quinoxyfen | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Sulfur co-treated with quinoxyfen co-treated with dimethomorph] results in decreased expression of NFE2L2 mRNA and [Sulfur co-treated with quinoxyfen] results in increased expression of NFE2L2 mRNA | CTD | PMID:35564597 |
Nfe2l2 | Rat | rac-1,2-dichloropropane | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 results in increased susceptibility to propylene dichloride | CTD | PMID:37326970 |
Nfe2l2 | Rat | rac-1,2-dichloropropane | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form inhibits the reaction [propylene dichloride results in increased expression of G6PD2 mRNA] more ... | CTD | PMID:37326970 |
Nfe2l2 | Rat | radon atom | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Radon results in increased expression of NFE2L2 protein | CTD | PMID:33107683 |
Nfe2l2 | Rat | radon(0) | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Radon results in increased expression of NFE2L2 protein | CTD | PMID:33107683 |
Nfe2l2 | Rat | ranitidine | multiple interactions | EXP | | 6480464 | Ranitidine inhibits the reaction [Indomethacin results in decreased expression of NFE2L2 mRNA] | CTD | PMID:28648817 |
Nfe2l2 | Rat | raspberry ketone | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | raspberry ketone affects the expression of NFE2L2 mRNA | CTD | PMID:36460224 |
Nfe2l2 | Rat | reactive oxygen species | decreases expression | EXP | | 6480464 | Reactive Oxygen Species results in decreased expression of NFE2L2 mRNA | CTD | PMID:29085557 |
Nfe2l2 | Rat | reactive oxygen species | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Reactive Oxygen Species results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | reactive oxygen species | multiple interactions | EXP | | 6480464 | [Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [manganese chloride promotes the reaction [NFE2L2 protein binds to HMOX1 promoter]] more ... | CTD | PMID:21384399 more ... |
Nfe2l2 | Rat | reactive oxygen species | affects abundance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the abundance of Reactive Oxygen Species | CTD | PMID:17420218 |
Nfe2l2 | Rat | reactive oxygen species | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [MAP3K7 protein results in increased expression of NFE2L2 protein] which results in decreased abundance of Reactive Oxygen Species more ... | CTD | PMID:17420218 more ... |
Nfe2l2 | Rat | reactive oxygen species | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Reactive Oxygen Species results in increased expression of NFE2L2 mRNA | CTD | PMID:25800948 |
Nfe2l2 | Rat | reactive oxygen species | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [[[Glutathione deficiency results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] which results in increased abundance of Glutathione more ... | CTD | PMID:19234301 more ... |
Nfe2l2 | Rat | rebaudioside A | multiple interactions | EXP | | 6480464 | rebaudioside A inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 protein] | CTD | PMID:30883860 |
Nfe2l2 | Rat | reserpine | decreases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Reserpine results in decreased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | resolvin D1 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | resolvin D1 analog inhibits the reaction [Paraquat affects the localization of NFE2L2 protein] more ... | CTD | PMID:30562684 and PMID:30571954 |
Nfe2l2 | Rat | resolvin D1 | multiple interactions | EXP | | 6480464 | resolvin D1 inhibits the reaction [Cadmium Chloride results in increased activity of NFE2L2 protein] and resolvin D1 inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased activity of NFE2L2 protein] | CTD | PMID:34405727 |
Nfe2l2 | Rat | resorcinol | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | resorcinol results in decreased expression of NFE2L2 mRNA | CTD | PMID:31967339 |
Nfe2l2 | Rat | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NFE2L2 mRNA and resveratrol results in increased expression of NFE2L2 protein | CTD | PMID:18616940 more ... |
Nfe2l2 | Rat | resveratrol | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Resveratrol affects the localization of NFE2L2 protein | CTD | PMID:36584933 |
Nfe2l2 | Rat | resveratrol | decreases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Resveratrol results in decreased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | resveratrol | affects localization | EXP | | 6480464 | resveratrol affects the localization of NFE2L2 protein | CTD | PMID:20486211 and PMID:22627169 |
Nfe2l2 | Rat | resveratrol | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | resveratrol results in increased activity of NFE2L2 protein | CTD | PMID:16322078 more ... |
Nfe2l2 | Rat | resveratrol | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | resveratrol results in decreased expression of NFE2L2 mRNA | CTD | PMID:25667456 |
Nfe2l2 | Rat | resveratrol | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | resveratrol affects the localization of NFE2L2 protein | CTD | PMID:22917016 and PMID:23829535 |
Nfe2l2 | Rat | resveratrol | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to resveratrol | CTD | PMID:20418481 |
Nfe2l2 | Rat | resveratrol | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Resveratrol | CTD | PMID:20418481 and PMID:30844440 |
Nfe2l2 | Rat | resveratrol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Resveratrol results in increased expression of NFE2L2 mRNA and Resveratrol results in increased expression of NFE2L2 protein | CTD | PMID:20060927 more ... |
Nfe2l2 | Rat | resveratrol | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | resveratrol results in increased activity of NFE2L2 promoter and resveratrol results in increased activity of NFE2L2 protein | CTD | PMID:20418481 more ... |
Nfe2l2 | Rat | resveratrol | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Resveratrol co-treated with 3 more ... | CTD | PMID:16322078 more ... |
Nfe2l2 | Rat | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NFE2L2 protein | CTD | PMID:22610192 |
Nfe2l2 | Rat | resveratrol | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Resveratrol results in decreased expression of NFE2L2 mRNA and Resveratrol results in decreased expression of NFE2L2 protein | CTD | PMID:22610192 |
Nfe2l2 | Rat | resveratrol | decreases methylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | resveratrol results in decreased methylation of NFE2L2 promoter | CTD | PMID:24894866 |
Nfe2l2 | Rat | resveratrol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Doxorubicin co-treated with Resveratrol] results in decreased expression of NFE2L2 protein more ... | CTD | PMID:16948474 more ... |
Nfe2l2 | Rat | resveratrol | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol affects the localization of NFE2L2 protein] more ... | CTD | PMID:15882976 more ... |
Nfe2l2 | Rat | Rhynchophylline | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | rhyncophylline inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein] | CTD | PMID:33838153 |
Nfe2l2 | Rat | rifampicin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Rifampin results in increased expression of NFE2L2 protein | CTD | PMID:31678598 |
Nfe2l2 | Rat | rifampicin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Rifampin inhibits the reaction [arsenite results in increased activity of NFE2L2 protein] | CTD | PMID:33412187 |
Nfe2l2 | Rat | rifampicin | decreases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Rifampin results in decreased activity of NFE2L2 protein | CTD | PMID:33412187 |
Nfe2l2 | Rat | rifampicin | multiple interactions | EXP | | 6480464 | [tanshinone co-treated with Rifampin] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:33307820 |
Nfe2l2 | Rat | rifampicin | decreases expression | EXP | | 6480464 | Rifampin results in decreased expression of NFE2L2 mRNA and Rifampin results in decreased expression of NFE2L2 protein | CTD | PMID:33307820 |
Nfe2l2 | Rat | rimonabant | increases expression | EXP | | 6480464 | Rimonabant results in increased expression of NFE2L2 mRNA | CTD | PMID:30365523 |
Nfe2l2 | Rat | ritonavir | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein mutant form inhibits the reaction [Ritonavir results in increased expression of HMOX1 mRNA] | CTD | PMID:26968795 |
Nfe2l2 | Rat | ritonavir | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ritonavir results in increased expression of NFE2L2 protein | CTD | PMID:26968795 |
Nfe2l2 | Rat | roflumilast | multiple interactions | EXP | | 6480464 | [Roflumilast co-treated with Rotenone] results in increased expression of and results in increased localization of NFE2L2 protein and Roflumilast promotes the reaction [Cisplatin results in increased expression of NFE2L2 mRNA] | CTD | PMID:33757793 and PMID:37105514 |
Nfe2l2 | Rat | roflumilast | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Roflumilast results in increased expression of NFE2L2 mRNA | CTD | PMID:33757793 |
Nfe2l2 | Rat | roflumilast | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Cisplatin promotes the reaction [Roflumilast results in increased expression of NFE2L2 mRNA] and Roflumilast promotes the reaction [Cisplatin results in increased expression of NFE2L2 mRNA] | CTD | PMID:33757793 |
Nfe2l2 | Rat | rosmarinic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Rosmarinic Acid results in increased expression of NFE2L2 mRNA and Rosmarinic Acid results in increased expression of NFE2L2 protein | CTD | PMID:31610155 |
Nfe2l2 | Rat | rosmarinic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [lead acetate results in increased abundance of Lead] inhibits the reaction [Rosmarinic Acid results in increased expression of NFE2L2 protein] more ... | CTD | PMID:31610155 and PMID:33476690 |
Nfe2l2 | Rat | rosuvastatin calcium | multiple interactions | EXP | | 6480464 | Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 mRNA] | CTD | PMID:32007421 and PMID:35130744 |
Nfe2l2 | Rat | rotenone | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in decreased susceptibility to Rotenone | CTD | PMID:17360324 |
Nfe2l2 | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of NFE2L2 protein | CTD | PMID:37224993 |
Nfe2l2 | Rat | rotenone | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Rotenone results in decreased expression of NFE2L2 protein | CTD | PMID:34391968 |
Nfe2l2 | Rat | rotenone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Rotenone results in increased expression of NFE2L2 mRNA | CTD | PMID:36586010 |
Nfe2l2 | Rat | rotenone | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Rotenone | CTD | PMID:36400285 |
Nfe2l2 | Rat | rotenone | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of NFE2L2 mRNA | CTD | PMID:29955902 and PMID:33512557 |
Nfe2l2 | Rat | rotenone | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Rotenone results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | rotenone | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Rotenone affects the localization of NFE2L2 protein | CTD | PMID:28245986 |
Nfe2l2 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of NFE2L2 protein | CTD | PMID:25446674 |
Nfe2l2 | Rat | rotenone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:24374061 and PMID:28245986 |
Nfe2l2 | Rat | rotenone | increases activity | EXP | | 6480464 | Rotenone results in increased activity of NFE2L2 protein | CTD | PMID:27016191 |
Nfe2l2 | Rat | rotenone | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:25446674 more ... |
Nfe2l2 | Rat | rotenone | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Rotenone results in increased expression of NFE2L2 mRNA | CTD | PMID:23186747 and PMID:30207190 |
Nfe2l2 | Rat | rotenone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Rotenone] which affects the expression of GFAP mRNA more ... | CTD | PMID:18325346 more ... |
Nfe2l2 | Rat | rotenone | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to Rotenone | CTD | PMID:12842875 |
Nfe2l2 | Rat | rotenone | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to Rotenone | CTD | PMID:12842875 |
Nfe2l2 | Rat | rottlerin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | rottlerin inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] more ... | CTD | PMID:18048804 more ... |
Nfe2l2 | Rat | rottlerin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin affects the localization of and results in increased activity of NFE2L2 protein]] more ... | CTD | PMID:25895139 more ... |
Nfe2l2 | Rat | rottlerin | multiple interactions | EXP | | 6480464 | rottlerin inhibits the reaction [naringin affects the localization of NFE2L2 protein] | CTD | PMID:25773745 |
Nfe2l2 | Rat | royal jelly | multiple interactions | EXP | | 6480464 | royal jelly inhibits the reaction [Fluorides results in decreased expression of NFE2L2 protein] | CTD | PMID:34227456 |
Nfe2l2 | Rat | Ruscogenin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [ruscogenin inhibits the reaction [IL1B protein results in increased expression of MMP1 protein]] more ... | CTD | PMID:38122922 |
Nfe2l2 | Rat | Rutecarpine | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | rutecarpine results in increased expression of NFE2L2 mRNA | CTD | PMID:34955744 |
Nfe2l2 | Rat | rutin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Rutin promotes the reaction [Carbon Tetrachloride results in increased expression of NFE2L2 protein] | CTD | PMID:22902988 |
Nfe2l2 | Rat | rutin | multiple interactions | EXP | | 6480464 | [Rutin co-treated with Chitosan] inhibits the reaction [Cyclophosphamide results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:31412289 more ... |
Nfe2l2 | Rat | S-adenosyl-L-methioninate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [S-Adenosylmethionine co-treated with Arsenic] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:20146260 and PMID:35490796 |
Nfe2l2 | Rat | S-adenosyl-L-methionine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [S-Adenosylmethionine co-treated with Arsenic] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:20146260 and PMID:35490796 |
Nfe2l2 | Rat | S-allylcysteine | multiple interactions | EXP | | 6480464 | S-allylcysteine promotes the reaction [Potassium Dichromate results in increased expression of NFE2L2 protein] | CTD | PMID:18548744 |
Nfe2l2 | Rat | S-allylcysteine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | S-allylcysteine inhibits the reaction [hydroquinone results in increased expression of NFE2L2 protein] | CTD | PMID:32141582 |
Nfe2l2 | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Buthionine Sulfoximine results in decreased abundance of Glutathione] which affects the localization of NFE2L2 protein] more ... | CTD | PMID:19608619 more ... |
Nfe2l2 | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | EXP | | 6480464 | Buthionine Sulfoximine results in increased expression of NFE2L2 protein | CTD | PMID:23876469 |
Nfe2l2 | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | EXP | | 6480464 | [Buthionine Sulfoximine co-treated with sulforaphane] affects the expression of and affects the localization of NFE2L2 protein more ... | CTD | PMID:23585199 more ... |
Nfe2l2 | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Buthionine Sulfoximine affects the expression of NFE2L2 protein | CTD | PMID:20934533 |
Nfe2l2 | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Buthionine Sulfoximine results in increased expression of NFE2L2 mRNA | CTD | PMID:17980396 and PMID:34036678 |
Nfe2l2 | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [6-formylindolo(3 more ... | CTD | PMID:17980396 more ... |
Nfe2l2 | Rat | sabinene | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFE2L2 mRNA | CTD | PMID:38000518 |
Nfe2l2 | Rat | Salinomycin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | salinomycin inhibits the reaction [[Hypoxanthine co-treated with potassium oxonate] results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:39222901 |
Nfe2l2 | Rat | salvianolic acid B | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [salvianolic acid B inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]] more ... | CTD | PMID:24991814 and PMID:33952797 |
Nfe2l2 | Rat | salvianolic acid B | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA] and salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein] | CTD | PMID:38272317 |
Nfe2l2 | Rat | salvianolic acid B | multiple interactions | EXP | | 6480464 | salvianolic acid B inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 protein] | CTD | PMID:33952797 |
Nfe2l2 | Rat | salvianolic acid B | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | salvianolic acid B results in increased expression of NFE2L2 protein | CTD | PMID:24991814 |
Nfe2l2 | Rat | saxagliptin | multiple interactions | EXP | | 6480464 | saxagliptin inhibits the reaction [Rotenone results in increased expression of NFE2L2 protein] more ... | CTD | PMID:25446674 and PMID:31629700 |
Nfe2l2 | Rat | saxagliptin | increases expression | EXP | | 6480464 | saxagliptin results in increased expression of NFE2L2 protein | CTD | PMID:25446674 |
Nfe2l2 | Rat | SB 203580 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [SB 203580 inhibits the reaction [Quercetin affects the localization of NFE2L2 protein]] more ... | CTD | PMID:17433488 more ... |
Nfe2l2 | Rat | SB 203580 | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [aureusidin affects the localization of NFE2L2 protein] more ... | CTD | PMID:17640564 more ... |
Nfe2l2 | Rat | SB 203580 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | SB 203580 affects the reaction [[NFE2L2 protein affects the susceptibility to sodium arsenite] affects the reaction [[CSF1R protein co-treated with TNFSF11 protein] affects the expression of ATP6V0D2 mRNA]] more ... | CTD | PMID:22488045 more ... |
Nfe2l2 | Rat | SB 431542 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 |
Nfe2l2 | Rat | SCH 23390 | multiple interactions | EXP | | 6480464 | SCH 23390 inhibits the reaction [Methamphetamine affects the localization of NFE2L2 protein] and SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of NFE2L2 mRNA] | CTD | PMID:19564919 |
Nfe2l2 | Rat | SCH772984 | multiple interactions | EXP | | 6480464 | SCH772984 inhibits the reaction [diphenylarsinic acid results in increased expression of NFE2L2 protein] | CTD | PMID:28087833 |
Nfe2l2 | Rat | scopolamine | multiple interactions | EXP | | 6480464 | Galantamine inhibits the reaction [Scopolamine results in decreased expression of NFE2L2 protein] and intybin inhibits the reaction [Scopolamine results in decreased expression of NFE2L2 protein] | CTD | PMID:27346436 |
Nfe2l2 | Rat | scopolamine | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Scopolamine results in decreased expression of NFE2L2 protein | CTD | PMID:32001261 |
Nfe2l2 | Rat | scopolamine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 7-fluoro-1 and 3-diphenylisoquinoline-1-amine inhibits the reaction [Scopolamine results in decreased expression of NFE2L2 protein] | CTD | PMID:32001261 |
Nfe2l2 | Rat | scopolamine | decreases expression | EXP | | 6480464 | Scopolamine results in decreased expression of NFE2L2 protein | CTD | PMID:27346436 |
Nfe2l2 | Rat | scutellarin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | scutellarin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 mRNA] and scutellarin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein] | CTD | PMID:34610774 |
Nfe2l2 | Rat | sebacic acid | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | sebacic acid results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | selenium atom | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Selenium results in decreased expression of NFE2L2 mRNA | CTD | PMID:19244175 |
Nfe2l2 | Rat | selenium atom | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased expression of NFE2L2 protein and [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | CTD | PMID:32233808 and PMID:37415728 |
Nfe2l2 | Rat | selenium atom | affects activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Selenium affects the activity of NFE2L2 protein | CTD | PMID:18279678 |
Nfe2l2 | Rat | selenium atom | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Selenium affects the activity of HMOX1 protein] | CTD | PMID:18279678 |
Nfe2l2 | Rat | selenium atom | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of NFE2L2 mRNA | CTD | PMID:19244175 |
Nfe2l2 | Rat | selenocystine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mutant form inhibits the reaction [selenocystine results in increased expression of GCLC mRNA] more ... | CTD | PMID:22807314 |
Nfe2l2 | Rat | selenocystine | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | selenocystine affects the localization of NFE2L2 protein | CTD | PMID:22807314 |
Nfe2l2 | Rat | selenomethionine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Selenomethionine inhibits the reaction [deoxynivalenol results in increased expression of NFE2L2 protein] | CTD | PMID:38040082 |
Nfe2l2 | Rat | sertraline | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Sertraline results in increased expression of NFE2L2 mRNA | CTD | PMID:24865413 |
Nfe2l2 | Rat | sesquiterpene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Sesquiterpenes analog results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:30672058 |
Nfe2l2 | Rat | sesquiterpene | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein promotes the reaction [Sesquiterpenes analog results in increased expression of HMOX1 protein] and Sesquiterpenes analog results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:30672058 |
Nfe2l2 | Rat | sevoflurane | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Sevoflurane affects the localization of NFE2L2 protein | CTD | PMID:35430185 |
Nfe2l2 | Rat | sevoflurane | multiple interactions | EXP | | 6480464 | 6 more ... | CTD | PMID:37041698 and PMID:37494465 |
Nfe2l2 | Rat | sevoflurane | decreases expression | EXP | | 6480464 | Sevoflurane results in decreased expression of NFE2L2 mRNA and Sevoflurane results in decreased expression of NFE2L2 protein | CTD | PMID:37041698 and PMID:37494465 |
Nfe2l2 | Rat | sevoflurane | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | MAF1 protein affects the reaction [Sevoflurane affects the localization of NFE2L2 protein] | CTD | PMID:35430185 |
Nfe2l2 | Rat | Shikonin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | shikonin inhibits the reaction [Benzene results in increased expression of and affects the localization of NFE2L2 protein] | CTD | PMID:36306860 |
Nfe2l2 | Rat | silibinin | multiple interactions | EXP | | 6480464 | Silybin inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2] | CTD | PMID:24062023 |
Nfe2l2 | Rat | silicon atom | multiple interactions | EXP | | 6480464 | Silicon inhibits the reaction [aluminum nitrate results in decreased expression of NFE2L2 mRNA] | CTD | PMID:29886234 |
Nfe2l2 | Rat | silicon atom | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Silicon results in decreased expression of NFE2L2 protein | CTD | PMID:34252510 |
Nfe2l2 | Rat | silicon atom | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Thioctic Acid inhibits the reaction [Silicon results in decreased expression of NFE2L2 protein] | CTD | PMID:34252510 |
Nfe2l2 | Rat | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of NFE2L2 mRNA | CTD | PMID:21602193 |
Nfe2l2 | Rat | silicon dioxide | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of NFE2L2 mRNA and Silicon Dioxide results in decreased expression of NFE2L2 protein | CTD | PMID:32017981 |
Nfe2l2 | Rat | silicon dioxide | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Silicon Dioxide results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | silicon dioxide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of NFE2L2 mRNA and Silicon Dioxide results in increased expression of NFE2L2 protein | CTD | PMID:30698894 and PMID:38403151 |
Nfe2l2 | Rat | silicon dioxide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Silicon Dioxide co-treated with Vitamin D] results in increased expression of NFE2L2 protein more ... | CTD | PMID:30698894 and PMID:32017981 |
Nfe2l2 | Rat | silicon dioxide | increases activity | EXP | | 6480464 | Silicon Dioxide results in increased activity of NFE2L2 protein | CTD | PMID:23973437 |
Nfe2l2 | Rat | silicon dioxide | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Silicon Dioxide results in increased expression of NFE2L2 protein | CTD | PMID:22985735 more ... |
Nfe2l2 | Rat | silicon dioxide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Silicon Dioxide co-treated with Vitamin D] results in increased expression of NFE2L2 protein more ... | CTD | PMID:19602432 more ... |
Nfe2l2 | Rat | silver atom | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Silver results in increased activity of NFE2L2 promoter and Silver results in increased activity of NFE2L2 protein | CTD | PMID:21643505 and PMID:23872425 |
Nfe2l2 | Rat | silver atom | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Silver | CTD | PMID:22546375 |
Nfe2l2 | Rat | silver atom | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Silver analog results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:22036727 more ... |
Nfe2l2 | Rat | silver atom | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [NFE2L2 protein affects the reaction [Silver results in increased abundance of Reactive Oxygen Species]] more ... | CTD | PMID:22036727 more ... |
Nfe2l2 | Rat | silver(0) | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Silver results in increased activity of NFE2L2 promoter and Silver results in increased activity of NFE2L2 protein | CTD | PMID:21643505 and PMID:23872425 |
Nfe2l2 | Rat | silver(0) | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to Silver | CTD | PMID:22546375 |
Nfe2l2 | Rat | silver(0) | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Silver analog results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:22036727 more ... |
Nfe2l2 | Rat | silver(0) | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [NFE2L2 protein affects the reaction [Silver results in increased abundance of Reactive Oxygen Species]] more ... | CTD | PMID:22036727 more ... |
Nfe2l2 | Rat | silver(1+) nitrate | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Silver Nitrate results in decreased expression of NFE2L2 mRNA | CTD | PMID:19733233 |
Nfe2l2 | Rat | silver(1+) nitrate | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Silver Nitrate results in increased activity of NFE2L2 protein | CTD | PMID:23872425 |
Nfe2l2 | Rat | simvastatin | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Simvastatin results in increased localization of NFE2L2 protein | CTD | PMID:17928392 |
Nfe2l2 | Rat | simvastatin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Simvastatin results in increased expression of NFE2L2 mRNA | CTD | PMID:30513525 |
Nfe2l2 | Rat | simvastatin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Simvastatin results in increased expression of NFE2L2 mRNA | CTD | PMID:30513525 |
Nfe2l2 | Rat | simvastatin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | MAPK1 promotes the reaction [Simvastatin results in increased expression of NFE2L2 mRNA] and Simvastatin results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:30513525 |
Nfe2l2 | Rat | simvastatin | increases localization | EXP | | 6480464 | Simvastatin results in increased localization of NFE2L2 protein | CTD | PMID:18787804 |
Nfe2l2 | Rat | simvastatin | multiple interactions | EXP | | 6480464 | Mevalonic Acid affects the reaction [Simvastatin results in increased localization of NFE2L2 protein] | CTD | PMID:18787804 |
Nfe2l2 | Rat | simvastatin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 mutant form inhibits the reaction [Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 mRNA]] | CTD | PMID:17928392 |
Nfe2l2 | Rat | sinapic acid | multiple interactions | EXP | | 6480464 | sinapinic acid inhibits the reaction [lead acetate results in decreased expression of NFE2L2 mRNA] and sinapinic acid inhibits the reaction [Vancomycin results in decreased expression of NFE2L2 mRNA] | CTD | PMID:37471654 and PMID:39059777 |
Nfe2l2 | Rat | Siomycin A | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | siomycin A inhibits the reaction [HRAS protein mutant form results in increased expression of NFE2L2 protein] | CTD | PMID:27517622 |
Nfe2l2 | Rat | sirolimus | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Sirolimus results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | sirolimus | multiple interactions | EXP | | 6480464 | NFE2L2 protein promotes the reaction [Sirolimus inhibits the reaction [Paraquat results in decreased expression of CDH1 protein]] more ... | CTD | PMID:28624451 |
Nfe2l2 | Rat | sirtinol | multiple interactions | EXP | | 6480464 | sirtinol inhibits the reaction [resveratrol results in increased expression of NFE2L2 protein] | CTD | PMID:24395567 |
Nfe2l2 | Rat | SL-327 | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | SL 327 inhibits the reaction [Melatonin inhibits the reaction [KL mutant form affects the localization of and results in decreased activity of NFE2L2 protein]] | CTD | PMID:25550330 |
Nfe2l2 | Rat | sodium arsenate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which affects the localization of NFE2L2 protein more ... | CTD | PMID:32525701 and PMID:33434570 |
Nfe2l2 | Rat | sodium arsenate | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of NFE2L2 mRNA | CTD | PMID:30503583 |
Nfe2l2 | Rat | sodium arsenate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ellagic Acid inhibits the reaction [sodium arsenate results in decreased expression of NFE2L2 mRNA] and ferulic acid inhibits the reaction [sodium arsenate results in decreased expression of NFE2L2 mRNA] | CTD | PMID:30503583 |
Nfe2l2 | Rat | sodium arsenate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of NFE2L2 protein | CTD | PMID:12745069 |
Nfe2l2 | Rat | sodium arsenite | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite affects the localization of NFE2L2 protein] more ... | CTD | PMID:10874044 more ... |
Nfe2l2 | Rat | sodium arsenite | increases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in increased susceptibility to sodium arsenite | CTD | PMID:27286880 |
Nfe2l2 | Rat | sodium arsenite | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | sodium arsenite results in increased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | sodium arsenite | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in increased susceptibility to sodium arsenite | CTD | PMID:29108910 |
Nfe2l2 | Rat | sodium arsenite | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of NFE2L2 protein | CTD | PMID:27459794 |
Nfe2l2 | Rat | sodium arsenite | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | sodium arsenite affects the localization of NFE2L2 protein | CTD | PMID:27723467 and PMID:28237703 |
Nfe2l2 | Rat | sodium arsenite | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of NFE2L2 mRNA | CTD | PMID:19822182 and PMID:33242462 |
Nfe2l2 | Rat | sodium arsenite | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to sodium arsenite | CTD | PMID:20932822 |
Nfe2l2 | Rat | sodium arsenite | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] which co-treated with biochanin A] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:16785233 more ... |
Nfe2l2 | Rat | sodium arsenite | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to sodium arsenite and NFE2L2 protein affects the susceptibility to sodium arsenite | CTD | PMID:19303893 and PMID:30742845 |
Nfe2l2 | Rat | sodium arsenite | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | sodium arsenite results in increased localization of NFE2L2 protein | CTD | PMID:16775837 |
Nfe2l2 | Rat | sodium arsenite | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of NFE2L2 mRNA and sodium arsenite results in increased expression of NFE2L2 protein | CTD | PMID:18417180 more ... |
Nfe2l2 | Rat | sodium arsenite | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | sodium arsenite results in increased activity of NFE2L2 promoter and sodium arsenite results in increased activity of NFE2L2 protein | CTD | PMID:12220541 more ... |
Nfe2l2 | Rat | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of NFE2L2 mRNA and sodium arsenite results in increased expression of NFE2L2 protein | CTD | PMID:19933942 more ... |
Nfe2l2 | Rat | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of NFE2L2 more ... | CTD | PMID:20699118 more ... |
Nfe2l2 | Rat | sodium arsenite | multiple interactions | EXP | | 6480464 | [lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of NFE2L2 protein more ... | CTD | PMID:24062023 more ... |
Nfe2l2 | Rat | sodium arsenite | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of NFE2L2 mRNA and sodium arsenite results in increased expression of NFE2L2 protein | CTD | PMID:12745069 more ... |
Nfe2l2 | Rat | sodium arsenite | decreases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 gene mutant form results in decreased susceptibility to sodium arsenite and NFE2L2 protein results in decreased susceptibility to sodium arsenite | CTD | PMID:17765279 and PMID:32682831 |
Nfe2l2 | Rat | sodium arsenite | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 gene SNP affects the susceptibility to sodium arsenite | CTD | PMID:26039680 |
Nfe2l2 | Rat | sodium arsenite | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | sodium arsenite affects the localization of NFE2L2 protein | CTD | PMID:16959797 and PMID:26291278 |
Nfe2l2 | Rat | sodium cholate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Cholesterol more ... | CTD | PMID:27394961 |
Nfe2l2 | Rat | sodium dichromate | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | sodium bichromate results in decreased expression of NFE2L2 mRNA | CTD | PMID:22155349 |
Nfe2l2 | Rat | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of NFE2L2 mRNA | CTD | PMID:22561333 |
Nfe2l2 | Rat | sodium dichromate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | sodium bichromate results in increased expression of NFE2L2 mRNA | CTD | PMID:22155349 |
Nfe2l2 | Rat | sodium fluoride | affects expression | EXP | | 6480464 | Sodium Fluoride affects the expression of NFE2L2 mRNA | CTD | PMID:25132241 |
Nfe2l2 | Rat | sodium fluoride | increases expression | EXP | | 6480464 | Sodium Fluoride results in increased expression of NFE2L2 mRNA | CTD | PMID:36736877 |
Nfe2l2 | Rat | sodium fluoride | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased ubiquitination of and results in increased stability of NFE2L2 protein | CTD | PMID:37694959 |
Nfe2l2 | Rat | sodium fluoride | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of NFE2L2 protein | CTD | PMID:37694959 |
Nfe2l2 | Rat | sodium fluoride | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Sodium Fluoride results in decreased expression of NFE2L2 mRNA and Sodium Fluoride results in decreased expression of NFE2L2 protein | CTD | PMID:38342390 |
Nfe2l2 | Rat | sodium fluoride | decreases expression | EXP | | 6480464 | Sodium Fluoride results in decreased expression of NFE2L2 mRNA | CTD | PMID:29758312 and PMID:30633982 |
Nfe2l2 | Rat | sodium fluoride | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Sodium Fluoride affects the localization of NFE2L2 protein] more ... | CTD | PMID:29758312 more ... |
Nfe2l2 | Rat | sodium fluoride | affects localization | EXP | | 6480464 | Sodium Fluoride affects the localization of NFE2L2 protein | CTD | PMID:30633982 |
Nfe2l2 | Rat | sodium fluoride | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Sodium Fluoride results in increased expression of NFE2L2 mRNA | CTD | PMID:28012895 |
Nfe2l2 | Rat | sodium fluoride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | protocatechuic acid methyl ester inhibits the reaction [Sodium Fluoride results in increased expression of NFE2L2 mRNA] | CTD | PMID:28012895 |
Nfe2l2 | Rat | Sodium oleate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [triclocarban co-treated with osteum] results in increased expression of NFE2L2 mRNA | CTD | PMID:38631510 |
Nfe2l2 | Rat | sodium selenide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | sodium selenide inhibits the reaction [Mercuric Chloride promotes the reaction [Lipopolysaccharides results in increased expression of NFE2L2 protein]] and sodium selenide inhibits the reaction [Mercuric Chloride results in increased expression of NFE2L2 protein] | CTD | PMID:17959236 |
Nfe2l2 | Rat | sodium sulfide (anhydrous) | multiple interactions | EXP | | 6480464 | NFE2L2 protein affects the reaction [[sodium sulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Paraquat results in decreased expression of SIRT3 protein]] | CTD | PMID:32064027 |
Nfe2l2 | Rat | solanesol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | solanesol affects the localization of and results in increased activity of NFE2L2 protein more ... | CTD | PMID:25645596 and PMID:37586544 |
Nfe2l2 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of NFE2L2 mRNA | CTD | PMID:19281266 |
Nfe2l2 | Rat | spathulenol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of NFE2L2 mRNA | CTD | PMID:38000518 |
Nfe2l2 | Rat | spermidine | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Spermidine affects the localization of NFE2L2 protein | CTD | PMID:12763045 |
Nfe2l2 | Rat | spermine | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Spermine affects the localization of NFE2L2 protein | CTD | PMID:12763045 |
Nfe2l2 | Rat | spironolactone | multiple interactions | EXP | | 6480464 | Spironolactone inhibits the reaction [Aldosterone results in increased activity of NFE2L2 protein] | CTD | PMID:25204689 |
Nfe2l2 | Rat | staurosporine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Staurosporine inhibits the reaction [Ethanol affects the localization of NFE2L2 protein] and Staurosporine inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein] | CTD | PMID:22530035 and PMID:30703377 |
Nfe2l2 | Rat | staurosporine | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Staurosporine results in decreased expression of NFE2L2 protein modified form | CTD | PMID:30703377 |
Nfe2l2 | Rat | sterigmatocystin | decreases expression | EXP | | 6480464 | Sterigmatocystin results in decreased expression of NFE2L2 mRNA | CTD | PMID:34126181 |
Nfe2l2 | Rat | streptozocin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:20086057 more ... |
Nfe2l2 | Rat | streptozocin | increases expression | ISO | Nfe2l2 (Mus musculus) | 156430337 | streptozocin increases expression of Nfe2l2 protein in heart | RGD | |
Nfe2l2 | Rat | streptozocin | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Streptozocin results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of NFE2L2 mRNA and Streptozocin results in decreased expression of NFE2L2 protein | CTD | PMID:22790776 more ... |
Nfe2l2 | Rat | streptozocin | affects localization | EXP | | 6480464 | Streptozocin affects the localization of NFE2L2 protein | CTD | PMID:21799698 more ... |
Nfe2l2 | Rat | streptozocin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Streptozocin results in increased expression of NFE2L2 mRNA | CTD | PMID:23319174 |
Nfe2l2 | Rat | streptozocin | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Streptozocin | CTD | PMID:20086057 |
Nfe2l2 | Rat | streptozocin | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Streptozocin results in decreased expression of NFE2L2 mRNA and Streptozocin results in decreased expression of NFE2L2 protein | CTD | PMID:24967692 and PMID:26700463 |
Nfe2l2 | Rat | streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of NFE2L2 mRNA and Streptozocin results in increased expression of NFE2L2 protein | CTD | PMID:20399799 and PMID:30817903 |
Nfe2l2 | Rat | streptozocin | multiple interactions | EXP | | 6480464 | 2-tert-butylhydroquinone inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:20399799 more ... |
Nfe2l2 | Rat | succimer | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFE2L2 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NFE2L2 mRNA | CTD | PMID:21641980 and PMID:26378955 |
Nfe2l2 | Rat | succimer | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFE2L2 mRNA | CTD | PMID:26378955 |
Nfe2l2 | Rat | sulfaphenazole | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Sulfaphenazole affects the reaction [nimesulide affects the localization of NFE2L2 protein] | CTD | PMID:20405857 |
Nfe2l2 | Rat | sulfasalazine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Sulfasalazine results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased localization of NFE2L2 protein and Acetylcysteine inhibits the reaction [[Sulfasalazine results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased localization of NFE2L2 protein] | CTD | PMID:19234301 |
Nfe2l2 | Rat | sulfasalazine | multiple interactions | EXP | | 6480464 | NFE2L2 protein promotes the reaction [Sulfasalazine results in increased expression of HMOX1 mRNA] more ... | CTD | PMID:19234301 and PMID:31428839 |
Nfe2l2 | Rat | sulfluramid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | sulfluramid results in increased expression of NFE2L2 mRNA | CTD | PMID:35337807 |
Nfe2l2 | Rat | sulforaphane | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein] more ... | CTD | PMID:19303893 more ... |
Nfe2l2 | Rat | sulforaphane | decreases expression | EXP | | 6480464 | sulforaphane results in decreased expression of NFE2L2 protein | CTD | PMID:37385402 |
Nfe2l2 | Rat | sulforaphane | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | sulforaphane results in increased activity of NFE2L2 protein | CTD | PMID:26454883 |
Nfe2l2 | Rat | sulforaphane | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | sulforaphane results in increased activity of NFE2L2 protein | CTD | PMID:19715681 more ... |
Nfe2l2 | Rat | sulforaphane | increases expression | EXP | | 6480464 | sulforaphane results in increased expression of NFE2L2 protein | CTD | PMID:20237067 more ... |
Nfe2l2 | Rat | sulforaphane | increases activity | EXP | | 6480464 | sulforaphane results in increased activity of NFE2L2 protein | CTD | PMID:20237067 more ... |
Nfe2l2 | Rat | sulforaphane | affects localization | EXP | | 6480464 | sulforaphane affects the localization of NFE2L2 protein | CTD | PMID:19071154 more ... |
Nfe2l2 | Rat | sulforaphane | decreases phosphorylation | EXP | | 6480464 | sulforaphane results in decreased phosphorylation of NFE2L2 protein | CTD | PMID:22558124 |
Nfe2l2 | Rat | sulforaphane | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein] more ... | CTD | PMID:20237067 more ... |
Nfe2l2 | Rat | sulforaphane | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | sulforaphane results in increased expression of NFE2L2 more ... | CTD | PMID:21177068 more ... |
Nfe2l2 | Rat | sulforaphane | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | sulforaphane results in increased expression of NFE2L2 mRNA and sulforaphane results in increased expression of NFE2L2 protein | CTD | PMID:19558496 more ... |
Nfe2l2 | Rat | sulforaphane | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | sulforaphane affects the localization of NFE2L2 mRNA and sulforaphane affects the localization of NFE2L2 protein | CTD | PMID:20599494 more ... |
Nfe2l2 | Rat | sulforaphane | increases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein mutant form results in increased susceptibility to sulforaphane and NFE2L2 protein results in increased susceptibility to sulforaphane | CTD | PMID:20600217 and PMID:23589329 |
Nfe2l2 | Rat | sulforaphane | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | sulforaphane results in increased localization of NFE2L2 protein | CTD | PMID:21684301 |
Nfe2l2 | Rat | sulforaphane | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | sulforaphane affects the localization of NFE2L2 protein | CTD | PMID:20600217 |
Nfe2l2 | Rat | sulforaphane | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | sulforaphane results in increased localization of NFE2L2 protein | CTD | PMID:21723306 |
Nfe2l2 | Rat | sulforaphane | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to 1 more ... | CTD | PMID:19303893 more ... |
Nfe2l2 | Rat | sulforaphane | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane affects the localization of NFE2L2 protein] more ... | CTD | PMID:16890772 more ... |
Nfe2l2 | Rat | sulforaphane | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in increased susceptibility to sulforaphane and NFE2L2 results in increased susceptibility to sulforaphane | CTD | PMID:20600217 and PMID:21382770 |
Nfe2l2 | Rat | sulforaphane | affects activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | sulforaphane affects the activity of NFE2L2 protein | CTD | PMID:11309284 |
Nfe2l2 | Rat | sulforaphane | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 gene mutant form results in decreased susceptibility to sulforaphane and NFE2L2 protein results in decreased susceptibility to sulforaphane | CTD | PMID:20932822 more ... |
Nfe2l2 | Rat | sulfur atom | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Sulfur co-treated with metrafenone] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:35564597 |
Nfe2l2 | Rat | sunitinib | increases expression | ISO | NFE2L2 (Homo sapiens) | 150537096 | Sunitinib increases expression of NFE2L2 mRNA in breast epithelium | RGD | |
Nfe2l2 | Rat | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of NFE2L2 protein | CTD | PMID:38101598 |
Nfe2l2 | Rat | sunitinib | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Sunitinib results in decreased expression of NFE2L2 protein | CTD | PMID:38101598 |
Nfe2l2 | Rat | surfactin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to [surfactin peptide results in increased expression of HMOX1 protein] and surfactin peptide affects the localization of and results in increased expression of NFE2L2 protein | CTD | PMID:20833156 |
Nfe2l2 | Rat | surfactin C | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to [surfactin peptide results in increased expression of HMOX1 protein] and surfactin peptide affects the localization of and results in increased expression of NFE2L2 protein | CTD | PMID:20833156 |
Nfe2l2 | Rat | T-2 toxin | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | T-2 Toxin results in decreased expression of NFE2L2 mRNA and T-2 Toxin results in decreased expression of NFE2L2 protein | CTD | PMID:20854872 and PMID:29432840 |
Nfe2l2 | Rat | T-2 toxin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | T-2 Toxin results in increased expression of NFE2L2 mRNA and T-2 Toxin results in increased expression of NFE2L2 protein | CTD | PMID:35842139 |
Nfe2l2 | Rat | T-2 toxin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [T-2 Toxin results in decreased expression of NRF1 mRNA] more ... | CTD | PMID:35842139 |
Nfe2l2 | Rat | T-2 toxin | multiple interactions | EXP | | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [T-2 Toxin results in increased expression of NFE2L2 protein] and NFE2L2 protein affects the reaction [T-2 Toxin results in increased expression of PINK1 protein] | CTD | PMID:29870751 |
Nfe2l2 | Rat | T-2 toxin | increases expression | EXP | | 6480464 | T-2 Toxin results in increased expression of NFE2L2 protein | CTD | PMID:29870751 |
Nfe2l2 | Rat | T-2 toxin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | T-2 Toxin results in increased expression of NFE2L2 mRNA and T-2 Toxin results in increased expression of NFE2L2 protein | CTD | PMID:33508416 |
Nfe2l2 | Rat | tacrolimus hydrate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Tacrolimus results in increased expression of NFE2L2 protein | CTD | PMID:23958496 |
Nfe2l2 | Rat | tadalafil | multiple interactions | EXP | | 6480464 | Tadalafil promotes the reaction [Cisplatin results in increased expression of NFE2L2 mRNA] | CTD | PMID:32621855 |
Nfe2l2 | Rat | tamibarotene | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | tamibarotene results in decreased expression of NFE2L2 mRNA | CTD | PMID:15498508 |
Nfe2l2 | Rat | tangeretin | multiple interactions | EXP | | 6480464 | tangeretin inhibits the reaction [9 more ... | CTD | PMID:24995432 and PMID:27616468 |
Nfe2l2 | Rat | tangeretin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | tangeretin metabolite results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:37517432 |
Nfe2l2 | Rat | tangeretin | decreases methylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | tangeretin metabolite results in decreased methylation of NFE2L2 promoter and tangeretin results in decreased methylation of NFE2L2 promoter | CTD | PMID:37517432 |
Nfe2l2 | Rat | Tanshinone I | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [tanshinone co-treated with Acetaminophen] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:32097614 and PMID:35243748 |
Nfe2l2 | Rat | Tanshinone I | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [tanshinone co-treated with Acetaminophen] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:35243748 and PMID:38348705 |
Nfe2l2 | Rat | Tanshinone I | multiple interactions | EXP | | 6480464 | [tanshinone co-treated with Rifampin] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:33307820 |
Nfe2l2 | Rat | taurocholic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Taurocholic Acid results in increased expression of NFE2L2 mRNA | CTD | PMID:27160211 |
Nfe2l2 | Rat | tectorigenin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of NFE2L2 protein and tectorigenin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of NFE2L2 mRNA] | CTD | PMID:37348807 |
Nfe2l2 | Rat | terbinafine | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to terbinafine | CTD | PMID:21540358 |
Nfe2l2 | Rat | terephthalic acid | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to terephthalic acid | CTD | PMID:32023790 |
Nfe2l2 | Rat | tert-butyl hydroperoxide | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA and tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein | CTD | PMID:20100471 more ... |
Nfe2l2 | Rat | tert-butyl hydroperoxide | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide affects the localization of NFE2L2 protein | CTD | PMID:27511913 and PMID:28025122 |
Nfe2l2 | Rat | tert-butyl hydroperoxide | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of NFE2L2 mRNA | CTD | PMID:27509014 |
Nfe2l2 | Rat | tert-butyl hydroperoxide | decreases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:20932822 |
Nfe2l2 | Rat | tert-butyl hydroperoxide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [3-methylquercetin results in decreased susceptibility to tert-Butylhydroperoxide] and NFE2L2 protein affects the susceptibility to [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species] | CTD | PMID:19647727 and PMID:24211276 |
Nfe2l2 | Rat | tert-butyl hydroperoxide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:20028456 more ... |
Nfe2l2 | Rat | testosterone | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Testosterone deficiency results in increased expression of NFE2L2 mRNA | CTD | PMID:22522787 |
Nfe2l2 | Rat | testosterone | decreases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Testosterone results in decreased activity of NFE2L2 protein | CTD | PMID:30114225 |
Nfe2l2 | Rat | testosterone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Testosterone deficiency inhibits the reaction [ABCC1 gene mutant form results in decreased expression of NFE2L2 mRNA] | CTD | PMID:22522787 |
Nfe2l2 | Rat | tetrachloromethane | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of NFE2L2 mRNA and Carbon Tetrachloride results in increased expression of NFE2L2 protein | CTD | PMID:21725986 more ... |
Nfe2l2 | Rat | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of NFE2L2 mRNA | CTD | PMID:32380060 |
Nfe2l2 | Rat | tetrachloromethane | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Carbon Tetrachloride results in increased expression of NFE2L2 protein | CTD | PMID:32234387 |
Nfe2l2 | Rat | tetrachloromethane | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | tetrachloromethane | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [2-cyano-3 more ... | CTD | PMID:22902988 more ... |
Nfe2l2 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:24293383 more ... |
Nfe2l2 | Rat | tetrachloromethane | affects localization | EXP | | 6480464 | Carbon Tetrachloride affects the localization of NFE2L2 protein | CTD | PMID:24975872 |
Nfe2l2 | Rat | tetrachloromethane | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the localization of NFE2L2 protein | CTD | PMID:23341968 |
Nfe2l2 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of NFE2L2 protein | CTD | PMID:18081878 |
Nfe2l2 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of NFE2L2 mRNA and Carbon Tetrachloride results in decreased expression of NFE2L2 protein | CTD | PMID:17202758 and PMID:35236242 |
Nfe2l2 | Rat | tetrachloromethane | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased localization of NFE2L2 protein | CTD | PMID:18078705 |
Nfe2l2 | Rat | tetrachloromethane | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of NFE2L2 mRNA and Carbon Tetrachloride results in decreased expression of NFE2L2 protein | CTD | PMID:25471833 more ... |
Nfe2l2 | Rat | tetramethylpyrazine | increases response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein results in increased susceptibility to tetramethylpyrazine | CTD | PMID:27477297 |
Nfe2l2 | Rat | tetramethylpyrazine | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 affects the susceptibility to tetramethylpyrazine | CTD | PMID:27837167 |
Nfe2l2 | Rat | tetramethylpyrazine | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | tetramethylpyrazine analog results in increased expression of NFE2L2 protein more ... | CTD | PMID:25056784 and PMID:27477297 |
Nfe2l2 | Rat | tetramethylpyrazine | increases response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein results in increased susceptibility to tetramethylpyrazine | CTD | PMID:27477297 |
Nfe2l2 | Rat | tetramethylpyrazine | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein promotes the reaction [tetramethylpyrazine results in decreased expression of ACTA2 mRNA] more ... | CTD | PMID:26404762 and PMID:27477297 |
Nfe2l2 | Rat | tetramethylpyrazine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 affects the reaction [tetramethylpyrazine inhibits the reaction [Ethanol results in decreased expression of PPARA mRNA]] more ... | CTD | PMID:27477297 more ... |
Nfe2l2 | Rat | tetrathiomolybdate(2-) | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | tetrathiomolybdate analog affects the localization of and results in increased activity of NFE2L2 protein | CTD | PMID:19323979 |
Nfe2l2 | Rat | thalidomide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Thalidomide promotes the reaction [Paraquat results in increased expression of NFE2L2 mRNA] and Thalidomide promotes the reaction [Paraquat results in increased expression of NFE2L2 protein] | CTD | PMID:25579023 |
Nfe2l2 | Rat | thapsigargin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Thapsigargin inhibits the reaction [sodium arsenite results in increased activity of NFE2L2 protein] | CTD | PMID:20805060 |
Nfe2l2 | Rat | Theaflavin 3,3'-digallate | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [theaflavin-3 more ... | CTD | PMID:32694992 and PMID:36638877 |
Nfe2l2 | Rat | Theaflavin 3,3'-digallate | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | theaflavin-3 and 3'-digallate results in increased expression of NFE2L2 protein | CTD | PMID:32694992 |
Nfe2l2 | Rat | Theaflavin 3,3'-digallate | multiple interactions | EXP | | 6480464 | theaflavin-3 and 3'-digallate results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:35847580 |
Nfe2l2 | Rat | thiamine(1+) chloride | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Thiamine results in increased expression of NQO1 mRNA] | CTD | PMID:29860433 |
Nfe2l2 | Rat | thiazoles | multiple interactions | EXP | | 6480464 | [Thiazoles analog binds to indoline analog] inhibits the reaction [SESN2 protein promotes the reaction [Hydrogen Peroxide results in increased activity of NFE2L2 protein]] more ... | CTD | PMID:32275923 and PMID:34351043 |
Nfe2l2 | Rat | thimerosal | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Aluminum Hydroxide promotes the reaction [Thimerosal results in increased expression of NFE2L2 protein] | CTD | PMID:36411272 |
Nfe2l2 | Rat | thimerosal | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Thimerosal results in increased expression of NFE2L2 protein | CTD | PMID:36411272 |
Nfe2l2 | Rat | thioacetamide | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of NFE2L2 mRNA more ... | CTD | PMID:23830814 more ... |
Nfe2l2 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of NFE2L2 mRNA and Thioacetamide results in decreased expression of NFE2L2 protein | CTD | PMID:30295103 more ... |
Nfe2l2 | Rat | thioacetamide | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Thioacetamide results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | thioacetamide | decreases expression | EXP | | 15090820 | thioacetamide decreases expression of Nfe2L2 protein in rat liver | RGD | |
Nfe2l2 | Rat | thioacetamide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Thioacetamide inhibits the reaction [SOD1 gene mutant form results in decreased expression of NFE2L2 protein] | CTD | PMID:27349771 |
Nfe2l2 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of NFE2L2 mRNA | CTD | PMID:23411599 and PMID:34492290 |
Nfe2l2 | Rat | thiram | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Thiram results in increased expression of NFE2L2 mRNA | CTD | PMID:38568856 |
Nfe2l2 | Rat | thymoquinone | multiple interactions | EXP | | 6480464 | thymoquinone inhibits the reaction [Doxorubicin results in decreased activity of NFE2L2 protein] and thymoquinone inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 mRNA] | CTD | PMID:25268985 |
Nfe2l2 | Rat | thymoquinone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [thymoquinone affects the localization of and results in increased activity of NFE2L2 protein] more ... | CTD | PMID:24355171 |
Nfe2l2 | Rat | tideglusib | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein promotes the reaction [tideglusib inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of HMOX1 mRNA]] more ... | CTD | PMID:30965670 |
Nfe2l2 | Rat | Tiron | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:22564156 |
Nfe2l2 | Rat | Tiron | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:22488045 and PMID:33368846 |
Nfe2l2 | Rat | titanium dioxide | decreases methylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of NFE2L2 gene and titanium dioxide results in decreased methylation of NFE2L2 promoter | CTD | PMID:35295148 |
Nfe2l2 | Rat | titanium dioxide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of NFE2L2 mRNA | CTD | PMID:31769605 |
Nfe2l2 | Rat | titanium dioxide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Grape Seed Proanthocyanidins inhibits the reaction [titanium dioxide results in decreased expression of NFE2L2 protein] | CTD | PMID:28780322 |
Nfe2l2 | Rat | titanium dioxide | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of NFE2L2 protein | CTD | PMID:28780322 |
Nfe2l2 | Rat | tolcapone | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | tolcapone results in decreased expression of NFE2L2 mRNA | CTD | PMID:28526448 |
Nfe2l2 | Rat | tolterodine tartrate | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Tolterodine Tartrate inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 protein] | CTD | PMID:37702107 |
Nfe2l2 | Rat | toluquinol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-methyl-1 and 4-hydroquinone results in increased expression of NFE2L2 mRNA | CTD | PMID:26862668 |
Nfe2l2 | Rat | torcetrapib | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | torcetrapib results in increased expression of NFE2L2 mRNA | CTD | PMID:23228038 |
Nfe2l2 | Rat | trabectedin | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Trabectedin results in decreased expression of NFE2L2 protein | CTD | PMID:36396105 |
Nfe2l2 | Rat | trans-anethole | multiple interactions | EXP | | 6480464 | anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 mRNA] and anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 protein] | CTD | PMID:35430261 |
Nfe2l2 | Rat | trans-chalcone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Chalcone analog results in decreased ubiquitination of and results in decreased degradation of and affects the localization of NFE2L2 protein and NFE2L2 promotes the reaction [Chalcone analog results in increased abundance of Glutathione] | CTD | PMID:31299238 |
Nfe2l2 | Rat | trans-piceid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [polydatin co-treated with Hydrogen Peroxide] results in increased expression of NFE2L2 protein more ... | CTD | PMID:31705858 |
Nfe2l2 | Rat | trans-piceid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | polydatin inhibits the reaction [TSHR protein results in decreased expression of NFE2L2 protein] | CTD | PMID:31705858 |
Nfe2l2 | Rat | trans-rhaponticin | multiple interactions | EXP | | 6480464 | rhapontin inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA] and rhapontin inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | CTD | PMID:32662907 |
Nfe2l2 | Rat | triadimefon | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | triadimefon results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | tributylstannane | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [tributyltin results in increased expression of NFE2L2 protein] and Phycocyanin inhibits the reaction [tributyltin results in increased expression of NFE2L2 protein] | CTD | PMID:26079211 |
Nfe2l2 | Rat | tributylstannane | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | tributyltin results in increased localization of NFE2L2 protein | CTD | PMID:36858641 |
Nfe2l2 | Rat | tributylstannane | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | PRKCD gene mutant form promotes the reaction [tributyltin affects the localization of and results in increased activity of NFE2L2 protein] | CTD | PMID:25895139 |
Nfe2l2 | Rat | tributylstannane | increases expression | EXP | | 6480464 | tributyltin results in increased expression of NFE2L2 protein | CTD | PMID:24055800 more ... |
Nfe2l2 | Rat | Tributyltin oxide | increases expression | EXP | | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of NFE2L2 mRNA | CTD | PMID:17553608 |
Nfe2l2 | Rat | Tributyltin oxide | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | tricalcium bis(phosphate) | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | tricalcium phosphate results in decreased expression of NFE2L2 protein | CTD | PMID:37678662 |
Nfe2l2 | Rat | tricetin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | tricetin results in increased expression of NFE2L2 mRNA | CTD | PMID:31176653 |
Nfe2l2 | Rat | tricetin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | tricetin results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:31176653 |
Nfe2l2 | Rat | trichlorfon | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Trichlorfon results in increased activity of NFE2L2 protein | CTD | PMID:20143881 |
Nfe2l2 | Rat | Trichloroacetonitrile | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | trichloroacetonitrile results in increased expression of NFE2L2 mRNA | CTD | PMID:35842135 |
Nfe2l2 | Rat | Trichloroacetonitrile | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to trichloroacetonitrile | CTD | PMID:35842135 |
Nfe2l2 | Rat | trichloroethene | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Trichloroethylene results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | trichloroethene | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Trichloroethylene results in decreased expression of NFE2L2 mRNA and Trichloroethylene results in decreased expression of NFE2L2 protein | CTD | PMID:32073640 more ... |
Nfe2l2 | Rat | trichloroethene | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | sulforaphane inhibits the reaction [Trichloroethylene results in decreased expression of NFE2L2 mRNA] and sulforaphane inhibits the reaction [Trichloroethylene results in decreased expression of NFE2L2 protein] | CTD | PMID:32073640 and PMID:33007382 |
Nfe2l2 | Rat | trichostatin A | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Decitabine co-treated with trichostatin A] results in decreased methylation of NFE2L2 promoter and [trichostatin A co-treated with Decitabine] results in decreased methylation of NFE2L2 promoter | CTD | PMID:26991801 and PMID:31181187 |
Nfe2l2 | Rat | trichostatin A | multiple interactions | EXP | | 6480464 | [manganese chloride results in increased susceptibility to trichostatin A] which results in increased expression of NFE2L2 mRNA and trichostatin A promotes the reaction [manganese chloride results in increased expression of and results in increased activity of NFE2L2 protein] | CTD | PMID:29054681 |
Nfe2l2 | Rat | trichostatin A | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | trichostatin A affects the expression of NFE2L2 mRNA | CTD | PMID:28542535 |
Nfe2l2 | Rat | trichostatin A | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NFE2L2 mRNA | CTD | PMID:27188386 |
Nfe2l2 | Rat | trichostatin A | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of NFE2L2 mRNA | CTD | PMID:24935251 and PMID:26272509 |
Nfe2l2 | Rat | triclocarban | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [triclocarban co-treated with osteum] results in increased expression of NFE2L2 mRNA | CTD | PMID:38631510 |
Nfe2l2 | Rat | triclosan | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Triclosan results in increased expression of NFE2L2 protein] more ... | CTD | PMID:34160118 |
Nfe2l2 | Rat | trifloxystrobin | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | trifloxystrobin results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | trifluridine | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Trifluridine results in increased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | trilobatin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [trilobatin inhibits the reaction [Isoflurane results in decreased activity of CAT protein]] and trilobatin promotes the reaction [Isoflurane results in increased expression of NFE2L2 protein] | CTD | PMID:32663520 |
Nfe2l2 | Rat | trilobatin | multiple interactions | EXP | | 6480464 | trilobatin promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein] | CTD | PMID:30104959 |
Nfe2l2 | Rat | trimellitic anhydride | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 affects the susceptibility to trimellitic anhydride | CTD | PMID:23564646 |
Nfe2l2 | Rat | trimethylarsine oxide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 mutant form inhibits the reaction [trimethylarsine oxide results in increased expression of NQO1 protein] and trimethylarsine oxide results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:24161444 |
Nfe2l2 | Rat | trimethyltin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin affects the localization of and results in increased activity of NFE2L2 protein]] more ... | CTD | PMID:25895139 |
Nfe2l2 | Rat | triphenyl phosphate | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of NFE2L2 mRNA | CTD | PMID:37042841 |
Nfe2l2 | Rat | Triptolide | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [triptolide affects the expression of NFE2L2 protein] more ... | CTD | PMID:22820427 more ... |
Nfe2l2 | Rat | Triptolide | affects expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | triptolide affects the expression of NFE2L2 protein | CTD | PMID:36990132 |
Nfe2l2 | Rat | Triptolide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | bergenin inhibits the reaction [triptolide results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:30836114 more ... |
Nfe2l2 | Rat | Triptolide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [catalpol co-treated with Saponins co-treated with triptolide] affects the localization of NFE2L2 protein more ... | CTD | PMID:30682494 and PMID:36990132 |
Nfe2l2 | Rat | Triptolide | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | triptolide results in decreased expression of NFE2L2 mRNA | CTD | PMID:30682494 |
Nfe2l2 | Rat | Triptolide | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | triptolide affects the localization of NFE2L2 protein | CTD | PMID:30682494 |
Nfe2l2 | Rat | Triptolide | decreases phosphorylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | triptolide results in decreased phosphorylation of NFE2L2 protein | CTD | PMID:30682494 |
Nfe2l2 | Rat | Triptolide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | triptolide results in increased expression of NFE2L2 mRNA and triptolide results in increased expression of NFE2L2 protein | CTD | PMID:31241159 and PMID:32835833 |
Nfe2l2 | Rat | Triptolide | affects expression | EXP | | 6480464 | triptolide affects the expression of NFE2L2 mRNA and triptolide affects the expression of NFE2L2 protein | CTD | PMID:25169008 |
Nfe2l2 | Rat | Triptolide | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | triptolide results in decreased expression of NFE2L2 protein | CTD | PMID:25169008 and PMID:38735593 |
Nfe2l2 | Rat | Triptolide | affects localization | EXP | | 6480464 | triptolide affects the localization of NFE2L2 protein | CTD | PMID:22820427 |
Nfe2l2 | Rat | Triptolide | decreases response to substance | EXP | | 6480464 | NFE2L2 protein results in decreased susceptibility to triptolide | CTD | PMID:22820427 |
Nfe2l2 | Rat | Tris(2,3-dibromopropyl) phosphate | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | tris(2 and 3-dibromopropyl)phosphate results in increased activity of NFE2L2 protein | CTD | PMID:30114225 and PMID:30203046 |
Nfe2l2 | Rat | troglitazone | affects response to substance | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the susceptibility to troglitazone | CTD | PMID:21540358 |
Nfe2l2 | Rat | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of NFE2L2 mRNA | CTD | PMID:25596134 |
Nfe2l2 | Rat | troglitazone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein promotes the reaction [troglitazone results in increased susceptibility to arsenic trioxide] | CTD | PMID:22684020 |
Nfe2l2 | Rat | tropisetron | multiple interactions | EXP | | 6480464 | methyllycaconitine inhibits the reaction [Tropisetron inhibits the reaction [3-nitropropionic acid results in decreased expression of NFE2L2 protein]] more ... | CTD | PMID:26286524 and PMID:38513929 |
Nfe2l2 | Rat | tubastatin A | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | tubastatin A inhibits the reaction [sodium arsenite results in increased expression of NFE2L2 protein] | CTD | PMID:22367689 |
Nfe2l2 | Rat | Tungsten carbide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[tungsten carbide co-treated with Cobalt] results in increased localization of NFE2L2 protein] which results in increased expression of NQO1 mRNA more ... | CTD | PMID:20528745 |
Nfe2l2 | Rat | tunicamycin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Tunicamycin inhibits the reaction [sodium arsenite results in increased activity of NFE2L2 protein] | CTD | PMID:20805060 |
Nfe2l2 | Rat | tunicamycin | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of NFE2L2 mRNA | CTD | PMID:36586010 |
Nfe2l2 | Rat | tunicamycin | affects localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Tunicamycin affects the localization of NFE2L2 protein | CTD | PMID:30253173 |
Nfe2l2 | Rat | tunicamycin | increases activity | ISO | Nfe2l2 (Mus musculus) | 6480464 | Tunicamycin results in increased activity of NFE2L2 protein | CTD | PMID:30203046 |
Nfe2l2 | Rat | tunicamycin | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Tunicamycin results in increased expression of NFE2L2 mRNA and Tunicamycin results in increased expression of NFE2L2 protein modified form | CTD | PMID:22959925 more ... |
Nfe2l2 | Rat | tunicamycin | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 mRNA affects the susceptibility to Tunicamycin | CTD | PMID:22959925 |
Nfe2l2 | Rat | tunicamycin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [PPARD gene mutant form results in increased susceptibility to Tunicamycin] which results in increased phosphorylation of NFE2L2 protein more ... | CTD | PMID:22959925 more ... |
Nfe2l2 | Rat | tyrphostin AG 1478 | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with RTKI cpd] inhibits the reaction [Pyocyanine affects the localization of NFE2L2 protein] and RTKI cpd inhibits the reaction [Pyocyanine affects the localization of NFE2L2 protein] | CTD | PMID:24015256 |
Nfe2l2 | Rat | tyrphostin AG 1478 | decreases phosphorylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | RTKI cpd results in decreased phosphorylation of NFE2L2 protein | CTD | PMID:33148531 |
Nfe2l2 | Rat | umbelliferone | multiple interactions | EXP | | 6480464 | 7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 mRNA] and 7-hydroxycoumarin inhibits the reaction [Cisplatin results in decreased expression of NFE2L2 protein] | CTD | PMID:33522649 |
Nfe2l2 | Rat | umbelliferone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 7-hydroxycoumarin results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:28263721 |
Nfe2l2 | Rat | umbelliferone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | 7-hydroxycoumarin results in increased expression of NFE2L2 mRNA | CTD | PMID:28263721 |
Nfe2l2 | Rat | umbelliferone | increases expression | EXP | | 6480464 | 7-hydroxycoumarin results in increased expression of NFE2L2 mRNA and 7-hydroxycoumarin results in increased expression of NFE2L2 protein | CTD | PMID:33522649 |
Nfe2l2 | Rat | undecan-2-one | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | undecan-2-one results in increased expression of and affects the localization of NFE2L2 protein | CTD | PMID:35285579 |
Nfe2l2 | Rat | undecan-2-one | multiple interactions | EXP | | 6480464 | [Particulate Matter co-treated with undecan-2-one] results in increased expression of NFE2L2 protein more ... | CTD | PMID:35285579 |
Nfe2l2 | Rat | ursodeoxycholic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ursodeoxycholic Acid results in increased localization of NFE2L2 protein] more ... | CTD | PMID:19073151 and PMID:20146260 |
Nfe2l2 | Rat | ursodeoxycholic acid | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ursodeoxycholic Acid results in increased expression of NFE2L2 mRNA | CTD | PMID:25582706 |
Nfe2l2 | Rat | ursodeoxycholic acid | increases localization | ISO | Nfe2l2 (Mus musculus) | 6480464 | Ursodeoxycholic Acid results in increased localization of NFE2L2 protein | CTD | PMID:18687751 and PMID:19073151 |
Nfe2l2 | Rat | ursodeoxycholic acid | increases localization | EXP | | 6480464 | Ursodeoxycholic Acid results in increased localization of NFE2L2 protein | CTD | PMID:19073151 |
Nfe2l2 | Rat | ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 protein] more ... | CTD | PMID:18687751 and PMID:34155936 |
Nfe2l2 | Rat | ursodeoxycholic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of ABCC2 mRNA] more ... | CTD | PMID:18687751 |
Nfe2l2 | Rat | ursodeoxycholic acid | increases localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ursodeoxycholic Acid results in increased localization of NFE2L2 protein | CTD | PMID:19073151 |
Nfe2l2 | Rat | usnic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | NFE2L2 protein inhibits the reaction [usnic acid results in increased expression of H2AX protein modified form] more ... | CTD | PMID:27369375 |
Nfe2l2 | Rat | valproic acid | increases methylation | ISO | NFE2L2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of NFE2L2 gene | CTD | PMID:29154799 |
Nfe2l2 | Rat | valproic acid | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of NFE2L2 mRNA and Valproic Acid results in decreased expression of NFE2L2 protein | CTD | PMID:39147356 |
Nfe2l2 | Rat | valproic acid | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Deferoxamine inhibits the reaction [Valproic Acid results in decreased expression of NFE2L2 protein] and ferrostatin-1 inhibits the reaction [Valproic Acid results in decreased expression of NFE2L2 protein] | CTD | PMID:39147356 |
Nfe2l2 | Rat | valproic acid | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of NFE2L2 mRNA | CTD | PMID:27188386 |
Nfe2l2 | Rat | valproic acid | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of NFE2L2 mRNA | CTD | PMID:24935251 and PMID:26272509 |
Nfe2l2 | Rat | valproic acid | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of NFE2L2 mRNA | CTD | PMID:25979313 |
Nfe2l2 | Rat | valproic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of NFE2L2 mRNA | CTD | PMID:24935251 and PMID:28001369 |
Nfe2l2 | Rat | valproic acid | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to Valproic Acid | CTD | PMID:25454122 |
Nfe2l2 | Rat | vancomycin | decreases expression | EXP | | 6480464 | Vancomycin results in decreased expression of NFE2L2 mRNA | CTD | PMID:39059777 |
Nfe2l2 | Rat | vancomycin | multiple interactions | EXP | | 6480464 | sinapinic acid inhibits the reaction [Vancomycin results in decreased expression of NFE2L2 mRNA] | CTD | PMID:39059777 |
Nfe2l2 | Rat | verapamil | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Verapamil affects the localization of NFE2L2 protein | CTD | PMID:21525764 |
Nfe2l2 | Rat | verapamil | multiple interactions | EXP | | 6480464 | Verapamil inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 mRNA] more ... | CTD | PMID:30295103 and PMID:30526075 |
Nfe2l2 | Rat | vincamine | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Vincamine inhibits the reaction [1-Methyl-4-phenyl-1 more ... | CTD | PMID:38629493 |
Nfe2l2 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of NFE2L2 mRNA | CTD | PMID:19015723 |
Nfe2l2 | Rat | vinclozolin | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the susceptibility to vinclozolin | CTD | PMID:35905821 |
Nfe2l2 | Rat | vincristine | decreases expression | EXP | | 6480464 | Vincristine results in decreased expression of NFE2L2 mRNA and Vincristine results in decreased expression of NFE2L2 protein | CTD | PMID:33038355 more ... |
Nfe2l2 | Rat | vincristine | multiple interactions | EXP | | 6480464 | coenzyme Q10 inhibits the reaction [Vincristine results in decreased expression of NFE2L2 mRNA] and Quercetin inhibits the reaction [Vincristine results in decreased expression of NFE2L2 protein] | CTD | PMID:33038355 more ... |
Nfe2l2 | Rat | Vinpocetine | multiple interactions | EXP | | 6480464 | vinpocetine inhibits the reaction [Fluoxetine results in increased expression of NFE2L2 protein] | CTD | PMID:34669537 |
Nfe2l2 | Rat | vitamin D | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [Particulate Matter co-treated with Vitamin D] results in increased expression of NFE2L2 protein and [Silicon Dioxide co-treated with Vitamin D] results in increased expression of NFE2L2 protein | CTD | PMID:30698894 |
Nfe2l2 | Rat | vitamin D | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Vitamin D results in increased expression of NFE2L2 protein | CTD | PMID:30698894 |
Nfe2l2 | Rat | vitamin D | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Vitamin D results in increased expression of NFE2L2 protein | CTD | PMID:30698894 |
Nfe2l2 | Rat | vitamin D | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Particulate Matter co-treated with Vitamin D] results in increased expression of NFE2L2 protein more ... | CTD | PMID:30698894 |
Nfe2l2 | Rat | vitamin E | multiple interactions | EXP | | 6480464 | [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 protein] and Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein] | CTD | PMID:29663635 more ... |
Nfe2l2 | Rat | vitamin E | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | Vitamin E inhibits the reaction [Ozone results in decreased expression of NFE2L2 protein] | CTD | PMID:30090343 |
Nfe2l2 | Rat | vitamin E | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of NFE2L2 mRNA | CTD | PMID:30513525 |
Nfe2l2 | Rat | vitamin E | decreases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of NFE2L2 mRNA | CTD | PMID:19244175 |
Nfe2l2 | Rat | vitamin E | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of NFE2L2 mRNA more ... | CTD | PMID:19244175 more ... |
Nfe2l2 | Rat | vitexin | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | vitexin inhibits the reaction [APP protein modified form results in decreased expression of NFE2L2 mRNA] | CTD | PMID:29545167 |
Nfe2l2 | Rat | vorinostat | decreases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Vorinostat results in decreased activity of NFE2L2 protein | CTD | PMID:30818834 |
Nfe2l2 | Rat | water | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of NFE2L2 mRNA | CTD | PMID:29335169 |
Nfe2l2 | Rat | wedelolactone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | wedelolactone inhibits the reaction [Oxygen results in decreased expression of NFE2L2 protein] | CTD | PMID:39110510 |
Nfe2l2 | Rat | withaferin A | affects binding | ISO | NFE2L2 (Homo sapiens) | 6480464 | withaferin A binds to NFE2L2 protein | CTD | PMID:22973447 |
Nfe2l2 | Rat | withaferin A | increases phosphorylation | ISO | Nfe2l2 (Mus musculus) | 6480464 | withaferin A results in increased phosphorylation of NFE2L2 protein | CTD | PMID:36716864 |
Nfe2l2 | Rat | Withanone | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | withanone results in increased expression of NFE2L2 protein | CTD | PMID:21573189 |
Nfe2l2 | Rat | Withanone | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | withanone inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFE2L2 protein] and withanone inhibits the reaction [methoxyacetic acid results in decreased expression of NFE2L2 protein] | CTD | PMID:21573189 |
Nfe2l2 | Rat | wortmannin | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | Wortmannin inhibits the reaction [formononetin promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein]] | CTD | PMID:34077701 |
Nfe2l2 | Rat | xanthohumol | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | xanthohumol affects the localization of NFE2L2 protein | CTD | PMID:23085367 |
Nfe2l2 | Rat | xanthohumol | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [xanthohumol co-treated with phenethyl isothiocyanate] results in increased activity of NFE2L2 protein more ... | CTD | PMID:32070777 |
Nfe2l2 | Rat | xanthohumol | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | xanthohumol results in increased activity of NFE2L2 protein | CTD | PMID:23085367 and PMID:32070777 |
Nfe2l2 | Rat | xanthohumol | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | xanthohumol results in increased expression of NFE2L2 mRNA and xanthohumol results in increased expression of NFE2L2 protein | CTD | PMID:23085367 and PMID:32070777 |
Nfe2l2 | Rat | yttrium chloride | affects expression | EXP | | 6480464 | yttrium chloride affects the expression of NFE2L2 protein | CTD | PMID:35088107 |
Nfe2l2 | Rat | yttrium chloride | multiple interactions | EXP | | 6480464 | Acetylcysteine affects the reaction [yttrium chloride affects the expression of NFE2L2 protein] | CTD | PMID:35088107 |
Nfe2l2 | Rat | zearalenone | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Zearalenone results in increased expression of NFE2L2 protein | CTD | PMID:36161741 |
Nfe2l2 | Rat | zearalenone | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | 6-chloro-2 more ... | CTD | PMID:36161741 |
Nfe2l2 | Rat | zidovudine | increases expression | EXP | | 6480464 | Zidovudine results in increased expression of NFE2L2 protein | CTD | PMID:29594326 |
Nfe2l2 | Rat | zinc atom | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Zinc results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | zinc atom | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Zinc] results in decreased expression of NFE2L2 protein and [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | CTD | PMID:32233808 and PMID:37415728 |
Nfe2l2 | Rat | zinc atom | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Zinc results in increased expression of HMOX1 mRNA] more ... | CTD | PMID:10473555 and PMID:27370414 |
Nfe2l2 | Rat | zinc atom | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Zinc deficiency affects the localization of NFE2L2 protein | CTD | PMID:23377617 |
Nfe2l2 | Rat | zinc atom | affects localization | EXP | | 6480464 | Zinc deficiency affects the localization of NFE2L2 protein | CTD | PMID:23377617 |
Nfe2l2 | Rat | zinc atom | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Zinc deficiency results in decreased expression of NFE2L2 protein | CTD | PMID:21078376 |
Nfe2l2 | Rat | zinc dichloride | affects response to substance | ISO | Nfe2l2 (Mus musculus) | 6480464 | [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to zinc chloride | CTD | PMID:19303893 |
Nfe2l2 | Rat | zinc dichloride | multiple interactions | EXP | | 6480464 | [Sodium Selenite co-treated with zinc chloride] inhibits the reaction [[lead chloride co-treated with Cadmium Chloride co-treated with Mercuric Chloride co-treated with sodium arsenite] results in increased expression of NFE2L2 protein] | CTD | PMID:36646412 |
Nfe2l2 | Rat | zinc dichloride | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | zinc chloride promotes the reaction [SLC39A2 protein results in increased activity of NFE2L2 protein] | CTD | PMID:18385089 |
Nfe2l2 | Rat | zinc oxide | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Zinc Oxide analog results in decreased expression of NFE2L2 protein | CTD | PMID:24614525 |
Nfe2l2 | Rat | zinc oxide | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Zinc Oxide analog results in increased expression of NFE2L2 protein | CTD | PMID:35247504 |
Nfe2l2 | Rat | zinc oxide | multiple interactions | EXP | | 6480464 | lead acetate promotes the reaction [Zinc Oxide results in increased expression of and affects the localization of NFE2L2 protein] more ... | CTD | PMID:34553816 and PMID:37682394 |
Nfe2l2 | Rat | zinc oxide | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein inhibits the reaction [Zinc Oxide analog results in decreased expression of GCLC mRNA] more ... | CTD | PMID:36100149 |
Nfe2l2 | Rat | zinc protoporphyrin | multiple interactions | EXP | | 6480464 | zinc protoporphyrin inhibits the reaction [Hemin results in increased expression of NFE2L2 protein] | CTD | PMID:25824035 |
Nfe2l2 | Rat | zinc protoporphyrin | affects expression | EXP | | 6480464 | zinc protoporphyrin affects the expression of NFE2L2 mRNA and zinc protoporphyrin affects the expression of NFE2L2 protein | CTD | PMID:23704825 |
Nfe2l2 | Rat | zinc pyrithione | increases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | pyrithione zinc results in increased expression of NFE2L2 protein | CTD | PMID:30261176 |
Nfe2l2 | Rat | zinc pyrithione | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | SQSTM1 protein affects the reaction [pyrithione zinc results in increased expression of NFE2L2 protein] | CTD | PMID:30261176 |
Nfe2l2 | Rat | zinc(0) | increases activity | ISO | NFE2L2 (Homo sapiens) | 6480464 | Zinc results in increased activity of NFE2L2 promoter | CTD | PMID:21643505 |
Nfe2l2 | Rat | zinc(0) | multiple interactions | EXP | | 6480464 | [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Zinc] results in decreased expression of NFE2L2 protein and [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] | CTD | PMID:32233808 and PMID:37415728 |
Nfe2l2 | Rat | zinc(0) | decreases expression | ISO | Nfe2l2 (Mus musculus) | 6480464 | Zinc deficiency results in decreased expression of NFE2L2 protein | CTD | PMID:21078376 |
Nfe2l2 | Rat | zinc(0) | affects localization | ISO | NFE2L2 (Homo sapiens) | 6480464 | Zinc deficiency affects the localization of NFE2L2 protein | CTD | PMID:23377617 |
Nfe2l2 | Rat | zinc(0) | affects localization | EXP | | 6480464 | Zinc deficiency affects the localization of NFE2L2 protein | CTD | PMID:23377617 |
Nfe2l2 | Rat | zinc(0) | multiple interactions | ISO | Nfe2l2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Zinc results in increased expression of HMOX1 mRNA] more ... | CTD | PMID:10473555 and PMID:27370414 |
Nfe2l2 | Rat | zingerone | multiple interactions | EXP | | 6480464 | zingerone inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of NFE2L2 protein] | CTD | PMID:30720227 |
Nfe2l2 | Rat | ziram | affects expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Ziram affects the expression of NFE2L2 mRNA | CTD | PMID:32712770 |
Nfe2l2 | Rat | zoledronic acid | increases expression | ISO | NFE2L2 (Homo sapiens) | 6480464 | Zoledronic Acid results in increased expression of NFE2L2 mRNA | CTD | PMID:20977926 and PMID:35587103 |
Nfe2l2 | Rat | zoxamide | multiple interactions | ISO | NFE2L2 (Homo sapiens) | 6480464 | [Sulfur co-treated with zoxamide co-treated with metrafenone] results in decreased expression of NFE2L2 mRNA | CTD | PMID:35564597 |